Publications – 2024

  • Laufs U, Lincoff AM, Nicholls SJ, Li N, Bloedon L, Sasiela WJ, Powell HA, Herout PM, Thompson PD, Nissen SE Characteristics and outcomes of patients with and without statin-associated muscle symptoms treated with bempedoic acid in the CLEAR Outcomes trial. J Clin Lipidol. 2024 Dec 25:S1933-2874(24)00300-3. doi: 10.1016/j.jacl.2024.12.014.
  • Khan LA, Jamil A, Greene SJ, Khan MS, Butler J Aldosterone and Potassium in Heart Failure: Overcoming This Major Impediment in Clinical Practice. Card Fail Rev. 2024 Dec 20;10:e18. doi: 10.15420/cfr.2024.09. eCollection 2024.
  • Villanueva-Valle JS, Amaro-Palomo EJ, Munive-Eyssautier MA, Gonzalez-Diaz F, Sotelo-Soleno A, Alba-Valencia S, Arias-Mendoza A, Araiza-Garaygordobil D Recurrent pulmonary thromboembolism with cardiac tamponade as initial manifestations of lupus and antiphospholipid syndrome: a case report. Arch Peru Cardiol Cir Cardiovasc. 2024 Dec 11;5(4):237-242. doi: 10.47487/apcyccv.v5i4.418. eCollection 2024 Oct-Dec.
  • Madero M, Chertow GM, Mark PB SGLT2 Inhibitor Use in Chronic Kidney Disease: Supporting Cardiovascular, Kidney, and Metabolic Health. Kidney Med. 2024 Jun 8;6(8):100851. doi: 10.1016/j.xkme.2024.100851. eCollection 2024 Aug.
  • Makarem A, Udeh P, Liquori C, Nam L, Sarma A, Salik J, Choy E, D’Alessandro D, Baron SJ, Osho A Atypical Location of Papillary Fibroelastoma in a Patient With Significant Oncologic History. JACC Case Rep. 2024 Dec 18;29(24):102853. doi: 10.1016/j.jaccas.2024.102853. eCollection 2024 Dec 18.
  • Agarwala A, Satish P, Ma TW, Ravindranathan P, Vajramani A, Balarbar N, Brumley C, Gami A, Nasir K, Nambi V, Butler J, Patel J Cardiovascular Disease Risk in South Asians in the Baylor Scott and White Health DILWALE Registry. JACC Adv. 2024 Oct 30;3(12):101349. doi: 10.1016/j.jacadv.2024.101349. eCollection 2024 Dec.
  • Salavitabar A, Al-Ahmadi M, Eng MH, Ing FF, Kar S, Kavinsky CJ, Lim DS, Stefanescu Schmidt AC, Fagan TE, Gutfinger D, Jacobsen K, Mueller M, Pritchett J, Tinberg N, Triche J, Williams D, SCAI 2024 Think Tank Congenital Consortium Transcatheter Atrioventricular Valve Repair and Replacement Technologies in Pediatric and Adult Congenital Heart Disease: A Paradigm for Improving Access. J Soc Cardiovasc Angiogr Interv. 2024 Dec 19;3(12):102398. doi: 10.1016/j.jscai.2024.102398. eCollection 2024 Dec.
  • Chamie D, Bahl R, Maia J, Echavarria-Pinto M, Gafore S, Saleh A, Cristea E, Seligman H, Joaquim RM, Feres F, Sen S, Al-Lamee R, Centemero M, Baker C, Johnson T, Shun-Shin MJ, Lansky AJ, Petraco R Can Contrast Injections Cause or Propagate Coronary Injuries? Insights From Vessel and Guiding Catheter Hemodynamics. J Soc Cardiovasc Angiogr Interv. 2024 Oct 29;3(12):102396. doi: 10.1016/j.jscai.2024.102396. eCollection 2024 Dec.
  • Young MN, Asgar AW, Goldsweig AM, Hermiller JB, Khalique O, Manoukian SV, Rao SV, Smith TBBJ, Szerlip M, Kliger C, Canpa K, Church M, Deible R, Ferguson R, Haddad M, Maguire L, Nelson D, Shetler J, Sultana N, SCAI 2024 Think Tank Structural Consortium – Optimizing Health Care Resource Allocation, Workforce “Right-Sizing,” and Stakeholder Collaboration. J Soc Cardiovasc Angiogr Interv. 2024 Dec 19;3(12):102397. doi: 10.1016/j.jscai.2024.102397. eCollection 2024 Dec.
  • Sampath-Kumar R, Ben-Yehuda O, Al Khiami B, Ang L, Melendez A, Reeves R, Mahmud E Peak Procedural ACT Is Associated With All-Cause Mortality After Femoral Access PCI. J Soc Cardiovasc Angiogr Interv. 2024 Sep 23;3(12):102387. doi: 10.1016/j.jscai.2024.102387. eCollection 2024 Dec.
  • Marinacci LX, Sethi SS, Paras ML, El Sabbagh A, Secemsky EA, Sohail MR, Starck C, Bearnot B, Yucel E, Schaerf RHM, Akhtar Y, Younes A, Patton M, Villablanca P, Reddy S, Enter D, Moriarty JM, Keeling WB, El Hajj Younes S, Kiell C, Rosenfield K Percutaneous Mechanical Aspiration for Infective Endocarditis: Proceedings From an Inaugural Multidisciplinary Summit and Comprehensive Review. J Soc Cardiovasc Angiogr Interv. 2024 Nov 14;3(12):102283. doi: 10.1016/j.jscai.2024.102283. eCollection 2024 Dec.
  • Fielding-Singh V, Vanneman MW, Hong T, Sun LY, Morris AM, Chertow GM, Lin E Association of Kidney Function With Inpatient Mortality and Morbidity After Cardiac Surgery. Ann Thorac Surg Short Rep. 2024 Jul 1;2(4):877-883. doi: 10.1016/j.atssr.2024.06.017. eCollection 2024 Dec.
  • Magda SL, Gheorghiu AM, Mincu RI, Ciobanu AO, Constantinescu T, Popa EC, Mihai C, Vinereanu D Non-Invasive Cardiac and Vascular Monitoring in Systemic Sclerosis: Impact of Therapy on Subclinical Dysfunction. Medicina (Kaunas). 2024 Dec 19;60(12):2080. doi: 10.3390/medicina60122080.
  • Costa F, Jurado-Roman A, Carciotto G, Becerra-Munoz V, Marquez DT, Gotzinger F, Cerrato E, Misra S, Spissu M, Pavani M, Mennuni M, Chinchilla FC, Dominguez-Franco A, Munoz-Garcia A, Navarrete RS, Varbella F, Salinas-Sanguino P, Secemsky EA, Mahfoud F, Micari A, Alonso-Briales JH, Navarro MJ Advanced Management of Patients Undergoing Transcatheter Treatment for Pulmonary Embolism: Evidence-Based Strategies for Optimized Patient Care. J Clin Med. 2024 Dec 20;13(24):7780. doi: 10.3390/jcm13247780.
  • Healy WJ, Kundel V, Taub PR, Cho Y, Healy SJ, Kwon Y Beyond continuous positive airway pressure for cardiovascular risk reduction in patients with obstructive sleep apnea. Sleep Adv. 2024 Dec 18;5(1):zpae094. doi: 10.1093/sleepadvances/zpae094. eCollection 2024.
  • Fujino M, Di Giovanni G, Nicholls SJ New Approaches to Lipoproteins for the Prevention of Cardiovascular Events. J Atheroscler Thromb. 2024 Dec 28. doi: 10.5551/jat.RV22031.
  • Paruchuri K, Bernardo R, Haidermota S, Lannery K, Finneran P, Wong M, Sanborn T, Joice M, Boyle-Kelly J, Silacci S, Hornsby W, Linganathan K, Olufade T, Januzzi JL Jr, Natarajan P Implementation of a Digital Disease Management Platform for Heart Failure: AMAZE. J Card Fail. 2024 Dec 30:S1071-9164(24)01008-X. doi: 10.1016/j.cardfail.2024.11.019.
  • Zannad F, McGuire DK, Ortiz A Treatment strategies to reduce cardiovascular risk in persons with chronic kidney disease and Type 2 diabetes. J Intern Med. 2024 Dec 31. doi: 10.1111/joim.20050.
  • Zainul O, Marshall D, Lau JD, Kelly B, Zarzuela K, Damluji A, Pandey A, Pastva AM, Goyal P Comparison of Physical Frailty Assessments in Heart Failure With Preserved Ejection Fraction. JACC Adv. 2024 Dec 26;3(12):101395. doi: 10.1016/j.jacadv.2024.101395. eCollection 2024 Dec.
  • Tromp J, Wong M, Ouwerkerk W, Wu MZ, Ren QW, Chandramouli C, Teramoto K, Teng KT, Huang J, To KK, Hung IF, Tse HF, Lam CSP, Yiu KH The association between baseline viral load and long-term risk in patients with COVID-19 in Hong Kong: a territory-wide study. Sci Rep. 2024 Dec 28;14(1):30644. doi: 10.1038/s41598-024-65764-0.
  • Munoz-Moreno JM, Gamarra-Valverde NN, Muedas-Porras G, Nombera-Aznaran M, Aguilar-Figueroa F, Gulati M Diagnostic and Therapeutic Approach to the Major Secondary Causes of Arterial Hypertension in Young Adults: A Narrative Review. Cardiol Rev. 2024 Oct 14. doi: 10.1097/CRD.0000000000000805.
  • Petrie MC, Udell JA, Anker SD, Harrington J, Jones WS, Mattheus M, Gasior T, van der Meer P, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chopra VK, Januzzi JL, Lopes RD, Ponikowski P, Rossello X, Schou M, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Hernandez AF, Butler J Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trial. Eur J Heart Fail. 2024 Dec 26. doi: 10.1002/ejhf.3548.
  • Araiza-Garaygordobil D, Preciado-Gutierrez OU, Sierra-Lara Martinez JD, Gonzalez-Pacheco H, Gopar-Nieto R, Latapi-Ruiz Esparza X, Hernandez-Pastrana S, Diaz-Herrera BA, Alvarez-Sangabriel A, Jordan-Rios A, Arias-Mendoza A Prospective registry of heart failure with preserved ejection fraction in Mexico: EDIFICE-Mx. Am Heart J Plus. 2024 Nov 23;48:100486. doi: 10.1016/j.ahjo.2024.100486. eCollection 2024 Dec.
  • Ambrosy AP, Sauer AJ, Patel S, Windsor SL, Borlaug BA, Husain M, Inzucchi SE, Kitzman DW, McGuire DK, Shah SJ, Sharma K, Umpierrez G, Kosiborod MN Baseline kidney function and the effects of dapagliflozin on health status in heart failure in DEFINE-HF and PRESERVED-HF. ESC Heart Fail. 2024 Dec 24. doi: 10.1002/ehf2.15184.
  • Rao SV, Lerner JB Inflammation in the Peri-ACS Period: Ready for Prime Time? Curr Atheroscler Rep. 2024 Dec 23;27(1):20. doi: 10.1007/s11883-024-01263-x.
  • Qin H, Tromp J, Ter Maaten JM, Voordes GHD, van Essen BJ, Andre de la Rambelje M, van der Hoef CCS, Santema BT, Lam CSP, Voors AA Clinical and Proteomic Risk Profiles of New-Onset Heart Failure in Men and Women. JACC Heart Fail. 2024 Dec 5:S2213-1779(24)00804-7. doi: 10.1016/j.jchf.2024.09.022.
  • Molina EJ, Ahmed MM, Sheikh FH, Cleveland JC Jr, Goldstein DJ, Uriel NY, Wang A, Revis JJ, Mehra MR Left Ventricular Dimensions and Clinical Outcomes With a Fully Magnetically Levitated Left Ventricular Assist Device. JACC Heart Fail. 2024 Dec 5:S2213-1779(24)00779-0. doi: 10.1016/j.jchf.2024.09.019.
  • Usman MS, Jamil A, Chunawala Z, Alam M, Nambi V, Abushamat LA, Misra A, Virani SS, Ballantyne CM, Taffet GE, Nasir K, Goel S, Al-Kindi S, Butler J, Minhas AMK Trends in Cardiovascular Disease-Related Mortality in Texas. Tex Heart Inst J. 2024 Dec 19;51(2):e248426. doi: 10.14503/THIJ-24-8426. eCollection 2024 Jul-Dec.
  • Di Vece D, Valgimigli M, Barnathan E, Connors JM, Cools F, Held U, Kakkar AK, Piazza G, Spirk D, Virdone S, Kucher N, Barco S Primary thromboprophylaxis in ambulatory symptomatic patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. Res Pract Thromb Haemost. 2024 Oct 29;8(8):102613. doi: 10.1016/j.rpth.2024.102613. eCollection 2024 Nov.
  • Rubino F, Pompei G, Mills GB, Kotanidis CP, Laudani C, Bendz B, Berg ES, Hildick-Smith D, Hirlekar G, Morici N, Myat A, Tegn N, Sanchis Fores J, Savonitto S, De Servi S, Kunadian V Older women with non-ST-elevation acute coronary syndrome undergoing invasive or conservative management: an individual patient data meta-analysis. Eur Heart J Open. 2024 Oct 26;4(6):oeae093. doi: 10.1093/ehjopen/oeae093. eCollection 2024 Nov.
  • Kang C, Mehta P, Chang YS, Bhadelia RA, Rojas R, Wintermark M, Andre JB, Yang E, Selim M, Thomas AJ, Filippidis A, Wen Y, Spincemaille P, Forkert ND, Wang Y, Soman S Enhanced Reader Confidence and Differentiation of Calcification from Cerebral Microbleed Diagnosis Using QSM Relative to SWI. Clin Neuroradiol. 2024 Dec 17. doi: 10.1007/s00062-024-01478-0.
  • Bainey KR, Welsh RC, Zheng Y, Arias-Mendoza A, Ristic AD, Averkov OV, Lambert Y, Kerr Saraiva JF, Sepulveda P, Rosell-Ortiz F, French JK, Music LB, Temple T, Ly E, Bogaerts K, Sinnaeve PR, Danays T, Westerhout CM, Van de Werf F, Armstrong PW, STREAM-2 Investigators Pharmaco-Invasive Strategy With Half-Dose Tenecteplase in Patients With STEMI: Prespecified Pooled Analysis of Patients Aged >/=75 Years in STREAM-1 and 2. Circ Cardiovasc Interv. 2024 Dec;17(12):e014251. doi: 10.1161/CIRCINTERVENTIONS.124.014251. Epub 2024 Dec 17.
  • Reynolds HR, Page CB, Shaw LJ, Berman DS, Chaitman BR, Picard MH, Kwong RY, Min JK, Leipsic J, Mancini GBJ, Budoff MJ, Hague CJ, Senior R, Szwed H, Bhargava B, Celutkiene J, Gadkari M, Bainey KR, Doerr R, Ramos RB, Ong P, Naik SR, Steg PG, Goetschalckx K, Chow BJW, Scherrer-Crosbie M, Phillips L, Mark DB, Spertus JA, Alexander KP, O’Brien SM, Boden WE, Bangalore S, Stone GW, Maron DJ, Hochman JS, ISCHEMIA Research Group Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial. Circ Cardiovasc Interv. 2024 Dec;17(12):e013743. doi: 10.1161/CIRCINTERVENTIONS.123.013743. Epub 2024 Dec 17.
  • Khan MS, Rashid AM, Shafi T, Rangaswami J, Cherney DZI, Butler J Residual Risk of Adverse Kidney and Cardiovascular Outcomes in Patients with CKD. Clin J Am Soc Nephrol. 2024 Dec 17. doi: 10.2215/CJN.0000000588.
  • Spencer M, Chan PMP, Liu J, Yang DM, Peterson ED, Billig JI Out-of-Pocket Expenses and Postoperative Therapy After Open Reduction Internal Fixation of a Distal Radius Fracture. Plast Reconstr Surg. 2024 Dec 17. doi: 10.1097/PRS.0000000000011930.
  • Geba GP, Chen R, Talapatra K, Brackin T, Mohammadi KA, Pordy R, Manvelian G, Maron DJ, Schwartz GG, Szarek M, Steg PG, Fazio S Alirocumab and chest pain after acute coronary syndrome: An analysis of ODYSSEY OUTCOMES. Am J Prev Cardiol. 2024 Nov 26;20:100900. doi: 10.1016/j.ajpc.2024.100900. eCollection 2024 Dec.
  • Bailey E, Lopes RD, Gibson CM, Eikelboom JW, Rao SV Correction: Factor XIa inhibition as a therapeutic strategy for atherothrombosis. J Thromb Thrombolysis. 2024 Dec 16. doi: 10.1007/s11239-024-03064-0.
  • Mai LM, Joundi RA, Katsanos AH, Selim M, Shoamanesh A Pathophysiology of Intracerebral Hemorrhage: Recovery Trajectories. Stroke. 2024 Dec 16. doi: 10.1161/STROKEAHA.124.046130.
  • Ortega-Paz L, Rollini F, Franchi F, Sibbing D, Angiolillo DJ Switching Platelet P2Y(12) Receptor Inhibiting Therapies. Interv Cardiol Clin. 2024 Oct;13(4S):e1-e30. doi: 10.1016/j.iccl.2024.11.001. Epub 2024 Dec 4.
  • Li S, Bahl A, Li BK, Kanwar MK, Li B, Sinha SS, Hernandez-Montfort J, Kong Q, Sangal P, Yeh RW, Burkhoff D, Mahr C, Kapur NK Practice Variation in Temporary Mechanical Circulatory Support for Cardiogenic Shock. J Card Fail. 2024 Dec 12:S1071-9164(24)00960-6. doi: 10.1016/j.cardfail.2024.10.447.
  • Kolte D, Tale A, Song Y, Yeh RW Relationship Between Hospital Mortality and Readmission Rates After Transcatheter Aortic Valve Replacement. Eur Heart J Qual Care Clin Outcomes. 2024 Nov 30:qcae102. doi: 10.1093/ehjqcco/qcae102.
  • Isath A, Mehra MR “Surveillance without scars”: The quest for noninvasive detection of cardiac allograft rejection. J Heart Lung Transplant. 2024 Dec 11:S1053-2498(24)02015-1. doi: 10.1016/j.healun.2024.12.005.
  • Khadke S, Kumar A, Bhatti A, Dani SS, Al-Kindi S, Nasir K, Virani SS, Upadhyay J, Garcia-Banigan DC, Abraham S, Husami R, Kong Y, Labib S, Venesy D, Shah S, Lenihan D, Vaduganathan M, Deswal A, Fonarow GC, Butler J, Nohria A, Kosiborod MN, Ganatra S GLP-1 Receptor Agonist in Nonobese Patients with Type 2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction. J Card Fail. 2024 Dec 10:S1071-9164(24)00962-X. doi: 10.1016/j.cardfail.2024.10.448.
  • Ortega-Hernandez JA, Gonzalez-Pacheco H, Garcia-Ruiz M, Manzur-Sandoval D, Gopar-Nieto R, Sierra-Lara-Martinez D, Araiza-Garaygordobil D, Mendoza-Garcia S, Arzate-Ramirez A, Montanez-Orozco A, Baeza-Herrera LA, Altamirano-Castillo A, Valdespino Trejo AA, Hernandez-Montfort J, Arias-Mendoza A Effect of pulmonary artery catheter, type & combination of vasoactives for optimizing lactate clearance in acute myocardial infarction complicated by cardiogenic shock. J Crit Care. 2024 Dec 11;86:154990. doi: 10.1016/j.jcrc.2024.154990.
  • Gragnano F, Angiolillo DJ Navigating the complexity of bleeding and hypercoagulable disorders in patients with acute myocardial infarction. Cardiovasc Revasc Med. 2024 Dec 5:S1553-8389(24)00745-0. doi: 10.1016/j.carrev.2024.11.015.
  • Ruberti A, Ortega-Paz L, Brugaletta S, CV COVID-19 Registry Investigators Which patients need thromboprophylaxis for venous thromboembolism prevention after hospitalization due to COVID-19? A sub-analysis from the CV COVID-19 registry. Med Clin (Barc). 2024 Dec 10:S0025-7753(24)00694-8. doi: 10.1016/j.medcli.2024.10.016.
  • Lakkireddy D, Angiolillo DJ, Charlton-Ouw K, Jefferson B, Peeran S, Bisharat M, Ortega-Paz L, Harxhi A, Kaul S, Michaud E, Juan S, Woods B, Damaraju CV, Fontana G, Bonaca MP Rationale and Design of a Study to Assess the Engagement and Usefulness of the Care4Today Connect Digital Health Application for Disease Management in Coronary Artery Disease and Peripheral Artery Disease (iPACE-CVD Study). Clin Cardiol. 2024 Dec;47(12):e70039. doi: 10.1002/clc.70039.
  • Lusebrink E, Lanz H, Kellnar A, Karam N, Kapadia S, Makkar R, Abraham WT, Latib A, Leon M, Sannino A, Shuvy M, Guerrero M, Fam N, Butler J, Adamo M, Rudolph V, Tang GHL, Stocker TJ, Rommel KP, Lurz P, Thiele H, Massberg S, Praz F, Prendergast B, Hausleiter J Management of acute decompensated valvular heart disease. Eur J Heart Fail. 2024 Dec 11. doi: 10.1002/ejhf.3549.
  • Adams DH, Tang GHL, Whisenant BK, Kodali SK, Singh GD, Fam NP, Kar S, Price MJ, Spies C, Schwartz JG, Makkar RR, Tadros P, Asgar AW, Jorde UP, Benza RL, Thourani VH, McCarthy PM, Bae R, Smith TWR, Lim DS, Makar MM, Naik H, Latib MA, Sitges M, von Bardeleben RS, Lurz P, Hamid N, Hahn RT, Sorajja P Transcatheter Edge-to-Edge Repair in Patients With Complex Tricuspid Valve Anatomy. JACC Cardiovasc Interv. 2024 Dec 9;17(23):2749-2760. doi: 10.1016/j.jcin.2024.08.035.
  • Metra M, Adamo M, Butler J Improving Outcome in Patients With Tricuspid Regurgitation: Look At the Kidneys and the Liver! J Am Coll Cardiol. 2024 Dec 17;84(25):2457-2459. doi: 10.1016/j.jacc.2024.09.1238.
  • Srivastava PK, Klomhaus AM, Greene SJ, Heidenreich P, Lewsey SC, Yancy CW, Fonarow GC Angiotensin Receptor-Neprilysin Inhibitor Prescribing Patterns in Patients Hospitalized for Heart Failure. JAMA Cardiol. 2024 Dec 11. doi: 10.1001/jamacardio.2024.3815.
  • Ferreira JP, Zannad F, Vasques-Novoa F, Neves JS, Filippatos G, Pocock SJ, Butler J, Packer M, Anker SD Anaemia, erythrocytosis, and empagliflozin in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial. Eur Heart J. 2024 Dec 6:ehae864. doi: 10.1093/eurheartj/ehae864.
  • Shoji S, Kaltenbach L, Granger BB, Fonarow GC, Al-Khalidi HR, Albert NM, Butler J, Allen LA, Lanfear DE, Thibodeau JT, Chapman BM, Oliver-McNeil SM, Felker GM, Pina IL, Granger CB, Hernandez AF, DeVore AD Guideline-Directed Medical Therapy After Hospitalization for Acute Heart Failure: Insights From the CONNECT-HF. J Am Heart Assoc. 2024 Dec 17;13(24):e036998. doi: 10.1161/JAHA.124.036998. Epub 2024 Dec 10.
  • Jorgensen CM, Boe NJ, Hald SM, Meyer-Kristensen F, Norlen MM, Ovesen C, Moller S, Hoyer BB, Bojsen JA, Elhakim MT, Harbo FSG, Al-Shahi Salman R, Goldstein LB, Hallas J, Garcia Rodriguez LA, Selim M, Gaist D Association of Prior Antithrombotic Drug Use with 90-Day Mortality After Intracerebral Hemorrhage. Clin Epidemiol. 2024 Dec 5;16:837-848. doi: 10.2147/CLEP.S493499. eCollection 2024.
  • Monzo L, Bresso E, Dickstein K, Pitt B, Cleland JGF, Anker SD, Lam CSP, Mehra MR, van Veldhuisen DJ, Greenberg B, Zannad F, Girerd N Machine learning approach to identify phenotypes in patients with ischaemic heart failure with reduced ejection fraction. Eur J Heart Fail. 2024 Dec 10. doi: 10.1002/ejhf.3547.
  • Khan MS, Zile MR, Kahwash R, Sarkar S, Van Dorn B, Koehler J, Franco N, Gerritse B, Butler J Incidence of atrial fibrillation in patients with an insertable cardiac monitor and symptomatic heart failure. ESC Heart Fail. 2024 Dec 9. doi: 10.1002/ehf2.15180.
  • Maier CL, Connors JM, Levy JH Troubleshooting heparin resistance. Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):186-191. doi: 10.1182/hematology.2024000659.
  • Caldwell JS, Chertow GM Declining Medicare Enrollment Among Patients Initiating Dialysis-Advantage Whom? JAMA Health Forum. 2024 Dec 6;5(12):e244300. doi: 10.1001/jamahealthforum.2024.4300.
  • Kadakia KT, Lalani C, Kramer DB, Orui H, Yeh RW Market of First Launch for High-Risk Therapeutic Medical Devices. JAMA Netw Open. 2024 Dec 2;7(12):e2449298. doi: 10.1001/jamanetworkopen.2024.49298.
  • Gibson CM In the Wake of OCEANIC-AF, Is Equipoise Regarding Factor XI Inhibition Still Afloat? J Am Coll Cardiol. 2024 Nov 26:S0735-1097(24)10317-8. doi: 10.1016/j.jacc.2024.10.105.
  • Crousillat D, Sarma A, Wood M, Naderi S, Leon K, Gibson CM, Aday A, Grodzinsky A, Izard K, Kovacic JC, Lindsay ME, Phelan D, Rodriguez-Lozano PF, Scott NS, Scherer M, Sharma A, Sweis R, Sumner JA, Kim ESH Spontaneous Coronary Artery Dissection: Current Knowledge, Research Gaps, and Innovative Research Initiatives: JACC Advances Expert Panel. JACC Adv. 2024 Nov 20;3(12):101385. doi: 10.1016/j.jacadv.2024.101385. eCollection 2024 Dec.
  • Giustino G, Sabik JF 3rd, Serruys PW, Puskas JD, Karmpaliotis D, Kandzari DE, Morice MC, Ragosta M 3rd, Zhang Z, Dressler O, Redfors B, Ben-Yehuda O, Sharma SK, Kappetein AP, Stone GW Major Bleeding and Mortality After Revascularization of Left Main Disease. J Am Coll Cardiol. 2024 Dec 10;84(24):2335-2346. doi: 10.1016/j.jacc.2024.07.065.
  • Lavie CJ, Tutor AW, Mehra MR, O’Connor CM Omega-3 Fish Oils in Prevention and Management of Heart Failure. Mayo Clin Proc. 2024 Dec;99(12):1857-1859. doi: 10.1016/j.mayocp.2024.10.011.
  • Hu JR, Power JR, Zannad F, Lam CSP Artificial intelligence and digital tools for design and execution of cardiovascular clinical trials. Eur Heart J. 2024 Nov 29:ehae794. doi: 10.1093/eurheartj/ehae794.
  • Zoccali C, Mallamaci F, Kanbay M, Dounousi E, Kotanko P, Jankowski J, Chertow GM Autonomic Dysfunction and Inflammation in CKD: A High-Risk Pathway. J Am Soc Nephrol. 2024 Dec 2. doi: 10.1681/ASN.0000000591.
  • Keshvani N, Rizvi S, Segar MW, Miller JW, Coellar JD, Patel KV, Roehm B, Tang WHW, Pandey A Diuretic efficiency of a single dose of subcutaneous versus oral furosemide after heart failure hospitalization across diuretic resistance strata: A pilot randomized controlled trial. Eur J Heart Fail. 2024 Dec 2. doi: 10.1002/ejhf.3537.
  • Zoller B, Connors JM Multimorbidity, comorbidity, frailty, and venous thromboembolism. Haematologica. 2024 Dec 1;109(12):3852-3859. doi: 10.3324/haematol.2023.284579.
  • Pollock C, Carrero JJ, Kanda E, Ofori-Asenso R, Chen H, Garcia Sanchez JJ, Pentakota S, Pecoits-Filho R, Fishbane S, Lam CSP, Kashihara N, Wheeler DC Baseline Characteristics of the DISCOVER CKD Prospective Cohort. Adv Ther. 2024 Nov 29. doi: 10.1007/s12325-024-03028-z.
  • Livori AC, Dalli L, Nicholls SJ, Nelson AJ Defining, measuring, and addressing medication non-adherence in cardiovascular disease. Future Cardiol. 2024 Dec-Dec;20(15-16):819-822. doi: 10.1080/14796678.2024.2433888. Epub 2024 Nov 29.
  • Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, Banning AP, Budaj A, Buechel RR, Chiariello GA, Chieffo A, Christodorescu RM, Deaton C, Doenst T, Jones HW, Kunadian V, Mehilli J, Milojevic M, Piek JJ, Pugliese F, Rubboli A, Semb AG, Senior R, Ten Berg JM, Van Belle E, Van Craenenbroeck EM, Vidal-Perez R, Winther S, ESC Scientific Document Group [2024 ESC Guidelines for the management of chronic coronary syndromes]. G Ital Cardiol (Rome). 2024 Dec;25(12 Suppl 1):e1-e132. doi: 10.1714/4375.43725.
  • Milutinovic S, Petrovic M, Ziq A, Sanchez C, Hammami AS, Escarcega RO, Begosh-Mayne D, Wood MJ, Chazal RA, Lopez-Mattei JC Rheumatic Heart Disease Burden: A Comparative Analysis between the United States and the European Union. JACC Adv. 2024 Nov 11;3(12):101393. doi: 10.1016/j.jacadv.2024.101393. eCollection 2024 Dec.
  • Vranckx P, Morrow D, van Diepen S, Verbrugge FH Heartfelt discoveries for winter nights: December’s game-changers in acute cardiovascular care. Eur Heart J Acute Cardiovasc Care. 2024 Dec 24;13(12):815-816. doi: 10.1093/ehjacc/zuae136.
  • Kamimura D, Yimer WK, Mentz RJ, Shah AM, White WB, Blaha MJ, Oshunbade A, Hamid A, Suzuki T, Clark DR, Fox ER, Correa A, Butler J, Hall ME Cigarette Smoking, Smoking Cessation, and Heart Failure Subtypes: Insights From the Jackson Heart Study. J Am Heart Assoc. 2024 Dec 3;13(23):e032921. doi: 10.1161/JAHA.123.032921. Epub 2024 Nov 27.
  • Roffi M, Landi A, Heg D, Frigoli E, Chalkou K, Chevalier B, Ijsselmuiden AJJ, Kastberg R, Komiyama N, Morice MC, Onuma Y, Ozaki Y, Peace A, Pyxaras S, Sganzerla P, Williams R, Xaplanteris P, Vranckx P, Windecker S, Smits PC, Valgimigli M, MASTER DAPT Investigators Abbreviated or Standard Antiplatelet Therapy After PCI in Diabetic Patients at High Bleeding Risk. JACC Cardiovasc Interv. 2024 Nov 25;17(22):2664-2677. doi: 10.1016/j.jcin.2024.08.030.
  • Angiolillo DJ, Galli M, Alexopoulos D, Aradi D, Bhatt DL, Bonello L, Capodanno D, Cavallari LH, Collet JP, Cuisset T, Ferreiro JL, Franchi F, Geisler T, Gibson CM, Gorog DA, Gurbel PA, Jeong YH, Marcucci R, Siller-Matula JM, Mehran R, Neumann FJ, Pereira NL, Rizas KD, Rollini F, So DYF, Stone GW, Storey RF, Tantry US, Berg JT, Trenk D, Valgimigli M, Waksman R, Sibbing D International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update. JACC Cardiovasc Interv. 2024 Nov 25;17(22):2639-2663. doi: 10.1016/j.jcin.2024.08.027.
  • Anker MS, Luck LC, Khan MS, Porthun J, Hadzibegovic S, Lena A, Wilkenshoff U, Weinlander P, Evertz R, Totzeck M, Mahabadi AA, Rassaf T, Anker SD, Bullinger L, Keller U, Karakas M, Landmesser U, Butler J, von Haehling S New cardiovascular biomarkers in patients with advanced cancer – A prospective study comparing MR-proADM, MR-proANP, copeptin, high-sensitivity troponin T and NT-proBNP. Eur J Heart Fail. 2024 Nov 26. doi: 10.1002/ejhf.3497.
  • Das AS, Erdman JW, Heistand EC, Lioutas VA, Fehnel CR, Yoon J, Kumar S, Regenhardt RW, Gurol ME, Ngo LH, Benitez BA, Selim MH Acute hyperglycemia is associated with intraventricular extension among patients with spontaneous intracerebral hemorrhage. J Neurol Sci. 2024 Dec 15;467:123320. doi: 10.1016/j.jns.2024.123320. Epub 2024 Nov 22.
  • Ezquerra-Osorio A, Brenes-Castro DA, Espinosa-Soto R, Vargas-Estrada JL, Cue-Sierra R, Arias-Mendoza A, Araiza-Garaygordobil D A rare presentation of Takotsubo syndrome and transient dilated cardiomyopathy due to severe hypocalcemia. Arch Cardiol Mex. 2024;94(4):502-505. doi: 10.24875/ACM.23000248.
  • Caemmerer JM, Scudder AM, Keith TZ, Reynolds MR Beyond Individual Tests: Youths’ Cognitive Abilities, Basic Reading, and Writing. J Intell. 2024 Nov 20;12(11):120. doi: 10.3390/jintelligence12110120.
  • Alvarado-Bolanos A, Ayan D, Lodol F, Khaw AV, Mai LM, Mandzia JL, Mrkobrada M, Bres-Bullrich M, Fleming L, Lippert C, Cecile M, Bagur R, Fridman S, Sposato LA Time-varying differences in stroke recurrence risk between types of atrial fibrillation based on screening methods and timing of detection. Eur Stroke J. 2024 Nov 26:23969873241300888. doi: 10.1177/23969873241300888.
  • Broussard JL, Garfield A, Zarini S, Brozinick JT, Perreault L, Newsom SA, Kahn D, Kerege A, Berry KZ, Bui HH, Bergman BC Combined diet and exercise training decreases serum lipids associated with insulin resistance. Obesity (Silver Spring). 2024 Dec;32(12):2334-2344. doi: 10.1002/oby.24156.
  • Dhingra R, Xu H, Hammill BG, Lynch SM, West JS, Green MD, Peterson ED, Curtis LH, Dupre ME Association Between Socioeconomic Disadvantage and Risks of Early and Recurrent Admissions Among Patients With Newly Diagnosed Heart Failure. Circ Cardiovasc Qual Outcomes. 2024 Dec;17(12):e011141. doi: 10.1161/CIRCOUTCOMES.124.011141. Epub 2024 Nov 25.
  • Rivera FB, Ybanez MJC, Magalong JV, Prado M, Aguirre EA, Canares APT, Rubia JM, Hiyas AR, Pine PLS, Lara-Breitinger K, Lopez-Jimenez F, Gulati M Enrollment of Females in Randomized Trials for Glucagon-Like Peptide 1 Receptor Agonists: A Systematic Review. JACC Adv. 2024 Nov 8;3(12):101386. doi: 10.1016/j.jacadv.2024.101386. eCollection 2024 Dec.
  • Iribarren C, Lu M, Gulati M, Wong ND, Elosua R, Rana JS Interplay between lifestyle factors and polygenic risk for incident coronary heart disease in a large multiethnic cohort. Int J Cardiol Cardiovasc Risk Prev. 2024 Nov 6;23:200350. doi: 10.1016/j.ijcrp.2024.200350. eCollection 2024 Dec.
  • Hetherington K, Cobb E, Nicholls SJ, Han HC A new Era in CPR: Are you … Ready For it? Resuscitation. 2024 Dec;205:110442. doi: 10.1016/j.resuscitation.2024.110442. Epub 2024 Nov 23.
  • Rastogi A, Chertow GM, Collins A, Kelepouris E, Kotzker W, Middleton JP, Rajpal M, Roy-Chaudhury P Utilization of Potassium Binders for the Management of Hyperkalemia in Chronic Kidney Disease: A Position Statement by US Nephrologists. Adv Kidney Dis Health. 2024 Nov;31(6):514-522. doi: 10.1053/j.akdh.2024.08.003.
  • Alli OO, Garg J, Boursiquot BC, Kapadia SR, Yeh RW, Price MJ, Piccini JP, Nair DG, Hsu JC, Gibson DN, Allocco D, Christen T, Sutton B, Freeman JV Racial and Ethnic Disparities in the Use and Outcomes With WATCHMAN FLX: A SURPASS Analysis of the NCDR Left Atrial Appendage Occlusion Registry. J Am Heart Assoc. 2024 Dec 3;13(23):e036406. doi: 10.1161/JAHA.124.036406. Epub 2024 Nov 22.
  • Philbin SE, Gleason LP, Persell SD, Walter E, Petito LC, Tibrewala A, Yancy CW, Beidas RS, Wilcox JE, Mutharasan RK, Lloyd-Jones D, O’Brien MJ, Kho AN, McHugh MC, Smith JD, Ahmad FS Barriers and Facilitators to Heart Failure Guideline-Directed Medical Therapy in an Integrated Health System and Federally-Qualified Health Centers: A Thematic Qualitative Analysis. medRxiv [Preprint]. 2024 Oct 29:2024.10.28.24316301. doi: 10.1101/2024.10.28.24316301.
  • Schuermans A, Pournamdari AB, Lee J, Bhukar R, Ganesh S, Darosa N, Small AM, Yu Z, Hornsby W, Koyama S, Kooperberg C, Reiner AP, Januzzi JL, Honigberg MC, Natarajan P Integrative proteomic analyses across common cardiac diseases yield mechanistic insights and enhanced prediction. Nat Cardiovasc Res. 2024 Dec;3(12):1516-1530. doi: 10.1038/s44161-024-00567-0. Epub 2024 Nov 21.
  • Gilpin TR, Morgan H, Camm CF, Moss A, Cotton J, Bhatia RT, McKenzie D, Al-Lamee R, Ray S, Curzen N British Cardiovascular Intervention Society Training Culture Focus Group Position Statement: Bringing Trainees and Trainers Together. Interv Cardiol. 2024 Nov 4;19:e22. doi: 10.15420/icr.2024.07. eCollection 2024.
  • Ostrominski JW, Hojbjerg Lassen MC, Claggett BL, Miao ZM, Inzucchi SE, Docherty KF, Desai AS, Jhund PS, Kober L, Ponikowski P, Sabatine MS, Lam CSP, Martinez FA, de Boer RA, Hernandez AF, Shah SJ, Petersson M, Langkilde AM, McMurray JJV, Solomon SD, Vaduganathan M Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease. Eur Heart J. 2024 Nov 21:ehae780. doi: 10.1093/eurheartj/ehae780.
  • Garcia Acevedo G, Ahmad A, Stall B, Mokhtarnia M, Lapp JM, Verma AA, Ebrahim J, Van Spall HGC, Razak F, Isenberg SR, Etchells E, Mak S, Steinberg L, Ko DT, Poon S, Quinn KL International Comparison of Quality Indicators for Adults Hospitalized for Heart Failure: A Systematic Review. Circ Cardiovasc Qual Outcomes. 2024 Nov;17(11):e010629. doi: 10.1161/CIRCOUTCOMES.123.010629. Epub 2024 Nov 19.
  • Thomas K, Ganesan C, Liu S, Thomas IC, Montez-Rath ME, Soerensen SJC, Chertow GM, Leppert JT, Pao AC Facility-Level Variation in Nephrology Care among Veterans after Urinary Stone Diagnosis. Kidney360. 2024 Nov 19. doi: 10.34067/KID.0000000639.
  • Nissen SE, Wang Q, Nicholls SJ, Navar AM, Ray KK, Schwartz GG, Szarek M, Stroes ESG, Troquay R, Dorresteijn JAN, Fok H, Rider DA, Romano S, Wolski K, Rambaran C Zerlasiran-A Small-Interfering RNA Targeting Lipoprotein(a): A Phase 2 Randomized Clinical Trial. JAMA. 2024 Dec 17;332(23):1992-2002. doi: 10.1001/jama.2024.21957.
  • Aikawa H, Fujino M, Nakao K, Nakai M, Kanaoka K, Sumita Y, Miyamoto Y, Takagi K, Otsuka F, Kataoka Y, Asaumi Y, Tahara Y, Nicholls SJ, Tsujita K, Noguchi T Diversity in Acute Autoimmune Pericarditis: Nationwide Analysis of In-Hospital Outcomes and Recurrence. JACC Asia. 2024 Aug 27;4(10):721-731. doi: 10.1016/j.jacasi.2024.06.008. eCollection 2024 Oct.
  • Zoungas S, Moran C, Curtis AJ, Spark S, Flanagan Z, Beilin L, Chong TT, Cloud GC, Hopper I, Kost A, McNeil JJ, Nicholls SJ, Reid CM, Ryan J, Tonkin AM, Ward S, Wierzbicki AS, Wolfe R, Zhou Z, Nelson MR, STAREE investigator group Baseline Characteristics of Participants in STAREE: A Randomized Trial for Primary Prevention of Cardiovascular Disease Events and Prolongation of Disability-Free Survival in Older People. J Am Heart Assoc. 2024 Nov 19;13(22):e036357. doi: 10.1161/JAHA.124.036357. Epub 2024 Nov 15.
  • Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, Hsiao LL, Khalife M, Kumaraswami LA, Loud F, Raghavan V, Roumeliotis S, Sierra M, Ulasi I, Wang B, Lui SF, Liakopoulos V, Balducci A, World Kidney Day Joint Steering Committee Mind the gap in kidney care: Translating what we know into what we do. Nefrologia (Engl Ed). 2024 Sep-Oct;44(5):731-742. doi: 10.1016/j.nefroe.2024.11.004.
  • Leith J, An KR, Harik L, Dell’Aquila M, Rossi CS, Cancelli G, Soletti G Jr, Fremes SE, Hare DL, Kulik A, Lamy A, Ruel M, Peper J, Ten Berg JM, Willemsen LM, Zhao Q, Zhu Y, Alexander JH, Wojdyla DM, Gibson CM, Redfors B, Sandner S, Gaudino M Sequential Grafting of the Left Internal Thoracic Artery to the Left Anterior Descending Artery and Graft Failure. Ann Thorac Surg. 2024 Nov 14:S0003-4975(24)00959-7. doi: 10.1016/j.athoracsur.2024.11.009.
  • Kim I, Li XE, Lauzier PT, Sharma RP, Haeffele C Interatrial septum dissection and closure from transseptal puncture during mitral transcatheter edge-to-edge repair: a case report. Eur Heart J Case Rep. 2024 Nov 2;8(11):ytae559. doi: 10.1093/ehjcr/ytae559. eCollection 2024 Nov.
  • Druey KM, Arnaud L, Parikh SM Systemic capillary leak syndrome. Nat Rev Dis Primers. 2024 Nov 14;10(1):86. doi: 10.1038/s41572-024-00571-5.
  • Birs AS, Kao AS, Silver E, Adler ED, Taub PR, Wilkinson MJ Burden of atherogenic lipids and association with cardiac allograft vasculopathy in heart transplant recipients(). J Clin Lipidol. 2024 Nov 13:S1933-2874(24)00263-0. doi: 10.1016/j.jacl.2024.10.005.
  • Jastreboff AM, le Roux CW, Stefanski A, Aronne LJ, Halpern B, Wharton S, Wilding JPH, Perreault L, Zhang S, Battula R, Bunck MC, Ahmad NN, Jouravskaya I, SURMOUNT-1 Investigators Tirzepatide for Obesity Treatment and Diabetes Prevention. N Engl J Med. 2024 Nov 13. doi: 10.1056/NEJMoa2410819.
  • Judge PK, Tuttle KR, Staplin N, Hauske SJ, Zhu D, Sardell R, Cronin L, Green JB, Agrawal N, Arimoto R, Mayne KJ, Sammons E, Brueckmann M, Shah SV, Rossing P, Nangaku M, Landray MJ, Wanner C, Baigent C, Haynes R, Herrington WG The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial. Nephrol Dial Transplant. 2024 Nov 12:gfae263. doi: 10.1093/ndt/gfae263.
  • Secchi TL, Sposato LA Screening for atrial fibrillation after stroke: is targeted patient selection the key? Arq Neuropsiquiatr. 2024 Oct;82(10):1-2. doi: 10.1055/s-0044-1791750. Epub 2024 Nov 11.
  • Koutroumpakis E, Patel R, Khadke S, Bedrosian A, Kumar A, Kong Y, Connell B, Upadhyay J, Dani SS, Hahn AW, Logothetis CJ, Al-Kindi S, Butler J, Nohria A, Ganatra S, Deswal A Associations of SGLT2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone Therapy. Cardiovasc Drugs Ther. 2024 Nov 11. doi: 10.1007/s10557-024-07646-1.
  • Sarwal A, Boucher RE, Hartsell SE, Wei G, Shen J, Chertow GM, Whelton PK, Cheung AK, McEvoy JW, Greene T, Beddhu S Baseline Diastolic BP and BP-Lowering Effects on Cardiovascular Outcomes and All-Cause Mortality: A Meta-Analysis. J Am Soc Nephrol. 2024 Nov 8. doi: 10.1681/ASN.0000000539.
  • Cusick MM, Tisdale RL, Chertow GM, Owens DK, Goldhaber-Fiebert JD, Salomon JA Populationwide Screening for Chronic Kidney Disease: A Cost-Effectiveness Analysis. JAMA Health Forum. 2024 Nov 1;5(11):e243892. doi: 10.1001/jamahealthforum.2024.3892.
  • Ferreira JP, Oliveira AC, Vasques-Novoa F, Leite AR, Mendonca L, Zannad F, Butler J, Leite-Moreira A, Saraiva F, Neves JS Mineralocorticoid Receptor Antagonist Combined with SGLT2 Inhibitor versus SGLT2 Inhibitor Alone in Chronic Kidney Disease: A Meta-Analysis of Randomized Trials. Am J Nephrol. 2024 Nov 7:1-7. doi: 10.1159/000541686.
  • Ho CN, Ayers AT, Beisswenger P, Chalew S, Schmidt AM, Pandey A, Kapahi P, Fleming A, Klonoff DC Advanced Glycation End Products (AGEs) Webinar Meeting Report. J Diabetes Sci Technol. 2024 Nov 7:19322968241296541. doi: 10.1177/19322968241296541.
  • Manzo-Silberman S, Hawranek M, Banerjee S, Kaluzna-Oleksy M, Alasnag M, Paradies V, Parapid B, Sabouret P, Wolczenko A, Kunadian V, Uchmanowicz I, Nizard J, Gilard M, Mehran R, Chieffo A Call to action for acute myocardial infarction in women: international multi-disciplinary practical roadmap. Eur Heart J Open. 2024 Oct 12;4(6):oeae087. doi: 10.1093/ehjopen/oeae087. eCollection 2024 Nov.
  • Shah P, Cowger JA, Mehra MR, Lu Q, Uriel N Reply: Enhancing Dynamic Risk Prediction in LVAD Patients: Methodological Considerations. JACC Heart Fail. 2024 Nov;12(11):1953. doi: 10.1016/j.jchf.2024.09.006.
  • Rajkumar CA, Al-Lamee RK REPLY: Let Us Focus on Angina Mechanisms in Many, Not Just Typical Symptoms in a Few. J Am Coll Cardiol. 2024 Nov 12;84(20):e277. doi: 10.1016/j.jacc.2024.08.075.
  • Van Spall HGC, Desveaux L, Finch T, Lewis CC, Mensah GA, Rosenberg Y, Singh K, Venter F, Weiner BJ, Zannad F A Guide to Implementation Science for Phase 3 Clinical Trialists: Designing Trials for Evidence Uptake. J Am Coll Cardiol. 2024 Nov 12;84(20):2063-2072. doi: 10.1016/j.jacc.2024.08.068.
  • Lotfollahi Z, Tan JTM, Nankivell VA, Sandeman L, Liyanage S, Solly EL, Stretton L, Williamson AE, Dawson J, Nicholls SJ, Psaltis PJ, Fitridge R, Bursill CA Topical Reconstituted High-Density Lipoproteins Elicit Anti-Inflammatory Effects in Diabetic Wounds. Adv Wound Care (New Rochelle). 2024 Nov 6. doi: 10.1089/wound.2023.0162.
  • Perkovic V, Tuttle KR, Pratley R Semaglutide for Chronic Kidney Disease in Type 2 Diabetes. Reply. N Engl J Med. 2024 Nov 7;391(18):1757. doi: 10.1056/NEJMc2410532.
  • Ferro EG, Mackel JB, Kramer RD, Torguson R, Whatley EM, O’Connell G, Pullin B, Watson NW, Li S, Song Y, Krawisz AK, Carroll BJ, Schermerhorn ML, Weinstein JL, Farb A, Zuckerman B, Yeh RW, Secemsky EA Postmarketing Surveillance of Inferior Vena Cava Filters Among US Medicare Beneficiaries: The SAFE-IVC Study. JAMA. 2024 Dec 24;332(24):2091-2100. doi: 10.1001/jama.2024.19553.
  • McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, Christodorescu RM, Daskalopoulou SS, Ferro CJ, Gerdts E, Hanssen H, Harris J, Lauder L, McManus RJ, Molloy GJ, Rahimi K, Regitz-Zagrosek V, Rossi GP, Sandset EC, Scheenaerts B, Staessen JA, Uchmanowicz I, Volterrani M, Touyz RM, ESC Scientific Document Group [2024 ESC Guidelines for the management of elevated blood pressure and hypertension]. G Ital Cardiol (Rome). 2024 Nov;25(11 Suppl 1):e1-e107. doi: 10.1714/4361.43518.
  • Averbuch T, Lee SF, Zagorski B, Pandey A, Petrie MC, Biering-Sorensen T, Xie F, Van Spall HGC Long-term clinical outcomes and healthcare resource utilization in male and female patients following hospitalization for heart failure. Eur J Heart Fail. 2024 Nov 5. doi: 10.1002/ejhf.3499.
  • Banach M, Reiner Z, Surma S, Bajraktari G, Bielecka-Dabrowa A, Bunc M, Bytyci I, Ceska R, Cicero AFG, Dudek D, Dyrbus K, Fedacko J, Fras Z, Gaita D, Gavish D, Gierlotka M, Gil R, Gouni-Berthold I, Jankowski P, Jarai Z, Jozwiak J, Katsiki N, Latkovskis G, Magda SL, Margetic E, Margoczy R, Mitchenko O, Durak-Nalbantic A, Ostadal P, Paragh G, Petrulioniene Z, Paneni F, Pecin I, Pella D, Postadzhiyan A, Stoian AP, Trbusic M, Udroiu CA, Viigimaa M, Vinereanu D, Vlachopoulos C, Vrablik M, Vulic D, Penson PE, International Lipid Expert Panel (ILEP) 2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP). Drugs. 2024 Dec;84(12):1541-1577. doi: 10.1007/s40265-024-02105-5. Epub 2024 Nov 4.
  • Averbuch T, Stelkia K, Van Spall HGC Cardiovascular Care in Canada: Strengths, Challenges, and Opportunities For Improvement. Circulation. 2024 Nov 5;150(19):1490-1492. doi: 10.1161/CIRCULATIONAHA.124.070628. Epub 2024 Nov 4.
  • Rout A, Moumneh MB, Kalra K, Singh S, Garg A, Kunadian V, Biscaglia S, Alkhouli MA, Rymer JA, Batchelor WB, Nanna MG, Damluji AA Invasive Versus Conservative Strategy in Older Adults >/=75 Years of Age With Non-ST-segment-Elevation Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2024 Nov 5;13(21):e036151. doi: 10.1161/JAHA.124.036151. Epub 2024 Nov 4.
  • Yeh RW, Lalani C The future of sirolimus-coated balloon use in percutaneous coronary intervention. EuroIntervention. 2024 Nov 4;20(21):e1320-e1321. doi: 10.4244/EIJ-E-24-00053.
  • Chen RT, Pearson V, Suebkinorn O, Bulto LN, Pincha Baduge M, Anderson A, Nelson AJ, Zoungas S, Clark RA, Nicholls SJ Impact of Genetic Risk Information for Cardiovascular Disease on Behavioural, Psychological Responses, and Risk Factor Modification: A Systematic Review. Eur J Prev Cardiol. 2024 Nov 4:zwae362. doi: 10.1093/eurjpc/zwae362.
  • Vranckx P, Morrow D, van Diepen S, Verbrugge FH A warm November rain: illuminating new approaches in cardiogenic shock management. Eur Heart J Acute Cardiovasc Care. 2024 Dec 3;13(11):755-756. doi: 10.1093/ehjacc/zuae116.
  • Brady BM, Suffoletto JA, Sankary R, Chertow GM Chronic kidney disease in older adults: challenges and opportunities for the primary care provider. BMC Prim Care. 2024 Nov 1;25(1):388. doi: 10.1186/s12875-024-02638-4.
  • Fletcher RA, Rockenschaub P, Neuen BL, Walter IJ, Conrad N, Mizani MA, Bolton T, Lawson CA, Tomlinson C, Logothetis SB, Petitjean C, Brizzi LF, Kaptoge S, Raffetti E, Calvert PA, Di Angelantonio E, Banerjee A, Mamas MA, Squire I, Denaxas S, McDonagh TA, Sudlow C, Petersen SE, Chertow GM, Khunti K, Sundstrom J, Arnott C, Cleland JGF, Danesh J, McMurray JJV, Vaduganathan M, Wood AM, CVD-COVID-UK/COVID-IMPACT Consortium Contemporary epidemiology of hospitalised heart failure with reduced versus preserved ejection fraction in England: a retrospective, cohort study of whole-population electronic health records. Lancet Public Health. 2024 Nov;9(11):e871-e885. doi: 10.1016/S2468-2667(24)00215-9.
  • Shimony S, Raman HS, Flamand Y, Keating J, Paolino JD, Valtis YK, Place AE, Silverman LB, Sallan SE, Vrooman LM, Brunner AM, Neuberg DS, Galinsky I, Garcia JS, Winer ES, Wadleigh M, Stone RM, Connors JM, DeAngelo DJ, Luskin MR Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen. Blood Cancer J. 2024 Oct 31;14(1):191. doi: 10.1038/s41408-024-01178-5.
  • Van Mieghem NM, Elmariah S, Spitzer E, Pibarot P, Nazif TM, Bax JJ, Hahn RT, Popma A, Ben-Yehuda O, Kallel F, Redfors B, Chuang ML, Alu MC, Lindeboom W, Kolte D, Zahr FE, Kodali SK, Strote JA, Hermanides RS, Cohen DJ, Tijssen JGP, Leon MB Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD. J Am Coll Cardiol. 2024 Oct 22:S0735-1097(24)09960-1. doi: 10.1016/j.jacc.2024.10.070.
  • Chan EC, Ablooglu AJ, Ghosh CC, Desai A, Schaible N, Chen X, Zhao M, Olano MR, Ganesan S, Lack JB, Krishnan R, Parikh SM, Druey KM PARP15 Is a Susceptibility Locus for Clarkson Disease (Monoclonal Gammopathy-Associated Systemic Capillary Leak Syndrome). Arterioscler Thromb Vasc Biol. 2024 Dec;44(12):2628-2646. doi: 10.1161/ATVBAHA.124.321522. Epub 2024 Oct 31.
  • Mohammadnia N, van Broekhoven A, Bax WA, Eikelboom JW, Mosterd A, Fiolet ATL, Tijssen JGP, Thompson PL, de Kleijn DPV, Tsimikas S, Cornel JH, Yeang C, El Messaoudi S The Effects of Colchicine on Lipoprotein(a) and Oxidized Phospholipid Associated Cardiovascular Disease Risk. Eur J Prev Cardiol. 2024 Oct 30:zwae355. doi: 10.1093/eurjpc/zwae355.
  • Herzig MS, Kennedy KF, Hawkins BM, Secemsky EA Contemporary Practice Patterns and Outcomes of Endovascular Revascularization of Acute Limb Ischemia. JACC Cardiovasc Interv. 2024 Oct 28;17(20):2379-2390. doi: 10.1016/j.jcin.2024.09.010.
  • Galli M, Gragnano F, Berteotti M, Marcucci R, Gargiulo G, Calabro P, Terracciano F, Andreotti F, Patti G, De Caterina R, Capodanno D, Valgimigli M, Mehran R, Perrone Filardi P, Cirillo P, Angiolillo DJ, Working Group of Thrombosis of the Italian Society of Cardiology Antithrombotic Therapy in High Bleeding Risk, Part II: Noncardiac Percutaneous Interventions. JACC Cardiovasc Interv. 2024 Oct 28;17(20):2325-2336. doi: 10.1016/j.jcin.2024.09.011.
  • van Mil D, Vart P, Chertow GM, Gansevoort RT, Rossing P, Toto RD, Correa-Rotter R, Langkilde AM, Sjostrom CD, Wheeler DC, Heerspink HJL Baseline, Early Changes, and Residual Albuminuria: Post Hoc Analysis of a Randomized Clinical Trial of Dapagliflozin in Chronic Kidney Disease. Clin J Am Soc Nephrol. 2024 Dec 1;19(12):1574-1584. doi: 10.2215/CJN.0000000000000550.
  • Reddy YNV, Butler J, Anstrom KJ, Blaustein RO, Bonaca MP, Corda S, Ezekowitz JA, Lam CSP, Lewis EF, Lindenfeld J, McMullan CJ, Mentz RJ, O’Connor C, Patel M, Ponikowski P, Rosano GMC, Saldarriaga CI, Senni M, Udelson J, Voors AA, Zannad F Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial. Eur J Heart Fail. 2024 Oct 30. doi: 10.1002/ejhf.3501.
  • Vaduganathan M, Filippatos G, Claggett BL, Desai AS, Jhund PS, Henderson A, Brinker M, Kolkhof P, Schloemer P, Lay-Flurrie J, Viswanathan P, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Rossing P, Ruilope LM, Anker SD, Pitt B, Agarwal R, McMurray JJV, Solomon SD Author Correction: Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes. Nat Med. 2024 Dec;30(12):3778. doi: 10.1038/s41591-024-03372-1.
  • Hsia J, Shivappa N, Bakhai A, Bover J, Butler J, Ferraro PM, Fried L, Schneider MP, Tangri N, Winkelmayer WC, Bishop M, Chen H, Sundin AK, Bonaca MP Design and cohort characteristics of TRACK, a prospective study of hyperkalaemia management decision-making. Clin Kidney J. 2024 Sep 30;17(10):sfae295. doi: 10.1093/ckj/sfae295. eCollection 2024 Oct.
  • Kolanczyk DM, Merlo JR, Bradley B, Flannery AH, Gibson CM, McBane S, Murphy JA, Noble JM, Noble MB, Patton HM, Rosselli JL, Stone RH, Thornby KA 2023 Update to the American College of Clinical Pharmacy Pharmacotherapy Didactic Curriculum Toolkit. J Am Coll Clin Pharm. 2024 Mar;7(3):255-269. doi: 10.1002/jac5.1930. Epub 2024 Feb 29.
  • Szklarzewicz J, Floege U, Gallego D, Gibson K, Kalantar-Zadeh K, Helm K, Robinson D, Schneider B, Smith P, Tullus K, Poyan-Mehr A, Hendry B, Balkaran BL, Jauregui AK, Wang A, Nason I, Hazra NC, Xu C, Liu J, Zhou ZY, Bensink M The humanistic burden of immunoglobulin A nephropathy on patients and care-partners in the United States. Qual Life Res. 2024 Oct 26. doi: 10.1007/s11136-024-03813-x.
  • Rodriguez BC, Secemsky EA, Swaminathan RV, Feldman DN, Schlaich M, Battaglia Y, Filippone EJ, Krittanawong C The Reply. Am J Med. 2024 Nov;137(11):e221-e222. doi: 10.1016/j.amjmed.2024.07.019.
  • Zieroth S, Giraldo CIS, Pinto F, Anker SD, Abraham WT, Atherton JJ, Butler J, Chopra V, Coats AJS, Dean V, Filippatos G, Zamorano JL, Zhang Y, Weiskopf RB, Colardelle Y Applicability of heart failure clinical practice guidelines in low- and middle-income countries. Eur J Heart Fail. 2024 Oct 25. doi: 10.1002/ejhf.3485.
  • Singh GD, Price MJ, Shuvy M, Rogers JH, Grasso C, Bedogni F, Asch F, Zamorano JL, Dong M, Peterman K, Rodriguez E, Kar S, von Bardeleben RS, Maisano F Combined Impact of Residual Mitral Regurgitation and Gradient After Mitral Valve Transcatheter Edge-to-Edge Repair. JACC Cardiovasc Interv. 2024 Nov 11;17(21):2530-2540. doi: 10.1016/j.jcin.2024.08.004. Epub 2024 Oct 23.
  • Rao SV, Ben-Ami Lerner J Radiation Exposure: The Risk Shared by Patient and Physician. JACC Cardiovasc Interv. 2024 Nov 11;17(21):2499-2501. doi: 10.1016/j.jcin.2024.09.012. Epub 2024 Oct 23.
  • Talha KM, Butler J, Packer M Consequences of Discontinuing Long-Term Drug Treatment in Patients With Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol. 2024 Nov 26;84(22):2215-2232. doi: 10.1016/j.jacc.2024.09.005. Epub 2024 Oct 23.
  • Doehner W, Anker SD, Butler J, Zannad F, Filippatos G, Coats AJS, Ferreira JP, Henrichmoeller I, Brueckmann M, Schueler E, Pocock SJ, Januzzi JL, Packer M Uric Acid and SGLT2 Inhibition With Empagliflozin in Heart Failure With Preserved Ejection Fraction: The EMPEROR-Preserved Trial. JACC Heart Fail. 2024 Dec;12(12):2057-2070. doi: 10.1016/j.jchf.2024.08.020. Epub 2024 Oct 23.
  • Stewart RAH, Robledo KP, Tonkin AM, Keech A, Kritharides L, Marschner I, Janus E, Thompson PL, Watts GF, Zeller T, White HD, Simes J Plasma Protein Biomarkers and Long-Term Cardiovascular Mortality Risk in Patients With Chronic Coronary Heart Disease. J Am Heart Assoc. 2024 Nov 5;13(21):e034367. doi: 10.1161/JAHA.123.034367. Epub 2024 Oct 25.
  • Gragnano F, Angiolillo DJ Ticagrelor Therapy Modifications after Acute Coronary Syndrome: An Ever-Evolving Issue. Thromb Haemost. 2024 Nov 18. doi: 10.1055/a-2448-7029.
  • Galli M, Cortellini G, Occhipinti G, Rossini R, Romano A, Angiolillo DJ Aspirin Hypersensitivity in Patients With Atherosclerotic Cardiovascular Disease. J Am Coll Cardiol. 2024 Oct 29;84(18):1748-1766. doi: 10.1016/j.jacc.2024.05.084.
  • Wasfy JH, Januzzi JL Jr The Long Pathway to Improving Clinical Decisions With Better Risk Markers: Recurrent Thrombosis After Myocardial Infarction. J Am Coll Cardiol. 2024 Oct 29;84(18):1730-1732. doi: 10.1016/j.jacc.2024.08.050.
  • Schneider DJ, McMahon SR, Angiolillo DJ, Fanaroff A, Ibrahim H, Hohl PK, Wanamaker BL, Effron MB, DiBattiste PM Platelet FcgammaRIIa as a Marker of Cardiovascular Risk After Myocardial Infarction. J Am Coll Cardiol. 2024 Oct 29;84(18):1721-1729. doi: 10.1016/j.jacc.2024.08.051.
  • Mori Y, Komura T, Adomi M, Yagi R, Fukuma S, Kondo N, Yanagita M, Duru OK, Tuttle KR, Inoue K Sodium-glucose cotransporter 2 inhibitors and cardiovascular events among patients with type 2 diabetes and low-to-normal body mass index: a nationwide cohort study. Cardiovasc Diabetol. 2024 Oct 22;23(1):372. doi: 10.1186/s12933-024-02478-7.
  • Nicholls SJ, Manmathan GP Single bolus PCSK9 Inhibition: A new approach to plaque stabilisation. Atherosclerosis. 2024 Dec;399:118628. doi: 10.1016/j.atherosclerosis.2024.118628. Epub 2024 Oct 11.
  • Pleasure M, Jaspan VN, Liu O, Lin E, Kwong RY, Huang J, Hausvater A, Sedlak T, Hashim H, Giesler C, Bainey KR, Chong AY, Heydari B, Ahmed M, Smilowitz NR, Reynolds HR Electrocardiographic correlates of cardiac magnetic resonance findings in women with myocardial infarction with non-obstructive coronary arteries. J Electrocardiol. 2024 Nov-Dec;87:153813. doi: 10.1016/j.jelectrocard.2024.153813. Epub 2024 Oct 9.
  • Thomas SM, Harrington RA, Yancy CW, Nugent D, Erzurum S, Bernard GR, Cushman M, Hochman JS, Ridker PM, Ortel TL, Collins SP, Callaway CW, Nolen TL, Womack KN, Brown SM, Gelijns A, Geraci M, Ginde AA, Key NS, Krishnan JA, LaVange L, Wisniewski SR, Berdan L, Punturieri A, Goff DC, Patterson AP Lessons Learned from National Heart, Lung, and Blood Institute Covid-19 Clinical Trials. NEJM Evid. 2024 Nov;3(11):EVIDctcs2300291. doi: 10.1056/EVIDctcs2300291. Epub 2024 Oct 22.
  • Kittipibul V, Mentz RJ, Young R, Butler J, Ezekowitz JA, Lam CSP, Ponikowski P, Voors A, Corda S, McMullan C, O’Connor CM, Anstrom KJ, Armstrong PW, VICTORIA Study Group Projecting the benefit of vericiguat in PARADIGM-HF and DAPA-HF populations: Insights from the VICTORIA trial. ESC Heart Fail. 2024 Oct 22. doi: 10.1002/ehf2.15134.
  • Harrington J, Kang YM, McGuire DK Is This the Real Life? Real-World Evidence of Empagliflozin in Health Care Resource Utilization and Cost. Diabetes Care. 2024 Nov 1;47(11):1897-1899. doi: 10.2337/dci24-0061.
  • Bangalore S, Rhodes G, Maron DJ, Anthopolos R, O’Brien SM, Jones PG, Mark DB, Reynolds HR, Spertus JA, Stone GW, White HD, Xu Y, Fremes SE, Hochman JS, Ischemia Research Group OBOT Outcomes with revascularisation versus conservative management of participants with 3-vessel coronary artery disease in the ISCHEMIA trial. EuroIntervention. 2024 Oct 21;20(20):e1276-e1287. doi: 10.4244/EIJ-D-24-00240.
  • Fiolet ATL, Poorthuis MHF, Opstal TSJ, Amarenco P, Boczar KE, Buysschaert I, Budgeon C, Chan NC, Cornel JH, Jolly SS, Layland J, Lemmens R, Mewton N, Nidorf SM, Pascual-Figal DA, Price C, Shah B, Tardif JC, Thompson PL, Tijssen JGP, Tsivgoulis G, Walsh C, Wang Y, Weimar C, Eikelboom JW, Mosterd A, Kelly PJ, Colchicine Cardiovascular Trialists Collaboration Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials. EClinicalMedicine. 2024 Oct 8;76:102835. doi: 10.1016/j.eclinm.2024.102835. eCollection 2024 Oct.
  • Shen L, Dewan P, Ferreira JP, Cunningham JW, Jhund PS, Anand IS, Chandra A, Chiang LM, Claggett B, Desai AS, Gong J, Lam CSP, Lefkowitz MP, Maggioni AP, Martinez F, Packer M, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Solomon SD, McMurray JJV Clinical Correlates and Prognostic Impact of Cognitive Dysfunction in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF. Circulation. 2024 Dec 10;150(24):1913-1927. doi: 10.1161/CIRCULATIONAHA.124.070553. Epub 2024 Oct 21.
  • Nicholls SJ, Nelson AJ, Kastelein JJP, Ditmarsch M, Hsieh A, Johnson J, Curcio D, Kling D, Kirkpatrick CF, Davidson MH Obicetrapib exhibits favorable physiochemical and pharmacokinetic properties compared to previous cholesteryl ester transfer protein inhibitors: An integrated summary of results from non-human primate studies and clinical trials. Pharmacol Res Perspect. 2024 Dec;12(6):e70010. doi: 10.1002/prp2.70010.
  • Patel L, Segar MW, Subramanian V, Singh S, Betts T, Lokesh N, Keshvani N, Patel K, Pandey A Frailty, age, and treatment effect of surgical coronary revascularization in ischemic cardiomyopathy: a post hoc analysis of the STICHES trial. Geroscience. 2024 Oct 19. doi: 10.1007/s11357-024-01377-9.
  • Selvaraj S, Patel S, Sauer AJ, McGarrah RW, Jones P, Kwee LC, Windsor SL, Ilkayeva O, Muehlbauer MJ, Newgard CB, Borlaug BA, Kitzman DW, Shah SJ, Margulies KB, Husain M, Inzucchi SE, McGuire DK, Lanfear DE, Javaheri A, Umpierrez G, Mentz RJ, Sharma K, Kosiborod MN, Shah SH Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction. Circ Heart Fail. 2024 Nov;17(11):e011980. doi: 10.1161/CIRCHEARTFAILURE.124.011980. Epub 2024 Oct 18.
  • Nerlekar N, Ramkumar S, Maggiore P, Teng J, Cimenkaya C, Be KK, Baumann A, Nicholls SJ, Moir S The mitral to aortic/pulmonary velocity-time integral ratio is a simple, feasible and accurate discriminator for echocardiographic evaluation of severe isolated mitral regurgitation. Int J Cardiovasc Imaging. 2024 Dec;40(12):2459-2467. doi: 10.1007/s10554-024-03249-x. Epub 2024 Oct 17.
  • Reed SD, Sutphin J, Wallace MJ, Gonzalez JM, Yang JC, Reed Johnson F, Tsapatsaris J, Tarver ME, Saha A, Chen AL, Gebben DJ, Malone M, Farb A, Babalola O, Rorer EM, Parikh SA, Simons JP, Jones WS, Krucoff MW, Secemsky EA, Corriere MA Quantifying patients’ preferences on tradeoffs between mortality risk and reduced need for target vessel revascularization for claudication. Vasc Med. 2024 Dec;29(6):675-683. doi: 10.1177/1358863X241290233. Epub 2024 Oct 16.
  • Galli M, Gragnano F, Berteotti M, Marcucci R, Gargiulo G, Calabro P, Terracciano F, Andreotti F, Patti G, De Caterina R, Capodanno D, Valgimigli M, Mehran R, Perrone Filardi P, Cirillo P, Angiolillo DJ, Working Group of Thrombosis of the Italian Society of Cardiology Antithrombotic Therapy in High Bleeding Risk, Part I: Percutaneous Cardiac Interventions. JACC Cardiovasc Interv. 2024 Oct 14;17(19):2197-2215. doi: 10.1016/j.jcin.2024.08.022.
  • Mengi S, Januzzi JL Jr, Cavalcante JL, Avvedimento M, Galhardo A, Bernier M, Rodes-Cabau J Aortic Stenosis, Heart Failure, and Aortic Valve Replacement. JAMA Cardiol. 2024 Dec 1;9(12):1159-1168. doi: 10.1001/jamacardio.2024.3486.
  • McCarthy CP, Rahimi K, McEvoy JW Age-Stratified Risk Categories for Cardiovascular Disease Prevention Therapies. JAMA Cardiol. 2024 Dec 1;9(12):1069-1070. doi: 10.1001/jamacardio.2024.3544.
  • McCarthy CP, Touyz RM, McEvoy JW The ‘ten commandments’ for the 2024 European Society of Cardiology guidelines on elevated blood pressure and hypertension. Eur Heart J. 2024 Nov 21;45(44):4682-4683. doi: 10.1093/eurheartj/ehae646.
  • Inciardi RM, Chandra A, Pandey A, Metra M Reframing the role of glucagon-like peptide 1 receptor agonists in cardiovascular medicine. ESC Heart Fail. 2024 Oct 15. doi: 10.1002/ehf2.15123.
  • Uno H, Xiong H, Cronin C, Schrag D, Connors JM Predictors of recurrent venous thromboembolism and major bleeding in patients with cancer: A secondary analysis of the CANVAS trial. Thromb Res. 2024 Dec;244:109184. doi: 10.1016/j.thromres.2024.109184. Epub 2024 Oct 13.
  • Miller RJH, Manral N, Lin A, Shanbhag A, Park C, Kwiecinski J, Killekar A, McElhinney P, Matsumoto H, Razipour A, Grodecki K, Kwan AC, Han D, Kuronuma K, Flores Tomasino G, Geers J, Goeller M, Marwan M, Gransar H, Tamarappoo BK, Cadet S, Cheng VY, Achenbach S, Nicholls SJ, Wong DT, Chen L, Cao JJ, Berman DS, Dweck MR, Newby DE, Williams MC, Slomka PJ, Dey D Patient-Specific Myocardial Infarction Risk Thresholds From AI-Enabled Coronary Plaque Analysis. Circ Cardiovasc Imaging. 2024 Oct;17(10):e016958. doi: 10.1161/CIRCIMAGING.124.016958. Epub 2024 Sep 30.
  • Byrne RA, Colleran R, Coughlan JJ, Jauhar R, Maillard L, De Labriolle A, Maeng M, Croft C, Brunner M, Leistner D, Zrenner B, Kollum M, Laugwitz KL, Xhepa E, Mayer K, Lahu S, Joner M, Kirtane A, Mehran R, Barakat M, Urban P, Cutlip DE, Kastrati A, COBRA-REDUCE Investigators Randomized Trial of COBRA PzF Stenting to Reduce the Duration of Triple Therapy: The COBRA-REDUCE Trial. Circ Cardiovasc Interv. 2024 Oct;17(10):e013735. doi: 10.1161/CIRCINTERVENTIONS.123.013735. Epub 2024 Oct 15.
  • Zannad F, Berwanger O, Corda S, Cowie MR, Gamra H, Gibson CM, Goncalves A, Hucko T, Khunti K, Kostrubiec M, Kraus BJ, Linde C, Luscher TF, Mafham M, Mindham R, Ortega RF, Prescott E, Thabane L, Yancy C, Ziegler A, Van Spall HGC How to make cardiology clinical trials more inclusive. Nat Med. 2024 Oct;30(10):2745-2755. doi: 10.1038/s41591-024-03273-3. Epub 2024 Oct 14.
  • Muthalaly RG, Abrahams T, Lin A, Patel K, Tan S, Dey D, Han D, Tamarappoo BK, Nicholls SJ, Nerlekar N Myocardial extracellular volume measurement using cardiac computed tomography. Int J Cardiovasc Imaging. 2024 Nov;40(11):2237-2245. doi: 10.1007/s10554-024-03226-4. Epub 2024 Oct 14.
  • Cherla A, Kyriopoulos I, Pearcy P, Tsangalidou Z, Hajrulahovic H, Theodorakis P, Andersson CE, Mehra MR, Mossialos E Trends in avoidable mortality from cardiovascular diseases in the European Union, 1995-2020: a retrospective secondary data analysis. Lancet Reg Health Eur. 2024 Sep 27;47:101079. doi: 10.1016/j.lanepe.2024.101079. eCollection 2024 Dec.
  • Barton AK, Lau ES, Gulati M Steps towards curing Yentl syndrome: appraising sex differences in circulating proteins and incident myocardial infarction. Eur Heart J. 2024 Nov 14;45(43):4658-4660. doi: 10.1093/eurheartj/ehae657.
  • Ahmed AFE, Zachariah S, Ismail AH, Gibson CM Variation among venous thromboembolism risk assessment tools for postcesarean patients: a retrospective cohort study. Blood Coagul Fibrinolysis. 2024 Dec 1;35(8):357-361. doi: 10.1097/MBC.0000000000001325. Epub 2024 Oct 14.
  • Faust JS, Renton B, Bongiovanni T, Chen AJ, Sheares KD, Du C, Essien UR, Fuentes-Afflick E, Haywood T, Khera R, King T, Li SX, Lin Z, Lu Y, Marshall ADA, Ndumele CD, Opara I, Loarte-Rodriguez T, Sawano M, Taparra K, Taylor HA, Watson KE, Yancy CW, Krumholz HM Racial and Ethnic Disparities in Age-Specific All-Cause Mortality During the COVID-19 Pandemic. JAMA Netw Open. 2024 Oct 1;7(10):e2438918. doi: 10.1001/jamanetworkopen.2024.38918.
  • Ullah W, Sandhyavenu H, Taha A, Narayana Gowda S, Mukhtar M, Reddy Polam A, Zahid S, Fischman DL, Savage MP, Rao SV, Alkhouli M Antiplatelet Strategy for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis. J Am Heart Assoc. 2024 Oct 15;13(20):e032490. doi: 10.1161/JAHA.122.032490. Epub 2024 Oct 11.
  • Kahwash R, Zile MR, Chalasani P, Bertolet B, Gravelin L, Khan MS, Wehking J, Van Dorn B, Sarkar S, Laager V, Gerritse B, Laechelt A, Butler J, ALLEVIATE-HF Phase I Investigators Personalized Intervention Strategy Based on a Risk Score Generated From Subcutaneous Insertable Cardiac Monitor: Results From Phase 1 of ALLEVIATE-HF. J Am Heart Assoc. 2024 Oct 15;13(20):e035501. doi: 10.1161/JAHA.124.035501. Epub 2024 Oct 11.
  • Rymer J, Pichan C, Page C, Alhanti B, Bhatt DL, Kochar A, Angiolillo DJ, Diaz M, Wimmer NJ, Waksman R, Ang L, Bach R, Jenkins R, El-Sabae H, Brothers L, Ohman EM, Jones WS, Washam JB, Wang TY, Narcisse D, Basir MB The Use of Cangrelor in Cardiogenic Shock: Insights from the CAMEO Registry. J Card Fail. 2024 Oct;30(10):1233-1240. doi: 10.1016/j.cardfail.2024.08.003.
  • Ostrominski JW, Hojbjerg Lassen MC, Claggett BL, Desai AS, Pfeffer MA, Pitt B, Lam CSP, McMurray JJV, Solomon SD, Vaduganathan M Undiagnosed Diabetes in Heart Failure With Preserved Ejection Fraction. JACC Heart Fail. 2024 Dec;12(12):2116-2119. doi: 10.1016/j.jchf.2024.07.021. Epub 2024 Oct 9.
  • Harrington J, McGuire DK, Inzucchi SE Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists: A One-Two Punch? JACC Heart Fail. 2024 Nov;12(11):1827-1829. doi: 10.1016/j.jchf.2024.08.013. Epub 2024 Oct 9.
  • Spahillari A, Cohen LP, Lin C, Liu Y, Tringale A, Sheppard KE, Ko C, Khairnar R, Williamson KM, Wasfy JH, Scott NS, Paquette C, Greene SJ, Fonarow GC, Januzzi JL Jr Efficacy, Safety and Mechanistic Impact of a Heart Failure Guideline-Directed Medical Therapy Clinic. JACC Heart Fail. 2024 Oct 9:S2213-1779(24)00623-1. doi: 10.1016/j.jchf.2024.08.017.
  • Robson C, Horvath R, Stuart RL, Nicholls SJ, Smith JA, Rogers BA A national study of infective endocarditis models of care in Australia. Intern Med J. 2024 Oct 10. doi: 10.1111/imj.16537.
  • Marx N, Ryden L, Federici M, Marx-Schutt K, Verket M, Muller-Wieland D, Gerstein HC, Chan J, Cosentino F, Holman RR, Mellbin L, Ray KK, Standl E, Verma S, Wood D, Tuomilehto J, De Caterina R Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction. Eur Heart J. 2024 Dec 23;45(48):5117-5126. doi: 10.1093/eurheartj/ehae533.
  • Zendjebil S, Steg PG PCSK9 Monoclonal Antibodies Have Come a Long Way. Curr Atheroscler Rep. 2024 Dec;26(12):721-732. doi: 10.1007/s11883-024-01243-1. Epub 2024 Oct 10.
  • Bhatty A, Wilkinson C, Batra G, Aktaa S, Smith AB, Wahab A, Chappell S, Alfredsson J, Erlinge D, Ferreira J, Guethmundsdottir IJ, Hrafnkelsdottir ThornJ, Ingimarsdottir IJ, Irs A, Janosi A, Jarai Z, Oliveira-Santos M, Popescu BA, Vasko P, Vinereanu D, Yap J, Bugiardini R, Cenko E, Nadarajah R, Sydes MR, James S, Maggioni AP, Wallentin L, Casadei B, Gale CP Standardised and hierarchically classified heart failure and complementary disease monitoring outcome measures: european Unified Registries for heart Care evaluation and randomised trials (EuroHeart). Eur Heart J Qual Care Clin Outcomes. 2024 Oct 9:qcae086. doi: 10.1093/ehjqcco/qcae086.
  • Stone GW, Valgimigli M, Erlinge D, Han Y, Steg PG, Stables RH, Frigoli E, James SK, Li Y, Goldstein P, Mehran R, Mehdipoor G, Crowley A, Chen S, Redfors B, Snyder C, Zhou Z, Bikdeli B Bivalirudin vs Heparin Anticoagulation in STEMI: Confirmation of the BRIGHT-4 Results. J Am Coll Cardiol. 2024 Oct 15;84(16):1512-1524. doi: 10.1016/j.jacc.2024.07.045.
  • Carvalho PEP, Gewehr DM, Nascimento BR, Melo L, Burkhardt G, Rivera A, Braga MAP, Guimaraes PO, Mehran R, Windecker S, Valgimigli M, Angiolillo DJ, Bhatt DL, Sandoval Y, Chen SL, Stone GW, Lopes RD Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis. JAMA Cardiol. 2024 Dec 1;9(12):1094-1105. doi: 10.1001/jamacardio.2024.3216.
  • Neves JS, Leite AR, Mentz RJ, Holman RR, Zannad F, Butler J, Packer M, Ferreira JP Cardiovascular outcomes with exenatide in type 2 diabetes according to ejection fraction: The EXSCEL trial. Eur J Heart Fail. 2024 Oct 9. doi: 10.1002/ejhf.3478.
  • Tang AB, Solomon N, Chiswell K, Greene SJ, Yancy CW, Jessup M, Kittleson M, Butler J, Sweitzer NK, Goldberg LR, Lindenfeld JA, Lewis EF, Peterson PN, Paul S, Serdynski LM, Rutan C, Congdon M, Cherkur S, Fonarow GC Home-Time, Mortality, and Readmissions Among Patients Hospitalized With Heart Failure: A Baseline Prior to IMPLEMENT-HF. Circ Heart Fail. 2024 Oct;17(10):e011795. doi: 10.1161/CIRCHEARTFAILURE.124.011795. Epub 2024 Oct 9.
  • Peters SAE, Van Spall HGC Advancing women’s cardiovascular health: an international lens on the Joint British Cardiovascular Societies’ consensus statement. Heart. 2024 Oct 28;110(22):1289-1290. doi: 10.1136/heartjnl-2024-324907.
  • Hameed I, Nusrat K, Jamil A, Fatima K, Minhas AMK, Greene SJ, Sauer AJ, Butler J, Khan MS Demographic and Regional Trends of Cardiovascular Disease and Obesity-Related Mortality in the United States From 1999 to 2021. Am J Cardiol. 2024 Dec 15;233:51-54. doi: 10.1016/j.amjcard.2024.09.028. Epub 2024 Oct 5.
  • Stefan MF, Magda LS, Rimbas RC, Vinereanu D Thromboembolic Disease and COVID-19: Experience of a University and Emergency Hospital During the Pandemic. Cureus. 2024 Sep 6;16(9):e68767. doi: 10.7759/cureus.68767. eCollection 2024 Sep.
  • Spanos M, Gokulnath P, Li G, Hutchins E, Meechoovet B, Sheng Q, Chatterjee E, Sharma R, Carnel-Amar N, Lin C, Azzam C, Ghaeli I, Amancherla KV, Victorino JF, Garcia-Mansfield K, Pfeffer R, Sahu P, Lindman BR, Elmariah S, Gamazon ER, Betti MJ, Bledsoe X, Lance ML, Absi T, Su YR, Do N, Contreras MG, Varrias D, Kladas M, Radulovic M, Tsiachris D, Spanos A, Tsioufis K, Ellinor PT, Tucker NR, Januzzi JL, Pirrotte P, Jovanovic-Talisman T, Van Keuren-Jensen K, Shah R, Das S Cardiomyocyte-derived circulating extracellular vesicles allow a non-invasive liquid biopsy of myocardium in health and disease. medRxiv [Preprint]. 2024 Sep 22:2024.09.19.24314009. doi: 10.1101/2024.09.19.24314009.
  • Hetherington K, Thomas J, Nicholls SJ, Barsha G, Bubb KJ Unique cardiometabolic factors in women that contribute to modified cardiovascular disease risk. Eur J Pharmacol. 2024 Dec 5;984:177031. doi: 10.1016/j.ejphar.2024.177031. Epub 2024 Oct 5.
  • Khan MS, Jamil A, Januzzi JL, Shakoor M, Bennett MM, Vanzyl JS, Vanspall HGC, Butler J POINT: Statistical Non-Significance, Likelihood Ratio, and The Interpretation of Clinical Trial Evidence: Insights from Heart Failure Randomized Trials. J Card Fail. 2024 Dec;30(12):1629-1632. doi: 10.1016/j.cardfail.2024.07.026. Epub 2024 Oct 2.
  • Zeitler EP, Bian B, Griffiths RI, Allocco DJ, Christen T, Roy K, Cohen DJ, Reynolds MR Long-Term Clinical Outcomes Following the WATCHMAN Device Use in Medicare Beneficiaries. Circ Cardiovasc Qual Outcomes. 2024 Oct;17(10):e011007. doi: 10.1161/CIRCOUTCOMES.124.011007. Epub 2024 Oct 4.
  • Maurina M, Pivato CA, Kunadian V, Testa L, Briguori C, Pacchioni A, Latini AC, Cesani N, Piccolo R, Musto C, Sardella G, Indolfi C, Regazzoli D, Paradies V, Stefanini G One-month DAPT after biodegradable-polymer everolimus-eluting stent implantation in women at high-bleeding risk: Insights from the POEM trial. Catheter Cardiovasc Interv. 2024 Nov;104(6):1129-1138. doi: 10.1002/ccd.31255. Epub 2024 Oct 3.
  • Dykun I, Carlo J, Nissen SE, Kapadia SR, Nicholls SJ, Puri R Interplay of Age and Risk Factor Control Upon Coronary Atheroma Progression. Heart Lung Circ. 2024 Nov;33(11):1593-1599. doi: 10.1016/j.hlc.2024.06.1031. Epub 2024 Oct 2.
  • Rymer JA, Narcisse DI, Jones WS, Rao SV, Doll JA Reply: Early-Career Interventionalists: Hope for the Future and Opportunity for Change. J Am Coll Cardiol. 2024 Oct 8;84(15):e241. doi: 10.1016/j.jacc.2024.07.039.
  • Tang AB, Ziaeian B, Butler J, Yancy CW, Fonarow GC Global Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart Failure. JAMA Cardiol. 2024 Dec 1;9(12):1154-1158. doi: 10.1001/jamacardio.2024.3023.
  • Wilson M, Incontri D, Vu S, Marchina S, Wang JY, Andreev A, Heistand E, Carvalho F, Selim M, Lioutas VA Association of Anticoagulant Use With Hemorrhage Location and Etiology in Incident Spontaneous Intracerebral Hemorrhage. Stroke. 2024 Nov;55(11):2677-2684. doi: 10.1161/STROKEAHA.124.048243. Epub 2024 Oct 2.
  • Defilippis EM, Donald E, Cho L, Sauer A, Maning J, Blumer V, Hajduczok A, Youmans Q, Gulati M, Hurt MT, Humphrey A, Reza N, Mentz R, Lala A Association of Double-Blind Reviews With Increases in Women as First Authors: An Initial Report From the Journal of Cardiac Failure. J Card Fail. 2024 Sep 29:S1071-9164(24)00378-6. doi: 10.1016/j.cardfail.2024.09.004.
  • Maron MS, Masri A, Nassif ME, Barriales-Villa R, Abraham TP, Arad M, Cardim N, Choudhury L, Claggett B, Coats CJ, Dungen HD, Garcia-Pavia P, Hagege AA, Januzzi JL, Kulac I, Lee MMY, Lewis GD, Ma CS, Michels M, Oreziak A, Owens AT, Spertus JA, Solomon SD, Tfelt-Hansen J, van Sinttruije M, Veselka J, Watkins HC, Jacoby DL, Heitner SB, Kupfer S, Malik FI, Meng L, Wohltman A, Olivotto I, SEQUOIA-HCM Investigators Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM. J Am Coll Cardiol. 2024 Nov 5;84(19):1821-1831. doi: 10.1016/j.jacc.2024.09.003. Epub 2024 Sep 30.
  • Masurkar AV, Bansal N, Prince DK, Winkelmayer WC, Ortiz DF, Ramos G, Soomro Q, Vedvyas A, Osorio RS, Bernard MA, Debure L, Ahmed W, Boutajangout A, Wisniewski T, Charytan DM Alzheimer Disease-Related Biomarkers in Patients on Maintenance Hemodialysis. Kidney Med. 2024 Aug 28;6(11):100897. doi: 10.1016/j.xkme.2024.100897. eCollection 2024 Nov.
  • Bolona CEA, Winkelmayer WC In advanced CKD, ACEis or ARBs reduce kidney failure vs. placebo or non-RAAS inhibitors at 34 mo. Ann Intern Med. 2024 Oct;177(10):JC113. doi: 10.7326/ANNALS-24-02169-JC. Epub 2024 Oct 1.
  • Portela GT, Carson JL, Swanson SA, Alexander JH, Hebert PC, Goodman SG, Steg PG, Bertolet M, Strom JB, Fergusson DA, Simon T, White HD, Cooper HA, Abbott JD, Rao SV, Chaitman BR, Fordyce CB, Lopes RD, Daneault B, Brooks MM, MINT Investigators Effect of Four Hemoglobin Transfusion Threshold Strategies in Patients With Acute Myocardial Infarction and Anemia : A Target Trial Emulation Using MINT Trial Data. Ann Intern Med. 2024 Nov;177(11):1489-1498. doi: 10.7326/M24-0571. Epub 2024 Oct 1.
  • Manoogian ENC, Wilkinson MJ, O’Neal M, Laing K, Nguyen J, Van D, Rosander A, Pazargadi A, Gutierrez NR, Fleischer JG, Golshan S, Panda S, Taub PR Time-Restricted Eating in Adults With Metabolic Syndrome : A Randomized Controlled Trial. Ann Intern Med. 2024 Nov;177(11):1462-1470. doi: 10.7326/M24-0859. Epub 2024 Oct 1.
  • Sinnaeve PR, Welsh RC, Arias Mendoza A, Ristic AD, Averkov OV, Lambert Y, Kerr Saraiva JF, Sepulveda P, Rosell-Ortiz F, French JK, Music LB, Vandenberghe K, Bogaerts K, Danays T, Bainey KR, Armstrong PW, Van de Werf F, STREAM-2 Investigators Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Elevation Myocardial Infarction: STREAM-2 1-Year Mortality Follow-Up. Circulation. 2024 Oct;150(14):1151-1153. doi: 10.1161/CIRCULATIONAHA.124.070347. Epub 2024 Sep 30.
  • Arun AS, Caraballo C, Sawano M, Lu Y, Khera R, Yancy CW, Krumholz HM Cause-Specific Mortality Rates Among the US Black Population. JAMA Netw Open. 2024 Sep 3;7(9):e2436402. doi: 10.1001/jamanetworkopen.2024.36402.
  • Zemski Berry KA, Garfield A, Jambal P, Zarini S, Perreault L, Bergman BC Oxidised phosphatidylcholine induces sarcolemmal ceramide accumulation and insulin resistance in skeletal muscle. Diabetologia. 2024 Dec;67(12):2819-2832. doi: 10.1007/s00125-024-06280-8. Epub 2024 Sep 30.
  • Ganzorig N, Pompei G, Jenkins K, Wang W, Rubino F, Gill K, Kunadian V Role of physiology in the management of multivessel disease among patients with acute coronary syndrome. AsiaIntervention. 2024 Sep 27;10(3):157-168. doi: 10.4244/AIJ-D-24-00051. eCollection 2024 Sep.
  • Caliskan E, Misfeld M, Sandner S, Boning A, Aramendi J, Salzberg SP, Choi YH, Perrault LP, Tekin I, Cuerpo GP, Lopez-Menendez J, Weltert LP, Bohm J, Krane M, Gonzalez-Santos JM, Tellez JC, Holubec T, Ferrari E, Doros G, Emmert MY Transatlantic analysis of patient profiles and mid-term survival after isolated coronary artery bypass grafting: a head-to-head comparison between the European DuraGraft Registry and the US STS Registry. Front Cardiovasc Med. 2024 Sep 12;11:1366460. doi: 10.3389/fcvm.2024.1366460. eCollection 2024.
  • Satish S, Subban V, Vijayachandra Y, Oomman A, Arumugam G, Senthil H, Kethavath H, Pulindram KD, Kar S, Kodali S, Chandrasekaran K Outcomes of mitral transcatheter edge to edge repair with MitraClip – An Indian single center experience. Indian Heart J. 2024 Sep-Oct;76(5):315-320. doi: 10.1016/j.ihj.2024.09.002. Epub 2024 Sep 28.
  • Chimura M, Petrie MC, Schou M, Martinez FA, Henderson AD, Claggett BL, Desai AS, Kolkhof P, Viswanathan P, Lage A, Lam CSP, Senni M, Shah SJ, Rohwedder K, Mueller K, Voors AA, Zannad F, Pitt B, Vaduganathan M, Jhund PS, Solomon SD, McMurray JJV Finerenone Improves Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction Irrespective of Age: A Prespecified Analysis of FINEARTS-HF. Circ Heart Fail. 2024 Nov;17(11):e012437. doi: 10.1161/CIRCHEARTFAILURE.124.012437. Epub 2024 Sep 29.
  • Del Prato S, Li Z, Ramasundarahettige C, Branch KRH, Lam CSP, Lopes RD, Pratley R, Rosenstock J, Sattar N, Gerstein HC Impact of baseline FIB-4 score on efpeglenatide benefits on cardiovascular outcomes in people with type 2 diabetes: a participant-level exploratory analysis of the AMPLITUDE-O trial. Cardiovasc Diabetol. 2024 Sep 28;23(1):352. doi: 10.1186/s12933-024-02432-7.
  • Coats AJS, Anker SD, Lund LH, Filippatos G, Rossignol P, Pitt B, Weir MR, Kosiborod MN, Metra M, Bohm M, Ezekowitz JA, Bayes-Genis A, Mentz RJ, Ponikowski P, Senni M, Cleland JGF, Goudev A, Khintibidze I, Lindenfeld J, Merkely B, Waechter S, Budden J, Perrin A, Butler J Patiromer for Heart Failure Medication Optimization in Patients With Current or Past Hyperkalemia: DIAMOND Subanalysis. JACC Heart Fail. 2024 Dec;12(12):2026-2037. doi: 10.1016/j.jchf.2024.08.003. Epub 2024 Sep 25.
  • De Luca G, Verburg A, Hof AV, Ten Berg J, Kereiakes DJ, Coller BS, Gibson CM Current and Future Roles of Glycoprotein IIb-IIIa Inhibitors in Primary Angioplasty for ST-Segment Elevation Myocardial Infarction. Biomedicines. 2024 Sep 4;12(9):2023. doi: 10.3390/biomedicines12092023.
  • Nordan T, Keshk M, Hackmann A, Givertz MM, Mehra MR, Cunningham MJ, Itoh A The impact of blood type and body size on successful bridging to heart transplantation using intra-aortic balloon pump or surgically implanted microaxial left ventricular assist device. J Thorac Cardiovasc Surg. 2024 Sep 25:S0022-5223(24)00835-3. doi: 10.1016/j.jtcvs.2024.09.028.
  • Connolly DL, Sharma V, Ray KK From clinical development to real-world outcomes with inclisiran. Curr Opin Lipidol. 2024 Dec 1;35(6):281-289. doi: 10.1097/MOL.0000000000000954. Epub 2024 Sep 27.
  • Nicholls SJ, Nelson AJ, Michael LF Oral agents for lowering lipoprotein(a). Curr Opin Lipidol. 2024 Dec 1;35(6):275-280. doi: 10.1097/MOL.0000000000000953. Epub 2024 Sep 25.
  • Nicholls SJ, Tan S, Butters J, Nelson AJ Evaluating obicetrapib as an emerging treatment for patients with dyslipidemia: a game changer? Expert Opin Pharmacother. 2024 Oct;25(14):1879-1885. doi: 10.1080/14656566.2024.2409324. Epub 2024 Sep 27.
  • Pitt B, Anker SD, Lund LH, Coats AJS, Filippatos G, Rossignol P, Weir MR, Friede T, Kosiborod MN, Metra M, Bohm M, Ezekowitz JA, Bayes-Genis A, Mentz RJ, Ponikowski P, Senni M, Pina IL, Pinto FJ, van der Meer P, Bahit C, Belohlavek J, Brugts JJ, Perrin A, Waechter S, Budden J, Butler J Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist Therapies in Patients With Heart Failure and Hyperkalemia. J Am Coll Cardiol. 2024 Oct 1;84(14):1295-1308. doi: 10.1016/j.jacc.2024.05.079.
  • Polsinelli VB, Sun JL, Greene SJ, Chiswell K, Grunwald GK, Allen LA, Peterson P, Pandey A, Fonarow GC, Heidenreich P, Ho PM, Hess PL Hospital Heart Failure Medical Therapy Score and Associated Clinical Outcomes and Costs. JAMA Cardiol. 2024 Nov 1;9(11):1029-1038. doi: 10.1001/jamacardio.2024.2969.
  • Poorthuis MHF, Hageman SHJ, Fiolet ATL, Kappelle LJ, Bots ML, Steg PG, Visseren FLJ, Bhatt DL, de Borst GJ Prediction of Severe Baseline Asymptomatic Carotid Stenosis and Subsequent Risk of Stroke and Cardiovascular Disease. Stroke. 2024 Nov;55(11):2632-2640. doi: 10.1161/STROKEAHA.123.046894. Epub 2024 Sep 25.
  • Tayal U, Pompei G, Wilkinson I, Adamson D, Sinha A, Hildick-Smith D, Cubbon R, Garbi M, Ingram TE, Colebourn CL, Camm CF, Guzik TJ, Anderson L, Page SP, Wicks E, Jenkins P, Rosen SD, Eftychiou S, Roberts E, Eftekhari H, Probert H, Cowie A, Thakkar R, Moore J, Berry C, Captur G, Deshpande A, Brown S, Malkin R, Harrison M, Lawson C, Ng GA, Kunadian V Advancing the access to cardiovascular diagnosis and treatment among women with cardiovascular disease: a joint British Cardiovascular Societies’ consensus document. Heart. 2024 Oct 28;110(22):e4. doi: 10.1136/heartjnl-2024-324625.
  • Budgeon CA, Nidorf S, Mosterd A, Fiolet A, Eikelboom J, O’Halloran S, Joyce D, Schut A, Tijssen J, Cornel JH, Murray K, Thompson P Exploration of the regional effects of colchicine in the LoDoCo2 trial. Am Heart J. 2024 Dec;278:186-194. doi: 10.1016/j.ahj.2024.09.006. Epub 2024 Sep 21.
  • Zuin M, Rigatelli G, Bilato C, Gibson CM, Nguyen T Disparities and Trends in Autopsy Rates Among Cardiovascular Disease Decedents in the United States, 2011 to 2020. Am J Cardiol. 2024 Dec 1;232:72-74. doi: 10.1016/j.amjcard.2024.09.018. Epub 2024 Sep 21.
  • Stone GW, Lindenfeld J, Rodes-Cabau J, Anker SD, Zile MR, Kar S, Holcomb R, Pfeiffer MP, Bayes-Genis A, Bax JJ, Bank AJ, Costanzo MR, Verheye S, Roguin A, Filippatos G, Nunez J, Lee EC, Laufer-Perl M, Moravsky G, Litwin SE, Prihadi E, Gada H, Chung ES, Price MJ, Thohan V, Schewel D, Kumar S, Kische S, Shah KS, Donovan DJ, Zhang Y, Eigler NL, Abraham WT, RELIEVE-HF Investigators Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial. Circulation. 2024 Dec 10;150(24):1931-1943. doi: 10.1161/CIRCULATIONAHA.124.070870. Epub 2024 Sep 23.
  • Milutinovic S, Petrovic M, Begosh-Mayne D, Lopez-Mattei J, Chazal RA, Wood MJ, Escarcega RO Evaluating Performance of ChatGPT on MKSAP Cardiology Board Review Questions. Int J Cardiol. 2024 Dec 15;417:132576. doi: 10.1016/j.ijcard.2024.132576. Epub 2024 Sep 19.
  • Vranckx P, Morrow D, van Diepen S, Verbrugge FH Resilience and renewal: charting the future of cardiovascular care in a changing world. Eur Heart J Acute Cardiovasc Care. 2024 Oct 28;13(10):683-684. doi: 10.1093/ehjacc/zuae107.
  • Teles RC, Van Belle E, Parma R, Tarantini G, van Mieghem N, Mylotte D, Silva JD, O’Connor S, Sondegaard L, Luz A, Amat-Santos IJ, Arzamendi D, Blackman D, De Backer O, Kunadian V, Buchanan GL, MacCarthy P, Lurz P, Naber C, Chieffo A, Paradies V, Gilard M, Vincent F, Fraccaro C, Mehilli J, Giannini C, Silva B, Poliacikova P, Karam N, Veulemans V, Thiele H, Pilgrim T, van Wely M, James S, Schmidt MR, Uebing A, Ruck A, Ghanem A, Ghazzal Z, Joshi FR, Favero L, Hermanides R, Ninios V, Fovino LN, Nuis RJ, Deharo P, Kala P, Elbaz-Greener G, Tchetche D, Agricola E, Thielmann M, Donal E, Bonaros N, Droogmans S, Czerny M, Baumbach A, Barbato E, Dudek D Percutaneous Valvular and Structural Heart Disease Interventions.2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC in collaboration with the European Association of Cardiovascular Imaging (EACVI) and the Cardiovascular Surgery Working Group (WG CVS) of the European Society of Cardiology. EuroIntervention. 2024 Aug 30:EIJ-D-23-00983. doi: 10.4244/EIJ-D-23-00983.
  • Ikemura N, Spertus JA, Nguyen D, Fu Z, Jones PG, Reynolds HR, Bangalore S, Bhargava B, Senior R, Elghamaz A, Goodman SG, Lopes RD, Pracon R, Lopez-Sendon J, Maggioni AP, Kohsaka S, Roth GA, White HD, Mavromatis K, Boden WE, Rodriguez F, Hochman JS, Maron DJ, ISCHEMIA Research Group International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial. Circ Cardiovasc Qual Outcomes. 2024 Oct;17(10):e010534. doi: 10.1161/CIRCOUTCOMES.123.010534. Epub 2024 Sep 20.
  • Pabon MA, Vaduganathan M, Claggett BL, Chatur S, Siqueira S, Marti-Castellote P, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, Desai AS, Jhund PS, McMurray JJV, Solomon SD, Vardeny O In-hospital course of patients with heart failure with improved ejection fraction in the DELIVER trial. Eur J Heart Fail. 2024 Dec;26(12):2532-2540. doi: 10.1002/ejhf.3410. Epub 2024 Sep 19.
  • Qazi SU, Hamid A, Ansari HUH, Khouri MG, Anker MS, Hall ME, Anker SD, Butler J, Khan MS Trends in cancer and heart failure related mortality in adult US population: A CDC WONDER database analysis from 1999 to 2020. Am Heart J. 2024 Dec;278:170-180. doi: 10.1016/j.ahj.2024.09.002. Epub 2024 Sep 17.
  • Montez-Rath M, Varkila M, Yu X, Brillhart S, Morgan C, Leppink A, Block MS, Mehta S, Hunsader P, Fountaine A, Subramanian N, Dittrich M, Owens DK, Chertow GM, Parsonnet J, Anand S, Block GA Acceptance of SARS-CoV-2 Surveillance Testing Among Patients Receiving Dialysis: A Cluster Randomized Trial. JAMA Netw Open. 2024 Sep 3;7(9):e2434159. doi: 10.1001/jamanetworkopen.2024.34159.
  • Genereux P, Amoroso NS, Thourani VH, Rodriguez E, Sharma RP, Pinto DS, Kwon M, Dobbles M, Pellikka PA, Gillam LD Mortality Burden for Patients With Untreated Aortic Regurgitation. JACC Adv. 2024 Sep 6;3(10):101228. doi: 10.1016/j.jacadv.2024.101228. eCollection 2024 Oct.
  • Weight N, Moledina S, Lawson CA, Van Spall HGC, Wijeysundera HC, Rashid M, Kontopantelis E, Mamas MA The Intersection of Socioeconomic Differences and Sex in the Management and Outcomes of Acute Myocardial Infarction: A Nationwide Cohort Study. Angiology. 2024 Sep 19:33197241273433. doi: 10.1177/00033197241273433.
  • Butler J, Brown M, Prokocimer P, Humphries AC, Pope S, Wright O, Su J, Elnawasany O, Muresan B The role of cardiac acoustic biomarkers in monitoring patients with heart failure: A systematic literature review. ESC Heart Fail. 2024 Sep 18. doi: 10.1002/ehf2.15075.
  • Kaul S, Butler J Stopping Trials Early for Benefit: Insights From Recent Pivotal Trials in Chronic Kidney Disease. J Am Coll Cardiol. 2024 Sep 24;84(13):1268-1271. doi: 10.1016/j.jacc.2024.07.026.
  • Elbadawi A, Mohamed A, Sedhom R, Garcia L, Pandey A, Girotra S, Bavry A, Vemulapalli S, Kumbhani DJ Clinical Outcomes in Relation to Total Hospital Surgical and Transcatheter Aortic Valve Replacement Volumes. J Am Heart Assoc. 2024 Oct;13(19):e035719. doi: 10.1161/JAHA.124.035719. Epub 2024 Sep 18.
  • da Silva Francisco R Jr, Punj S, Vincent L, Sanapareddy N, Bhalla V, Chertow GM, Keen-Kim D, Charu V Prevalence of Mendelian Kidney Disease Among Patients With High-Risk APOL1 Genotypes Undergoing Commercial Genetic Testing in the United States. Kidney Int Rep. 2024 Jun 22;9(9):2667-2676. doi: 10.1016/j.ekir.2024.06.028. eCollection 2024 Sep.
  • Bohra C, Asch FM, Lerakis S, Little SH, Redfors B, Zhou Z, Li Y, Weissman NJ, Grayburn PA, Kar S, Lim DS, Abraham WT, Lindenfeld J, Mack MJ, Bax JJ, Stone GW Pulmonary Vein Systolic Flow Reversal and Outcomes in Patients From the Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (COAPT) Trial. Struct Heart. 2024 Jun 26;8(5):100333. doi: 10.1016/j.shj.2024.100333. eCollection 2024 Sep.
  • Mach F, Visseren FLJ, Cater NB, Salhi N, Soronen J, Ray KK, Delgado V, Jukema JW, Laufs U, Zamorano JL, Ros E, Plat J, Gesztes AG, Tokgozoglu L, Packard C, Libby P Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias-A report from the European Society of Cardiology Cardiovascular Round Table. J Clin Lipidol. 2024 Sep-Oct;18(5):e685-e700. doi: 10.1016/j.jacl.2024.07.001. Epub 2024 Jul 6.
  • Talasaz AH, McGonagle B, HajiQasemi M, Ghelichkhan ZA, Sadeghipour P, Rashedi S, Cuker A, Lech T, Goldhaber SZ, Jennings DL, Piazza G, Bikdeli B Pharmacokinetic and Pharmacodynamic Interactions between Food or Herbal Products and Oral Anticoagulants: Evidence Review, Practical Recommendations, and Knowledge Gaps. Semin Thromb Hemost. 2024 Sep 17. doi: 10.1055/s-0044-1790258.
  • Rajkumar CA, Al-Lamee RK Do Current Clinical Guidelines Set Percutaneous Coronary Intervention Up to Fail? Insights From the ORBITA-2 Trial. Circ Cardiovasc Qual Outcomes. 2024 Sep;17(9):e011201. doi: 10.1161/CIRCOUTCOMES.124.011201. Epub 2024 Sep 17.
  • Gerstein HC, Yang M, Lee SF, Branch KRH, Del Prato S, Lam CSP, Lopes RD, Pratley R, Rosenstock J, Sattar N Do nonglycaemic effects such as weight loss account for HbA1c lowering with efpeglenatide?: Insights from the AMPLITUDE-O trial. Diabetes Obes Metab. 2024 Dec;26(12):6080-6084. doi: 10.1111/dom.15957. Epub 2024 Sep 16.
  • Wang S, Spincemaille P, Selim M, Hasan D, Thomas AJ, Filippidis A, Wen Y, Wang Y, Soman S CSF Susceptibility Variation in Patient With Intracranial Hemorrhage: Implications for Quantitative Susceptibility Mapping Reference Selection. J Comput Assist Tomogr. 2024 Sep 4. doi: 10.1097/RCT.0000000000001660.
  • Lund LH, James S, DeVore AD, Anstrom KJ, Fudim M, Aaronson KD, Dahlstrom U, Desvigne-Nickens P, Fleg JL, Yang S, Fu M, Hage C, Held C, Karlstrom P, Nygren M, Peterson ED, Pol T, Sapp S, Sundstrom J, Ostlund O, Oldgren J, Pitt B The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design. Eur J Heart Fail. 2024 Nov;26(11):2453-2463. doi: 10.1002/ejhf.3453. Epub 2024 Sep 16.
  • Jones B, Rane N, Finnegan M, Quest R, Abdel-Malek M, Biasiolli L, Shalhoub J, Davies A, Loyse N, Bassett P, Ray KK, Cegla J Effect of evolocumab on carotid plaque composition in asymptomatic carotid artery stenosis (EVOCAR-1) using magnetic resonance imaging. J Clin Lipidol. 2024 Sep-Oct;18(5):e855-e866. doi: 10.1016/j.jacl.2024.06.004. Epub 2024 Jun 14.
  • Vallejo-Vaz AJ, Dharmayat KI, Nzeakor N, Carrasco CP, Fatoba ST, Fonseca MJ, Tolani E, Lee C, Ray KK Recurrent cardiovascular and limb events in 294,428 patients with coronary or peripheral artery disease or ischemic stroke on antiplatelet monotherapy: The RESRISK cohort study. Atherosclerosis. 2024 Nov;398:118589. doi: 10.1016/j.atherosclerosis.2024.118589. Epub 2024 Sep 4.
  • Greene SJ, Bohm M, Bozkurt B, Butler J, Cleland JGF, Coats AJS, Desai NR, Grobbee DE, Kelepouris E, Pinto F, Rosano G, Morin I, Szecsody P, Fabien S, Waechter S, Crespo-Leiro MG, Hulsmann M, Kempf T, Pfister O, Pouleur AC, Sauer AJ, Saxena M, Schulz M, Volterrani M, Anker SD, Kosiborod MN Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalemia or High Risk of Hyperkalemia: Rationale and Design of the CARE-HK in HF Registry. J Card Fail. 2024 Sep 12:S1071-9164(24)00368-3. doi: 10.1016/j.cardfail.2024.08.048.
  • Abu-Much A, Grines CL, Chen S, Batchelor WB, Zhao D, Falah B, Maini AS, Redfors B, Bellumkonda L, Bharadwaj AS, Moses JW, Truesdell AG, Zhang Y, Zhou Z, Baron SJ, Lansky AJ, Basir MB, O’Neill WW, Cohen DJ Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCI. Int J Cardiol. 2024 Dec 15;417:132555. doi: 10.1016/j.ijcard.2024.132555. Epub 2024 Sep 11.
  • Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Goh R, Kueh MTW, Li H, Chin YH, Kong G, Anand VV, Wang JW, Muthiah M, Jain V, Mehta A, Lim SL, Foo R, Figtree GA, Nicholls SJ, Mamas MA, Januzzi JL, Chew NWS, Richards AM, Chan MY Global burden of cardiovascular diseases: projections from 2025 to 2050. Eur J Prev Cardiol. 2024 Sep 13:zwae281. doi: 10.1093/eurjpc/zwae281.
  • Sposato LA, Coutinho JM Cardiac CT for Thrombus Detection: Prime Time for Stroke Patients? Neurology. 2024 Oct 8;103(7):e209870. doi: 10.1212/WNL.0000000000209870. Epub 2024 Sep 13.
  • Rosenfield K, Bowers TR, Barnett CF, Davis GA, Giri J, Horowitz JM, Huisman MV, Hunt BJ, Keeling B, Kline JA, Klok FA, Konstantinides SV, Lanno MT, Lookstein R, Moriarty JM, Ni Ainle F, Reed JL, Rosovsky RP, Royce SM, Secemsky EA, Sharp ASP, Sista AK, Smith RE, Wells P, Yang J, Whatley EM, Pulmonary Embolism Research Collaborative (PERC) Attendees Standardized Data Elements for Patients With Acute Pulmonary Embolism: A Consensus Report From the Pulmonary Embolism Research Collaborative. Circulation. 2024 Oct;150(14):1140-1150. doi: 10.1161/CIRCULATIONAHA.124.067482. Epub 2024 Sep 12.
  • Estep JD, Salah HM, Kapadia SR, Burkhoff D, Lala A, Butler J, Hall S, Fudim M HFSA Scientific Statement: Update on Device Based Therapies in Heart Failure. J Card Fail. 2024 Nov;30(11):1472-1488. doi: 10.1016/j.cardfail.2024.07.007. Epub 2024 Sep 10.
  • van den Broek WWA, Ingraham BS, Pereira NL, Lee CR, Cavallari LH, Swen JJ, Angiolillo DJ, Ten Berg JM Genotype-Guided Antiplatelet Therapy: JACC Review Topic of the Week. J Am Coll Cardiol. 2024 Sep 17;84(12):1107-1118. doi: 10.1016/j.jacc.2024.06.038.
  • Bhatt AS, Bhatt DL, Steg PG, Szarek M, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Voors AA, Metra M, Lund LH, Testani JM, Wilcox CS, Davies M, Pitt B, Kosiborod MN Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF. J Am Coll Cardiol. 2024 Sep 17;84(12):1078-1088. doi: 10.1016/j.jacc.2024.06.036.
  • Celutkiene J, Cerlinskaite-Bajore K, Cotter G, Edwards C, Adamo M, Arrigo M, Barros M, Biegus J, Chioncel O, Cohen-Solal A, Damasceno A, Diaz R, Filippatos G, Gayat E, Kimmoun A, Leopold V, Deniau B, Metra M, Novosadova M, Pagnesi M, Pang PS, Ponikowski P, Saidu H, Sliwa K, Takagi K, Ter Maaten JM, Tomasoni D, Lam CSP, Voors AA, Mebazaa A, Davison B Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF study. Clin Res Cardiol. 2024 Nov;113(11):1589-1603. doi: 10.1007/s00392-024-02518-y. Epub 2024 Sep 11.
  • Halvorsen S, Vranckx P, van Diepen S Should renin-angiotensin system inhibitors be stopped or not before non-cardiac surgery? Eur Heart J Acute Cardiovasc Care. 2024 Sep 25;13(9):670-671. doi: 10.1093/ehjacc/zuae101.
  • Segar MW, Patel KV, Keshvani N, Kannan V, Willett D, Klonoff DC, Pandey A Electronic Health Record Alert With Heart Failure Risk and Sodium Glucose Cotransporter 2 Inhibitor Prescriptions in Diabetes: A Randomized Clinical Trial. J Diabetes Sci Technol. 2024 Sep 10:19322968241264747. doi: 10.1177/19322968241264747.
  • Sinha S, Nigwekar SU, Brandenburg V, Gould LJ, Serena TE, Moe SM, Aronoff GR, Chatoth DK, Hymes JL, Carroll KJ, Alperovich G, Keller LH, Perello J, Gold A, Chertow GM Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension. EClinicalMedicine. 2024 Aug 16;75:102784. doi: 10.1016/j.eclinm.2024.102784. eCollection 2024 Sep.
  • Koczo A, Reza N, Hayes SN, Freed BH, Gulati M, Merz NB, Berlacher K, Sunthankar K, Tamirisa KP Beyond Parental Leave: Addressing Infertility, Pregnancy, and Postpartum Complications Among Cardiologists. JACC Adv. 2024 Aug 21;3(10):101213. doi: 10.1016/j.jacadv.2024.101213. eCollection 2024 Oct.
  • Monagle SR, Spear E, Abrahams T, Thakur U, Pol D, Bellamy K, Hickman J, Nicholls SJ, Nelson AJ Cardiology patients are unaware of the benefits of seasonal influenza immunization. Am J Prev Cardiol. 2024 Aug 13;19:100716. doi: 10.1016/j.ajpc.2024.100716. eCollection 2024 Sep.
  • Talha KM, Hammonds K, Alhamdow A, Bennett MM, Bomar JVA, Ettlinger JA, Martinez-Traba M, Hartgers-Gubbels ES, Priest EL, Shaver CN, Afzal A, Widmer RJ, Gottlieb RL, Mack MJ, Butler J Health Care Resource Utilization Following Acute Myocardial Infarction: Findings from the RECORD-MI Registry. Am J Cardiol. 2024 Dec 1;232:1-7. doi: 10.1016/j.amjcard.2024.08.034. Epub 2024 Sep 7.
  • Talha KM, Metra M, Butler J Heart failure with preserved ejection fraction: underdiagnosed and undertreated in patients with tricuspid regurgitation. Eur Heart J. 2024 Nov 8;45(42):4539-4541. doi: 10.1093/eurheartj/ehae544.
  • de Waha S, Patel MR, Thiele H, Udelson JE, Granger CB, Ben-Yehuda O, Kotinkaduwa L, Redfors B, Eitel I, Selker HP, Maehara A, Stone GW Relationship Between Infarct Artery, Myocardial Injury, and Outcomes After Primary Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction. J Am Heart Assoc. 2024 Sep 17;13(18):e034748. doi: 10.1161/JAHA.123.034748. Epub 2024 Sep 9.
  • Ortega-Paz L Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions. Interv Cardiol Clin. 2024 Oct;13(4):xiii-xiv. doi: 10.1016/j.iccl.2024.07.007. Epub 2024 Aug 10.
  • Mahowald MK, Choi C, Angiolillo DJ Considerations in Antiplatelet Therapy in Women Undergoing Treatment of Acute Coronary Syndrome or Percutaneous Coronary Intervention. Interv Cardiol Clin. 2024 Oct;13(4):577-586. doi: 10.1016/j.iccl.2024.07.005. Epub 2024 Aug 8.
  • Canonico ME, Hess CN, Secemsky EA, Bonaca MP Antithrombotic Therapy in Patients Undergoing Peripheral Artery Interventions. Interv Cardiol Clin. 2024 Oct;13(4):553-559. doi: 10.1016/j.iccl.2024.07.003. Epub 2024 Aug 1.
  • Konstantinides SV, Sanchez O, Goldhaber SZ, Meneveau N Advancing the management of acute intermediate-high-risk pulmonary embolism: The enduring legacy of Professor Guy Meyer. Presse Med. 2024 Sep;53(3):104248. doi: 10.1016/j.lpm.2024.104248. Epub 2024 Sep 6.
  • Khan MS, Ochani RK, Butler J Implications of Diuretic Use in Contextualizing Clinical Trial Results in Patients With Heart Failure With Preserved Ejection Fraction. Am J Cardiol. 2024 Nov 15;231:79-81. doi: 10.1016/j.amjcard.2024.08.022. Epub 2024 Sep 5.
  • Chang J, Ambrosy AP, Vardeny O, Van Spall HGC, Mentz RJ, Sauer AJ Mineralocorticoid Antagonism in Heart Failure: Established and Emerging Therapeutic Role. JACC Heart Fail. 2024 Dec;12(12):1979-1993. doi: 10.1016/j.jchf.2024.08.007. Epub 2024 Sep 1.
  • Yong Y, Giovannucci J, Pang SN, Hong W, Han D, Berman DS, Dey D, Nicholls SJ, Nerlekar N, Lin A Coronary Artery Calcium Density and Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis. JACC Cardiovasc Imaging. 2024 Aug 25:S1936-878X(24)00314-0. doi: 10.1016/j.jcmg.2024.07.024.
  • Jayawardana S, Campbell A, Aitken M, Andersson CE, Mehra MR, Mossialos E Global consumption patterns of combination hypertension medication: An analysis of pharmaceutical sales data from 2010-2021. PLOS Glob Public Health. 2024 Sep 6;4(9):e0003698. doi: 10.1371/journal.pgph.0003698. eCollection 2024.
  • Segar MW, Usman MS, Patel KV, Khan MS, Butler J, Manjunath L, Lam CSP, Verma S, Willett D, Kao D, Januzzi JL, Pandey A Development and validation of a machine learning-based approach to identify high-risk diabetic cardiomyopathy phenotype. Eur J Heart Fail. 2024 Oct;26(10):2183-2192. doi: 10.1002/ejhf.3443. Epub 2024 Sep 6.
  • Vranckx P, Morrow D, van Diepen S, Verbrugge FH Embracing the Olympic spirit: pioneering cardiac care insights from the 2024 European Society of Cardiology scientific meeting and more! Eur Heart J Acute Cardiovasc Care. 2024 Sep 25;13(9):645. doi: 10.1093/ehjacc/zuae099.
  • Litwin SE, Komtebedde J, Borlaug BA, Kaye DM, Hasenfubeta G, Kawash R, Hoendermis E, Hummel SL, Cikes M, Gustafsson F, Chung ES, Mohan RC, Sverdlov AL, Swarup V, Winkler S, Hayward CS, Bergmann MW, Bugger H, McKenzie S, Nair A, Rieth A, Burkhoff D, Cutlip DE, Solomon SD, van Veldhuisen DJ, Leon MB, Shah SJ Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials. Am Heart J. 2024 Dec;278:106-116. doi: 10.1016/j.ahj.2024.08.014. Epub 2024 Sep 3.
  • Streiff MB, Holmstrom B, Angelini D, Ashrani A, Buckner T, Diep R, Fertrin KY, Fogerty AE, Crestani NG, Gangaraju R, Rojas-Hernandez C, Goldhaber SZ, Ibrahim I, Kubal T, Leavitt AD, Lim M, Mann J, Mantha S, Morton C, Nester A, O’Brien A, Ortel TL, Pine A, Pishko A, Ranade M, Salmasi A, Schaefer J, Williams E, Wool G, Wun T, Montgomery S, Nguyen J, Freedman-Cass D, Sliker B Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 Sep;22(7):483-506. doi: 10.6004/jnccn.2024.0046.
  • De Cock E, Kautbally S, Timmermans F, Bogaerts K, Hanet C, Desmet W, Gurne O, Vranckx P, Hiltrop N, Dujardin K, Vanduynhoven P, Vermeersch P, Pirlet C, Hermans K, Van Reet B, Ferdinande B, Aminian A, Dewilde W, Guedes A, Simon F, De Roeck F, De Vroey F, Jukema JW, Sinnaeve P, Buysschaert I Low-dose colchicine for the prevention of cardiovascular events after percutaneous coronary intervention: Rationale and design of the COL BE PCI trial. Am Heart J. 2024 Dec;278:61-71. doi: 10.1016/j.ahj.2024.08.022. Epub 2024 Sep 2.
  • Zahger D, Schwartz GG, Du W, Szarek M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Jukema JW, Kiss RG, Harrington RA, Moriarty PM, Scemama M, Manvelian G, Pordy R, White HD, Zeiher AM, Fazio S, Geba GP, Steg PG, ODYSSEY OUTCOMES Investigators Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome. J Am Coll Cardiol. 2024 Sep 10;84(11):994-1006. doi: 10.1016/j.jacc.2024.06.035.
  • Jhund PS, Talebi A, Henderson AD, Claggett BL, Vaduganathan M, Desai AS, Lam CSP, Pitt B, Senni M, Shah SJ, Voors AA, Zannad F, Solomon SD, McMurray JJV Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis. Lancet. 2024 Sep 21;404(10458):1119-1131. doi: 10.1016/S0140-6736(24)01733-1. Epub 2024 Sep 1.
  • Stone GW, Yancy CW, Gaudino M Addressing Evidence Gaps in Coronary Revascularization Trials. JAMA Cardiol. 2024 Nov 1;9(11):1062-1063. doi: 10.1001/jamacardio.2024.2778.
  • Gibson CM, Chi G, Duffy D, Bahit MC, White H, Korjian S, Alexander JH, Lincoff AM, Anschuetz G, Girgis IG, Nicolau JC, Lopes RD, Cornel JH, Bainey KR, Libby P, Sacks FM, Ridker PM, Goodman SG, Mahaffey KW, Nicholls SJ, Pocock SJ, Mehran R, Harrington RA, AEGIS-II Committees and Investigators ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial. J Am Coll Cardiol. 2024 Nov 26;84(22):2185-2192. doi: 10.1016/j.jacc.2024.08.001. Epub 2024 Sep 2.
  • Balagny P, Vidal-Petiot E, Kab S, Frija J, Steg PG, Goldberg M, Zins M, d’Ortho MP, Wiernik E Association of Snoring and Daytime Sleepiness With Subsequent Incident Hypertension: A Population-Based Cohort Study. Hypertension. 2024 Nov;81(11):2286-2297. doi: 10.1161/HYPERTENSIONAHA.124.23007. Epub 2024 Sep 4.
  • Zannad F, Sanyal AJ, Butler J, Miller V, Harrison SA Integrating liver endpoints in clinical trials of cardiovascular and kidney disease. Nat Med. 2024 Sep;30(9):2423-2431. doi: 10.1038/s41591-024-03223-z. Epub 2024 Sep 3.
  • Valgimigli M, Hong SJ, Gragnano F, Chalkou K, Franzone A, da Costa BR, Baber U, Kim BK, Jang Y, Chen SL, Stone GW, Hahn JY, Windecker S, Gibson MC, Song YB, Ge Z, Vranckx P, Mehta S, Gwon HC, Lopes RD, Dangas GD, McFadden EP, Angiolillo DJ, Leonardi S, Heg D, Calabro P, Juni P, Mehran R, Hong MK, Single Versus Dual Antiplatelet Therapy (Sidney-4) collaborator group De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials. Lancet. 2024 Sep 7;404(10456):937-948. doi: 10.1016/S0140-6736(24)01616-7. Epub 2024 Aug 31.
  • Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS, Henderson AD, Lam CSP, Pitt B, Senni M, Shah SJ, Voors AA, Zannad F, Abidin IZ, Alcocer-Gamba MA, Atherton JJ, Bauersachs J, Chang-Sheng M, Chiang CE, Chioncel O, Chopra V, Comin-Colet J, Filippatos G, Fonseca C, Gajos G, Goland S, Goncalvesova E, Kang S, Katova T, Kosiborod MN, Latkovskis G, Lee AP, Linssen GCM, Llamas-Esperon G, Mareev V, Martinez FA, Melenovsky V, Merkely B, Nodari S, Petrie MC, Saldarriaga CI, Saraiva JFK, Sato N, Schou M, Sharma K, Troughton R, Udell JA, Ukkonen H, Vardeny O, Verma S, von Lewinski D, Voronkov L, Yilmaz MB, Zieroth S, Lay-Flurrie J, van Gameren I, Amarante F, Kolkhof P, Viswanathan P, FINEARTS-HF Committees and Investigators Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med. 2024 Oct 24;391(16):1475-1485. doi: 10.1056/NEJMoa2407107. Epub 2024 Sep 1.
  • Kunadian V, Mossop H, Shields C, Bardgett M, Watts P, Teare MD, Pritchard J, Adams-Hall J, Runnett C, Ripley DP, Carter J, Quigley J, Cooke J, Austin D, Murphy J, Kelly D, McGowan J, Veerasamy M, Felmeden D, Contractor H, Mutgi S, Irving J, Lindsay S, Galasko G, Lee K, Sultan A, Dastidar AG, Hussain S, Haq IU, de Belder M, Denvir M, Flather M, Storey RF, Newby DE, Pocock SJ, Fox KAA, British Heart Foundation SENIOR-RITA Trial Team and Investigators Invasive Treatment Strategy for Older Patients with Myocardial Infarction. N Engl J Med. 2024 Nov 7;391(18):1673-1684. doi: 10.1056/NEJMoa2407791. Epub 2024 Sep 1.
  • Chen RT, Pearson V, Suebkinorn O, Bulto LN, Anderson A, Nelson AJ, Zoungas S, Nicholls SJ, Clark RA Effectiveness of receiving cardiovascular disease genetic risk information on health behaviors, psychological responses, and associated risk factor modification in individuals: a systematic review protocol. JBI Evid Synth. 2024 Dec 1;22(12):2567-2576. doi: 10.11124/JBIES-23-00313.
  • Angiolillo DJ Management of Antiplatelet Therapy After Coronary Stenting in Patients Requiring Noncardiac Surgery. J Am Coll Cardiol. 2024 Dec 10;84(24):2390-2392. doi: 10.1016/j.jacc.2024.08.039. Epub 2024 Aug 31.
  • Jorde UP, Benza R, McCarthy PM, Ailawadi G, Whisenant B, Makkar R, Tadros P, Naik H, Fam N, Sauer AJ, Murthy S, Kar S, von Bardeleben RS, Hahn RT, Hamid N, Zbinden J, Sorajja P, Adams D Impact of Renal and Liver Function on Clinical Outcomes Following Tricuspid Valve Transcatheter Edge-to-Edge Repair. J Am Coll Cardiol. 2024 Dec 17;84(25):2446-2456. doi: 10.1016/j.jacc.2024.08.044. Epub 2024 Aug 31.
  • Kosiborod MN, Deanfield J, Pratley R, Borlaug BA, Butler J, Davies MJ, Emerson SS, Kahn SE, Kitzman DW, Lingvay I, Mahaffey KW, Petrie MC, Plutzky J, Rasmussen S, Ronnback C, Shah SJ, Verma S, Weeke PE, Lincoff AM, SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM Trial Committees and Investigators Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials. Lancet. 2024 Sep 7;404(10456):949-961. doi: 10.1016/S0140-6736(24)01643-X. Epub 2024 Aug 30.
  • Gibson CM, Duffy D, Bahit MC, Chi G, White H, Korjian S, Alexander JH, Lincoff AM, Heise M, Kingwell BA, Nicolau JC, Lopes RD, Cornel JH, Lewis BS, Vinereanu D, Goodman SG, Bode C, Steg PG, Libby P, Sacks FM, Bainey KR, Ridker PM, Mahaffey KW, Aylward P, Nicholls SJ, Pocock SJ, Mehran R, Harrington RA, AEGIS-II Committees and Investigators Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial. Eur Heart J. 2024 Dec 16;45(47):5023-5038. doi: 10.1093/eurheartj/ehae614.
  • Simon T, Herbert BM, Brooks MM, Goodman SG, Alexander JH, Steg PG, Lopes RD, Ghafghazi S, Bouleti C, Cooper HA, McCamant EL, Bainey KR, Aronow HD, Abbott JD, Alsweiler C, Bertolet M, Fergusson DA, Goldsweig AM, Hebert PC, Carson JL, MINT Trial Investigators Restrictive or Liberal Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: 6-Month Mortality in the MINT Trial. Circulation. 2024 Sep 24;150(13):1064-1066. doi: 10.1161/CIRCULATIONAHA.124.069917. Epub 2024 Sep 2.
  • Srivastava PK, Klomhaus AM, Rafique A, Desai PS, Daniels LB, Yancy CW, Yang EH, Fonarow GC, Parikh RV Guideline-directed medical therapy prescribing patterns and in-hospital outcomes among heart failure patients during COVID-19. Am Heart J Plus. 2024 Aug 2;45:100440. doi: 10.1016/j.ahjo.2024.100440. eCollection 2024 Sep.
  • Sridhar VS, Cosentino F, Dagogo-Jack S, McGuire DK, Pratley RE, Cater NB, Noyes Essex M, Mancuso JP, Zhao Y, Cherney DZI Effects of ertugliflozin on uric acid and gout-related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from VERTIS CV. Diabetes Obes Metab. 2024 Nov;26(11):5336-5346. doi: 10.1111/dom.15895. Epub 2024 Sep 2.
  • Vaduganathan M, Filippatos G, Claggett BL, Desai AS, Jhund PS, Henderson A, Brinker M, Kolkhof P, Schloemer P, Lay-Flurrie J, Viswanathan P, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Rossing P, Ruilope LM, Anker SD, Pitt B, Agarwal R, McMurray JJV, Solomon SD Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes. Nat Med. 2024 Dec;30(12):3758-3764. doi: 10.1038/s41591-024-03264-4. Epub 2024 Sep 1.
  • Ponikowski P, Friede T, von Bardeleben RS, Butler J, Shahzeb Khan M, Diek M, Heinrich J, Geyer M, Placzek M, Ferrari R, Abraham WT, Alfieri O, Auricchio A, Bayes-Genis A, Cleland JGF, Filippatos G, Gustafsson F, Haverkamp W, Kelm M, Kuck KH, Landmesser U, Maggioni AP, Metra M, Ninios V, Petrie MC, Rassaf T, Ruschitzka F, Schafer U, Schulze PC, Spargias K, Vahanian A, Zamorano JL, Zeiher A, Karakas M, Koehler F, Lainscak M, Oner A, Mezilis N, Theofilogiannakos EK, Ninios I, Chrissoheris M, Kourkoveli P, Papadopoulos K, Smolka G, Wojakowski W, Reczuch K, Pinto FJ, Wiewiorka L, Streb W, Adamo M, Santiago-Vacas E, Friedrich Ruf T, Gross M, Tongers J, Hasenfuss G, Schillinger W, Anker SD Hospitalization of Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation Treated With MitraClip: Insights From RESHAPE-HF2. J Am Coll Cardiol. 2024 Dec 10;84(24):2347-2363. doi: 10.1016/j.jacc.2024.08.027. Epub 2024 Aug 31.
  • Sherrod CF 4th, Saberi S, Nassif ME, Claggett BL, Coats CJ, Garcia-Pavia P, Januzzi JL, Lewis GD, Ma C, Maron MS, Miao ZM, Olivotto I, Veselka J, Butzner M, Jacoby DL, Heitner SB, Kupfer S, Malik FI, Meng L, Wohltman A, Spertus JA Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM. J Am Coll Cardiol. 2024 Nov 5;84(19):1773-1785. doi: 10.1016/j.jacc.2024.08.014. Epub 2024 Sep 1.
  • Solomon SD, Ostrominski JW, Wang X, Shah SJ, Borlaug BA, Butler J, Davies MJ, Kitzman DW, Verma S, Abildstrom SZ, Nygaard Einfeldt M, Rasmussen S, Abhayaratna WP, Ahmed FZ, Ben-Gal T, Chopra V, Ito H, Merkely B, Nunez J, Senni M, van der Meer P, Wolf D, Petrie MC, Kosiborod MN, STEP-HFpEF Trial Committees and Investigators Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart Failure. J Am Coll Cardiol. 2024 Oct 22;84(17):1587-1602. doi: 10.1016/j.jacc.2024.08.021. Epub 2024 Aug 30.
  • Verma S, Butler J, Borlaug BA, Davies MJ, Kitzman DW, Petrie MC, Shah SJ, Jensen TJ, Rasmussen S, Ronnback C, Merkely B, O’Keefe E, Kosiborod MN, STEP-HFpEF and STEP-HFpEF DM Investigators Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Program. J Am Coll Cardiol. 2024 Oct 22;84(17):1603-1614. doi: 10.1016/j.jacc.2024.08.023. Epub 2024 Aug 30.
  • Verma S, Petrie MC, Borlaug BA, Butler J, Davies MJ, Kitzman DW, Shah SJ, Ronnback C, Abildstrom SZ, Liisberg K, Wolf D, von Lewinski D, Lelonek M, Melenovsky V, Senni M, Kosiborod MN, STEP-HFpEF Trial Committees and Investigators Inflammation in Obesity-Related HFpEF: The STEP-HFpEF Program. J Am Coll Cardiol. 2024 Oct 22;84(17):1646-1662. doi: 10.1016/j.jacc.2024.08.028. Epub 2024 Aug 30.
  • Pratley RE, Tuttle KR, Rossing P, Rasmussen S, Perkovic V, Nielsen OW, Mann JFE, MacIsaac RJ, Kosiborod MN, Kamenov Z, Idorn T, Hansen MB, Hadjadj S, Bakris G, Baeres FMM, Mahaffey KW, FLOW Trial Committees and Investigators Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial. J Am Coll Cardiol. 2024 Oct 22;84(17):1615-1628. doi: 10.1016/j.jacc.2024.08.004. Epub 2024 Aug 30.
  • Ahmad Y, Reddy RK, Mehta SR Myocardial Infarction and Multivessel Disease: Completing the Story. J Am Coll Cardiol. 2024 Nov 12;84(20):2023-2025. doi: 10.1016/j.jacc.2024.08.008. Epub 2024 Aug 31.
  • Packer M, Ferreira JP, Butler J, Filippatos G, Januzzi JL Jr, Gonzalez Maldonado S, Panova-Noeva M, Pocock SJ, Prochaska JH, Saadati M, Sattar N, Sumin M, Anker SD, Zannad F Reaffirmation of Mechanistic Proteomic Signatures Accompanying SGLT2 Inhibition in Patients With Heart Failure: A Validation Cohort of the EMPEROR Program. J Am Coll Cardiol. 2024 Nov 12;84(20):1979-1994. doi: 10.1016/j.jacc.2024.07.013. Epub 2024 Aug 31.
  • Morrow A, Young R, Abraham GR, Hoole S, Greenwood JP, Arnold JR, El Shibly M, Shanmuganathan M, Ferreira V, Rakhit R, Galasko G, Sinha A, Perera D, Al-Lamee R, Spyridopoulos I, Kotecha A, Clesham G, Ford TJ, Davenport A, Padmanabhan S, Jolly L, Kellman P, Kaski JC, Weir RA, Sattar N, Kennedy J, Macfarlane PW, Welsh P, McConnachie A, Berry C, PRIZE Study Group Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial. Circulation. 2024 Nov 19;150(21):1671-1683. doi: 10.1161/CIRCULATIONAHA.124.069901. Epub 2024 Sep 1.
  • Schubert J, Leosdottir M, Lindahl B, Westerbergh J, Melhus H, Modica A, Cater N, Brinck J, Ray KK, Hagstrom E Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry. Eur Heart J. 2024 Oct 14;45(39):4204-4215. doi: 10.1093/eurheartj/ehae576.
  • Butt JH, McMurray JJV, Claggett BL, Jhund PS, Neuen BL, McCausland FR, Desai AS, Lam CSP, Pitt B, Pfeffer MA, Packer M, Beldhuis IE, Voors AA, Zannad F, Heerspink HJL, Solomon SD, Vaduganathan M Therapeutic Effects of Heart Failure Medical Therapies on Standardized Kidney Outcomes: Comprehensive Individual Participant-Level Analysis of 6 Randomized Clinical Trials. Circulation. 2024 Dec 3;150(23):1858-1868. doi: 10.1161/CIRCULATIONAHA.124.071110. Epub 2024 Sep 1.
  • Coats CJ, Masri A, Barriales-Villa R, Abraham TP, Brinkley DM, Claggett BL, Hagege A, Hegde SM, Ho CY, Kulac IJ, Lee MMY, Maron MS, Olivotto I, Owens AT, Solomon SD, Tfelt-Hansen J, Watkins H, Jacoby DL, Heitner SB, Kupfer S, Malik FI, Meng L, Wohltman A, Januzzi JL Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial. Eur Heart J. 2024 Nov 8;45(42):4464-4478. doi: 10.1093/eurheartj/ehae590.
  • Talha KM, Greene SJ, Butler J, Khan MS Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction: Impact on Prognosis and Treatment. Heart Fail Clin. 2024 Oct;20(4):387-398. doi: 10.1016/j.hfc.2024.06.005.
  • Anker SD, Friede T, von Bardeleben RS, Butler J, Khan MS, Diek M, Heinrich J, Geyer M, Placzek M, Ferrari R, Abraham WT, Alfieri O, Auricchio A, Bayes-Genis A, Cleland JGF, Filippatos G, Gustafsson F, Haverkamp W, Kelm M, Kuck KH, Landmesser U, Maggioni AP, Metra M, Ninios V, Petrie MC, Rassaf T, Ruschitzka F, Schafer U, Schulze PC, Spargias K, Vahanian A, Zamorano JL, Zeiher A, Karakas M, Koehler F, Lainscak M, Oner A, Mezilis N, Theofilogiannakos EK, Ninios I, Chrissoheris M, Kourkoveli P, Papadopoulos K, Smolka G, Wojakowski W, Reczuch K, Pinto FJ, Wiewiorka L, Kalarus Z, Adamo M, Santiago-Vacas E, Ruf TF, Gross M, Tongers J, Hasenfuss G, Schillinger W, Ponikowski P, RESHAPE-HF2 Investigators Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation. N Engl J Med. 2024 Nov 14;391(19):1799-1809. doi: 10.1056/NEJMoa2314328. Epub 2024 Aug 31.
  • Jain SS, Mahaffey KW, Pieper KS, Shimizu W, Potpara T, Ruff CT, Kamel H, Lewis BS, Cornel JH, Kowey PR, Horrow J, Strony J, Plotnikov AN, Li D, Weng S, Donahue J, Gibson CM, Steg PG, Mehran R, Weitz JI, Johnston SC, Hankey GJ, Harrington RA, Lam CSP, LIBREXIA AF Trial Investigators and Committees Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design. Am Heart J. 2024 Nov;277:145-158. doi: 10.1016/j.ahj.2024.08.011. Epub 2024 Aug 29.
  • Myhre PL, Tromp J, Ouwerkerk W, Ting DSW, Docherty KF, Gibson CM, Lam CSP Digital tools in heart failure: addressing unmet needs. Lancet Digit Health. 2024 Oct;6(10):e755-e766. doi: 10.1016/S2589-7500(24)00158-4. Epub 2024 Aug 29.
  • Mihan A, Pandey A, Van Spall HG Mitigating the risk of artificial intelligence bias in cardiovascular care. Lancet Digit Health. 2024 Oct;6(10):e749-e754. doi: 10.1016/S2589-7500(24)00155-9. Epub 2024 Aug 29.
  • Verma K, Staron A, Zheng L, Cetin O, Doros G, Sanchorawala V Systemic AL Amyloidosis in Patients Younger Than 40 Years of Age: Clinical Presentation and Outcomes. Clin Lymphoma Myeloma Leuk. 2024 Dec;24(12):869-872. doi: 10.1016/j.clml.2024.08.002. Epub 2024 Aug 10.
  • Russmann D, Roy-Chaudhury P, Chertow GM, Gee P, Chauhan C, Macari S, Murphy M, Rossignol P Where Are Patients’ Voices in Chronic Kidney Disease? Clin J Am Soc Nephrol. 2024 Nov 1;19(11):1496-1498. doi: 10.2215/CJN.0000000581. Epub 2024 Aug 30.
  • McEvoy JW, Jennings C, Kotseva K, De Bacquer D, De Backer G, Erlund I, Vihervaara T, Lip GYH, Ray KK, Ryden L, Abreu A, Almahmeed W, Ambari AM, Ge J, Hasan-Ali H, Huo Y, Jankowski P, Jimenez RM, Li Y, Mahmood Zuhdi AS, Makubi A, Mbakwem AC, Mbau L, Navarro Estrada JL, Ogah OS, Ogola EN, Quintero-Baiz A, Sani MU, Sosa Liprandi MI, Tan JWC, Urina Triana MA, Yeo TJ, Ganly S, Adamska A, Wood D Variation in secondary prevention of coronary heart disease: the INTERASPIRE study. Eur Heart J. 2024 Oct 14;45(39):4184-4196. doi: 10.1093/eurheartj/ehae558.
  • Lu H, Chatur S, Lee S, Inciardi RM, Abanda M, Mc Causland FR, Kalayci A, Taheri KK, Shah AM, Cikes M, Claggett BL, Prasad N, Lam CSP, O’Meara E, Wang X, McMurray JJV, Pfeffer MA, Hegde SM, Solomon SD, Skali H Relationship Between Cardiac Structure and Function With Renal Function Trajectory and Outcomes in Patients With Heart Failure: Insights From the PARAGON-HF Trial. Circ Heart Fail. 2024 Oct;17(10):e011942. doi: 10.1161/CIRCHEARTFAILURE.124.011942. Epub 2024 Aug 30.
  • Boden WE, De Caterina R, Kaski JC, Bairey Merz N, Berry C, Marzilli M, Pepine CJ, Barbato E, Stefanini G, Prescott E, Steg PG, Bhatt DL, Hill JA, Crea F Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelines. Eur Heart J. 2024 Sep 29;45(36):3701-3706. doi: 10.1093/eurheartj/ehae278.
  • Mahaffey KW, Tuttle KR, Arici M, Baeres FMM, Bakris G, Charytan DM, Cherney DZI, Chernin G, Correa-Rotter R, Gumprecht J, Idorn T, Pugliese G, Rasmussen IKB, Rasmussen S, Rossing P, Sokareva E, Mann JFE, Perkovic V, Pratley R Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial. Eur Heart J. 2024 Aug 30:ehae613. doi: 10.1093/eurheartj/ehae613.
  • Boden WE, De Caterina R, Kaski JC, Bairey Merz N, Berry C, Marzilli M, Pepine CJ, Barbato E, Stefanini G, Prescott E, Steg PG, Bhatt DL, Hill JA, Crea F Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice Guidelines. Circulation. 2024 Nov 12;150(20):1631-1637. doi: 10.1161/CIRCULATIONAHA.123.065656. Epub 2024 Aug 30.
  • Neuen BL, Fletcher RA, Heath L, Perkovic A, Vaduganathan M, Badve SV, Tuttle KR, Pratley R, Gerstein HC, Perkovic V, Heerspink HJL Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis. Circulation. 2024 Nov 26;150(22):1781-1790. doi: 10.1161/CIRCULATIONAHA.124.071689. Epub 2024 Aug 30.
  • Lu H, Claggett BL, Packer M, Lam CSP, Swedberg K, Rouleau J, Zile MR, Lefkowitz M, Desai AS, Jhund P, McMurray JJV, Solomon SD, Vaduganathan M Effects of Sacubitril/Valsartan on All-Cause Hospitalizations in Heart Failure: Post Hoc Analysis of the PARADIGM-HF and PARAGON-HF Randomized Clinical Trials. JAMA Cardiol. 2024 Nov 1;9(11):1047-1052. doi: 10.1001/jamacardio.2024.2566.
  • McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, Christodorescu RM, Daskalopoulou SS, Ferro CJ, Gerdts E, Hanssen H, Harris J, Lauder L, McManus RJ, Molloy GJ, Rahimi K, Regitz-Zagrosek V, Rossi GP, Sandset EC, Scheenaerts B, Staessen JA, Uchmanowicz I, Volterrani M, Touyz RM, ESC Scientific Document Group 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024 Oct 7;45(38):3912-4018. doi: 10.1093/eurheartj/ehae178.
  • Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, Banning AP, Budaj A, Buechel RR, Chiariello GA, Chieffo A, Christodorescu RM, Deaton C, Doenst T, Jones HW, Kunadian V, Mehilli J, Milojevic M, Piek JJ, Pugliese F, Rubboli A, Semb AG, Senior R, Ten Berg JM, Van Belle E, Van Craenenbroeck EM, Vidal-Perez R, Winther S, ESC Scientific Document Group 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024 Sep 29;45(36):3415-3537. doi: 10.1093/eurheartj/ehae177.
  • Teles RC, Van Belle E, Parma R, Tarantini G, van Mieghem N, Mylotte D, Silva JD, O’Connor S, Sondegaard L, Luz A, Amat-Santos IJ, Arzamendi D, Blackman D, De Backer O, Kunadian V, Buchanan GL, MacCarthy P, Lurz P, Naber C, Chieffo A, Paradies V, Gilard M, Vincent F, Fraccaro C, Mehilli J, Giannini C, Silva B, Poliacikova P, Karam N, Veulemans V, Thiele H, Pilgrim T, van Wely M, James S, Schmidt MR, Uebing A, Ruck A, Ghanem A, Ghazzal Z, Joshi FR, Favero L, Hermanides R, Ninios V, Fovino LN, Nuis RJ, Deharo P, Kala P, Elbaz-Greener G, Tchetche D, Agricola E, Thielmann M, Donal E, Bonaros N, Droogmans S, Czerny M, Baumbach A, Barbato E, Dudek D Percutaneous Valvular and Structural Heart Disease Interventions. 2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. EuroIntervention. 2024 Aug 30:EIJ-D-23-00983. doi: 10.4244/EIJ-D-23-00983.
  • Patel R, Wadid M, Makwana B, Kumar A, Khadke S, Bhatti A, Banker A, Husami Z, Labib S, Venesy D, Fonarow G, Kosiborod M, Al-Kindi S, Bhatt DL, Dani S, Nohria A, Butler J, Ganatra S GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors. JACC Heart Fail. 2024 Nov;12(11):1814-1826. doi: 10.1016/j.jchf.2024.07.006. Epub 2024 Aug 28.
  • DeFilippis AP, Abbott JD, Herbert BM, Bertolet MH, Chaitman BR, White HD, Goldsweig AM, Polonsky TS, Gupta R, Alsweiler C, Silvain J, de Barros E Silva PGM, Hillis GS, Daneault B, Tessalee M, Menegus MA, Rao SV, Lopes RD, Hebert PC, Alexander JH, Brooks MM, Carson JL, Goodman SG, MINT Investigators Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial. Circulation. 2024 Dec 3;150(23):1826-1836. doi: 10.1161/CIRCULATIONAHA.124.071208. Epub 2024 Aug 29.
  • deFilippi CR, Shah P, Shah SJ, Alemayehu W, Lam CSP, Butler J, Roessig L, O’Connor CM, Westerhout CM, Armstrong PW, VITALITY-HFpEF Study Group Proteomics Identify Clinical Phenotypes and Predict Functional Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From VITALITY-HFpEF. Circ Heart Fail. 2024 Sep;17(9):e011792. doi: 10.1161/CIRCHEARTFAILURE.124.011792. Epub 2024 Aug 29.
  • Zahr F, Elmariah S, Vemulapalli S, Kodali SK, Hahn RT, Anderson AS, Eleid MF, Davidson CJ, Sharma RP, O’Neill WW, Bethea B, Thourani VH, Chakravarty T, Gupta A, Makkar RR Impact of Tricuspid Regurgitation on Outcomes of Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves. JACC Cardiovasc Interv. 2024 Aug 26;17(16):1916-1931. doi: 10.1016/j.jcin.2024.07.005.
  • Reinhardt SW, Gibson DN, Hsu JC, Kapadia SR, Yeh RW, Price MJ, Piccini JP, Nair DG, Christen T, Allocco DJ, Freeman JV Anticoagulation Alone vs Anticoagulation Plus Aspirin or DAPT Following Left Atrial Appendage Occlusion. J Am Coll Cardiol. 2024 Sep 3;84(10):889-900. doi: 10.1016/j.jacc.2024.05.067.
  • Van Spall HGC, Bastien A, Gersh B, Greenberg B, Mohebi R, Min J, Strauss K, Thirstrup S, Zannad F The role of early-phase trials and real-world evidence in drug development. Nat Cardiovasc Res. 2024 Feb;3(2):110-117. doi: 10.1038/s44161-024-00420-4. Epub 2024 Feb 15.
  • Iacobescu L, Ciobanu AO, Macarie R, Vadana M, Ciortan L, Tucureanu MM, Butoi E, Simionescu M, Vinereanu D Diagnostic and Prognostic Role of Circulating microRNAs in Patients with Coronary Artery Disease-Impact on Left Ventricle and Arterial Function. Curr Issues Mol Biol. 2024 Aug 3;46(8):8499-8511. doi: 10.3390/cimb46080500.
  • Roger G, Ducrocq G, Mesnier J, Sayah N, Abtan J, Ferrari R, Ford I, Fox KM, Tardif JC, Tendera M, Feldman LJ, Elbez Y, Steg PG, CLARIFY Investigators Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry. Eur Heart J. 2024 Jul 12;45(27):2396-2406. doi: 10.1093/eurheartj/ehae299.
  • Sposato LA, Gupta AK, Wu KC JAHA Spotlight on Neurocardiology: An Emerging Field Gaining Traction Among Neurologists and Cardiologists. J Am Heart Assoc. 2024 Sep 3;13(17):e038026. doi: 10.1161/JAHA.124.038026. Epub 2024 Aug 27.
  • Psaltis PJ, Nguyen MT, Singh K, Sinhal A, Wong DTL, Alcock R, Rajendran S, Dautov R, Barlis P, Patel S, Salagaras T, Marathe JA, Bursill CA, Montarello NJ, Nidorf SM, Thompson PL, Butters J, Cuthbert AR, Yelland LN, Ottaway JL, Kataoka Y, Di Giovanni G, Nicholls SJ Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction. Cardiovasc Res. 2024 Aug 27:cvae191. doi: 10.1093/cvr/cvae191.
  • von Haehling S, Doehner W, Evertz R, Garfias-Veitl T, Derad C, Diek M, Karakas M, Birkemeyer R, Fillippatos G, Lainscak M, Butler J, Ponikowski P, Bohm M, Friede T, Anker SD Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trial. Eur Heart J. 2024 Oct 5;45(37):3789-3800. doi: 10.1093/eurheartj/ehae479.
  • Oskouie S, Pandey A, Sauer AJ, Greene SJ, Mullens W, Khan MS, Quinn KL, Ho JE, Albert NM, Van Spall HG From Hospital to Home: Evidence-Based Care for Worsening Heart Failure. JACC Adv. 2024 Jul 31;3(9):101131. doi: 10.1016/j.jacadv.2024.101131. eCollection 2024 Sep.
  • Jaeger BC, Welden S, Lenoir K, Speiser JL, Segar MW, Pandey A, Pajewski NM Accelerated and Interpretable Oblique Random Survival Forests. J Comput Graph Stat. 2024;33(1):192-207. doi: 10.1080/10618600.2023.2231048.
  • Ortega-Paz L, Franchi F, Rollini F, Galli M, Been L, Ghanem G, Shalhoub A, Ossi T, Rivas A, Zhou X, Pineda AM, Suryadevara S, Soffer D, Zenni MM, Mahowald MK, Langaee T, Jakubowski JA, Cavallari LH, Angiolillo DJ Clopidogrel-Mediated P2Y(12) Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD. JACC Basic Transl Sci. 2024 Mar 25;9(7):865-876. doi: 10.1016/j.jacbts.2024.03.003. eCollection 2024 Jul.
  • Yang M, Kondo T, Anand IS, de Boer RA, Campbell RT, Kober L, Lam CSP, Maggioni AP, Martinez FA, O’Meara E, Packer M, Sabatine MS, Kerr Saraiva JF, Shah SJ, Zannad F, Zile MR, Jhund PS, Solomon SD, McMurray JJV Clinical characteristics and outcomes of patients aged 80 years and over with heart failure: Need for better treatment. Eur J Heart Fail. 2024 Aug 21. doi: 10.1002/ejhf.3417.
  • Medranda GA, Faraz HA, Thompson JB, Zhang Y, Bharadwaj AS, Osborn EA, Abu-Much A, Lansky AJ, Basir MB, Moses JW, O’Neill WW, Grines CL, Baron SJ Association of Preprocedural SYNTAX Score With Outcomes in Impella-Assisted High-Risk Percutaneous Coronary Intervention. J Soc Cardiovasc Angiogr Interv. 2024 Apr 17;3(8):101981. doi: 10.1016/j.jscai.2024.101981. eCollection 2024 Aug.
  • Mittleider D, Gibson CM, Dexter D Outcomes From Mechanical Thrombectomy for Deep Vein Thrombosis: Insights From the PINC AI Healthcare Database. J Soc Cardiovasc Angiogr Interv. 2024 Jul 25;3(8):102149. doi: 10.1016/j.jscai.2024.102149. eCollection 2024 Aug.
  • Pompei G, Ganzorig N, Kotanidis CP, Alkhalil M, Collet C, Sinha A, Perera D, Beltrame J, Kunadian V Novel diagnostic approaches and management of coronary microvascular dysfunction. Am J Prev Cardiol. 2024 Jul 22;19:100712. doi: 10.1016/j.ajpc.2024.100712. eCollection 2024 Sep.
  • Weir MR, Rossignol P, Pitt B, Lund LH, Coats AJS, Filippatos G, Perrin A, Waechter S, Budden J, Kosiborod M, Metra M, Boehm M, Ezekowitz JA, Bayes-Genis A, Mentz RJ, Ponikowski P, Senni M, Castro-Montes E, Nicolau JC, Parkhomenko A, Seferovic P, Cohen-Solal A, Anker SD, Butler J Patiromer-Facilitated Renin-Angiotensin-Aldosterone System Inhibitor Utilization in Patients with Heart Failure with or without Comorbid Chronic Kidney Disease: Subgroup Analysis of DIAMOND Randomized Trial. Am J Nephrol. 2024;55(6):672-689. doi: 10.1159/000540453. Epub 2024 Aug 19.
  • Nadarajah R, Ludman P, Laroche C, Appelman Y, Brugaletta S, Budaj A, Bueno H, Huber K, Kunadian V, Leonardi S, Lettino M, Milasinovic D, Clegg A, Gale CP Presentation, care, coronary intervention and outcomes of patients with NSTEMI according to age: insights from the international prospective ACVC-EAPCI EORP NSTEMI registry. Age Ageing. 2024 Aug 6;53(8):afae179. doi: 10.1093/ageing/afae179.
  • Hashem A, Khalouf A, Mohamed MS, Nayfeh T, Elkhapery A, Zahid S, Altibi A, Thyagaturu H, Kashou A, Anavekar NS, Gulati M, Balla S Racial, ethnic and sex disparity in acute heart failure patients with COVID-19: A nationwide analysis. Heliyon. 2024 Jul 20;10(15):e34513. doi: 10.1016/j.heliyon.2024.e34513. eCollection 2024 Aug 15.
  • Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WW, Haris A, Hsiao LL, Khalife M, Kumaraswami LA, Loud F, Raghavan V, Roumeliotis S, Sierra M, Ulasi I, Wang B, Fai Lui S, Liakopoulos V, Balducci A Mind the Gap in Kidney Care: Translating What We Know into What We Do. Indian J Nephrol. 2024 Jul-Aug;34(4):281-290. doi: 10.25259/IJN_145_2024. Epub 2024 Jun 29.
  • Jagannathan R, Anand S, Kondal D, Han J, Montez-Rath M, Ali MK, Patel SA, Singh K, Shivashankar R, Anjana RM, Gupta R, Mohan S, Chertow GM, Mohan V, Tandon N, Venkat Narayan KM, Prabhakaran D Prospective Study on Kidney Dysfunction Markers and Risk for Mortality among South Asians. Kidney Int Rep. 2024 May 29;9(8):2537-2545. doi: 10.1016/j.ekir.2024.05.025. eCollection 2024 Aug.
  • Guedeney P, Rodes-Cabau J, Ten Berg JM, Windecker S, Angiolillo DJ, Montalescot G, Collet JP Antithrombotic therapy for transcatheter structural heart intervention. EuroIntervention. 2024 Aug 19;20(16):972-986. doi: 10.4244/EIJ-D-23-01084.
  • Cikes M, Yuzefpolskaya M, Gustafsson F, Mehra MR Antithrombotic Strategies With Left Ventricular Assist Devices. J Card Fail. 2024 Nov;30(11):1489-1495. doi: 10.1016/j.cardfail.2024.07.024. Epub 2024 Aug 16.
  • Serpa F, Rivera A, Fernandes JM, Braga MAP, Araujo B, Ferreira Felix I, Ferro EG, Zimetbaum PJ, d’Avila A, Kramer DB Intracardiac vs transesophageal echocardiography for left atrial appendage occlusion: An updated systematic review and meta-analysis. Heart Rhythm. 2024 Aug 16:S1547-5271(24)03145-X. doi: 10.1016/j.hrthm.2024.08.027.
  • Williamson AE, Liyanage S, Hassanshahi M, Dona MSI, Toledo-Flores D, Tran DXA, Dimasi C, Schwarz N, Fernando S, Salagaras T, Long A, Kazenwadel J, Harvey NL, Drummond GR, Vinh A, Chandrakanthan V, Misra A, Neufeld Z, Tan JTM, Martelotto L, Polo JM, Bonder CS, Pinto AR, Sharma S, Nicholls SJ, Bursill CA, Psaltis PJ Discovery of an embryonically derived bipotent population of endothelial-macrophage progenitor cells in postnatal aorta. Nat Commun. 2024 Aug 17;15(1):7097. doi: 10.1038/s41467-024-51637-7.
  • Parsa S, Jain SS, Akinrimisi O, Lam CSP, Mahaffey KW Milvexian: An Oral, Bioavailable Factor XIa Inhibitor. Cardiol Ther. 2024 Dec;13(4):645-661. doi: 10.1007/s40119-024-00379-0. Epub 2024 Aug 17.
  • Cavallari LH, Lee CR, Franchi F, Keeley EC, Rossi JS, Thomas CD, Gong Y, McDonough CW, Starostik P, Al Saeed MJ, Been L, Kulick N, Malave J, Mulrenin IR, Nguyen AB, Terrell JN, Tillotson G, Beitelshees AL, Winterstein AG, Stouffer GA, Angiolillo DJ Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry – Informing optimal antiplatelet strategies. Clin Transl Sci. 2024 Aug;17(8):e70004. doi: 10.1111/cts.70004.
  • Chertow GM, Heerspink HL, Mark PB, Dwyer JP, Nowicki M, Wheeler DC, Correa-Rotter R, Rossing P, Toto RD, Langkilde AM, Jongs N Effects of Dapagliflozin in Patients with Membranous Nephropathy. Glomerular Dis. 2024 Jun 21;4(1):137-145. doi: 10.1159/000539770. eCollection 2024 Jan-Dec.
  • Rastogi A, Collins A, Kelepouris E, Kotzker W, Middleton JP, Rajpal M, Roy-Chaudhury P, Chertow GM Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists. J Prim Care Community Health. 2024 Jan-Dec;15:21501319241259905. doi: 10.1177/21501319241259905.
  • O’Reilly RL, Burke J, Harraka P, Yeh P, Howlett K, Behrouzfar K, Rewse A, Tsimiklis H, Giles GG, Bubb KJ, Nicholls SJ, Milne RL, Southey MC Saliva-derived DNA is suitable for the detection of clonal haematopoiesis of indeterminate potential. Sci Rep. 2024 Aug 14;14(1):18917. doi: 10.1038/s41598-024-69398-0.
  • Hamo CE, DeJong C, Hartshorne-Evans N, Lund LH, Shah SJ, Solomon S, Lam CSP Heart failure with preserved ejection fraction. Nat Rev Dis Primers. 2024 Aug 14;10(1):55. doi: 10.1038/s41572-024-00540-y.
  • Montone RA, Rinaldi R, Niccoli G, Ando G, Gragnano F, Piccolo R, Pelliccia F, Moscarella E, Zimarino M, Fabris E, de Rosa S, Calabro P, Porto I, Burzotta F, Grigioni F, Barbato E, Chieffo A, Capodanno D, Al-Lamee R, Ford TJ, Brugaletta S, Indolfi C, Sinagra G, Perrone Filardi P, Crea F, Interventional Cardiology Working Group of the Italian Society of Cardiology Optimizing Management of Stable Angina: A Patient-Centered Approach Integrating Revascularization, Medical Therapy, and Lifestyle Interventions. J Am Coll Cardiol. 2024 Aug 20;84(8):744-760. doi: 10.1016/j.jacc.2024.06.015.
  • Edmonston D, Mulder H, Lydon E, Chiswell K, Lampron Z, Shay C, Marsolo K, Shah RC, Jones WS, Gordon H, Hwang W, Ayoub I, Ford D, Chamberlain A, Rao A, Fonseca V, Chang A, Ahmad F, Hung A, Hunt K, Butler J, Bosworth HB, Pagidipati N Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes. J Am Coll Cardiol. 2024 Aug 20;84(8):696-708. doi: 10.1016/j.jacc.2024.06.016.
  • Cohoon KP, Porres-Aguilar M, Tomihama RT, Thomas SE, Buckley A, Rogers E, Brunton NE, Henkin S, Hornacek D, Secemsky EA Steering the multidisciplinary landscape of vascular medicine: Collaboration as the key to success for aspiring vascular medicine specialists. Vasc Med. 2024 Aug;29(4):462-466. doi: 10.1177/1358863X241262723.
  • Bakker WM, Gansevoort RT, Yang C, Chertow GM, Heerspink HJL, Vart P Sodium-Glucose Cotransporter 2 Inhibitors in Older Patients with CKD. J Am Soc Nephrol. 2024 Oct 1;35(10):1446-1449. doi: 10.1681/ASN.0000000000000466. Epub 2024 Jul 29.
  • Kobayashi T, Secemsky EA, Klein AJ, Faintuch S, Bulman JC, Weinstein JL, Bitton-Faiwiszewski Y, Bisharat M, Metzger DC, Rosenberg RD, Weinberg I, Vadlamudi V, Matthai WH Jr, Saleh A, Cristea E, Lansky AJ, Giri J A Safety and Feasibility Single-Arm Study of a Novel Catheter Thrombectomy Device for the Treatment of Pulmonary Embolism (ENGULF). J Soc Cardiovasc Angiogr Interv. 2024 May 3;3(6):102049. doi: 10.1016/j.jscai.2024.102049. eCollection 2024 Jun.
  • Lerakis S, Kini AS, Giustino G, Anastasius M, Asch FM, Weissman NJ, Grayburn PA, Kar S, Lim DS, Mishell JM, Whisenant BK, Rinaldi MJ, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Tang GHL, Li Y, Alu MC, Lindenfeld J, Abraham WT, Sharma SK, Mack MJ, Stone GW Changes in Left Ventricular Function and Outcomes After Trancatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation. J Soc Cardiovasc Angiogr Interv. 2024 Feb 23;3(5):101345. doi: 10.1016/j.jscai.2024.101345. eCollection 2024 May.
  • Butala NM, Waldo SW, Secemsky EA, Kennedy KF, Spertus JA, Rymer JA, Rao SV, Messenger JC, Yeh RW Use of Calcium Modification During Percutaneous Coronary Intervention After Introduction of Coronary Intravascular Lithotripsy. J Soc Cardiovasc Angiogr Interv. 2024 Jan 22;3(2):101254. doi: 10.1016/j.jscai.2023.101254. eCollection 2024 Feb.
  • Rymer J, Alhanti B, Kemp S, Bhatt DL, Kochar A, Angiolillo DJ, Diaz M, Garratt KN, Wimmer NJ, Waksman R, Kirtane AJ, Ang L, Bach R, Barker C, Jenkins R, Basir MB, Sullivan A, El-Sabae H, Brothers L, Ohman EM, Jones WS, Washam JB, Wang TY Risk of Bleeding Among Cangrelor-Treated Patients Administered Upstream P2Y(12) Inhibitor Therapy: The CAMEO Registry. J Soc Cardiovasc Angiogr Interv. 2023 Nov 27;3(2):101202. doi: 10.1016/j.jscai.2023.101202. eCollection 2024 Feb.
  • Estevez-Loureiro R, Shah N, Raposeiras-Roubin S, Kotinkaduwa LN, Madhavan MV, Gray WA, Lindenfeld J, Adamo M, Abraham WT, Freixa X, Grayburn PA, Arzamendi D, Kar S, Benito-Gonzalez T, Lim DS, Montefusco A, Redfors B, Pascual I, Nombela-Franco L, Rodes-Cabau J, Shuvy M, Monivas V, Godino C, Mack MJ, Bedogni F, Stone GW Cross-Validation of Risk Scores for Patients Undergoing Transcatheter Edge-to-Edge Repair for Mitral Regurgitation. J Soc Cardiovasc Angiogr Interv. 2023 Nov 27;3(2):101227. doi: 10.1016/j.jscai.2023.101227. eCollection 2024 Feb.
  • Gupta T, DeVries JT, Gilani F, Hassan A, Ross CS, Dauerman HL Temporal Trends in Transcatheter Aortic Valve Replacement for Isolated Severe Aortic Stenosis. J Soc Cardiovasc Angiogr Interv. 2024 Apr 5;3(7):101861. doi: 10.1016/j.jscai.2024.101861. eCollection 2024 Jul.
  • Siddiqui SA, Kazemian S, Gupta T, Patel NK, Sakhuja R, Inglessis I, Jassar A, Langer N, Passeri JJ, Dauerman HL, Elmariah S, Kolte D Outcomes of Transcatheter Aortic Valve Replacement Using Third-Generation Balloon-Expandable Versus Self-Expanding Valves: A Meta-analysis. J Soc Cardiovasc Angiogr Interv. 2024 May 22;3(7):102146. doi: 10.1016/j.jscai.2024.102146. eCollection 2024 Jul.
  • Drachman DE, Addo T, Applegate RJ, Bartel RC, Bortnick AE, Dea FM, Helmy T, Henry TD, Khalif A, Kirtane AJ, Levy M, Lim MJ, Mahmud E, Mihatov N, Parikh SA, Porter L, Prasad A, Rao SV, Razzouk L, Shah S, Shroff A, Tamis-Holland JE, Velagapudi P, Welt FG, Abbott JD The Path to a Match for Interventional Cardiology Fellowship: A Major SCAI Initiative. J Soc Cardiovasc Angiogr Interv. 2024 May 28;3(7):101980. doi: 10.1016/j.jscai.2024.101980. eCollection 2024 Jul.
  • Secemsky EA, Aronow HD, Kwolek CJ, Meissner M, Muck PE, Parikh SA, Winokur RS, George JC, Salazar G, Murphy EH, Costantino MM, Zhou W, Li J, Lookstein R, Desai KR Intravascular Ultrasound Use in Peripheral Arterial and Deep Venous Interventions: Multidisciplinary Expert Opinion From SCAI/AVF/AVLS/SIR/SVM/SVS. J Soc Cardiovasc Angiogr Interv. 2024 Jan 9;3(1):101205. doi: 10.1016/j.jscai.2023.101205. eCollection 2024 Jan.
  • Ortega-Paz L, Bikdeli B Endovascular Therapies for Pulmonary Embolism: A Landscape of Uncertainties and Opportunities. J Soc Cardiovasc Angiogr Interv. 2023 Nov 11;3(1):101221. doi: 10.1016/j.jscai.2023.101221. eCollection 2024 Jan.
  • Medranda GA, Baron SJ Optimizing the Management of Conduction Disturbances After Self-Expanding TAVR: A Step in the Right Direction. J Soc Cardiovasc Angiogr Interv. 2023 Nov 27;3(1):101250. doi: 10.1016/j.jscai.2023.101250. eCollection 2024 Jan.
  • Goto S, Goto S Extensive lipid lowering, thickness of the fibrous caps, and plaque stability. Eur Heart J Open. 2024 Jul 3;4(4):oeae056. doi: 10.1093/ehjopen/oeae056. eCollection 2024 Jul.
  • Sandoval Y, Cigarroa JE, Dangas GD, Lansky AJ, Naidu SS, Rao SV, Seto AH, Shah S, Shroff AR, Toleva O, Tremmel JA, Riley RF, Henry TD, Baumgard CS, Bijoux I, Cavaliere L, Culbertson C, Deible R, El-Sabban M, Jackson J, Jackson M, Kalich B, Long V, Newell A, Perkins D, Ramakrishnan K, Russell K, Sharma V, West NEJ, Whalen-Morton C, Underwood P, Winterfeldt K, Wojcik C, Zizzo S, SCAI 2023 Think Tank Coronary Consortium Coronary Microvascular Dysfunction. J Soc Cardiovasc Angiogr Interv. 2023 Dec 4;3(3Part A):101230. doi: 10.1016/j.jscai.2023.101230. eCollection 2024 Mar.
  • Almarzooq ZI, Li S, Song Y, Secemsky EA, Pinto DS, Yeh RW Are There Disparities in the Utilization of the Impella Device in Acute Myocardial Infarction and Cardiogenic Shock in the United States? J Soc Cardiovasc Angiogr Interv. 2024 Apr 2;3(4):101336. doi: 10.1016/j.jscai.2024.101336. eCollection 2024 Apr.
  • Perpetua EM, Palmer R, Le VT, Al-Khatib SM, Beavers CJ, Beckman JA, Bozkurt B, Coylewright M, Lloyd Doherty C, Guibone KA, Hawkey M, Keegan PA, Kirkpatrick JN, Laperle J, Lauck SB, Levine G, Lindman BR, Mack MJ, Price AL, Strong S, Wyman JF, Youmans QR, Gulati M JACC: Advances Expert Panel Perspective: Shared Decision-Making in Multidisciplinary Team-Based Cardiovascular Care. JACC Adv. 2024 Jul 3;3(7):100981. doi: 10.1016/j.jacadv.2024.100981. eCollection 2024 Jul.
  • Gibson CM Reducing Inferiority in the Design, Conduct, Analysis, Reporting, and Interpretation of Noninferiority Trials. JACC Adv. 2024 Jun 4;3(7):101026. doi: 10.1016/j.jacadv.2024.101026. eCollection 2024 Jul.
  • Divakaran S, Li S, Song Y, Krawisz AK, Carroll BJ, Secemsky EA Underutilization of supervised exercise therapy for symptomatic peripheral artery disease among Medicare beneficiaries. Vasc Med. 2024 Oct;29(5):559-560. doi: 10.1177/1358863X241266859. Epub 2024 Aug 12.
  • Hollenberg SM, Stevenson LW, Ahmad T, Bozkurt B, Butler J, Davis LL, Drazner MH, Kirkpatrick JN, Morris AA, Page RL 2nd, Siddiqi HK, Storrow AB, Teerlink JR, Writing Committee 2024 ACC Expert Consensus Decision Pathway on Clinical Assessment, Management, and Trajectory of Patients Hospitalized With Heart Failure Focused Update: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2024 Sep 24;84(13):1241-1267. doi: 10.1016/j.jacc.2024.06.002. Epub 2024 Aug 8.
  • Kittleson MM, Breathett K, Ziaeian B, Aguilar D, Blumer V, Bozkurt B, Diekemper RL, Dorsch MP, Heidenreich PA, Jurgens CY, Khazanie P, Koromia GA, Van Spall HGC, Writing Committee Members 2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures. J Am Coll Cardiol. 2024 Sep 17;84(12):1123-1143. doi: 10.1016/j.jacc.2024.05.014. Epub 2024 Aug 8.
  • Agiro A, Cook E, Mu F, Greatsinger A, Chen J, Zhao A, Louden E, Colman E, Desai P, Chertow GM Hyperkalemia and Risk of CKD Progression: A Propensity Score-Matched Analysis. Kidney360. 2024 Dec 1;5(12):1824-1834. doi: 10.34067/KID.0000000000000541. Epub 2024 Aug 9.
  • Cao TH, Tay WT, Jones DJL, Cleland JGF, Tromp J, Emmens JE, Teng TK, Chandramouli C, Slingsby OC, Anker SD, Dickstein K, Filippatos G, Lang CC, Metra M, Ponikowski P, Samani NJ, Van Veldhuisen DJ, Zannad F, Anand IS, Lam CSP, Voors AA, Ng LL Heart failure with improved versus persistently reduced left ventricular ejection fraction: A comparison of the BIOSTAT-CHF (European) study with the ASIAN-HF registry. Eur J Heart Fail. 2024 Dec;26(12):2518-2528. doi: 10.1002/ejhf.3378. Epub 2024 Aug 9.
  • Hamid A, Yimer WK, Oshunbade AA, Khan MS, Kamimura D, Kipchumba RK, Pandey A, Clark D 3rd, Mentz RJ, Fox ER, Berry JD, Stacey RB, Shah A, Correa A, Virani SS, Butler J, Hall ME Trajectory of C-Reactive Protein and Incident Heart Failure in Black Adults: The Jackson Heart Study. Circ Heart Fail. 2024 Aug;17(8):e011199. doi: 10.1161/CIRCHEARTFAILURE.123.011199. Epub 2024 Aug 9.
  • Campos C, Magwire M, Butler J, Hoovler A, Sabharwal A, Shah SJ Diagnostic and therapeutic challenges for PCPs regarding heart failure with preserved ejection fraction and obesity: results of an online internet-based survey. BMC Prim Care. 2024 Aug 8;25(1):288. doi: 10.1186/s12875-024-02549-4.
  • Kittleson MM, Breathett K, Ziaeian B, Aguilar D, Blumer V, Bozkurt B, Diekemper RL, Dorsch MP, Heidenreich PA, Jurgens CY, Khazanie P, Koromia GA, Van Spall HGC 2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures. Circ Cardiovasc Qual Outcomes. 2024 Sep;17(9):e000132. doi: 10.1161/HCQ.0000000000000132. Epub 2024 Aug 8.
  • Gibson CM, Beard MM, Escano AK, Good BL, Potter TG, Truong AM, Van Tassell B Metolazone Versus Chlorothiazide in Acute Heart Failure Patients With Diuretic Resistance and Renal Dysfunction: A Retrospective Cohort Study. J Cardiovasc Pharmacol. 2024 Oct 1;84(4):451-456. doi: 10.1097/FJC.0000000000001623.
  • Neves JS, Zannad F, Butler J, Packer M, Ferreira JP Should the SELECT Trial Make Us Comfortable Using GLP-1 Receptor Agonists in HFrEF? J Am Coll Cardiol. 2024 Sep 17;84(12):1119-1122. doi: 10.1016/j.jacc.2024.06.026. Epub 2024 Aug 7.
  • Rao VN, Hellkamp AS, Thomas LE, Fonarow GC, Fiuzat M, O’Connor CM, Spertus JA, Desai AS, Albert NM, Butler J, Hernandez AF, DeVore AD Optimal Medical Therapy and Outcomes Among Patients With Chronic Heart Failure With Reduced Ejection Fraction. JACC Heart Fail. 2024 Nov;12(11):1862-1875. doi: 10.1016/j.jchf.2024.05.026. Epub 2024 Aug 7.
  • Tercan H, van Broekhoven A, Bahrar H, Opstal T, Cossins BC, Rother N, Rodwell L, Bekkering S, El Messaoudi S, Riksen NP, Cornel JH The Effect of Low-Dose Colchicine on the Phenotype and Function of Neutrophils and Monocytes in Patients with Chronic Coronary Artery Disease: A Double-Blind Randomized Placebo-Controlled Cross-Over Study. Clin Pharmacol Ther. 2024 Nov;116(5):1325-1333. doi: 10.1002/cpt.3394. Epub 2024 Aug 8.
  • Villalobos-Pedroza M, Hernandez-Pastrana S, Arias-Mendoza A, Latapi-Ruiz Esparza X, Robles-Ledesma M, Guerrero-Ochoa A, Milanes-Gonzalez NA, Solis-Jimenez F, Sierra Gonzalez-De Cossio A, Flores-Batres AP, Brindis-Aranda AA, Rivera-Pedrote E, Jara-Nevarez A, Gonzalez-Macedo E, Gopar-Nieto R, Gonzalez-Pacheco H, Briseno-De la Cruz JL, Araiza-Garaygordobil D Adherence to optimal medical therapy and control of cardiovascular risk factors in patients after ST elevation myocardial infarction in Mexico. Front Cardiovasc Med. 2024 Jul 23;11:1384684. doi: 10.3389/fcvm.2024.1384684. eCollection 2024.
  • Iacobescu L, Ciobanu AO, Corlatescu AD, Simionescu M, Iacobescu GL, Dragomir E, Vinereanu D The Role of Circulating MicroRNAs in Cardiovascular Diseases: A Novel Biomarker for Diagnosis and Potential Therapeutic Targets? Cureus. 2024 Jul 8;16(7):e64100. doi: 10.7759/cureus.64100. eCollection 2024 Jul.
  • Chidambaram V, Kumar A, Sadaf MI, Lu E, Al’Aref SJ, Tarun T, Galiatsatos P, Gulati M, Blumenthal RS, Leucker TM, Karakousis PC, Mehta JL COVID-19 in the Initiation and Progression of Atherosclerosis: Pathophysiology During and Beyond the Acute Phase. JACC Adv. 2024 Jul 17;3(8):101107. doi: 10.1016/j.jacadv.2024.101107. eCollection 2024 Aug.
  • Kumar A, Dani S, Sharma A, Khadke S, Gulati M, Rajagopalan S, Al-Kindi SG, Ganatra S The projected impact of the inflation reduction act’s climate provisions on cardiovascular and respiratory outcomes. Am J Prev Cardiol. 2024 Jul 10;19:100707. doi: 10.1016/j.ajpc.2024.100707. eCollection 2024 Sep.
  • Kanbay M, Brinza C, Copur S, Sekreter O, Burlacu A, Tuttle KR, Rossing P, Covic A SGLT-2 inhibitors and nephrolithiasis risk: a meta-analysis. Nephrol Dial Transplant. 2024 Aug 7:gfae179. doi: 10.1093/ndt/gfae179.
  • Bocchi EA, Echeverria LE, Demacq C, de Barros E Silva PGM, Mazza Barbosa L, Chiang LM, Damiani L, Morillo CA, Kevorkian R, Ramires F, Bahit MC, Ferrari A, Chavez-Mendoza A, Magana-Serrano JA, McMurray JJV, Gimpelewicz C, Lopes RD, PARACHUTE-HF Investigators Sacubitril/Valsartan Versus Enalapril in Chronic Chagas Cardiomyopathy: Rationale and Design of the PARACHUTE-HF Trial. JACC Heart Fail. 2024 Aug;12(8):1473-1486. doi: 10.1016/j.jchf.2024.05.021.
  • Brunham LR, Lonn E, Mehta SR Dyslipidemia and the Current State of Cardiovascular Disease: Epidemiology, Risk Factors, and Effect of Lipid Lowering. Can J Cardiol. 2024 Aug;40(8S):S4-S12. doi: 10.1016/j.cjca.2024.04.017.
  • Tsukagoshi J, Bhuyan A, Secemsky EA, Shirasu T, Nakama T, Jujo K, Wiley J, Kuno T Procedural Feasibility and Peri-procedural Outcomes of Peripheral Endovascular Therapy via Transradial versus Transfemoral Access: A Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg. 2024 Nov;68(5):605-616. doi: 10.1016/j.ejvs.2024.07.036. Epub 2024 Aug 5.
  • Curtain JP, Pfeffer MA, Braunwald E, Claggett BL, Granger CB, Kober L, Lewis EF, Maggioni AP, Mann DL, Rouleau JL, Solomon SD, Steg PG, Finn PV, Fernandez A, Jering KS, McMurray JJV Rates of Sudden Death After Myocardial Infarction-Insights From the VALIANT and PARADISE-MI Trials. JAMA Cardiol. 2024 Oct 1;9(10):928-933. doi: 10.1001/jamacardio.2024.2356.
  • Fonarow GC, Patton KK, Yancy CW Changing the Frame of Post-AMI Left Ventricular Dysfunction: Sudden Cardiac Death, a Diminishing Complication. JAMA Cardiol. 2024 Oct 1;9(10):933-934. doi: 10.1001/jamacardio.2024.2362.
  • Koutroumpakis E, Patel R, Khadke S, Bedrosian A, Kumar A, Kong Y, Connell B, Upadhyay J, Dani SS, Hahn AW, Logothetis CJ, Al-Kindi S, Butler J, Nohria A, Ganatra S, Deswal A Associations of SGLT-2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone Therapy. Res Sq [Preprint]. 2024 Jul 26:rs.3.rs-4510870. doi: 10.21203/rs.3.rs-4510870/v1.
  • Marston NA, Pirruccello JP, Melloni GEM, Kamanu F, Bonaca MP, Giugliano RP, Scirica BM, Wiviott SD, Bhatt DL, Steg PG, Raz I, Braunwald E, Libby P, Ellinor PT, Bick AG, Sabatine MS, Ruff CT Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials. Nat Med. 2024 Sep;30(9):2641-2647. doi: 10.1038/s41591-024-03188-z. Epub 2024 Aug 6.
  • Wassberg C, Batra G, Hadziosmanovic N, Hagstrom E, White HD, Stewart RAH, Siegbahn A, Wallentin L, Held C Associations between psychosocial burden and prognostic biomarkers in patients with chronic coronary syndrome: a STABILITY substudy. Eur J Prev Cardiol. 2024 Aug 6:zwae252. doi: 10.1093/eurjpc/zwae252.
  • Anderson TS, Yeh RW, Herzig SJ, Marcantonio ER, Hatfield LA, Souza J, Landon BE Trends and Disparities in Ambulatory Follow-Up After Cardiovascular Hospitalizations : A Retrospective Cohort Study. Ann Intern Med. 2024 Sep;177(9):1190-1198. doi: 10.7326/M23-3475. Epub 2024 Aug 6.
  • Greene SJ, Butler J, Fonarow GC Rapid and Intensive Guideline-Directed Medical Therapy for Heart Failure: 5 Core Principles. Circulation. 2024 Aug 6;150(6):422-424. doi: 10.1161/CIRCULATIONAHA.124.070228. Epub 2024 Aug 5.
  • Ali A, Siddiqui AA, Shahid I, Van Spall HGC, Greene SJ, Fudim M, Khan MS Prognostic value of quality of life and functional status in patients with heart failure: a systematic review and meta-analysis. Egypt Heart J. 2024 Aug 5;76(1):97. doi: 10.1186/s43044-024-00532-z.
  • Angoulvant D, Granjeon-Noriot S, Amarenco P, Bastien A, Bechet E, Boccara F, Boissel JP, Cariou B, Courcelles E, Diatchenko A, Filipovics A, Kahoul R, Mahe G, Peyronnet E, Portal L, Porte S, Wang Y, Steg PG In-silico trial emulation to predict the cardiovascular protection of new lipid-lowering drugs: an illustration through the design of the SIRIUS programme. Eur J Prev Cardiol. 2024 Nov 11;31(15):1820-1830. doi: 10.1093/eurjpc/zwae254.
  • Goh RSJ, Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Kueh MTW, Shankar K, Li H, Chin YH, Kong G, Anand VV, Chan KA, Sukmawati I, Toh SA, Muthiah M, Wang JW, Tse G, Mehta A, Fong A, Baskaran L, Zhong L, Yap J, Yeo KK, Hausenloy DJ, Tan JWC, Chao TF, Li YH, Lim SL, Chan KH, Loh PH, Chai P, Yeo TC, Low AF, Lee CH, Foo R, Tan HC, Yip J, Rao S, Honda S, Yasuda S, Kajiya T, Goto S, Yan BP, Zhou X, Figtree GA, Mamas MA, Kim Y, Jeong YH, Kim MH, Park DW, Park SJ, Richards AM, Chan MY, Lip GYH, Chew NWS The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions. Lancet Reg Health West Pac. 2024 Jul 10;49:101138. doi: 10.1016/j.lanwpc.2024.101138. eCollection 2024 Aug.
  • Abdel-Razek O, El Khoury A, McGrail D, Laham RJ Successful transcatheter aortic valve replacement in a failing HAART 300 aortic valve annuloplasty ring: A case report. Catheter Cardiovasc Interv. 2024 Sep;104(3):629-632. doi: 10.1002/ccd.31177. Epub 2024 Aug 5.
  • Zomer E, Zhou J, Nelson AJ, Sumithran P, Nanayakkara S, Ball J, Kaye D, Liew D, Nicholls SJ, Stub D, Zoungas S The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetes. Eur Heart J Qual Care Clin Outcomes. 2024 Aug 2:qcae063. doi: 10.1093/ehjqcco/qcae063.
  • Gouda P, Liu Y, Butler J, Del Prato S, Ibrahim NE, Lam CSP, Marwick T, Rosenstock J, Tang W, Zannad F, Januzzi J, Ezekowitz J Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical siabetic cardiomyopathy. Cardiovasc Diabetol. 2024 Aug 2;23(1):281. doi: 10.1186/s12933-024-02378-w.
  • Fox J, Bond R, Matulewicz AT, Gibson CM, Sanders K, Dixon DL Exploring the Impact of Generation Status on Pharmacy Admissions: A Comparative Study of First-Generation and Continuing-Generation College Students. Am J Pharm Educ. 2024 Sep;88(9):101258. doi: 10.1016/j.ajpe.2024.101258. Epub 2024 Jul 31.
  • Wright RS, Ray KK, Landmesser U, Koenig W, Raal FJ, Leiter LA, Conde LG, Han J, Schwartz GG Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease: A Pooled Analysis of the ORION-10 and ORION-11 Randomized Trials. Mayo Clin Proc. 2024 Jul 5:S0025-6196(24)00167-8. doi: 10.1016/j.mayocp.2024.03.025.
  • Hummel J, Houmsse M, Tomassoni G, Nair D, Romero J, Hargrove J, Mathews K, Thakkar AB, Ullery S, Eapen ZJ, Kumar UN, Mehran R, Butler J, Jewel IDE Study Investigators A Patch Wearable Cardioverter-Defibrillator for Patients at Risk of Sudden Cardiac Arrest. J Am Coll Cardiol. 2024 Aug 6;84(6):525-536. doi: 10.1016/j.jacc.2024.04.063.
  • Wilcock AD, Zubizarreta JR, Wadhera RK, Yeh RW, Zachrison KS, Schwamm LH, Mehrotra A Factors Underlying Reduced Hospitalizations for Myocardial Infarction During the COVID-19 Pandemic. JAMA Cardiol. 2024 Oct 1;9(10):914-920. doi: 10.1001/jamacardio.2024.2031.
  • Guduguntla V, Bonow RO, Yancy CW Acute Myocardial Infarction Admissions During the COVID-19 Peak. JAMA Cardiol. 2024 Oct 1;9(10):920-921. doi: 10.1001/jamacardio.2024.2187.
  • Mentias A, Desai MY, Pandey A, Motairek I, Moudgil R, Albert C, Deo SV, Brook RD, Menon V, Rajagopalan S, Al-Kindi S Ambient Air Pollution Exposure and Adverse Outcomes Among Medicare Beneficiaries With Heart Failure. J Am Heart Assoc. 2024 Aug 6;13(15):e032902. doi: 10.1161/JAHA.123.032902. Epub 2024 Jul 31.
  • Tuttle KR, Bain SC, Bosch-Traberg H, Khunti K, Rasmussen S, Sokareva E, Cherney DZ Effects of Once-Weekly Semaglutide on Kidney Disease Outcomes by KDIGO Risk Category in the SUSTAIN 6 Trial. Kidney Int Rep. 2024 May 22;9(7):2006-2015. doi: 10.1016/j.ekir.2024.04.028. eCollection 2024 Jul.
  • Raines NH, Leone DA, Amador JJ, Lopez-Pilarte D, Ramirez-Rubio O, Delgado IS, Francey LJ, Leibler JH, Asara JM, Scammell MK, Parikh SM, Brooks DR, Friedman DJ Derangement in Nicotinamide Adenine Dinucleotide Metabolism is Observed During Acute Kidney Injury Among Male Agricultural Workers at Risk for Mesoamerican Nephropathy. Kidney Int Rep. 2024 Apr 18;9(7):2250-2259. doi: 10.1016/j.ekir.2024.04.027. eCollection 2024 Jul.
  • Ben Yehuda O, Itelman E, Vaisman A, Segal G, Lerner B Early Detection of Pulmonary Embolism in a General Patient Population Immediately Upon Hospital Admission Using Machine Learning to Identify New, Unidentified Risk Factors: Model Development Study. J Med Internet Res. 2024 Jul 30;26:e48595. doi: 10.2196/48595.
  • Pajewski NM, Beddhu S, Bress AP, Chang TI, Chertow GM, Cheung AK, Cushman WC, Freedman BI, Greene T, Johnson KC, Jaeger BC, Tamura MK, Lewis CE, Rahman M, Reboussin DM, Rocco MV, Williamson JD, Whelton PK, Wright JT Jr, Drawz PE, Ix JH The Legacy Effect of Intensive versus Standard BP Control on the Incidence of Needing Dialysis or Kidney Transplantation. J Am Soc Nephrol. 2024 Dec 1;35(12):1737-1745. doi: 10.1681/ASN.0000000000000459. Epub 2024 Jul 30.
  • Tromp J, Lam CSP, Alemayehu W, de Filippi CR, Melenovsky V, Sliwa K, Lopatin Y, Arango JL, Bahit MC, Roessig L, O’Connor CM, Shah P, Westerhout CM, Voors AA, Pieske B, Armstrong PW, VICTORIA Study Group Biomarker profiles associated with reverse ventricular remodelling in patients with heart failure and a reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trial. Eur J Heart Fail. 2024 Oct;26(10):2231-2239. doi: 10.1002/ejhf.3397. Epub 2024 Jul 30.
  • Bailey E, Lopes RD, Gibson CM, Eikelboom JW, Rao SV Factor XIa inhibition as a therapeutic strategy for atherothrombosis. J Thromb Thrombolysis. 2024 Dec;57(8):1297-1307. doi: 10.1007/s11239-024-03023-9. Epub 2024 Jul 29.
  • Singh A, Laffin LJ, Sarraju A, Michael Lincoff A, Nicholls SJ, Bloedon L, Sasiela WJ, Li N, Robinson P, Kelly S, Mason D, Nissen SE Impact of the COVID-19 Pandemic on Conduct and Results of CLEAR Outcomes Trial. Clin Cardiol. 2024 Aug;47(8):e24328. doi: 10.1002/clc.24328.
  • Khan MS, Talha KM, Maqsood MH, Rymer JA, Borlaug BA, Docherty KF, Pandey A, Kahles F, Cikes M, Lam CSP, Ducharme A, Voors AA, Hernandez AF, Lincoff AM, Petrie MC, Ridker PM, Fudim M Interleukin-6 and Cardiovascular Events in Healthy Adults: MESA. JACC Adv. 2024 Jul 9;3(8):101063. doi: 10.1016/j.jacadv.2024.101063. eCollection 2024 Aug.
  • Rubino F, Brugaletta S, Mills G, Pompei G, Scarsini R, Ribichini F, Raber L, Kunadian V Coronary Artery Plaque Phenotype and 5-Year Clinical Outcomes in Older Patients with Non-ST Elevation Acute Coronary Syndrome. Rev Cardiovasc Med. 2024 May 14;25(5):168. doi: 10.31083/j.rcm2505168. eCollection 2024 May.
  • Diao JA, Shi I, Murthy VL, Buckley TA, Patel CJ, Pierson E, Yeh RW, Kazi DS, Wadhera RK, Manrai AK Projected Changes in Statin and Antihypertensive Therapy Eligibility With the AHA PREVENT Cardiovascular Risk Equations. JAMA. 2024 Sep 24;332(12):989-1000. doi: 10.1001/jama.2024.12537.
  • Galli M, Occhipinti G, Ortega-Paz L, Franchi F, Rollini F, Brugaletta S, Capodanno D, Sciarretta S, Angiolillo DJ Therapeutic Potential of FXI Inhibitors: Hype or Hope? Drugs. 2024 Sep;84(9):1055-1070. doi: 10.1007/s40265-024-02049-w. Epub 2024 Jul 29.
  • Menard MT, Farber A, Doros G, McGinigle KL, Chisci E, Clavijo LC, Kayssi A, Schneider PA, Hawkins BM, Dake MD, Hamza T, Strong MB, Rosenfield K, Conte MS The impact of revascularization strategy on clinical failure, hemodynamic failure, and chronic limb-threatening ischemia symptoms in the BEST-CLI Trial. J Vasc Surg. 2024 Dec;80(6):1755-1765.e4. doi: 10.1016/j.jvs.2024.07.085. Epub 2024 Jul 26.
  • Shah P, Sayer G, Sinha SS, Kanwar MK, Cowger JA, Pagani FD, Nayak A, Mehra MR, Cleveland JC Jr, Psotka MA, Singh R, Desai SS, Lu Q, Hu Y, Connolly A, Kormos RL, Uriel N Dynamic Risk Estimation of Adverse Events in Ambulatory LVAD Patients: A MOMENTUM 3 Analysis. JACC Heart Fail. 2024 Nov;12(11):1898-1912. doi: 10.1016/j.jchf.2024.05.018. Epub 2024 Jul 24.
  • Milutinovic S, Bell A, Jancic P, Stanojevic D, Borghol AH, Mina J, Chebib FT, Khambati I, Escarcega RO, Wood MJ Spontaneous Coronary Artery Dissection in Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review of the Literature. J Pers Med. 2024 Jun 29;14(7):702. doi: 10.3390/jpm14070702.
  • Coats CJ, Masri A, Nassif ME, Barriales-Villa R, Arad M, Cardim N, Choudhury L, Claggett B, Dungen HD, Garcia-Pavia P, Hagege AA, Januzzi JL, Lee MMY, Lewis GD, Ma CS, Maron MS, Miao ZM, Michels M, Olivotto I, Oreziak A, Owens AT, Spertus JA, Solomon SD, Tfelt-Hansen J, van Sinttruije M, Veselka J, Watkins H, Jacoby DL, German P, Heitner SB, Kupfer S, Lutz JD, Malik FI, Meng L, Wohltman A, Abraham TP, SEQUOIA-HCM Investigators * Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM. J Am Heart Assoc. 2024 Aug 6;13(15):e035993. doi: 10.1161/JAHA.124.035993. Epub 2024 Jul 26.
  • Kapadia SR, Yeh RW, Price MJ, Piccini JP, Nair DG, Bansal A, Hsu JC, Freeman JV, Christen T, Allocco DJ, Gibson DN Outcomes With the WATCHMAN FLX in Everyday Clinical Practice From the NCDR Left Atrial Appendage Occlusion Registry. Circ Cardiovasc Interv. 2024 Sep;17(9):e013750. doi: 10.1161/CIRCINTERVENTIONS.123.013750. Epub 2024 Jul 26.
  • Pandey A, Zieroth S A simple tool to screen for heart failure with preserved ejection fraction. Nat Med. 2024 Aug;30(8):2127-2128. doi: 10.1038/s41591-024-03154-9.
  • Galli M, Laudani C, Occhipinti G, Spagnolo M, Gragnano F, D’Amario D, Navarese EP, Mehran R, Valgimigli M, Capodanno D, Angiolillo DJ P2Y12 inhibitor monotherapy after short DAPT in acute coronary syndrome: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2024 Nov 6;10(7):588-598. doi: 10.1093/ehjcvp/pvae057.
  • Gikandi A, Connors JM, Nabzdyk CG, Zenati MA Perioperative risks associated with administration of andexanet alfa during emergency cardiac surgery with circulatory arrest. Perfusion. 2024 Jul 25:2676591241268395. doi: 10.1177/02676591241268395.
  • Hatfield J, Woods MD, Hammonds K, Wahab L, Nguyen V, Hassan OA, Butler J, Widmer RJ Global hypokinesis in resting transthoracic echocardiography diagnosis of heart failure and coronary artery disease. J Invasive Cardiol. 2024 Dec;36(12). doi: 10.25270/jic/24.00192.
  • Ji H, Gulati M, Cheng S Reply: Sex Diversity in Physical Activity Benefits: Absolute and Relative Differences in Context. J Am Coll Cardiol. 2024 Jul 30;84(5):e35-e36. doi: 10.1016/j.jacc.2024.04.058.
  • Laudani C, Capodanno D, Angiolillo DJ The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic stroke. Expert Opin Pharmacother. 2024 Jul;25(10):1373-1390. doi: 10.1080/14656566.2024.2385135. Epub 2024 Aug 2.
  • El-Zein RS, Mohammed M, Nguyen DD, Hill CL Jr, Thomas L, Nassif M, DeVore AD, Albert NM, Butler J, Patterson JH, Williams FB, Hernandez A, Fonarow GC, Spertus JA Association of Medication Adherence and Health Status in Heart Failure With Reduced Ejection Fraction: Insights From the CHAMP-HF Registry. Circ Cardiovasc Qual Outcomes. 2024 Sep;17(9):e010211. doi: 10.1161/CIRCOUTCOMES.123.010211. Epub 2024 Jul 24.
  • Kang J, Yun J, Park KW, Park M, Park S, Hwang D, Han JK, Yang HM, Kang HJ, Koo BK, Angiolillo DJ, Urban P, Kim HS Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry. Eur Heart J. 2024 Sep 29;45(36):3721-3731. doi: 10.1093/eurheartj/ehae462.
  • Silva A, Edelstein S, Yang Y, Rosenbaum D, Battelli L, Chertow GM Tenapanor improves long-term control of high phosphate concentrations in the blood in patients receiving maintenance dialysis: a plain language summary of the NORMALIZE study. Curr Med Res Opin. 2024 Aug;40(8):1345-1356. doi: 10.1080/03007995.2024.2364824. Epub 2024 Jul 23.
  • Taylor SR, Connors JM, Venkataraman V Hyperfibrinolysis during the treatment of rhabdomyosarcoma. Res Pract Thromb Haemost. 2024 May 31;8(4):102467. doi: 10.1016/j.rpth.2024.102467. eCollection 2024 May.
  • Valgimigli M, Landi A, Angiolillo DJ, Baber U, Bhatt DL, Bonaca MP, Capodanno D, Cohen DJ, Gibson CM, James S, Kimura T, Lopes RD, Mehta SR, Montalescot G, Sibbing D, Steg PG, Stone GW, Storey RF, Vranckx P, Windecker S, Mehran R Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome. Circulation. 2024 Jul 23;150(4):317-335. doi: 10.1161/CIRCULATIONAHA.124.069012. Epub 2024 Jul 22.
  • Desai KR, Sabri SS, Elias S, Gagne PJ, Garcia MJ, Gibson K, Kiguchi MM, Mathews SJ, Murphy EH, Secemsky EA, Ting W, Kolluri R Consensus Statement on the Management of Nonthrombotic Iliac Vein Lesions From the VIVA Foundation, the American Venous Forum, and the American Vein and Lymphatic Society. Circ Cardiovasc Interv. 2024 Aug;17(8):e014160. doi: 10.1161/CIRCINTERVENTIONS.124.014160. Epub 2024 Jul 22.
  • Chouhan A, Bhat SN, Rao SV Comparison of the Influence of Intraoperative Use of Sevoflurane and Isoflurane on Postoperative Nausea, Vomiting, and Cough. Ann Afr Med. 2024 Jul 1;23(3):385-390. doi: 10.4103/aam.aam_26_24. Epub 2024 May 20.
  • Jefferies JL, Stavish CA, Silver MA, Butler J, Humes HD, Strobeck J Blood Volume Analysis and Cardiorenal Syndrome: From Bench to Bedside. Cardiorenal Med. 2024;14(1):483-497. doi: 10.1159/000540497. Epub 2024 Jul 20.
  • Gibson CM, Lacroix M, Hevener KE Professional Pharmacy Fraternities as a Mechanism for Cocurricular Learning: A Qualitative Analysis of Two Organizations. Am J Pharm Educ. 2024 Aug;88(8):101249. doi: 10.1016/j.ajpe.2024.101249. Epub 2024 Jul 18.
  • Soriano K, Jiang GY, Balkan L, Tamez H, Yeh RW Who Should Undergo Chronic Total Occlusions Percutaneous Coronary Intervention and When?: An Evidence-Based Approach to the Patient Referred for Percutaneous Coronary Intervention of Chronic Total Occlusion. Am J Cardiol. 2024 Sep 15;227:18-28. doi: 10.1016/j.amjcard.2024.07.017. Epub 2024 Jul 18.
  • AlSaeed MJ, Thomas CD, Franchi F, Keeley EC, Duarte JD, Gong Y, Rossi JS, Beitelshees AL, Stouffer GA, Lee CR, Angiolillo DJ, Cavallari LH Evaluating the Effect of Estimating Renal Function With the CKD-EPI 2021 Equation on the ABCD-GENE Score for Clopidogrel Response Prediction. Clin Pharmacol Ther. 2024 Nov;116(5):1227-1230. doi: 10.1002/cpt.3385. Epub 2024 Jul 19.
  • Levy JH, Shaw JR, Castellucci LA, Connors JM, Douketis J, Lindhoff-Last E, Rocca B, Samama CM, Siegal D, Weitz JI Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. J Thromb Haemost. 2024 Oct;22(10):2889-2899. doi: 10.1016/j.jtha.2024.07.009. Epub 2024 Jul 17.
  • Matasic DS, Zeitoun R, Fonarow GC, Razavi AC, Blumenthal RS, Gulati M Advancements in Incident Heart Failure Risk Prediction and Screening Tools. Am J Cardiol. 2024 Sep 15;227:105-110. doi: 10.1016/j.amjcard.2024.07.014. Epub 2024 Jul 18.
  • Godinez-Cordova LB, Gonzalez-Pacheco H, Eid-Lidt G, Manzur-Sandoval D, Gopar-Nieto R, Sierra-Lara-Martinez D, Cruz JLB, Araiza-Garaygordobil D, Mendoza-Garcia S, Altamirano-Castillo A, Arias-Mendoza A Prevalence and prognostic implications of the no-reflux phenomenon in patients undergoing primary percutaneous coronary intervention at a university center in a middle-income country. Arch Cardiol Mex. 2024;94(3):331-340. doi: 10.24875/ACM.23000120.
  • Maqsood MH, Yong CM, Rao SV, Cohen MG, Pancholy S, Bangalore S Procedural Outcomes With Femoral, Radial, Distal Radial, and Ulnar Access for Coronary Angiography: A Network Meta-Analysis. Circ Cardiovasc Interv. 2024 Sep;17(9):e014186. doi: 10.1161/CIRCINTERVENTIONS.124.014186. Epub 2024 Jul 19.
  • Shiyovich A, Berman AN, Besser SA, Biery DW, Cardoso R, Divakaran S, Singh A, Huck DM, Weber B, Plutzky J, Cannon C, Nasir K, Di Carli MF, Januzzi JL, Bhatt DL, Blankstein R Lipoprotein(a) as a cardiovascular risk factor among patients with and without diabetes Mellitus: the Mass General Brigham Lp(a) Registry. Cardiovasc Diabetol. 2024 Jul 18;23(1):257. doi: 10.1186/s12933-024-02348-2.
  • Cohen LP, Januzzi JL No Matter the Breakdown, Heart Failure Is Costly: Heart Failure Costs and Cost-Offsets by Subtype. JACC Heart Fail. 2024 Aug;12(8):1422-1424. doi: 10.1016/j.jchf.2024.05.023. Epub 2024 Jul 17.
  • Vranckx P, Morrow D, van Diepen S, Verbrugge F Revolutionizing cardiac care: insights into shock prognosis, myocardial infarction management, and platelet inhibition. Eur Heart J Acute Cardiovasc Care. 2024 Aug 28;13(8):593-594. doi: 10.1093/ehjacc/zuae083.
  • Ahmed-Jushuf F, Chotai S, Al-Lamee RK Does REVIVED Complete You? J Am Coll Cardiol. 2024 Jul 23;84(4):351-353. doi: 10.1016/j.jacc.2024.05.024.
  • Biegus J, Mebazaa A, Davison B, Cotter G, Edwards C, Celutkiene J, Chioncel O, Cohen-Solal A, Filippatos G, Novosadova M, Sliwa K, Adamo M, Arrigo M, Lam CSP, Ter Maaten JM, Deniau B, Barros M, Cerlinskaite-Bajore K, Damasceno A, Diaz R, Gayat E, Kimmoun A, Pang PS, Pagnesi M, Saidu H, Takagi K, Tomasoni D, Voors AA, Metra M, Ponikowski P Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF. J Am Coll Cardiol. 2024 Jul 23;84(4):323-336. doi: 10.1016/j.jacc.2024.04.055.
  • Heerspink HJL, Perkovic V, Tuttle KR, Pergola PE, Mahaffey KW, Patel UD, Ishida JH, Kuo A, Chen F, Kustra R, Petrovic V, Rossing P, Kashihara N, Chertow GM Selonsertib in Patients with Diabetic Kidney Disease: A Phase 2b Randomized Active Run-In Clinical Trial. J Am Soc Nephrol. 2024 Dec 1;35(12):1726-1736. doi: 10.1681/ASN.0000000000000444. Epub 2024 Jul 17.
  • Abdin A, Kondo T, Bohm M, Jhund PS, Claggett BL, Vaduganathan M, Hernandez AF, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Desai AS, Kober L, Sabatine MS, Petersson M, Bachus E, Solomon SD, McMurray JJV,  on behalf of the DAPA-HF and DELIVER Committees and Investigators Effects of dapagliflozin according to QRS duration across the spectrum of left ventricular ejection fraction: An analysis of DAPA-HF and DELIVER. Eur J Heart Fail. 2024 Sep;26(9):1952-1963. doi: 10.1002/ejhf.3350. Epub 2024 Jul 17.
  • Alcaraz-Guzman A, Amaro-Palomo EJ, Ruiz-Beltran AM, Diaz-Herrera BA, Neri-Bale RR, Hernandez-Bravo L, Candia-Ramirez MA, Gopar-Nieto R, Gonzalez-Pacheco H, Sierra-Lara Martinez JD, Arias-Mendoza A, Araiza-Garaygordobil D A randomized controlled trial of ivabradine in patients with acute myocardial infarction related cardiogenic shock. Arch Peru Cardiol Cir Cardiovasc. 2024 Jun 24;5(2):e342. doi: 10.47487/apcyccv.v5i2.342. eCollection 2024 Apr-Jun.
  • Chertow GM, Correa-Rotter R, Eckardt KU, Kanda E, Karasik A, Li G, Christiansen CF, Stafylas P, Holt SG, Hagen EC, Garcia Sanchez JJ, Barone S, Cabrera C, Nolan S, Coker T, Webber L, Retat L Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study. EClinicalMedicine. 2024 May 2;72:102614. doi: 10.1016/j.eclinm.2024.102614. eCollection 2024 Jun.
  • Yoo SGK, Lam CSP, Sweitzer NK “Asian” Heart Failure. Circulation. 2024 Jul 16;150(3):177-179. doi: 10.1161/CIRCULATIONAHA.123.068576. Epub 2024 Jul 15.
  • Tao J, Yasui OW, Kamdar NS, Zheng S, Popat RA, Rehkopf DH, Chertow GM Plasmapheresis in ANCA-Associated Vasculitis with Active Kidney Involvement in the United States (2016-2020): A Cross-Sectional Study. Kidney360. 2024 Oct 1;5(10):1518-1524. doi: 10.34067/KID.0000000000000496. Epub 2024 Jul 15.
  • Verburg A, Bor WL, Kucuk IT, Henriques JPS, Vink MA, Ruifrok WT, Plomp J, Heestermans TACM, Schotborgh CE, Vlaar PJ, Magro M, Rikken SAOF, van den Broek WWA, van Mieghem CAG, Cornelis K, Rosseel L, Dujardin KS, Vandeloo B, Vandendriessche T, Ferdinande B, van ‘t Hof AWJ, Tijssen JGP, Limbruno U, De Caterina R, Rubboli A, Angiolillo DJ, Adriaenssens T, Dewilde W, Ten Berg JM Temporary omission of oral anticoagulation in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and design of the WOEST-3 randomised trial. EuroIntervention. 2024 Jul 15;20(14):e898-e904. doi: 10.4244/EIJ-D-24-00100.
  • Kuno T, Weisz G, Genereux P, Claessen BE, Shechter M, Alexander KP, James SK, Ohman EM, Dressler O, Mehran R, Ben-Yehuda O, Stone GW Predictors of outcomes after PCI with incomplete revascularization: Impact of CTO and LAD vessel. Catheter Cardiovasc Interv. 2024 Sep;104(3):483-491. doi: 10.1002/ccd.31142. Epub 2024 Jul 15.
  • Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, Hsiao LL, Khalife M, Kumaraswami LA, Loud F, Raghavan V, Roumeliotis S, Sierra M, Ulasi I, Wang B, Lui SF, Liakopoulos V, Balducci A Mind the Gap in Kidney Care: Translating What We Know Into What We Do. Am J Hypertens. 2024 Jul 15;37(8):640-649. doi: 10.1093/ajh/hpae056.
  • Blumer V, Januzzi JL Jr, Lindenfeld J, Solomon SD, Psotka MA, Carson PE, Bristow MR, Abraham WT, Gandotra C, Saville BR, O’Connor C, Fiuzat M, Heart Failure Collaboratory Heart Failure Drug Development Over the Eras: From the Heart Failure Collaboratory. JACC Heart Fail. 2024 Nov;12(11):1803-1813. doi: 10.1016/j.jchf.2024.03.021. Epub 2024 Jul 10.
  • Doll JA, Kataruka A, Manandhar P, Wojdyla DM, Yeh RW, Wang TY, Hira RS Failure to Rescue After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry. Circ Cardiovasc Interv. 2024 Aug;17(8):e013670. doi: 10.1161/CIRCINTERVENTIONS.123.013670. Epub 2024 Jul 12.
  • Connors JM Thrombotic risks associated with COVID-19 vaccination in atrial fibrillation or atrial flutter: no reason for alarm. Eur Heart J. 2024 Aug 21;45(32):2992-2994. doi: 10.1093/eurheartj/ehae336.
  • Apperloo EM, Neuen BL, Fletcher RA, Jongs N, Anker SD, Bhatt DL, Butler J, Cherney DZI, Herrington WG, Inzucchi SE, Jardine MJ, Liu CC, Mahaffey KW, McGuire DK, McMurray JJV, Neal B, Packer M, Perkovic V, Sabatine MS, Solomon SD, Staplin N, Szarek M, Vaduganathan M, Wanner C, Wheeler DC, Wiviott SD, Zannad F, Heerspink HJL Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials. Lancet Diabetes Endocrinol. 2024 Aug;12(8):545-557. doi: 10.1016/S2213-8587(24)00155-4. Epub 2024 Jul 8.
  • Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, Hsiao LL, Khalife M, Kumaraswami LA, Loud F, Raghavan V, Roumeliotis S, Sierra M, Ulasi I, Wang B, Lui SF, Liakopoulos V, Balducci A, World Kidney Day Joint Steering Committee Mind the gap in kidney care: translating what we know into what we do. J Bras Nefrol. 2024 Jul 5;46(3):e2024E007. doi: 10.1590/2175-8239-JBN-2024-E007en. eCollection 2024.
  • Schutte AE, Bennett B, Chow CK, Cloud GC, Doyle K, Girdis Z, Golledge J, Goodman A, Hespe CM, Hsu MP, James S, Jennings G, Khan T, Lee A, Murphy L, Nelson MR, Nicholls SJ, Raffoul N, Robson B, Rodgers A, Sanders A, Shang C, Sharman JE, Stocks NP, Usherwood T, Webster R, Yang J, Schlaich M National Hypertension Taskforce of Australia: a roadmap to achieve 70% blood pressure control in Australia by 2030. Med J Aust. 2024 Aug 5;221(3):126-134. doi: 10.5694/mja2.52373. Epub 2024 Jul 11.
  • Hsueh C, Esin G, Breen T, Gitto M, Katz M, Gulati M, Capers Iv Q, Reynolds HR, Volgman AS, Wenger N, Altin SE Myocardial infarction with nonobstructive coronary arteries: a single-center retrospective study by sex and race. Coron Artery Dis. 2024 Dec 1;35(8):684-691. doi: 10.1097/MCA.0000000000001402. Epub 2024 Jul 8.
  • Natov PS, Ivey-Miranda JB, Cox ZL, Rao VS, Butler J, Konstam MA, Kiernan MS, Kapur NK, Testani JM Increased Spironolactone Dosing in Acute Heart Failure Alters Potassium Homeostasis but Does not Enhance Decongestion. J Card Fail. 2024 Nov;30(11):1522-1526. doi: 10.1016/j.cardfail.2024.06.008. Epub 2024 Jul 8.
  • Lopez J, Liu Y, Butler J, Del Prato S, Ezekowitz JA, Lam CSP, Marwick TH, Rosenstock J, Tang WHW, Perfetti R, Urbinati A, Zannad F, Januzzi JL Jr, Ibrahim NE Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial. J Am Coll Cardiol. 2024 Jul 16;84(3):233-243. doi: 10.1016/j.jacc.2024.04.053.
  • Pavasini R, Biscaglia S, Kunadian V, Hakeem A, Campo G Coronary artery disease management in older adults: revascularization and exercise training. Eur Heart J. 2024 Aug 16;45(31):2811-2823. doi: 10.1093/eurheartj/ehae435.
  • Lim YMF, Asselbergs FW, Bagheri A, Denaxas S, Tay WT, Voors A, Lam CSP, Koudstaal S, Grobbee DE, Vaartjes I Eligibility of Asian and European registry patients for phase III trials in heart failure with reduced ejection fraction. ESC Heart Fail. 2024 Dec;11(6):3559-3571. doi: 10.1002/ehf2.14751. Epub 2024 Jul 10.
  • Roh DJ, Poyraz FC, Mao E, Shen Q, Kansara V, Cottarelli A, Song S, Nemkov T, Kumar A, Hudson KE, Ghoshal S, Park S, Agarwal S, Connolly ES, Claassen J, Kreuziger LB, Hod E, Yeatts S, Foster LD, Selim M Anemia From Inflammation After Intracerebral Hemorrhage and Relationships With Outcome. J Am Heart Assoc. 2024 Jul 16;13(14):e035524. doi: 10.1161/JAHA.124.035524. Epub 2024 Jul 9.
  • Cheng K, Lin A, Psaltis PJ, Rajwani A, Baumann A, Brett N, Kangaharan N, Otton J, Nicholls SJ, Dey D, Wong DTL Protocol and rationale of the Australian multicentre registry for serial cardiac computed tomography angiography (ARISTOCRAT): a prospective observational study of the natural history of pericoronary adipose tissue attenuation and radiomics. Cardiovasc Diagn Ther. 2024 Jun 30;14(3):447-458. doi: 10.21037/cdt-23-392. Epub 2024 Jun 27.
  • Maqsood MH, Tamis-Holland JE, Rao SV, Stone GW, Bangalore S Culprit-Only Revascularization, Single-Setting Complete Revascularization, and Staged Complete Revascularization in Acute Myocardial Infarction: Insights From a Mixed Treatment Comparison Meta-Analysis of Randomized Trials. Circ Cardiovasc Interv. 2024 Jul;17(7):e013737. doi: 10.1161/CIRCINTERVENTIONS.123.013737. Epub 2024 Jul 8.
  • Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, Hsiao LL, Khalife M, Kumaraswami LA, Loud F, Raghavan V, Roumeliotis S, Sierra M, Ulasi I, Wang B, Lui SF, Liakopoulos V, Balducci A, World Kidney Day Joint Steering Committee Mind the gap in kidney care: translating what we know into what we do. Clin Exp Nephrol. 2024 Sep;28(9):835-846. doi: 10.1007/s10157-024-02518-2. Epub 2024 Jul 6.
  • Gomez KA, Tromp J, Figarska SM, Beldhuis IE, Cotter G, Davison BA, Felker GM, Gimpelewicz C, Greenberg BH, Lam CSP, Voors AA, Metra M, Teerlink JR, van der Meer P Distinct Comorbidity Clusters in Patients With Acute Heart Failure: Data From RELAX-AHF-2. JACC Heart Fail. 2024 Oct;12(10):1762-1774. doi: 10.1016/j.jchf.2024.04.028. Epub 2024 Jul 3.
  • Kercheval JB, Narcisse DI, Nguyen M, Rao SV, Gutierrez JA, Leeper NJ, Maron DJ, Rodriguez F, Hernandez AF, Mahaffey KW, Shah SH, Swaminathan RV, Project Baseline Health Study Group Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health study. Am Heart J. 2024 Sep;275:183-190. doi: 10.1016/j.ahj.2024.06.010. Epub 2024 Jul 3.
  • Chunawala ZS, Bhatt DL, Qamar A, Vaduganathan M, Mentz RJ, Matsushita K, Grodin JL, Pandey A, Caughey MC Peripheral artery disease, chronic kidney disease, and recurrent admissions for acute decompensated heart failure: The ARIC study. Atherosclerosis. 2024 Aug;395:118521. doi: 10.1016/j.atherosclerosis.2024.118521. Epub 2024 Jun 12.
  • Fujino M, Aikawa H, Nakao K, Takagi K, Otsuka F, Kataoka Y, Asaumi Y, Sumita Y, Nakai M, Kanaoka K, Miyamoto Y, Nicholls SJ, Noguchi T Comparison of embolic risk in left ventricular thrombus between nonischemic and ischemic cardiomyopathy: A nationwide database analysis. Int J Cardiol. 2024 Sep 15;411:132329. doi: 10.1016/j.ijcard.2024.132329. Epub 2024 Jul 2.
  • Chertow GM, Chang AM, Felker GM, Heise M, Velkoska E, Fellstrom B, Charytan DM, Clementi R, Gibson CM, Goodman SG, Jardine M, Levin A, Lokhnygina Y, Mears J, Mehran R, Stenvinkel P, Wang AY, Wheeler DC, Zoccali C, Ridker PM, Mahaffey KW, Tricoci P, Wolf M Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nat Med. 2024 Aug;30(8):2373. doi: 10.1038/s41591-024-03156-7.
  • Bittner VA, Schwartz GG, Bhatt DL, Chua T, De Silva HA, Diaz R, Goodman SG, Harrington RA, Jukema JW, McGinniss J, Pordy R, Garon G, Scemama M, White HD, Steg PG, Szarek M, ODYSSEY OUTCOMES Investigators Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study. J Clin Lipidol. 2024 Jul-Aug;18(4):e548-e561. doi: 10.1016/j.jacl.2024.04.122. Epub 2024 Apr 10.
  • Hahn RT, Lindenfeld J, Bohm M, Edelmann F, Lund LH, Lurz P, Metra M, Tedford RJ, Butler J, Borlaug BA Tricuspid Regurgitation in Patients With Heart Failure and Preserved Ejection Fraction: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024 Jul 9;84(2):195-212. doi: 10.1016/j.jacc.2024.04.047.
  • Lincoff AM, Ray KK, Sasiela WJ, Haddad T, Nicholls SJ, Li N, Cho L, Mason D, Libby P, Goodman SG, Nissen SE Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs. J Am Coll Cardiol. 2024 Jul 9;84(2):152-162. doi: 10.1016/j.jacc.2024.04.048.
  • Heerspink H, Nolan S, Carrero JJ, Arnold M, Pecoits-Filho R, Garcia Sanchez JJ, Wittbrodt E, Cabrera C, Lam CSP, Chen H, Kanda E, Lainscak M, Pollock C, Wheeler DC Clinical Outcomes in Patients with CKD and Rapid or Non-rapid eGFR Decline: A Report from the DISCOVER CKD Retrospective Cohort. Adv Ther. 2024 Aug;41(8):3264-3277. doi: 10.1007/s12325-024-02913-x. Epub 2024 Jul 3.
  • Himmelreich JCL, Virdone S, Camm J, Pieper K, Harskamp RE, Oto A, Jacobson BF, Sawhney JPS, Lim TW, Gibbs H, Goto S, Haas S, Fox KAA, Jansky P, Verheugt F, Kakkar AK, GARFIELD-AF investigators Impact of patient selection in clinical trials: application of ROCKET AF and ARISTOTLE criteria in GARFIELD-AF. Open Heart. 2024 Jul 1;11(2):e002708. doi: 10.1136/openhrt-2024-002708.
  • Bartlett VL, Liu M, Ati S, Yeh RW, Zheng Z, Wadhera RK Private Equity Acquisitions of Outpatient Cardiology Practices in the United States, 2013-2023. J Am Coll Cardiol. 2024 Sep 3;84(10):953-956. doi: 10.1016/j.jacc.2024.06.011. Epub 2024 Jun 30.
  • Vranckx P, Morrow D, van Diepen S, Verbrugge FH Editor’s chronicles: redefining pathways in acute cardiac care. Eur Heart J Acute Cardiovasc Care. 2024 Jul 24;13(7):523-524. doi: 10.1093/ehjacc/zuae076.
  • Zon RL, Sylvester KW, Rubins D, Grandoni J, Kelly J, Timilsina S, Akladious M, Patel R, Connors JM Electronic alerts to improve management of heparin-induced thrombocytopenia. Res Pract Thromb Haemost. 2024 Apr 30;8(4):102423. doi: 10.1016/j.rpth.2024.102423. eCollection 2024 May.
  • Samarasekera N, Ferguson K, Parry-Jones AR, Rodrigues M, Loan J, Moullaali TJ, Hughes J, Shoveller L, Wardlaw J, McColl B, Allan SM, Selim M, Norrie J, Smith C, Al-Shahi Salman R Perihaematomal Oedema Evolution over 2 Weeks after Spontaneous Intracerebral Haemorrhage and Association with Outcome: A Prospective Cohort Study. Cerebrovasc Dis. 2024 Jul 17:1-10. doi: 10.1159/000540099.
  • De Oliveira-Gomes D, Joshi PH, Peterson ED, Rohatgi A, Khera A, Navar AM Apolipoprotein B: Bridging the Gap Between Evidence and Clinical Practice. Circulation. 2024 Jul 2;150(1):62-79. doi: 10.1161/CIRCULATIONAHA.124.068885. Epub 2024 Jul 1.
  • Nicholls SJ, Lam CSP, Nelson AJ Cardiovascular Clinical Trials in the Asia-Pacific Region. JAMA. 2024 Aug 6;332(5):367-368. doi: 10.1001/jama.2024.6313.
  • Mayne KJ, Sardell RJ, Staplin N, Judge PK, Zhu D, Sammons E, Cherney DZ, Cheung AK, Maggioni AP, Nangaku M, Rossello X, Tuttle KR, Ihara K, Iwata T, Wanner C, Emberson J, Preiss D, Landray MJ, Baigent FMedSci C, Haynes R, Herrington WG, EMPA-KIDNEY Collaborative Group Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial. Clin J Am Soc Nephrol. 2024 Jul 1;19(9):1119-29. doi: 10.2215/CJN.0000000000000498.
  • Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, Hsiao LL, Khalife M, Kumaraswami LA, Loud F, Raghavan V, Roumeliotis S, Sierra M, Ulasi I, Wang B, Lui SF, Liakopoulos V, Balducci A, World Kidney Day Joint Steering Committee Mind the gap in kidney care: Translating what we know into what we do. J Family Med Prim Care. 2024 May;13(5):1594-1611. doi: 10.4103/jfmpc.jfmpc_518_24. Epub 2024 May 24.
  • Bellomo TR, Liu Y, Gilliland TC, Miksenas H, Haidermota S, Wong M, Hu X, Cristino JR, Browne A, Plutzky J, Tsimikas S, Januzzi JL Jr, Natarajan P Associations between lipoprotein(a), oxidized phospholipids, and extracoronary vascular disease. J Lipid Res. 2024 Jul;65(7):100585. doi: 10.1016/j.jlr.2024.100585. Epub 2024 Jun 26.
  • Hoeper MM, Oerke B, Wissmuller M, Leuchte H, Opitz C, Halank M, Seyfarth HJ, Baldus S, Bauersachs J, Bohm M, Ghofrani HA, Konstantinides S, Olsson KM, Wachter R, Lam CSP, Aminossadati B, Rosenkranz S Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study. Circulation. 2024 Aug 20;150(8):600-610. doi: 10.1161/CIRCULATIONAHA.124.069340. Epub 2024 Jun 28.
  • El-Dalati S, Paras ML, Strnad L, Harris AW, Gurley JC, Sekela M, Nauriyal V, Januzzi JL, DeFaria Yeh D, Yucel E In Plain Sight: The Need for a Dedicated Cardiovascular Infectious Disease Subspecialty. JACC Adv. 2023 Nov 30;3(1):100748. doi: 10.1016/j.jacadv.2023.100748. eCollection 2024 Jan.
  • Kaur G, Kobo O, Parwani P, Chieffo A, Gulati M, Mamas MA Sex differences in Life’s Essential Eight and its Association with mortality among US adults without known cardiovascular disease. Am J Prev Cardiol. 2024 Jun 3;18:100685. doi: 10.1016/j.ajpc.2024.100685. eCollection 2024 Jun.
  • Mehra MR, Castagna F The Clinical Conundrum of Vasoplegia With Mechanical Circulatory Support Devices. JACC Adv. 2024 Mar 23;3(5):100914. doi: 10.1016/j.jacadv.2024.100914. eCollection 2024 May.
  • Giacona JM, Chia R, Kositanurit W, Wang J, Ayers C, Pandey A, Kozlitina J, Drazner MH, Garg S, de Lemos JA, Zhang R, Hajjar I, Yu FF, Lacritz L, Vongpatanasin W Associations Between Cardiac Function and Brain Health in Diverse Middle-Aged Adults: The Dallas Heart Study-2. JACC Adv. 2023 Dec 22;3(2):100777. doi: 10.1016/j.jacadv.2023.100777. eCollection 2024 Feb.
  • Sagheer U, Al-Kindi S, Abohashem S, Phillips CT, Rana JS, Bhatnagar A, Gulati M, Rajagopalan S, Kalra DK Environmental Pollution and Cardiovascular Disease: Part 2 of 2: Soil, Water, and Other Forms of Pollution. JACC Adv. 2024 Jan 4;3(2):100815. doi: 10.1016/j.jacadv.2023.100815. eCollection 2024 Feb.
  • Sagheer U, Al-Kindi S, Abohashem S, Phillips CT, Rana JS, Bhatnagar A, Gulati M, Rajagopalan S, Kalra DK Environmental Pollution and Cardiovascular Disease: Part 1 of 2: Air Pollution. JACC Adv. 2023 Dec 28;3(2):100805. doi: 10.1016/j.jacadv.2023.100805. eCollection 2024 Feb.
  • Lin C, McCarthy CP, Mohebi R, Liu Y, Blankstein R, Murphy SP, Miksenas H, Rogers C, Amponsah DK, Rambarat PK, Raghavan A, Levin A, Ghoshhajra B, Wasfy JH, Hedgire S, Januzzi JL Jr Sex Differences in Coronary Artery Disease Characteristics Among Patients With Type 2 Myocardial Infarction. JACC Adv. 2023 Dec 22;3(2):100795. doi: 10.1016/j.jacadv.2023.100795. eCollection 2024 Feb.
  • Jamil Y, Park DY, Rao SV, Ahmad Y, Sikand NV, Bosworth HB, Coles T, Damluji AA, Nanna MG, Samsky MD Association Between Frailty and Management and Outcomes of Acute Myocardial Infarction Complicated by Cardiogenic Shock. JACC Adv. 2024 May 17;3(6):100949. doi: 10.1016/j.jacadv.2024.100949. eCollection 2024 Jun.
  • Haltom TM, Lew SQ, Winkelmayer WC, Chertow GM, Jaure A, Erickson KF Patient Perspectives on Using Telemedicine During In-Center Hemodialysis: A Qualitative Study. Kidney Med. 2024 May 22;6(7):100848. doi: 10.1016/j.xkme.2024.100848. eCollection 2024 Jul.
  • Montone RA, Ford TJ, Galli M, Rinaldi R, Bland A, Morrow A, Angiolillo DJ, Berry C, Kaski JC, Crea F Stratified medicine for acute and chronic coronary syndromes: A patient-tailored approach. Prog Cardiovasc Dis. 2024 Jul-Aug;85:2-13. doi: 10.1016/j.pcad.2024.06.003. Epub 2024 Jun 25.
  • d’Entremont MA, Lee SF, Mian R, Kedev S, Montalescot G, Cornel JH, Stankovic G, Moreno R, Storey RF, Henry TD, Skuriat E, Tyrwhitt J, Mehta SR, Devereaux PJ, Eikelboom J, Cairns JA, Pitt B, Jolly SS Design and rationale of the CLEAR SYNERGY (OASIS 9) trial: A 2×2 factorial randomized controlled trial of colchicine versus placebo and spironolactone vs placebo in patients with myocardial infarction. Am Heart J. 2024 Sep;275:173-182. doi: 10.1016/j.ahj.2024.06.007. Epub 2024 Jun 25.
  • Khan MS, Butler J, Young R, Lewis BS, Escobedo J, Refsgaard J, Reyes E, Roessig L, Blaustein RO, Lam CSP, Voors AA, Ponikowski P, Anstrom KJ, Armstrong PW, VICTORIA Study Group Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status: Insights From the VICTORIA Trial. JACC Heart Fail. 2024 Oct;12(10):1750-1759. doi: 10.1016/j.jchf.2024.05.007. Epub 2024 Jun 26.
  • Gustafsson F, Petrie MC, Komtebedde J, Swarup V, Winkler S, Hasenfuss G, Borlaug BA, Mohan RC, Flaherty JD, Sverdlov AL, Fail PS, Chung ES, Lurz P, Lilly S, Kaye DM, Cleland JGF, Cikes M, Leon MB, Cutlip DE, van Veldhuisen DJ, Solomon SD, Shah SJ 2-Year Outcomes of an Atrial Shunt Device in HFpEF/HFmrEF: Results From REDUCE LAP-HF II. JACC Heart Fail. 2024 Aug;12(8):1425-1438. doi: 10.1016/j.jchf.2024.04.011. Epub 2024 Jun 26.
  • Secchi TL, Pille A, da Silva MMD, Martins SCO, Bagur R, Sposato LA, Ayan D Neurologists Preferences on Basic and Advanced Cardiac Imaging Utilization in Ischemic Stroke Patients. Cerebrovasc Dis. 2024 Jun 22:1-6. doi: 10.1159/000539998.
  • Sposato LA, Ayan D, Ahmed M, Fridman S, Mandzia JL, Lodol FF, Elrayes M, Pandey S, Bagur R Extended Computed Tomography Angiography for the Successful Diagnosis of Cardioaortic Thrombus in Acute Ischemic Stroke and TIA: Study Protocol for a Randomized Controlled Trial. Cerebrovasc Dis. 2024 Jun 26:1-10. doi: 10.1159/000540034.
  • Tannu M, Kaltenbach L, Pagidipati NJ, McGuire DK, Aroda VR, Pop-Busui R, Kondamudi N, Al-Khalidi HR, Lopes RD, Cavender MA, Nelson AJ, Kirk J, Lingvay I, Magwire M, Richardson CR, Webb L, Leyva M, Pandey A, Washington A, Pak J, Gaynor T, Khan W, Weston P, Granger CB, Green J Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial. Circulation. 2024 Jul 16;150(3):180-189. doi: 10.1161/CIRCULATIONAHA.124.068962. Epub 2024 Jun 27.
  • Swiatkiewicz I, Nuszkiewicz J, Wroblewska J, Nartowicz M, Sokolowski K, Sutkowy P, Rajewski P, Buczkowski K, Chudzinska M, Manoogian ENC, Taub PR, Wozniak A Feasibility and Cardiometabolic Effects of Time-Restricted Eating in Patients with Metabolic Syndrome. Nutrients. 2024 Jun 7;16(12):1802. doi: 10.3390/nu16121802.
  • Khan MS, Shahid I, Bennis A, Rakisheva A, Metra M, Butler J Global epidemiology of heart failure. Nat Rev Cardiol. 2024 Oct;21(10):717-734. doi: 10.1038/s41569-024-01046-6. Epub 2024 Jun 26.
  • Rehan R, Virk S, Wong CCY, Passam F, Layland J, Keech A, Yong A, White HD, Fearon W, Ng M Intracoronary thrombolysis in ST-elevation myocardial infarction: a systematic review and meta-analysis. Heart. 2024 Jul 10;110(15):988-996. doi: 10.1136/heartjnl-2024-324078.
  • Frere C, Mazzeffi M, Maier CL, Helms J, Steiner ME, Sullenger BA, Tanaka KA, Connors JM, Levy JH Acquired von Willebrand syndrome during extracorporeal membrane oxygenation support: a comprehensive review of current evidence: communication from the ISTH SSC on perioperative and critical care thrombosis and hemostasis. J Thromb Haemost. 2024 Sep;22(9):2608-2628. doi: 10.1016/j.jtha.2024.06.007. Epub 2024 Jun 24.
  • Venermo MA, Farber A, Schanzer A, Menard MT, Rosenfield K, Dosluoglu H, Goodney PP, Abou-Zamzam AM, Motaganahalli R, Doros G, Creager MA Editor’s Choice – Reduction of Major Amputations after Surgery versus Endovascular Intervention: The BEST-CLI Randomised Trial. Eur J Vasc Endovasc Surg. 2024 Nov;68(5):590-597. doi: 10.1016/j.ejvs.2024.06.018. Epub 2024 Jun 24.
  • Kitzman DW, Lewis GD, Pandey A, Borlaug BA, Sauer AJ, Litwin SE, Sharma K, Jorkasky DK, Khan S, Shah SJ A novel controlled metabolic accelerator for the treatment of obesity-related heart failure with preserved ejection fraction: Rationale and design of the Phase 2a HuMAIN trial. Eur J Heart Fail. 2024 Sep;26(9):2013-2024. doi: 10.1002/ejhf.3305. Epub 2024 Jun 26.
  • Yang M, Kondo T, Jhund PS, Alcocer-Gamba MA, Borleffs CJW, Chiang CE, Comin-Colet J, Desai AS, Dobreanu D, Drozdz J, Han Y, Janssens SP, Katova T, Kosiborod MN, Lam CSP, Merkely B, Pham VN, Thierer J, Vaduganathan M, Verma S, Solomon SD, McMurray JJV Geographical variation in patient characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction. Eur J Heart Fail. 2024 Aug;26(8):1788-1803. doi: 10.1002/ejhf.3352. Epub 2024 Jun 23.
  • Edmonston D, Lydon E, Mulder H, Chiswell K, Lampron Z, Marsolo K, Goss A, Ayoub I, Shah RC, Chang AR, Ford DE, Jones WS, Fonesca V, Machineni S, Fort D, Butler J, Hunt KJ, Pitlosh M, Rao A, Ahmad FS, Gordon HS, Hung AM, Hwang W, Bosworth HB, Pagidipati NJ Concordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 Diabetes. JAMA Netw Open. 2024 Jun 3;7(6):e2418808. doi: 10.1001/jamanetworkopen.2024.18808.
  • Mann JFE, Rossing P, Bakris G, Belmar N, Bosch-Traberg H, Busch R, Charytan DM, Hadjadj S, Gillard P, Gorriz JL, Idorn T, Ji L, Mahaffey KW, Perkovic V, Rasmussen S, Schmieder RE, Pratley RE, Tuttle KR Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial. Nat Med. 2024 Oct;30(10):2849-2856. doi: 10.1038/s41591-024-03133-0. Epub 2024 Jun 24.
  • Sise ME, Santos JR, Goldman JD, Tuttle KR, Teixeira JP, Seibert AF, Koullias Y, Llewellyn J, Regan S, Zhao Y, Huang H, Hyland RH, Osinusi A, Winter H, Humeniuk R, Hulter HN, Gottlieb RL, Fusco DN, Birne R, Stancampiano FF, Libertin CR, Small CB, Plate M, McPhail MJ, REDPINE Investigators Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial. Clin Infect Dis. 2024 Nov 22;79(5):1172-1181. doi: 10.1093/cid/ciae333.
  • Schou M, Petrie MC, Borlaug BA, Butler J, Davies MJ, Kitzman DW, Shah SJ, Verma S, Patel S, Chinnakondepalli KM, Harring S, Abildstrom SZ, Liisberg K, Kosiborod MN, STEP-HFpEF Trial Committees and Investigators Semaglutide and NYHA Functional Class in Obesity-Related Heart Failure With Preserved Ejection Fraction: The STEP-HFpEF Program. J Am Coll Cardiol. 2024 Jul 16;84(3):247-257. doi: 10.1016/j.jacc.2024.04.038. Epub 2024 Jun 23.
  • Verma S, Butler J, Borlaug BA, Davies M, Kitzman DW, Shah SJ, Petrie MC, Barros E, Ronnback C, Vestergaard LS, Schou M, Ezekowitz JA, Sharma K, Patel S, Chinnakondepalli KM, Kosiborod MN, STEP-HFpEF Trial Committees and Investigators Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials. J Am Coll Cardiol. 2024 Aug 27;84(9):773-785. doi: 10.1016/j.jacc.2024.06.001. Epub 2024 Jun 23.
  • Jha M, Musani S, McCarthy I, Hundley WG, Carr JJ, Terry JG, Oshunbade A, Vasan RS, Butler J, Hall M, Mitchell GF, Fox E, Tsao CW Subclinical association of aortic stiffness with cardiac structure and function in African-Americans: The Jackson Heart Study. Int J Cardiovasc Imaging. 2024 Aug;40(8):1705-1712. doi: 10.1007/s10554-024-03159-y. Epub 2024 Jun 23.
  • Giles KA, Farber A, Menard MT, Conte MS, Nolan BW, Siracuse JJ, Strong MB, Doros G, Venermo M, Azene E, Rosenfield K, Powell RJ Surgery or endovascular therapy for patients with chronic limb-threatening ischemia requiring infrapopliteal interventions. J Vasc Surg. 2024 Nov;80(5):1515-1524. doi: 10.1016/j.jvs.2024.05.049. Epub 2024 Jun 21.
  • Rivera FB, Bantayan NRB, Aparece JP, Cruz LLA, Magallong JV, Pine PL, Idian-Javier AMN, Lumbang GNO, Lerma EV, Lara-Breitinger KM, Gulati M, Vijayaraghavan K Sex, racial, ethnic, and geographical disparities in major adverse cardiovascular outcome of glucagon-like peptide-1 receptor agonists among patients with and without diabetes mellitus: A meta-analysis of placebo-controlled randomized controlled trials. J Clin Lipidol. 2024 Jul-Aug;18(4):e588-e601. doi: 10.1016/j.jacl.2024.03.011. Epub 2024 Apr 4.
  • Kondo T, Campbell R, Jhund PS, Anand IS, Carson PE, Lam CSP, Shah SJ, Vaduganathan M, Zannad F, Zile MR, Solomon SD, McMurray JJV Low Natriuretic Peptide Levels and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction. JACC Heart Fail. 2024 Aug;12(8):1442-1455. doi: 10.1016/j.jchf.2024.04.027. Epub 2024 Jun 19.
  • Wallace MJ, Weissler EH, Yang JC, Brotzman L, Corriere MA, Secemsky EA, Sutphin J, Johnson FR, Marcos Gonzalez J, Tarver ME, Saha A, Chen AL, Gebben DJ, Malone M, Farb A, Babalola O, Rorer EM, Zikmund-Fisher BJ, Reed SD Using Separate Single-Outcome Risk Presentations Instead of Integrated Multioutcome Formats Improves Comprehension in Discrete Choice Experiments. Med Decis Making. 2024 Aug;44(6):649-660. doi: 10.1177/0272989X241258466. Epub 2024 Jun 21.
  • Arun AS, Sawano M, Lu Y, Warner F, Caraballo C, Khera R, Echols MR, Yancy CW, Krumholz HM Excess Cardiovascular Mortality Among Black Americans 2000-2022. J Am Coll Cardiol. 2024 Aug 6;84(6):581-588. doi: 10.1016/j.jacc.2024.06.004. Epub 2024 Jun 18.
  • Pereira NL, Cresci S, Angiolillo DJ, Batchelor W, Capers Q 4th, Cavallari LH, Leifer D, Luzum JA, Roden DM, Stellos K, Turrise SL, Tuteja S, American Heart Association Professional/Public Education and Publications, Committee of the Council on Genomic and Precision Medicine; Council on, Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and, Stroke Nursing; Council on Clinical Cardiology; Council on Peripheral Vascular, Disease; and Stroke Council CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association. Circulation. 2024 Aug 6;150(6):e129-e150. doi: 10.1161/CIR.0000000000001257. Epub 2024 Jun 20.
  • Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, Hsiao LL, Khalife M, Kumaraswami LA, Loud F, Raghavan V, Roumeliotis S, Sierra M, Ulasi I, Wang B, Lui SF, Liakopoulos V, Balducci A, World Kidney Day Joint Steering Committee Mind the Gap in Kidney Care: Translating What We Know into What We Do. Kidney Int Rep. 2024 Jun 5;9(6):1541-1552. doi: 10.1016/j.ekir.2024.04.019. eCollection 2024 Jun.
  • Wells BJ, Wood MJ, O’Duffy AE, Sumner JA, Chi G, Grodzinsky A, Gornik HL, Kadian-Dodov D, Taylor A, Hess CN, Sanghavi M, Henkin S, Wells G, Tam L, Orford J, Lindley K, Kumbhani DJ, Vitarello C, Alkhalfan F, Gibson CM, Leon KK, Naderi S, Kim ES Migraine headache in patients with spontaneous coronary artery dissection: A report of the iSCAD Registry. Vasc Med. 2024 Jun;29(3):286-295. doi: 10.1177/1358863X241252444.
  • Vervoort D, Wang R, Li G, Filbey L, Maduka O, Brewer LC, Mamas MA, Bahit MC, Ahmed SB, Van Spall HGC Addressing the Global Burden of Cardiovascular Disease in Women: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024 Jun 25;83(25):2690-2707. doi: 10.1016/j.jacc.2024.04.028.
  • Nouhravesh N, Garg J, Rockhold FW, De Pasquale CG, O’Meara E, Lewis GD, Butler J, Harrington J, Ezekowitz JA, Ponikowski P, Troughton RW, Wong YW, Blackman N, Numan S, Adamczyk R, Hernandez AF, Mentz RJ Characterization of serum phosphate levels over time with intravenous ferric carboxymaltose versus placebo as treatment for heart failure with reduced ejection fraction and iron deficiency: An exploratory prospective substudy from HEART-FID. Eur J Heart Fail. 2024 Jun 19:10.1002/ejhf.3348. doi: 10.1002/ejhf.3348.
  • McKenna CF, Stierwalt HD, Zemski Berry KA, Ehrlicher SE, Robinson MM, Zarini S, Kahn DE, Snell-Bergeon JK, Perreault L, Bergman BC, Newsom SA Intramuscular diacylglycerol accumulates with acute hyperinsulinemia in insulin-resistant phenotypes. Am J Physiol Endocrinol Metab. 2024 Aug 1;327(2):E183-E193. doi: 10.1152/ajpendo.00368.2023. Epub 2024 Jun 19.
  • Xu K, Dor A, Mohanty S, Han J, Parvathinathan G, Braggs-Gresham JL, Held PJ, Roberts JP, Vaughan W, Tan JC, Scandling JD, Chertow GM, Busque S, Cheng XS The Medical Costs of Determining Eligibility and Waiting for a Kidney Transplantation. Med Care. 2024 Aug 1;62(8):521-529. doi: 10.1097/MLR.0000000000002028. Epub 2024 Jun 12.
  • Schlotter F, Huber K, Hassager C, Halvorsen S, Vranckx P, Poss J, Krychtiuk K, Lorusso R, Bonaros N, Calvert PA, Montorfano M, Thiele H Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the ESC Working Group on Cardiovascular Surgery. Eur Heart J. 2024 Jul 21;45(28):2478-2492. doi: 10.1093/eurheartj/ehae363.
  • Morrow DA, Jessup M, Abraham WT, Acker M, Aringo A, Batchelor W, Chikwe J, Costello S, Drakos SG, Farmer S, Gelijns A, Gillette N, Hochman JS, Isler M, Kapur NK, Kilic A, Kormos R, Lewis EF, Lindenfeld J, Lombardi P, Mancini D, Rao SV, Rutan C, Samsky M, Krucoff MW American Heart Association Cardiogenic Shock Registry: Design and Implementation. Circ Cardiovasc Qual Outcomes. 2024 Jul;17(7):e010637. doi: 10.1161/CIRCOUTCOMES.123.010637. Epub 2024 Jun 18.
  • d’Entremont MA, Seto AH, Alrashidi S, Alansari O, Brochu B, Lemaire-Paquette S, Heenan L, Skuriat E, Tyrwhitt J, Raco M, Tsang MB, Valettas N, Velianou J, Sheth T, Sibbald M, Mehta SR, Pinilla-Echeverri N, Schwalm JD, Natarajan MK, Abu-Fadel M, Kelly A, Akl E, Tawadros S, Faidi W, Bauer J, Moxham R, Nkurunziza J, Dutra G, Winter J, Couture EL, Jolly SS Ultrasound-Guided Transfemoral Access for Coronary Procedures: A Pooled Learning Curve Analysis From the FAUST and UNIVERSAL Trials. Circ Cardiovasc Interv. 2024 Aug;17(8):e013817. doi: 10.1161/CIRCINTERVENTIONS.123.013817. Epub 2024 Jun 18.
  • McCarthy CP, Jackson R, McEvoy JW, Rahimi K From Treating Hypertension to Lowering Cardiovascular Disease Risk. Hypertension. 2024 Aug;81(8):1655-1658. doi: 10.1161/HYPERTENSIONAHA.124.21722. Epub 2024 Jun 18.
  • Paquin A, Rezaeian P, Cui Y, Nelson MD, Shufelt C, Coutinho T, Gulati M, Maughan J, Petersen JW, Anderson RD, Wei J, Bairey Merz CN Aortic Health and Coronary Function in Women with Suspected Ischemia and Nonobstructive Coronary Artery Disease. Can J Cardiol. 2024 Nov;40(11):2218-2220. doi: 10.1016/j.cjca.2024.06.005. Epub 2024 Jun 14.
  • Gami A, Blumenthal RS, McGuire DK, Sarkar S, Kohli P New Perspectives in Management of Cardiovascular Risk Among People With Diabetes. J Am Heart Assoc. 2024 Jun 18;13(12):e034053. doi: 10.1161/JAHA.123.034053. Epub 2024 Jun 15.
  • Stevens CAT, Vallejo-Vaz AJ, Chora JR, Barkas F, Brandts J, Mahani A, Abar L, Sharabiani MTA, Ray KK Improving the Detection of Potential Cases of Familial Hypercholesterolemia: Could Machine Learning Be Part of the Solution? J Am Heart Assoc. 2024 Jun 18;13(12):e034434. doi: 10.1161/JAHA.123.034434. Epub 2024 Jun 15.
  • Muthalaly RG, Tan S, Nelson AJ, Abrahams T, Han D, Tamarappoo BK, Dey D, Nicholls SJ, Lin A, Nerlekar N Variation of computed tomography-derived extracellular volume fraction and the impact of protocol parameters: A systematic review and meta-analysis. J Cardiovasc Comput Tomogr. 2024 Sep-Oct;18(5):457-464. doi: 10.1016/j.jcct.2024.06.002. Epub 2024 Jun 14.
  • Guimaraes PO, Lopes RD, Wojdyla DM, Alexander JH, Goodman SG, Aronson R, Halvorsen S, Sinnaeve P, Vinereanu D, Storey RF, Berwanger O, Windecker S, Mehran R, Granger CB, Alexander KP, AUGUSTUS Investigators Antithrombotic Strategies According to Age: Insights from the AUGUSTUS Trial. Am J Med. 2024 Oct;137(10):958-965. doi: 10.1016/j.amjmed.2024.06.001. Epub 2024 Jun 13.
  • Voordes G, Davison B, Biegus J, Edwards C, Damman K, Ter Maaten J, Mebazaa A, Takagi K, Adamo M, Ambrosy AP, Arrigo M, Barros M, Celutkiene J, Cerlinskaite-Bajore K, Chioncel O, Cohen-Solal A, Damasceno A, Deniau B, Diaz R, Filippatos G, Gayat E, Kimmoun A, Lam CSP, Metra M, Novosadova M, Pagnesi M, Pang P, Ponikowski P, Saidu H, Sliwa K, Tomasoni D, Cotter G, Voors AA Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF. Eur J Heart Fail. 2024 Jul;26(7):1480-1492. doi: 10.1002/ejhf.3336. Epub 2024 Jun 14.
  • Tunehag KR, Thomas CD, Franchi F, Rossi JS, Keeley EC, Anderson RD, Beitelshees AL, Duarte JD, Gong Y, Kerensky RA, McDonough CW, Nguyen AB, Ortega-Paz L, Venkatesh S, Wang Y, Johnson JA, Winterstein AG, Stouffer GA, Angiolillo DJ, Cavallari LH, Lee CR CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention. J Am Heart Assoc. 2024 Jun 18;13(12):e033791. doi: 10.1161/JAHA.123.033791. Epub 2024 Jun 14.
  • Mankerious N, Toelg R, Vogel B, Sartori S, Angiolillo DJ, Vranckx P, Feng Y, de la Torre Hernandez JM, Krucoff MW, Bhatt DL, Spirito A, Cao D, Chehab BM, Kunadian V, Maksoud A, Picon H, Sardella G, Thiele H, Varenne O, Windecker S, Richardt G, Valgimigli M, Mehran R One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease. Am J Cardiol. 2024 Aug 15;225:25-34. doi: 10.1016/j.amjcard.2024.06.003. Epub 2024 Jun 12.
  • Tan S, Nelson AJ, Muthalaly RG, Ramkumar S, Hamilton J, Nerlekar N, Segelov E, Nicholls SJ Cardiovascular Risk in Cancer Patients Treated with Immune Checkpoint Inhibitors: Challenges and Future Directions. Eur J Prev Cardiol. 2024 Jun 13:zwae204. doi: 10.1093/eurjpc/zwae204.
  • Dinu M, Sofi F, Lotti S, Colombini B, Mattioli AV, Catapano AL, Casula M, Baragetti A, Wong ND, Steg PG, Ambrosio G Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis. Eur J Prev Cardiol. 2024 Nov 11;31(15):1863-1875. doi: 10.1093/eurjpc/zwae184.
  • Huang W, Koh T, Tromp J, Chandramouli C, Ewe SH, Ng CT, Lee ASY, Teo LLY, Hummel Y, Huang F, Lam CSP Point-of-care AI-enhanced novice echocardiography for screening heart failure (PANES-HF). Sci Rep. 2024 Jun 12;14(1):13503. doi: 10.1038/s41598-024-62467-4.
  • Yeh RW, Kirtane AJ, AGENT IDE Investigators Coronary In-Stent Restenosis Treated With Paclitaxel-Coated Balloon vs Uncoated Balloon-Reply. JAMA. 2024 Jul 9;332(2):169-170. doi: 10.1001/jama.2024.9523.
  • Sayed A, Peterson ED, Virani SS, Sniderman AD, Navar AM Individual Variation in the Distribution of Apolipoprotein B Levels Across the Spectrum of LDL-C or Non-HDL-C Levels. JAMA Cardiol. 2024 Aug 1;9(8):741-747. doi: 10.1001/jamacardio.2024.1310.
  • Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, Hsiao LL, Khalife M, Kumaraswami LA, Loud F, Raghavan V, Roumeliotis S, Sierra M, Ulasi I, Wang B, Lui SF, Liakopoulos V, Balducci A Mind the gap in kidney care: translating what we know into what we do. Nephrol Ther. 2024 Jun;20(3):164-175. doi: 10.1684/ndt.2024.80. Epub 2024 Jun 13.
  • De Pasquale CG, Claggett B, Jering K, McMurray JJV, Mann D, Miao ZM, Granger CB, Kober L, Maggioni AP, Rouleau JL, Solomon SD, Steg PG, van der Meer P, Braunwald E, Pfeffer MA Safety and Tolerability of Angiotensin Receptor-Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Care Setting: A Subgroup Analysis of the PARADISE-MI Trial. Circ Heart Fail. 2024 Jul;17(7):e011393. doi: 10.1161/CIRCHEARTFAILURE.123.011393. Epub 2024 Jun 12.
  • Abramovitz Fouks A, Yaghi S, Selim MH, Gokcal E, Das AS, Rotschild O, Silverman SB, Singhal AB, Kapur S, Greenberg SM, Gurol ME Left atrial appendage closure in patients with atrial fibrillation and acute ischaemic stroke despite anticoagulation. Stroke Vasc Neurol. 2024 Jun 11:svn-2024-003143. doi: 10.1136/svn-2024-003143.
  • Sposato LA, Sur NB, Katan M, Johansen MC, De Marchis GM, Caso V, Fischer U, Chaturvedi S Embolic Stroke of Undetermined Source: New Data and New Controversies on Cardiac Monitoring and Anticoagulation. Neurology. 2024 Jul 9;103(1):e209535. doi: 10.1212/WNL.0000000000209535. Epub 2024 Jun 11.
  • Ray KK, Aguiar C, Arca M, Connolly DL, Eriksson M, Ferrieres J, Laufs U, Mostaza JM, Nanchen D, Bardet A, Lamparter M, Chhabra R, Soronen J, Rietzschel E, Strandberg T, Toplak H, Visseren FLJ, Catapano AL, SANTORINI Study Investigators Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study. Eur J Prev Cardiol. 2024 Nov 11;31(15):1792-1803. doi: 10.1093/eurjpc/zwae199.
  • Scarlatescu E, Iba T, Maier CL, Moore H, Othman M, Connors JM, Levy JH Deranged Balance of Hemostasis and Fibrinolysis in Disseminated Intravascular Coagulation: Assessment and Relevance in Different Clinical Settings. Anesthesiology. 2024 Sep 1;141(3):570-583. doi: 10.1097/ALN.0000000000005023.
  • Novelli A, Gogo P, Dauerman HL, Polomsky M Management of severe aortic stenosis in the presence of an 8 mm right coronary stent protrusion. Catheter Cardiovasc Interv. 2024 Sep;104(3):625-628. doi: 10.1002/ccd.31120. Epub 2024 Jun 11.
  • Bikdeli B, Tajrishi FZ, Connors JM Risk of myopathy and hepatotoxicity in patients with cancer receiving statin therapy: Systematic review of randomized controlled trials. Vasc Med. 2024 Oct;29(5):556-558. doi: 10.1177/1358863X241246471. Epub 2024 Jun 11.
  • Januzzi JL Jr, van Kimmenade RRJ, Liu Y, Hu X, Browne A, Plutzky J, Tsimikas S, Blankstein R, Natarajan P Lipoprotein(a), Oxidized Phospholipids, and Progression to Symptomatic Heart Failure: The CASABLANCA Study. J Am Heart Assoc. 2024 Jun 18;13(12):e034774. doi: 10.1161/JAHA.124.034774. Epub 2024 Jun 11.
  • Rossing P, Groop PH, Singh R, Lawatscheck R, Tuttle KR Prevalence of Chronic Kidney Disease in Type 1 Diabetes Among Adults in the U.S. Diabetes Care. 2024 Aug 1;47(8):1395-1399. doi: 10.2337/dc24-0335.
  • Adamopoulos S, Bonios M, Ben Gal T, Gustafsson F, Abdelhamid M, Adamo M, Bayes-Genis A, Bohm M, Chioncel O, Cohen-Solal A, Damman K, Di Nora C, Hashmani S, Hill L, Jaarsma T, Jankowska E, Lopatin Y, Masetti M, Mehra MR, Milicic D, Moura B, Mullens W, Nalbantgil S, Panagiotou C, Piepoli M, Rakisheva A, Ristic A, Rivinius R, Savarese G, Thum T, Tocchetti CG, Tops LF, Van Laake LW, Volterrani M, Seferovic P, Coats A, Metra M, Rosano G Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2024 Nov;26(11):2304-2322. doi: 10.1002/ejhf.3323. Epub 2024 Jun 10.
  • Pacheco C, Coutinho T, Bastiany A, Beanlands R, Boczar KE, Gulati M, Liu S, Luu J, Mulvagh SL, Paquin A, Saw J, Sedlak T Canadian Cardiovascular Society/Canadian Women’s Heart Health Alliance Clinical Practice Update on Myocardial Infarction With No Obstructive Coronary Artery Disease (MINOCA). Can J Cardiol. 2024 Jun;40(6):953-968. doi: 10.1016/j.cjca.2024.02.032.
  • Handelsman Y, Anderson JE, Bakris GL, Ballantyne CM, Bhatt DL, Bloomgarden ZT, Bozkurt B, Budoff MJ, Butler J, Cherney DZI, DeFronzo RA, Del Prato S, Eckel RH, Filippatos G, Fonarow GC, Fonseca VA, Garvey WT, Giorgino F, Grant PJ, Green JB, Greene SJ, Groop PH, Grunberger G, Jastreboff AM, Jellinger PS, Khunti K, Klein S, Kosiborod MN, Kushner P, Leiter LA, Lepor NE, Mantzoros CS, Mathieu C, Mende CW, Michos ED, Morales J, Plutzky J, Pratley RE, Ray KK, Rossing P, Sattar N, Schwarz PEH, Standl E, Steg PG, Tokgozoglu L, Tuomilehto J, Umpierrez GE, Valensi P, Weir MR, Wilding J, Wright EE Jr DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases. Metabolism. 2024 Oct;159:155931. doi: 10.1016/j.metabol.2024.155931. Epub 2024 Jun 7.
  • Mo CC, Richardson E, Calabretta E, Corrado F, Kocoglu MH, Baron RM, Connors JM, Iacobelli M, Wei LJ, Rapoport AP, Diaz-Ricart M, Moraleda JM, Carlo-Stella C, Richardson PG Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide. Blood Rev. 2024 Jul;66:101218. doi: 10.1016/j.blre.2024.101218. Epub 2024 Jun 3.
  • Nicholls SJ Therapeutic Potential of Lipoprotein(a) Inhibitors. Drugs. 2024 Jun;84(6):637-643. doi: 10.1007/s40265-024-02046-z. Epub 2024 Jun 8.
  • Anker SD, Friede T, von Bardeleben RS, Butler J, Khan MS, Diek M, Heinrich J, Geyer M, Placzek M, Ferrari R, Abraham WT, Alfieri O, Auricchio A, Bayes-Genis A, Cleland JGF, Filippatos G, Gustafsson F, Haverkamp W, Kelm M, Kuck KH, Landmesser U, Maggioni AP, Metra M, Ninios V, Petrie MC, Rassaf T, Ruschitzka F, Schafer U, Schulze PC, Spargias K, Vahanian A, Zamorano JL, Zeiher A, Karakas M, Koehler F, Lainscak M, Oner A, Mezilis N, Theofilogiannakos EK, Ninios I, Chrissoheris M, Kourkoveli P, Papadopoulos K, Smolka G, Wojakowski W, Reczuch K, Pinto FJ, Zmudka K, Kalarus Z, Adamo M, Santiago-Vacas E, Ruf TF, Gross M, Tongers J, Hasenfuss G, Schillinger W, Ponikowski P Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials. Eur J Heart Fail. 2024 Jul;26(7):1608-1615. doi: 10.1002/ejhf.3286. Epub 2024 Jun 7.
  • Hayek A, MacDonald BJ, Marquis-Gravel G, Bainey KR, Mansour S, Ackman ML, Cantor WJ, Turgeon RD Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease With Recent or Remote Events: Systematic Review and Meta-analysis. CJC Open. 2024 Jan 12;6(5):708-720. doi: 10.1016/j.cjco.2024.01.001. eCollection 2024 May.
  • Boivin-Proulx LA, Bainey KR, Marquis-Gravel G, Graham MM Potent P2Y(12) Inhibitor Selection and De-escalation Strategies in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: Systematic Review and Meta-analysis. CJC Open. 2023 Dec 5;6(5):677-688. doi: 10.1016/j.cjco.2023.11.024. eCollection 2024 May.
  • Haller PM, Kazem N, Agewall S, Borghi C, Ceconi C, Dobrev D, Cerbai E, Grove EL, Kaski JC, Lewis BS, Niessner A, Rocca B, Rosano G, Savarese G, Schnabel RB, Semb AG, Sossalla S, Wassmann S, Sulzgruber P Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2024 Aug 14;10(5):444-453. doi: 10.1093/ehjcvp/pvae042.
  • Vivarelli M, Barratt J, Beck LH Jr, Fakhouri F, Gale DP, Goicoechea de Jorge E, Mosca M, Noris M, Pickering MC, Susztak K, Thurman JM, Cheung M, King JM, Jadoul M, Winkelmayer WC, Smith RJH, for Conference Participants The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2024 Sep;106(3):369-391. doi: 10.1016/j.kint.2024.05.015. Epub 2024 Jun 4.
  • Laudani C, Angiolillo DJ Ticagrelor in Clopidogrel-Treated Patients With Chronic Coronary Syndrome Undergoing PCI: Translating Pharmacodynamic Into Clinical Evidence. JACC Cardiovasc Interv. 2024 Jun 24;17(12):1422-1424. doi: 10.1016/j.jcin.2024.04.038. Epub 2024 Jun 5.
  • Gonuguntla K, Badu I, Duhan S, Sandhyavenu H, Chobufo MD, Taha A, Thyagaturu H, Sattar Y, Keisham B, Ali S, Khan MZ, Latchana S, Naeem M, Shaik A, Balla S, Gulati M Sex and Racial Disparities in Proportionate Mortality of Premature Myocardial Infarction in the United States: 1999 to 2020. J Am Heart Assoc. 2024 Jun 18;13(12):e033515. doi: 10.1161/JAHA.123.033515. Epub 2024 Jun 6.
  • Dewan P, Shen L, Pedro Ferreira J, Jhund PS, Anand IS, Chandra A, Chiang LM, Claggett B, Desai AS, Gong J, Lam CSP, Lefkowitz MP, Maggioni AP, Martinez F, Packer M, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Solomon SD, McMurray JJV Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF. Circulation. 2024 Jul 23;150(4):272-282. doi: 10.1161/CIRCULATIONAHA.124.068774. Epub 2024 Jun 6.
  • Lee SY, Cho JY, Gorog DA, Angiolillo DJ, Yun KH, Ahn JH, Koh JS, Park Y, Hwang SJ, Hwang JY, Kim JW, Jang Y, Jeong YH Inflammation and platelet reactivity during adjunctive colchicine versus aspirin in patients with acute coronary syndrome treated with potent P2Y12 inhibitor. Front Med (Lausanne). 2024 Apr 19;11:1349577. doi: 10.3389/fmed.2024.1349577. eCollection 2024.
  • Odutayo A, Cosentino F, Pratley RE, Dagogo-Jack S, McGuire DK, Frederich R, Fu W, Cannon CP, Cherney DZI, VERTIS CV Investigators Hypoglycaemia and kidney events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial. Diabetes Obes Metab. 2024 Aug;26(8):3478-3481. doi: 10.1111/dom.15687. Epub 2024 Jun 5.
  • Butler J, Anderson JE Managing Patients on SGLT2 Inhibitors in Primary Care. JACC Heart Fail. 2024 Jun;12(6S):S7-S9. doi: 10.1016/j.jchf.2023.12.023.
  • Butler J, Pessah-Pollack R Use of SGLT2 Inhibitors in Patients With HF With and Without Type 2 Diabetes: An Endocrinologist’s Perspective. JACC Heart Fail. 2024 Jun;12(6S):S4-S6. doi: 10.1016/j.jchf.2024.01.024.
  • Butler J, Rich J, Pessah-Pollack R, Anderson JE Summary and Panel Discussion. JACC Heart Fail. 2024 Jun;12(6S):S10-S11. doi: 10.1016/j.jchf.2023.11.022.
  • Butler J, Rich J Epidemiology of Heart Failure and the Discovery of the Cardioprotective Effects of SGLT2 Inhibitors. JACC Heart Fail. 2024 Jun;12(6S):S1-S3. doi: 10.1016/j.jchf.2024.01.025.
  • Zhang J, Liu Y, Thabane L, Li J, Bai X, Li L, Lip GYH, Sun X, Xia M, Van Spall HGC, Li G Journal requirement for data sharing statements in clinical trials: a cross-sectional study. J Clin Epidemiol. 2024 Aug;172:111405. doi: 10.1016/j.jclinepi.2024.111405. Epub 2024 Jun 4.
  • Butala NM, Kapadia SR, Secemsky EA, Gallup D, Kosinski AS, Vemulapalli S, Messenger JC, Yeh RW, Cohen DJ Impact of Cerebral Embolic Protection Devices on Disabling Stroke After TAVR: Updated Results From the STS/ACC TVT Registry. Circ Cardiovasc Interv. 2024 Sep;17(9):e013697. doi: 10.1161/CIRCINTERVENTIONS.123.013697. Epub 2024 Jun 5.
  • Butala NM, Kapadia SR, Yeh RW, Cohen DJ Use of Discharge Disposition to Determine Stroke Severity After TAVR. Circ Cardiovasc Interv. 2024 Sep;17(9):e013698. doi: 10.1161/CIRCINTERVENTIONS.123.013698. Epub 2024 Jun 5.
  • Yancy CW, Khan SS Social Vulnerability and Poor Health Outcomes: There Is No Nadir. JAMA Cardiol. 2024 Aug 1;9(8):701-702. doi: 10.1001/jamacardio.2024.1298.
  • Mittal N, Sonners C, Raphelson J, Sykes A, Roberts E, Swiatkiewicz I, Taub PR, Malhotra A, Schmickl CN The Impact of Obesity on Cardiorespiratory Fitness and Weight Changes in a Cardiac Rehabilitation Program. J Cardiopulm Rehabil Prev. 2024 Jul 1;44(4):E9-E11. doi: 10.1097/HCR.0000000000000870. Epub 2024 Jun 6.
  • McCoy IE, Chertow GM The Use of Kidney Disease Improving Global Outcomes AKI Definitions in AKI Research: PRO. Kidney360. 2024 Jul 1;5(7):941-943. doi: 10.34067/KID.0000000000000486.
  • An KR, Sandner S, Redfors B, Alexander JH, Alzghari T, Caldonazo T, Cancelli G, Dell’Aquila M, Dimagli A, Gibson CM, Harik L, Heise R, Kulik A, Lamy A, Leith J, Peper J, Perezgrovas-Olaria R, Rossi CS, Ruel M, Soletti GJ, Ten Berg JM, Willemsen LM, Wojdyla DM, Zhao Q, Zhu Y, Verma S, Gaudino MFL Association between overweight and obesity with coronary artery bypass graft failure: an individual patient data analysis of clinical trials. Eur J Cardiothorac Surg. 2024 Jun 3;65(6):ezae221. doi: 10.1093/ejcts/ezae221.
  • Vernon ST, Brentnall S, Currie DJ, Peng C, Gray MP, Botta G, Mujwara D, Nicholls SJ, Grieve SM, Redfern J, Chow C, Levesque JF, Meikle PJ, Jennings G, Ademi Z, Wilson A, Figtree GA Health economic analysis of polygenic risk score use in primary prevention of coronary artery disease – A system dynamics model. Am J Prev Cardiol. 2024 May 18;18:100672. doi: 10.1016/j.ajpc.2024.100672. eCollection 2024 Jun.
  • Heindel P, Fitzgibbon JJ, Secemsky EA, Belkin M, Ozaki CK, Hussain MA Evaluating the Effectiveness of Systemic Heparin During Arteriovenous Fistula Creation by Emulating a Target Trial. Am J Epidemiol. 2024 May 31:kwae098. doi: 10.1093/aje/kwae098.
  • Netuka I, Tucanova Z, Mehra MR Direct Oral Anticoagulant Therapy With A Fully Magnetically Levitated LVAD and Bridging to Heart Transplantation: A DOT-HM3 Study Analysis. J Card Fail. 2024 Nov;30(11):1512-1515. doi: 10.1016/j.cardfail.2024.05.005. Epub 2024 May 31.
  • Gautier A, Danchin N, Ducrocq G, Rousseau A, Cottin Y, Cayla G, Prunier F, Durand-Zaleski I, Ravaud P, Angoulvant D, Coste P, Lemesle G, Bouleti C, Popovic B, Ferrari E, Silvain J, Dubreuil O, Lhermusier T, Goube P, Schiele F, Vanzetto G, Aboyans V, Gallet R, Eltchaninoff H, Thuaire C, Dillinger JG, Paganelli F, Gourmelen J, Steg PG, Simon T, FRENCHIE investigators Rationale and design of the FRENch CoHort of myocardial Infarction Evaluation (FRENCHIE) study. Arch Cardiovasc Dis. 2024 Jun-Jul;117(6-7):417-426. doi: 10.1016/j.acvd.2024.04.004. Epub 2024 May 22.
  • Petrie MC, Borlaug BA, Butler J, Davies MJ, Kitzman DW, Shah SJ, Verma S, Jensen TJ, Einfeldt MN, Liisberg K, Perna E, Sharma K, Ezekowitz JA, Fu M, Melenovsky V, Ito H, Lelonek M, Kosiborod MN, STEP-HFpEF Trial Committees and Investigators Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program. J Am Coll Cardiol. 2024 Jul 2;84(1):27-40. doi: 10.1016/j.jacc.2024.04.022. Epub 2024 May 13.
  • Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, Hsiao LL, Khalife M, Kumaraswami LA, Loud F, Raghavan V, Roumeliotis S, Sierra M, Ulasi I, Wang B, Lui SF, Liakopoulos V, Balducci A Mind the gap in kidney care: Translating what we know into what we do. Clin Nephrol. 2024 Aug;102(2):59-72. doi: 10.5414/CNWKDEdi24.
  • Nicholls SJ, Nelson AJ New targets and mechanisms of action for lipid-lowering and anti-inflammatory therapies in atherosclerosis: where does the field stand? Expert Opin Ther Targets. 2024 May;28(5):375-384. doi: 10.1080/14728222.2024.2362644. Epub 2024 Jun 4.
  • Cohen DJ, Omar W Myocardial Infarction After TAVR: Much Ado About Nothing? JACC Cardiovasc Interv. 2024 May 27;17(10):1277-1279. doi: 10.1016/j.jcin.2024.03.009. Epub 2024 Mar 25.
  • Chertow GM Revisiting a “Paradigm” in Cardiovascular and Kidney Disease. J Am Coll Cardiol. 2024 Jun 4;83(22):2160-2162. doi: 10.1016/j.jacc.2024.04.018.
  • Ostrominski JW, Greene SJ, Patel RB, Solomon NC, Chiswell K, DeVore AD, Butler J, Heidenreich PA, Huang JC, Kittleson MM, Joynt Maddox KE, Linganathan KK, McDermott JJ, Owens AT, Peterson PN, Solomon SD, Vardeny O, Yancy CW, Fonarow GC, Vaduganathan M Kidney Outcomes Among Medicare Beneficiaries After Hospitalization for Heart Failure. JAMA Cardiol. 2024 Jul 1;9(7):667-672. doi: 10.1001/jamacardio.2024.1108.
  • Hayat J, Shah NP, Agarwala A, Khan MS, Butler J GLP-1 Receptor Agonists and Cardiovascular Disease: What Do Clinicians Need to Know? Curr Atheroscler Rep. 2024 Aug;26(8):341-351. doi: 10.1007/s11883-024-01214-6. Epub 2024 May 29.
  • Landi A, Morici N, Vranckx P, Frigoli E, Bonacchini L, Omazzi B, Tresoldi M, Camponovo C, Moccetti T, Windecker S, Valgimigli M Edoxaban and/or colchicine for patients with coronavirus disease 2019 managed in the out-of-hospital setting (CONVINCE): a randomized clinical trial. J Cardiovasc Med (Hagerstown). 2024 Jul 1;25(7):565-568. doi: 10.2459/JCM.0000000000001639. Epub 2024 May 28.
  • Rosenson RS, Gaudet D, Hegele RA, Ballantyne CM, Nicholls SJ, Lucas KJ, San Martin J, Zhou R, Muhsin M, Chang T, Hellawell J, Watts GF, ARCHES-2 Trial Team Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia. N Engl J Med. 2024 Sep 12;391(10):913-925. doi: 10.1056/NEJMoa2404147. Epub 2024 May 29.
  • Kelham M, Vyas R, Ramaseshan R, Rathod K, de Winter RJ, de Winter RW, Bendz B, Thiele H, Hirlekar G, Morici N, Myat A, Michalis LK, Sanchis J, Kunadian V, Berry C, Mathur A, Jones DA Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: a meta-analysis of invasive vs. conservative management. Eur Heart J. 2024 Jul 12;45(27):2380-2391. doi: 10.1093/eurheartj/ehae245.
  • Galindo RJ, Moazzami B, Tuttle KR, Bergenstal RM, Peng L, Umpierrez GE Continuous Glucose Monitoring Metrics and Hemoglobin A1c Relationship in Patients with Type 2 Diabetes Treated by Hemodialysis. Diabetes Technol Ther. 2024 Nov;26(11):862-868. doi: 10.1089/dia.2024.0145. Epub 2024 Jun 14.
  • Rawshani A, Eliasson B, Boren J, Sattar N, Bhatt D, El-Khalili L, Nordanstig J, Avdic T, Beckman JA, Gerstein HC, McGuire DK, Omerovic E, Rawshani A Non-coronary peripheral arterial complications in people with type 2 diabetes: a Swedish retrospective cohort study. Lancet Reg Health Eur. 2024 Mar 19;39:100888. doi: 10.1016/j.lanepe.2024.100888. eCollection 2024 Apr.
  • Avdic T, Eliasson B, Rawshani A, Boren J, Gerstein HC, Nordanstig J, Rihawi M, Beckman JA, McGuire DK, Omerovic E, Sattar N, Bhatt DL, Rawshani A Non-coronary arterial outcomes in people with type 1 diabetes mellitus: a Swedish retrospective cohort study. Lancet Reg Health Eur. 2024 Feb 15;39:100852. doi: 10.1016/j.lanepe.2024.100852. eCollection 2024 Apr.
  • Pabon MA, Vaduganathan M, Lam CSP Is the optimal dose of heart failure medical therapy different in women and men? Eur J Heart Fail. 2024 Aug;26(8):1699-1702. doi: 10.1002/ejhf.3320. Epub 2024 May 27.
  • Aglan A, Fath AR, Maron BJ, Maron MS, Prasad A, Almomani A, Hammadah M, Reynolds MR, Rowin EJ Percutaneous left atrial appendage closure for stroke prevention in hypertrophic cardiomyopathy patients with atrial fibrillation. Heart Rhythm. 2024 Sep;21(9):1677-1683. doi: 10.1016/j.hrthm.2024.05.038. Epub 2024 May 24.
  • Behary Paray N, Ramphul K, Picker SM, Akkaramani S, Memon RA, Ahmed M, Aggarwal S, Dhaliwal JS, Mactaggart S, Jeelani S, Sombans S, Sakthivel H, Lohana P, Kunadian V, Ahmed R Age-related disparities in complications among women with peripartum cardiomyopathy. Curr Probl Cardiol. 2024 Aug;49(8):102647. doi: 10.1016/j.cpcardiol.2024.102647. Epub 2024 May 25.
  • Chertow GM, Chang AM, Felker GM, Heise M, Velkoska E, Fellstrom B, Charytan DM, Clementi R, Gibson CM, Goodman SG, Jardine M, Levin A, Lokhnygina Y, Mears J, Mehran R, Stenvinkel P, Wang AY, Wheeler DC, Zoccali C, Ridker PM, Mahaffey KW, Tricoci P, Wolf M IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nat Med. 2024 Aug;30(8):2328-2336. doi: 10.1038/s41591-024-03043-1. Epub 2024 May 25.
  • Sattar N, Lee MMY, McGuire DK What the SELECT trial of semaglutide means for clinicians. Nat Med. 2024 Jul;30(7):1830-1831. doi: 10.1038/s41591-024-03013-7.
  • Colhoun HM, Lingvay I, Brown PM, Deanfield J, Brown-Frandsen K, Kahn SE, Plutzky J, Node K, Parkhomenko A, Ryden L, Wilding JPH, Mann JFE, Tuttle KR, Idorn T, Rathor N, Lincoff AM Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial. Nat Med. 2024 Jul;30(7):2058-2066. doi: 10.1038/s41591-024-03015-5. Epub 2024 May 25.
  • Hamid A, Greene SJ, Mehta A, Butler J, Khan MS Estimated Glomerular Filtration Rate Slope as an Endpoint in Cardiovascular Trials. Curr Heart Fail Rep. 2024 Aug;21(4):407-416. doi: 10.1007/s11897-024-00668-8. Epub 2024 May 25.
  • Pio SM, Medvedofsky D, Delgado V, Stassen J, Weissman NJ, Grayburn PA, Kar S, Lim DS, Redfors B, Snyder C, Zhou Z, Alu MC, Kapadia SR, Lindenfeld J, Abraham WT, Mack MJ, Asch FM, Stone GW, Bax JJ, COAPT Trial Investigators Left Atrial Improvement in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial. JACC Cardiovasc Imaging. 2024 Sep;17(9):1015-1027. doi: 10.1016/j.jcmg.2024.03.016. Epub 2024 May 22.
  • Ferro EG, Reynolds MR, Xu J, Song Y, Cohen DJ, Wadhera RK, d’Avila A, Zimetbaum PJ, Yeh RW, Kramer DB Outcomes of Atrial Fibrillation Ablation Among Older Adults in the United States: A Nationwide Study. JACC Clin Electrophysiol. 2024 Jul;10(7 Pt 1):1341-1350. doi: 10.1016/j.jacep.2024.03.032. Epub 2024 May 22.
  • De Oliveira-Gomes D, Guilliod C, Gebran K, Martinez de Majo A, Lombardo G, Garcia R, Abadi V, Gulati M Equity and representation in cardiology research: A comprehensive analysis of authorship from low and low-middle income countries in cardiology journals. Curr Probl Cardiol. 2024 Aug;49(8):102667. doi: 10.1016/j.cpcardiol.2024.102667. Epub 2024 May 22.
  • Shahim B, Cohen DJ, Asch FM, Bax J, George I, Ruck A, Ben-Yehuda O, Kar S, Lim DS, Saxon JT, Zhou Z, Lindenfeld J, Abraham WT, Mack MJ, Stone GW Repeat Mitral Valve Interventions After Transcatheter Edge-to-Edge Repair: The COAPT Trial. Am J Cardiol. 2024 Jul 15;223:7-14. doi: 10.1016/j.amjcard.2024.05.025. Epub 2024 May 23.
  • Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris G, Baeres FMM, Idorn T, Bosch-Traberg H, Lausvig NL, Pratley R, FLOW Trial Committees and Investigators Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. N Engl J Med. 2024 Jul 11;391(2):109-121. doi: 10.1056/NEJMoa2403347. Epub 2024 May 24.
  • Puymirat E, Cayla G, Simon T, Steg PG, Montalescot G, Durand-Zaleski I, Ngaleu Siaha F, Gallet R, Khalife K, Morelle JF, Motreff P, Lemesle G, Dillinger JG, Lhermusier T, Silvain J, Roule V, Labeque JN, Range G, Ducrocq G, Cottin Y, Blanchard D, Charles Nelson A, Djadi-Prat J, Chatellier G, Danchin N, FLOWER-MI Study Investigators Three-Year Outcomes With Fractional Flow Reserve-Guided or Angiography-Guided Multivessel Percutaneous Coronary Intervention for Myocardial Infarction. Circ Cardiovasc Interv. 2024 Jun;17(6):e013913. doi: 10.1161/CIRCINTERVENTIONS.123.013913. Epub 2024 May 24.
  • Lam CSP, Kober L, Kuwahara K, Lund LH, Mark PB, Mellbin LG, Schou M, Ely Pizzato P, Gabrielsen A, Gasparyan SB, Ghiretti A, Hartleib-Geschwindner J, Housler GJ, Fanti P, Leonsson-Zachrisson M, McMurray JJV, Solomon SD, MIRACLE Study Investigators Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial. Eur J Heart Fail. 2024 Aug;26(8):1727-1735. doi: 10.1002/ejhf.3294. Epub 2024 May 23.
  • Moloney BM, Chertow GM, Mc Causland FR Association of Diabetes with Changes in Blood Pressure during Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial. Am J Nephrol. 2024;55(4):409-416. doi: 10.1159/000539451. Epub 2024 May 24.
  • Lorenz EC, Winkelmayer WC Prospectively Examining Outcomes After Living Kidney Donation: Informing the Altruist. JAMA. 2024 Jul 23;332(4):285-286. doi: 10.1001/jama.2024.8733.
  • Simader FA, Al-Lamee RK To Test or Not to Test? The Utility of Noninvasive Cardiac Testing for Chest Pain Without Myocardial Infarction. Circ Cardiovasc Qual Outcomes. 2024 Jun;17(6):e011017. doi: 10.1161/CIRCOUTCOMES.124.011017. Epub 2024 May 23.
  • Koczo A, Brickshawana A, Zhu J, Thoma F, Countouris M, Berlacher K, Gulati M, Michos ED, Reis S, Mulukutla S, Saeed A Sex-based utilization of guideline recommended statin therapy and cardiovascular disease outcomes: Data from a multisite healthcare network primary prevention cohort. Am J Prev Cardiol. 2024 May 9;18:100667. doi: 10.1016/j.ajpc.2024.100667. eCollection 2024 Jun.
  • Rivera FB, Cruz LLA, Magalong JV, Ruyeras JMMJ, Aparece JP, Bantayan NRB, Lara-Breitinger K, Gulati M Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials. Am J Prev Cardiol. 2024 May 7;18:100679. doi: 10.1016/j.ajpc.2024.100679. eCollection 2024 Jun.
  • Nielsen RV, Fuster V, Bundgaard H, Fuster JJ, Johri AM, Kofoed KF, Douglas PS, Diederichsen A, Shapiro MD, Nicholls SJ, Nordestgaard BG, Lindholt JS, MacRae C, Yuan C, Newby DE, Urbina EM, Bergstrom G, Ridderstrale M, Budoff MJ, Bottcher M, Raitakari OT, Hansen TH, Naslund U, Sillesen H, Eldrup N, Ibanez B Personalized Intervention Based on Early Detection of Atherosclerosis: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024 May 28;83(21):2112-2127. doi: 10.1016/j.jacc.2024.02.053.
  • Kusner J, Patel RB, Hu M, Bertoni AG, Michos ED, Pandey A, VanWagner LB, Shah S, Fudim M Association of disproportionate liver fat with markers of heart failure: The multi-ethnic study of atherosclerosis. Am Heart J. 2024 Sep;275:1-8. doi: 10.1016/j.ahj.2024.05.010. Epub 2024 May 21.
  • Gonzalez-Pacheco H, Amezcua-Guerra LM, Franco M, Arias-Mendoza A, Ortega-Hernandez JA, Masso F Cytoprotection as an Innovative Therapeutic Strategy to Cardiogenic Shock: Exploring the Potential of Cytidine-5-Diphosphocholine to Mitigate Target Organ Damage. J Vasc Res. 2024;61(4):160-165. doi: 10.1159/000538946. Epub 2024 May 22.
  • Cao D, Vranckx P, Valgimigli M, Sartori S, Angiolillo DJ, Bangalore S, Bhatt DL, Feng Y, Ge J, Hermiller J, Makkar RR, Neumann FJ, Saito S, Picon H, Toelg R, Maksoud A, Chehab BM, Choi JW, Campo G, De la Torre Hernandez JM, Krucoff MW, Kunadian V, Sardella G, Spirito A, Thiele H, Varenne O, Vogel B, Zhou Y, Windecker S, Mehran R One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes. EuroIntervention. 2024 May 20;20(10):e630-e642. doi: 10.4244/EIJ-D-23-00658.
  • Mahmood F, Sharkey A, Mahmood F, Seth R, Liu D, Laham R Aortic Valve Replacement: Hemodynamic Consequences and Impact on Coronary Perfusion Pressure. JACC Case Rep. 2024 Apr 17;29(8):102278. doi: 10.1016/j.jaccas.2024.102278. eCollection 2024 Apr 17.
  • Pfeiffer M, Boehmer J, Gorcsan J, Eguchi S, Orihara Y, Perl ML, Eigler N, Abraham WT, Villota JN, Lee E, Bayes-Genis A, Moravsky G, Kar S, Zile MR, Holcomb R, Anker SD, Stone GW, Rodes-Cabau J, Lindenfeld J, Bax JJ In vivo fluid dynamics of the Ventura interatrial shunt device in patients with heart failure. ESC Heart Fail. 2024 Oct;11(5):2499-2509. doi: 10.1002/ehf2.14859. Epub 2024 May 22.
  • Boe NJ, Hald SM, Kristensen AR, Moller S, Bojsen JA, Elhakim MT, Rodrigues MA, Al-Shahi Salman R, Hallas J, Garcia Rodriguez LA, Selim M, Goldstein LB, Gaist D Association of Antithrombotic Drug Use With Incident Intracerebral Hemorrhage Location. Neurology. 2024 Jun 25;102(12):e209442. doi: 10.1212/WNL.0000000000209442. Epub 2024 May 21.
  • Korjian S, McCarthy KJ, Larnard EA, Cutlip DE, McEntegart MB, Kirtane AJ, Yeh RW Drug-Coated Balloons in the Management of Coronary Artery Disease. Circ Cardiovasc Interv. 2024 May;17(5):e013302. doi: 10.1161/CIRCINTERVENTIONS.123.013302. Epub 2024 May 21.
  • Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, Hsiao LL, Khalife M, Kumaraswami LA, Loud F, Raghavan V, Roumeliotis S, Sierra M, Ulasi I, Wang B, Lui SF, Liakopoulos V, Balducci A, World Kidney Day Joint Steering Committee Mind the gap in kidney care: Translating what we know into what we do. J Ren Care. 2024 Jun;50(2):79-91. doi: 10.1111/jorc.12495.
  • Shimoda T, D’Oria M, Kuno T, Heindel P, Lepidi S, Hussain MA, Takagi H, Secemsky EA Comparative Effectiveness of Intravascular Ultrasound Versus Angiography in Abdominal and Thoracic Endovascular Aortic Repair: Systematic Review and Meta-Analysis. Am J Cardiol. 2024 Jul 15;223:81-91. doi: 10.1016/j.amjcard.2024.05.017. Epub 2024 May 18.
  • Usman MS, Bhatt DL, Hameed I, Anker SD, Cheng AYY, Hernandez AF, Jones WS, Khan MS, Petrie MC, Udell JA, Friede T, Butler J Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2024 Jul;12(7):447-461. doi: 10.1016/S2213-8587(24)00102-5. Epub 2024 May 17.
  • Sattar N, Neeland IJ, McGuire DK Obesity and Cardiovascular Disease: A New Dawn. Circulation. 2024 May 21;149(21):1621-1623. doi: 10.1161/CIRCULATIONAHA.123.065485. Epub 2024 May 20.
  • Gaggin HK, Greene SJ, Zhou M, Lautsch D, Bash LD, Djatche L, Song Y, Signorovitch J, Stevenson AS, Blaustein RO, Butler J Contemporary outpatient management of patients with worsening heart failure with reduced ejection fraction: Clinical outcome results from the CHART-HF study. Int J Cardiol Cardiovasc Risk Prev. 2024 May 6;21:200278. doi: 10.1016/j.ijcrp.2024.200278. eCollection 2024 Jun.
  • Dushay J, Rickers ES, Wang E, Gilman J, Zhang Y, Blankstein R, Gervino EV, Jerosch-Herold M, Veves A Effects of Age and Sex on Systemic Inflammation and Cardiometabolic Function in Individuals with Type 2 Diabetes. medRxiv [Preprint]. 2024 May 10:2024.05.08.24307092. doi: 10.1101/2024.05.08.24307092.
  • Lodhi S, Kibret T, Mangalgi S, Reid L, Noel A, Syed S, Beauregard N, Dhaliwal S, Hussain J, Vinson AJ, Van Spall HGC, Sood MM, Shorr R, Bugeja A Systematic Review of Women Leading and Participating in Nephrology Randomized Clinical Trials. Kidney Int Rep. 2024 Jan 28;9(4):898-906. doi: 10.1016/j.ekir.2024.01.031. eCollection 2024 Apr.
  • Mehrotra R, Williamson DE, Betts CR, Greco BA, Yu E, El-Badry A, Fisher B, Mehoudar PD, Briggs B, Chertow GM A Prospective Clinical Study to EvaluAte the AbiliTy of the CloudCath System to Detect Peritonitis During In-Home Peritoneal Dialysis (CATCH). Kidney Int Rep. 2024 Jan 28;9(4):929-940. doi: 10.1016/j.ekir.2024.01.033. eCollection 2024 Apr.
  • Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, Hsiao LL, Khalife M, Kumaraswami LA, Loud F, Raghavan V, Roumeliotis S, Sierra M, Ulasi I, Wang B, Lui SF, Liakopoulos V, Balducci A Mind the Gap in Kidney Care: Translating What We Know Into What We do. Can J Kidney Health Dis. 2024 May 17;11:20543581241252506. doi: 10.1177/20543581241252506. eCollection 2024.
  • Amoroso NS, Sharma RP, Genereux P, Pinto DS, Dobbles M, Kwon M, Thourani VH, Gillam LD Clinical journey for patients with aortic regurgitation: A retrospective observational study from a multicenter database. Catheter Cardiovasc Interv. 2024 Jul;104(1):145-154. doi: 10.1002/ccd.31085. Epub 2024 May 19.
  • Dirjayanto VJ, Martin-Ruiz C, Pompei G, Rubino F, Kunadian V The association of inflammatory biomarkers and long-term clinical outcomes in older adults with non-ST elevation acute coronary syndrome. Int J Cardiol. 2024 Aug 15;409:132177. doi: 10.1016/j.ijcard.2024.132177. Epub 2024 May 16.
  • Li L, Wang C, Ye Z, Van Spall HGC, Zhang J, Lip GYH, Li G Association Between Remnant Cholesterol and Risk of Incident Atrial Fibrillation: Population-Based Evidence From a Large-Scale Prospective Cohort Study. J Am Heart Assoc. 2024 May 21;13(10):e033840. doi: 10.1161/JAHA.123.033840. Epub 2024 May 18.
  • Shiyovich A, Berman AN, Besser SA, Biery DW, Kaur G, Divakaran S, Singh A, Huck DM, Weber B, Plutzky J, Di Carli MF, Nasir K, Cannon C, Januzzi JL, Bhatt DL, Blankstein R Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp(a) Registry. J Am Heart Assoc. 2024 May 21;13(10):e034493. doi: 10.1161/JAHA.123.034493. Epub 2024 May 18.
  • Simader FA, Rajkumar CA, Foley MJ, Ahmed-Jushuf F, Chotai S, Bual N, Khokhar A, Gohar A, Lampadakis I, Ganesananthan S, Pathimagaraj RH, Nowbar A, Davies JR, Keeble TR, O’Kane PD, Haworth P, Routledge H, Kotecha T, Spratt JC, Williams R, Nijjer SS, Sen S, Curzen N, Sinha M, Howard JP, Cole G, Harrell FE Jr, Francis DP, Shun-Shin MJ, Al-Lamee RK, ORBITA-2 Investigators Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease. J Am Coll Cardiol. 2024 Jul 2;84(1):13-24. doi: 10.1016/j.jacc.2024.04.016. Epub 2024 May 15.
  • Lalani C, Yeh RW Residual Chest Pain After PCI: A Failure in Diagnosis Rather Than Treatment. J Am Coll Cardiol. 2024 Jul 2;84(1):25-26. doi: 10.1016/j.jacc.2024.04.042. Epub 2024 May 15.
  • Reijman MD, Tromp TR, Hutten BA, Hovingh GK, Blom DJ, Catapano AL, Cuchel M, Dann EJ, Gallo A, Hudgins LC, Raal FJ, Ray KK, Sadiq F, Soran H, Groothoff JW, Wiegman A, Kusters DM, Homozygous Familial Hypercholesterolaemia International Clinical Collaborators, (HICC), Children with Homozygous Hypercholesterolemia on Lipoprotein Apheresis: an, International Registry (CHAIN) consortia Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries. Lancet Child Adolesc Health. 2024 Jul;8(7):491-499. doi: 10.1016/S2352-4642(24)00073-7. Epub 2024 May 14.
  • Leiter LA, Raal FJ, Schwartz GG, Koenig W, Ray KK, Landmesser U, Han J, Conde LG, Wright RS Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION-9, ORION-10 and ORION-11 Phase 3 randomized trials. Diabetes Obes Metab. 2024 Aug;26(8):3223-3237. doi: 10.1111/dom.15650. Epub 2024 May 17.
  • Galli M, Occhipinti G, Benenati S, Laborante R, Ortega-Paz L, Franchi F, D’Amario D, Nerla R, Castriota F, Frati G, Biondi-Zoccai G, Sciarretta S, Angiolillo DJ Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 4;10(6):526-536. doi: 10.1093/ehjcvp/pvae036.
  • Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, Hsiao LL, Khalife M, Kumaraswami LA, Loud F, Raghavan V, Roumeliotis S, Sierra M, Ulasi I, Wang B, Lui SF, Liakopoulos V, Balducci A, World Kidney Day Joint Steering Committee Mind the Gap in Kidney Care: Translating What We Know into What We Do. Blood Purif. 2024;53(9):691-703. doi: 10.1159/000539071. Epub 2024 May 16.
  • de Cossio AS, Araiza-Garaygordobil D, Najera-Rojas NA, Alonso-Bringas AP, Robles-Ledesma M, la Cruz JLB, Gopar-Nieto R, Gonzalez-Pacheco H, Sierra-Lara-Martinez D, Arias-Mendoza A Impact of previous percutaneous coronary intervention on angiographic and clinical outcomes in patients with ST-segment elevation myocardial infarction. Gac Med Mex. 2024;160(1):45-52. doi: 10.24875/GMM.M24000847.
  • Wright RS, Raal FJ, Koenig W, Landmesser U, Leiter LA, Vikarunnessa S, Lesogor A, Maheux P, Talloczy Z, Zang X, Schwartz GG, Ray KK Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial. Cardiovasc Res. 2024 Oct 14;120(12):1400-1410. doi: 10.1093/cvr/cvae109.
  • Pandey A, Patel KV, Segar MW, Shapiro MD, Ballantyne CM, Virani SS, Nambi V, Michos ED, Blaha MJ, Nasir K, Cainzos-Achirica M, Ayers CR, Westenbrink BD, Flores-Guerrero JL, Bakker SJL, Connelly MA, Dullaart RPF, Rohatgi A Association of High-Density Lipoprotein Parameters and Risk of Heart Failure: A Multicohort Analysis. JACC Heart Fail. 2024 Jul;12(7):1242-1253. doi: 10.1016/j.jchf.2024.03.007. Epub 2024 May 15.
  • Rajkumar CA, Foley MJ, Ahmed-Jushuf F, Simader FA, Mohsin M, Ganesananthan S, Nowbar AN, Chotai S, Sen S, Petraco R, Nijjer SS, Sehmi J, Ruparelia N, Dungu JN, Kabir A, Tang K, Gamma R, Davies JR, Kotecha T, Cole GD, Howard JP, Keeble TR, Clesham G, O’Kane PD, Harrell FE Jr, Francis DP, Shun-Shin MJ, Al-Lamee RK N-of-1 Trial of Angina Verification Before Percutaneous Coronary Intervention. J Am Coll Cardiol. 2024 Jul 2;84(1):1-12. doi: 10.1016/j.jacc.2024.04.001. Epub 2024 May 14.
  • Gornik HL, Aronow HD, Goodney PP, Arya S, Brewster LP, Byrd L, Chandra V, Drachman DE, Eaves JM, Ehrman JK, Evans JN, Getchius TSD, Gutierrez JA, Hawkins BM, Hess CN, Ho KJ, Jones WS, Kim ESH, Kinlay S, Kirksey L, Kohlman-Trigoboff D, Long CA, Pollak AW, Sabri SS, Sadwin LB, Secemsky EA, Serhal M, Shishehbor MH, Treat-Jacobson D, Wilkins LR, Writing Committee Members 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2024 Jun 18;83(24):2497-2604. doi: 10.1016/j.jacc.2024.02.013. Epub 2024 May 14.
  • Butler J, Arshad MS, Khan MS Role of anti-obesity drugs in heart failure regardless of ejection fraction. Eur J Heart Fail. 2024 Aug;26(8):1703-1706. doi: 10.1002/ejhf.3224. Epub 2024 May 16.
  • Escarcega RO, Singh K, Chazal RA, Wood MJ Exercise Stress Testing Specificity in Patients With ANOCA: Beware When Applying to a General Population. J Am Coll Cardiol. 2024 May 21;83(20):e187-e188. doi: 10.1016/j.jacc.2024.02.049.
  • Rymer JA, Narcisse DI, Chen A, Wojdyla D, Ashley S, Damluji AA, Shah B, Nanna MG, Swaminathan R, Gutierrez JA, Uzendu A, Nelson AJ, Bethel G, Kearney K, Jones WS, Rao SV, Doll JA Case Volumes and Outcomes Among Early-Career Interventional Cardiologists in the United States. J Am Coll Cardiol. 2024 May 21;83(20):1990-1998. doi: 10.1016/j.jacc.2024.03.395.
  • Tio MC, Butler J, Zhu X, Obi Y, Yen TE, Kalantar-Zadeh K, Streja E, Dossabhoy NR, Hall ME, Shafi T Individualized Risk of CKD Progression among US Adults. J Am Soc Nephrol. 2024 Aug 1;35(8):1076-1083. doi: 10.1681/ASN.0000000000000377. Epub 2024 May 15.
  • Dvir D, Tchetche D, Leon MB, Genereux P, Seguy B, Makkar R, Pibarot P, Gada H, Nazif T, Hildick-Smith D, Kempfert J, Dumonteil N, Unbehaun A, Modine T, Whisenant B, Caussin C, Conradi L, Waggoner T, Mishell JM, Chetcuti SJ, Kar S, Rinaldi MJ, Szerlip M, Ramana RK, Blackman DJ, Ben-Dor I, Kornowski R, Waksman R, Gerckens U, Denti P, Kukucka M, Ternacle J, Skaf S, Kovac J, Jilaihawi H, Patel V, Jubeh R, Abdel-Wahab M, Kodali S Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study. Eur Heart J. 2024 Sep 1;45(33):3031-3041. doi: 10.1093/eurheartj/ehae303.
  • Lassen MCH, Ostrominski JW, Inzucchi SE, Claggett BL, Kulac I, Jhund P, de Boer RA, Hernandez AF, Kosiborod MN, Lam CSP, Martinez FA, Shah SJ, Desai AS, Petersson M, Langkilde AM, Docherty KF, McMurray JJV, Solomon SD, Vaduganathan M Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose-lowering therapy: A pre-specified analysis of the DELIVER trial. Eur J Heart Fail. 2024 Jul;26(7):1539-1548. doi: 10.1002/ejhf.3269. Epub 2024 May 15.
  • Swiatkiewicz I, Patel NT, Villarreal-Gonzalez M, Taub PR Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical center. BMC Med. 2024 May 14;22(1):195. doi: 10.1186/s12916-024-03401-3.
  • Ostrominski JW, Claggett BL, Miao ZM, Mc Causland FR, Anand IS, Desai AS, Jhund PS, Lam CSP, Pfeffer MA, Pitt B, Zannad F, Zile MR, Bomfim Wirtz A, Lay-Flurrie J, Viswanathan P, McMurray JJV, Solomon SD, Vaduganathan M Cardiovascular-Kidney-Metabolic Overlap in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Trial-Level Analysis. J Am Coll Cardiol. 2024 Jul 9;84(2):223-228. doi: 10.1016/j.jacc.2024.05.005. Epub 2024 May 12.
  • Gornik HL, Aronow HD, Goodney PP, Arya S, Brewster LP, Byrd L, Chandra V, Drachman DE, Eaves JM, Ehrman JK, Evans JN, Getchius TSD, Gutierrez JA, Hawkins BM, Hess CN, Ho KJ, Jones WS, Kim ESH, Kinlay S, Kirksey L, Kohlman-Trigoboff D, Long CA, Pollak AW, Sabri SS, Sadwin LB, Secemsky EA, Serhal M, Shishehbor MH, Treat-Jacobson D, Wilkins LR, Peer Review Committee Members 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024 Jun 11;149(24):e1313-e1410. doi: 10.1161/CIR.0000000000001251. Epub 2024 May 14.
  • Tannu M, Hess CN, Gutierrez JA, Lopes R, Swaminathan RV, Altin SE, Rao SV Polyvascular Disease: A Narrative Review of Risk Factors, Clinical Outcomes and Treatment. Curr Cardiol Rep. 2024 Jun;26(6):505-520. doi: 10.1007/s11886-024-02063-0. Epub 2024 May 14.
  • Khan MS, Chan PS, Sherrod CF, Ikemura N, Sauer AJ, Jones PG, Fonarow GC, Butler J, DeVore AD, Lund LH, Spertus JA Generalizable Approach to Quantifying Guideline-Directed Medical Therapy. Circ Heart Fail. 2024 May;17(5):e011164. doi: 10.1161/CIRCHEARTFAILURE.123.011164. Epub 2024 May 14.
  • Vaduganathan M, Claggett BL, Lam CSP, Pitt B, Senni M, Shah SJ, Voors AA, Zannad F, Desai AS, Jhund PS, Viswanathan P, Bomfim Wirtz A, Schloemer P, Lay-Flurrie J, McMurray JJV, Solomon SD Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS-HF trial. Eur J Heart Fail. 2024 Jun;26(6):1324-1333. doi: 10.1002/ejhf.3253. Epub 2024 May 14.
  • Aytekin A, Scalamogna M, Coughlan JJ, Lahu S, Ndrepepa G, Menichelli M, Mayer K, Wohrle J, Bernlochner I, Witzenbichler B, Hochholzer W, Sibbing D, Angiolillo DJ, Hemetsberger R, Tolg R, Valina C, Muller A, Kufner S, Liebetrau C, Xhepa E, Hapfelmeier A, Sager HB, Joner M, Richardt G, Laugwitz KL, Neumann FJ, Schunkert H, Schupke S, Kastrati A, Cassese S Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel. Clin Res Cardiol. 2024 Jul;113(7):1060-1069. doi: 10.1007/s00392-024-02454-x. Epub 2024 May 13.
  • Arrigo M, Davison B, Edwards C, Adamo M, Ambrosy AP, Barros M, Biegus J, Celutkiene J, Cerlinskaite-Bajore K, Chioncel O, Cohen-Solal A, Damasceno A, Diaz R, Filippatos G, Gayat E, Kimmoun A, Lam CSP, Metra M, Novosadova M, Pagnesi M, Pang PS, Ponikowski P, Saidu H, Sliwa K, Takagi K, Ter Maaten JM, Tomasoni D, Voors AA, Cotter G, Mebazaa A Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial. Am Heart J. 2024 Aug;274:119-129. doi: 10.1016/j.ahj.2024.04.019. Epub 2024 May 12.
  • Thule J, Yu X, Montez-Rath ME, Chertow GM MyPlate Awareness and Engagement and Perceived and Objective Diet Quality in US Adults With Chronic Kidney Disease. J Ren Nutr. 2024 Nov;34(6):493-499. doi: 10.1053/j.jrn.2024.04.007. Epub 2024 May 11.
  • Ostrominski JW, Aggarwal R, Claggett BL, Kulac IJ, Desai AS, Jhund PS, Lam CSP, Pitt B, Senni M, Shah SJ, Voors AA, Zannad F, Lay-Flurrie J, Viswanathan P, McMurray JJV, Solomon SD, Vaduganathan M Generalizability of the Spectrum of Kidney Risk in the FINEARTS-HF Trial to U.S. Adults With Heart Failure. J Card Fail. 2024 Sep;30(9):1170-1174. doi: 10.1016/j.cardfail.2024.04.015. Epub 2024 May 11.
  • Butler J, Stockbridge N, Packer M Win Ratio: A Seductive But Potentially Misleading Method for Evaluating Evidence from Clinical Trials. Circulation. 2024 May 14;149(20):1546-1548. doi: 10.1161/CIRCULATIONAHA.123.067786. Epub 2024 May 13.
  • Ambrosy AP, Chang AJ, Davison B, Voors A, Cohen-Solal A, Damasceno A, Kimmoun A, Lam CSP, Edwards C, Tomasoni D, Gayat E, Filippatos G, Saidu H, Biegus J, Celutkiene J, Ter Maaten JM, Cerlinskaite-Bajore K, Sliwa K, Takagi K, Metra M, Novosadova M, Barros M, Adamo M, Pagnesi M, Arrigo M, Chioncel O, Diaz R, Pang PS, Ponikowski P, Cotter G, Mebazaa A Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk. JACC Heart Fail. 2024 Sep;12(9):1566-1582. doi: 10.1016/j.jchf.2024.04.017. Epub 2024 May 12.
  • Shah SJ, Sharma K, Borlaug BA, Butler J, Davies M, Kitzman DW, Petrie MC, Verma S, Patel S, Chinnakondepalli KM, Einfeldt MN, Jensen TJ, Rasmussen S, Asleh R, Ben-Gal T, Kosiborod MN Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials. Eur Heart J. 2024 Sep 14;45(35):3254-3269. doi: 10.1093/eurheartj/ehae322.
  • Maron MS, Masri A, Nassif ME, Barriales-Villa R, Arad M, Cardim N, Choudhury L, Claggett B, Coats CJ, Dungen HD, Garcia-Pavia P, Hagege AA, Januzzi JL, Lee MMY, Lewis GD, Ma CS, Michels M, Olivotto I, Oreziak A, Owens AT, Spertus JA, Solomon SD, Tfelt-Hansen J, van Sinttruije M, Veselka J, Watkins H, Jacoby DL, Heitner SB, Kupfer S, Malik FI, Meng L, Wohltman A, Abraham TP, SEQUOIA-HCM Investigators Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy. N Engl J Med. 2024 May 30;390(20):1849-1861. doi: 10.1056/NEJMoa2401424. Epub 2024 May 13.
  • Zannad F, Sanyal AJ, Butler J, Ferreira JP, Girerd N, Miller V, Pandey A, Parikh CR, Ratziu V, Younossi ZM, Harrison SA MASLD and MASH at the crossroads of hepatology trials and cardiorenal metabolic trials. J Intern Med. 2024 Jul;296(1):24-38. doi: 10.1111/joim.13793. Epub 2024 May 13.
  • Yancy CW Heart Failure in African American Individuals, Version 2.0. JAMA. 2024 Jun 4;331(21):1807-1808. doi: 10.1001/jama.2024.5217.
  • Packer M, Anker SD, Butler J, Cleland JGF, Kalra PR, Mentz RJ, Ponikowski P, Talha KM Redefining Iron Deficiency in Patients With Chronic Heart Failure. Circulation. 2024 Jul 9;150(2):151-161. doi: 10.1161/CIRCULATIONAHA.124.068883. Epub 2024 May 11.
  • Packer M, Anker SD, Butler J, Cleland JGF, Kalra PR, Mentz RJ, Ponikowski P Identification of three mechanistic pathways for iron-deficient heart failure. Eur Heart J. 2024 Jul 9;45(26):2281-2293. doi: 10.1093/eurheartj/ehae284.
  • Solomon SD, Ostrominski JW, Vaduganathan M, Claggett B, Jhund PS, Desai AS, Lam CSP, Pitt B, Senni M, Shah SJ, Voors AA, Zannad F, Abidin IZ, Alcocer-Gamba MA, Atherton JJ, Bauersachs J, Ma CS, Chiang CE, Chioncel O, Chopra V, Comin-Colet J, Filippatos G, Fonseca C, Gajos G, Goland S, Goncalvesova E, Kang SM, Katova T, Kosiborod MN, Latkovskis G, Lee AP, Linssen GCM, Llamas-Esperon G, Mareev V, Martinez FA, Melenovsky V, Merkely B, Nodari S, Petrie MC, Saldarriaga CI, Saraiva JFK, Sato N, Schou M, Sharma K, Troughton R, Udell JA, Ukkonen H, Vardeny O, Verma S, von Lewinski D, Voronkov LG, Yilmaz MB, Zieroth S, Lay-Flurrie J, van Gameren I, Amarante F, Viswanathan P, McMurray JJV Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial. Eur J Heart Fail. 2024 Jun;26(6):1334-1346. doi: 10.1002/ejhf.3266. Epub 2024 May 11.
  • Greene SJ, Chambers R, Lerman JB, Harrington J, deFilippi CR, Wendell DC, Kim HW, Green CL, Butler J, Felker GM Sacubitril/valsartan and cardiovascular biomarkers among patients with recent COVID-19 infection: The PARACOR-19 randomized clinical trial. Eur J Heart Fail. 2024 Jun;26(6):1393-1398. doi: 10.1002/ejhf.3199. Epub 2024 May 11.
  • Cooreman MP, Butler J, Giugliano RP, Zannad F, Dzen L, Huot-Marchand P, Baudin M, Beard DR, Junien JL, Broqua P, Abdelmalek MF, Francque SM The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis. Nat Commun. 2024 May 10;15(1):3962. doi: 10.1038/s41467-024-47919-9.
  • Packer M, Anker SD, Butler J, Cleland JGF, Kalra PR, Mentz RJ, Ponikowski P, Talha KM Critical re-evaluation of the identification of iron deficiency states and effective iron repletion strategies in patients with chronic heart failure. Eur J Heart Fail. 2024 Jun;26(6):1298-1312. doi: 10.1002/ejhf.3237. Epub 2024 May 10.
  • Kittipibul V, Vaduganathan M, Ikeaba U, Chiswell K, Butler J, DeVore AD, Heidenreich PA, Huang JC, Kittleson MM, Joynt Maddox KE, Linganathan KK, McDermott JJ, Owens AT, Peterson PN, Solomon SD, Vardeny O, Yancy CW, Fonarow GC, Greene SJ Cause-Specific Health Care Costs Following Hospitalization for Heart Failure and Cost Offset With SGLT2i Therapy. JACC Heart Fail. 2024 Aug;12(8):1409-1421. doi: 10.1016/j.jchf.2024.04.003. Epub 2024 Apr 6.
  • Garot P, Morice MC, Angiolillo DJ, Cabau JR, Park DW, Van Mieghem NM, Collet JP, Leon MB, Sengottuvelu G, Neylon A, Ten Berg JM, Mylotte D, Tchetche D, Krucoff MW, Reardon MJ, Piazza N, Mack MJ, Genereux P, Makkar R, Hayashida K, Ohno Y, Mochizuki S, Shirai Y, Matsumara R, Jin Y, Webb JG, Cutlip DE, Chen M, Spitzer E, Mehran R, Capodanno D Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document. EuroIntervention. 2024 May 10;20(9):536-550. doi: 10.4244/EIJ-D-23-01020.
  • Earle WB, Li S, Yang S, Krawisz A, Aronow HD, Parikh SA, Juraschek SP, Cluett JL, Schermerhorn ML, Carroll BJ, Secemsky EA Procedural trends and event rates in severe renovascular hypertension. EuroIntervention. 2024 May 10;20(9):616-618. doi: 10.4244/EIJ-D-23-01030.
  • Kessler M, Rottbauer W, von Bardeleben RS, Grasso C, Lurz P, Mahoney P, Price M, Williams M, Denti P, Estevez-Loureiro R, Kar S, Maisano F Impact of heart failure hospitalizations on clinical outcomes after mitral transcatheter edge-to-edge repair: Results from the EXPAND study. Eur J Heart Fail. 2024 Jul;26(7):1495-1503. doi: 10.1002/ejhf.3250. Epub 2024 May 10.
  • Gordon LB, Basso S, Maestranzi J, Aikawa E, Clift CL, Cammardella AG, Danesi TH, Del Nido PJ, Edelman ER, Hamdy A, Hegde SM, Kleinman ME, Maschietto N, Mehra MR, Mukundan S, Musumeci F, Russo M, Rybicki FJ, Shah PB, Suarez WA, Tuminelli K, Zaleski K, Prakash A, Gerhard-Herman M Intervention for critical aortic stenosis in Hutchinson-Gilford progeria syndrome. Front Cardiovasc Med. 2024 Apr 25;11:1356010. doi: 10.3389/fcvm.2024.1356010. eCollection 2024.
  • Bugiardini R, Gale CP, Gulati M, Anand SS, Maas AHEM, Townsend N, Vaccarino V, Badimon L, Cenko E, Manfrini O, Jha P Announcing The Lancet Regional Health-Europe commission on inequalities and disparities in cardiovascular health. Lancet Reg Health Eur. 2024 May 4;41:100926. doi: 10.1016/j.lanepe.2024.100926. eCollection 2024 Jun.
  • Vranckx P, Morrow D, van Diepen S, Verbrugge F Unveiling new horizons: revolutionary insights into acute myocarditis and optimal mechanical circulatory support timing. Eur Heart J Acute Cardiovasc Care. 2024 May 28;13(5):389. doi: 10.1093/ehjacc/zuae043.
  • Diaz N, Perez C, Escribano AM, Sanz G, Priego J, Lafuente C, Barberis M, Calle L, Espinosa JF, Priest BT, Zhang HY, Nosie AK, Haas JV, Cannady E, Borel A, Schultze AE, Sauder JM, Hendle J, Weichert K, Nicholls SJ, Michael LF Discovery of potent small-molecule inhibitors of lipoprotein(a) formation. Nature. 2024 May;629(8013):945-950. doi: 10.1038/s41586-024-07387-z. Epub 2024 May 8.
  • Guseh JS 2nd, Januzzi JL Jr The Hidden Cardiovascular Crisis Among Former NFL Athletes: After the HUDDLE. J Am Coll Cardiol. 2024 May 14;83(19):1838-1840. doi: 10.1016/j.jacc.2024.03.403.
  • Sposato LA, Hill MD In AF, CHA(2)DS(2)-VASc 1 subgroups did not differ for predicting risk for arterial thromboembolism at 1 y. Ann Intern Med. 2024 May;177(5):JC59. doi: 10.7326/J24-0023. Epub 2024 May 7.
  • Bharadwaj AS, Abu-Much A, Maini AS, Zhou Z, Li Y, Batchelor WB, Grines CL, Baron SJ, Redfors B, Lansky AJ, Basir MB, O’Neill WW Angiographic Characteristics and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study. Circ Cardiovasc Interv. 2024 Jul;17(7):e013503. doi: 10.1161/CIRCINTERVENTIONS.123.013503. Epub 2024 May 6.
  • Limonte CP, Lamprea-Montealegre JA, Tuttle KR Challenges and Strategies in Implementing Novel Kidney Protective and Cardioprotective Therapies in Patients With Diabetes and Kidney Disease. Semin Nephrol. 2024 Mar;44(2):151520. doi: 10.1016/j.semnephrol.2024.151520. Epub 2024 May 5.
  • Nicholls SJ, Nelson AJ, Ditmarsch M, Kastelein JJP, Ballantyne CM, Ray KK, Navar AM, Nissen SE, Golberg AC, Brunham LR, Curcio D, Wuerdeman E, Neild A, Kling D, Hsieh A, Dicklin MR, Ference BA, Laufs U, Banach M, Mehran R, Catapano AL, Davidson MH Obicetrapib on top of maximally tolerated lipid-modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN. Am Heart J. 2024 Aug;274:32-45. doi: 10.1016/j.ahj.2024.05.002. Epub 2024 May 4.
  • Landi A, Heg D, Frigoli E, Tonino PAL, Vranckx P, Pourbaix S, Chevalier B, Iniguez A, Pinar E, Lesiak M, Kala P, Donahue M, Windecker S, Roffi M, Smits PC, Valgimigli M, MASTER DAPT Investigators Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trial. Eur J Intern Med. 2024 Aug;126:89-94. doi: 10.1016/j.ejim.2024.04.016. Epub 2024 May 3.
  • Yang M, Kondo T, Talebi A, Jhund PS, Docherty KF, Claggett BL, Vaduganathan M, Bachus E, Hernandez AF, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Kosiborod MN, Desai AS, Kober L, Ponikowski P, Sabatine MS, Solomon SD, McMurray JJV Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction. Eur J Heart Fail. 2024 Jul;26(7):1524-1538. doi: 10.1002/ejhf.3263. Epub 2024 May 3.
  • Oo MM, Gao C, Cole C, Hummel Y, Guignard-Duff M, Jefferson E, Hare J, Voors AA, de Boer RA, Lam CSP, Mordi IR, Tromp J, Lang CC Artificial intelligence-assisted automated heart failure detection and classification from electronic health records. ESC Heart Fail. 2024 Oct;11(5):2769-2777. doi: 10.1002/ehf2.14828. Epub 2024 May 3.
  • Assadourian JN, Peterson ED, Gupta A, Navar AM Use of Dietary Supplements Among People With Atherosclerotic Cardiovascular Disease in the United States: A Population-Based Analysis From NHANES. J Am Heart Assoc. 2024 May 7;13(9):e033748. doi: 10.1161/JAHA.123.033748. Epub 2024 May 3.
  • Kingwell BA, Duffy D, Clementi R, Velkoska E, Feaster J, Gibson CM CSL112 (Apolipoprotein A-I [Human]) Reduces the Elevation in Neutrophil-to-Lymphocyte Ratio Induced by Acute Myocardial Infarction. J Am Heart Assoc. 2024 May 7;13(9):e033541. doi: 10.1161/JAHA.123.033541. Epub 2024 May 3.
  • Vranckx P, Morrow D, van Diepen S, Verbrugge F Acute cardiovascular and intensive care chronicles: crossing new frontiers in advanced cardiovascular therapeutics. Eur Heart J Acute Cardiovasc Care. 2024 Jun 30;13(6):457. doi: 10.1093/ehjacc/zuae059.
  • Jhand AS, Abusnina W, Tak HJ, Ahmed A, Ismayl M, Altin SE, Sherwood MW, Alexander JH, Rao SV, Abbott JD, Carson JL, Goldsweig AM Impact of anemia on outcomes and resource utilization in patients with myocardial infarction: A national database analysis. Int J Cardiol. 2024 Aug 1;408:132111. doi: 10.1016/j.ijcard.2024.132111. Epub 2024 Apr 30.
  • Huang J, Yang DM, Rong R, Nezafati K, Treager C, Chi Z, Wang S, Cheng X, Guo Y, Klesse LJ, Xiao G, Peterson ED, Zhan X, Xie Y A critical assessment of using ChatGPT for extracting structured data from clinical notes. NPJ Digit Med. 2024 May 1;7(1):106. doi: 10.1038/s41746-024-01079-8.
  • Wang V, Wang CL, Assimon MM, Pun PH, Winkelmayer WC, Flythe JE Prescription and Dispensation of QT-Prolonging Medications in Individuals Receiving Hemodialysis. JAMA Netw Open. 2024 Apr 1;7(4):e248732. doi: 10.1001/jamanetworkopen.2024.8732.
  • Xu X, Ren QW, Chandramouli C, Ng MY, Tsang CT, Tse YK, Li XL, Liu MY, Wu MZ, Huang JY, Cheang IF, Yang JF, Wang F, Lam CSP, Yiu KH Glycated Hemoglobin Variability Is Associated With Adverse Outcomes in Patients With Heart Failure Irrespective of Diabetic Status. J Am Heart Assoc. 2024 May 7;13(9):e034109. doi: 10.1161/JAHA.123.034109. Epub 2024 Apr 30.
  • Nguyen DQ, Keshvani N, Chandra A, Alebna PL, Dixon DL, Shapiro MD, Michos ED, Sperling LS, Pandey A, Mehta A Temporal trends and racial/ethnic- and sex-differences in LDL cholesterol control among US adults with self-reported atherosclerotic cardiovascular disease. Am J Prev Cardiol. 2024 Apr 15;18:100673. doi: 10.1016/j.ajpc.2024.100673. eCollection 2024 Jun.
  • Huang AL, Navar AM, Ayers C, Rohatgi A, Michos ED, Virani SS, Joshi P, Peterson ED, Khera A US population qualifying for aspirin use for primary prevention of cardiovascular disease. Am J Prev Cardiol. 2024 Apr 16;18:100669. doi: 10.1016/j.ajpc.2024.100669. eCollection 2024 Jun.
  • Tsai MH, Goldstein JC, Goldstein HV, Wang Z, Dauerman HL Toppling the Tower of Babel: Large Language Models in Academia. J Clin Anesth. 2024 Sep;96:111462. doi: 10.1016/j.jclinane.2024.111462. Epub 2024 Apr 27.
  • Burger PM, Bhatt DL, Dorresteijn JAN, Koudstaal S, Mosterd A, Martens FMAC, Steg PG, Visseren FLJ, REDUCE-IT Investigators Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 4;10(6):488-499. doi: 10.1093/ehjcvp/pvae030.
  • Bikdeli B, Krishnathasan D, Khairani CD, Bejjani A, Davies J, Porio N, Tristani A, Armero A, Assi AA, Nauffal V, Campia U, Almarzooq Z, Wei E, Ortiz-Rios MD, Zuluaga-Sanchez V, Achanta A, Jesudasen SJ, Tiu B, Merli GJ, Leiva O, Fanikos J, Grandone E, Sharma A, Rizzo S, Pfeferman MB, Morrison RB, Vishnevsky A, Hsia J, Nehler MR, Welker J, Bonaca MP, Carroll B, Goldhaber SZ, Lan Z, Piazza G, CORONA-VTE-Network Investigators Low absolute risk of thrombotic and cardiovascular events in outpatient pregnant women with COVID-19. Thromb Res. 2024 May;237:209-215. doi: 10.1016/j.thromres.2024.02.021. Epub 2024 Apr 6.
  • O’Hara DV, Lam CSP, McMurray JJV, Yi TW, Hocking S, Dawson J, Raichand S, Januszewski AS, Jardine MJ Applications of SGLT2 inhibitors beyond glycaemic control. Nat Rev Nephrol. 2024 Aug;20(8):513-529. doi: 10.1038/s41581-024-00836-y. Epub 2024 Apr 26.
  • Duvalyan A, La Hoz RM, McGuire DK, Drazner MH Sodium-Glucose Cotransporter 2 Inhibitors and Mycotic Genital or Urinary Tract Infections in Heart Failure. J Card Fail. 2024 Aug;30(8):1031-1040. doi: 10.1016/j.cardfail.2024.04.009. Epub 2024 Apr 25.
  • Wong CCY, Pogatchnik BP, Clark DE, Sharma RP A case report of successful primary percutaneous coronary intervention to an occluded anomalous left main coronary artery arising from the right coronary sinus. Eur Heart J Case Rep. 2024 Apr 15;8(4):ytae192. doi: 10.1093/ehjcr/ytae192. eCollection 2024 Apr.
  • Walker AJ, Zhu J, Thoma F, Marroquin O, Makani A, Gulati M, Gianos E, Virani SS, Rodriguez F, Reis SE, Ballantyne C, Mulukutla S, Saeed A Statin utilization and cardiovascular outcomes in a real-world primary prevention cohort of older adults. Am J Prev Cardiol. 2024 Apr 5;18:100664. doi: 10.1016/j.ajpc.2024.100664. eCollection 2024 Jun.
  • Pabon MA, Wang X, Lam CSP, O’Meara E, Vaduganathan M, Claggett BL, Foa A, Lu H, Langkilde AM, De Boer RA, Desai AS, Hernandez AF, Inzucchi SE, Jhund PS, Kosiborod MN, Martinez FA, Shah SJ, Petersson M, McMurray JJV, Solomon SD, Vardeny O Sex Differences in Heart Failure With Improved Ejection Fraction: The DELIVER Trial. JACC Heart Fail. 2024 Jun;12(6):1119-1122. doi: 10.1016/j.jchf.2024.03.011. Epub 2024 Apr 8.
  • Lemesle G, Lamblin N, Schurtz G, Labreuche J, Duhamel A, Verdier B, Steg PG, Bauters C Comparison of Incidence and Prognostic Impact of Ischemic, Major Bleeding and Heart Failure Events in Patients With Chronic Coronary Syndrome: Insights From the CORONOR Registry. Circulation. 2024 May 28;149(22):1708-1716. doi: 10.1161/CIRCULATIONAHA.123.067938. Epub 2024 Apr 25.
  • Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, Hsiao LL, Khalife M, Kumaraswami LA, Loud F, Raghavan V, Roumeliotis S, Sierra M, Ulasi I, Wang B, Lui SF, Liakopoulos V, Balducci A, Joint Steering Committee OTWKD Mind the Gap in Kidney Care: Translating What We Know Into What We Do. Iran J Kidney Dis. 2024 Mar;18(2):68-86. doi: 10.5254/sqbbj216.
  • Nelson AJ, Azzopardi R, Lam CSP, Nicholls SJ Reply: Low Asian Enrollment in Cardiometabolic Studies and the Importance of Trial Context. JACC Asia. 2024 Feb 27;4(4):343. doi: 10.1016/j.jacasi.2024.01.012. eCollection 2024 Apr.
  • Goodman SG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Harrington RA, Jukema JW, White HD, Zeiher AM, Manvelian G, Pordy R, Poulouin Y, Stipek W, Garon G, Schwartz GG, ODYSSEY OUTCOMES Investigators Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation. Eur Heart J Cardiovasc Pharmacother. 2024 Jul 16;10(4):342-352. doi: 10.1093/ehjcvp/pvae025.
  • Kleiman NS, Van Mieghem NM, Reardon MJ, Gada H, Mumtaz M, Olsen PS, Heiser J, Merhi W, Chetcuti S, Deeb GM, Chawla A, Kiaii B, Teefy P, Chu MWA, Yakubov SJ, Windecker S, Althouse AD, Baron SJ Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients. JACC Cardiovasc Interv. 2024 Apr 22;17(8):979-988. doi: 10.1016/j.jcin.2024.02.014.
  • Bonaca MP, Bhatt DL, Simon T, Fox KM, Mehta S, Harrington RA, Leiter LA, Capell WH, Held C, Himmelmann A, Ridderstrale W, Chen J, Lee JJ, Song Y, Andersson M, Prats J, Kosiborod M, McGuire DK, Steg PG Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis. J Am Coll Cardiol. 2024 Apr 30;83(17):1627-1636. doi: 10.1016/j.jacc.2024.03.377.
  • Yokose C, Challener G, Jiang B, Zhou B, McCormick N, Tanikella S, Panchot KMQ, Kohler MJ, Yinh J, Zhang Y, Bates DW, Januzzi JL, Sise M, Wexler D, Choi HK Serum urate change among gout patients treated with sodium-glucose cotransporter type 2 inhibitors vs. sulfonylurea: A comparative effectiveness analysis. Semin Arthritis Rheum. 2024 Jun;66:152441. doi: 10.1016/j.semarthrit.2024.152441. Epub 2024 Apr 5.
  • Patton KK, Yancy CW Atrial Fibrillation Ablation in Heart Failure-More Data Are Needed. JAMA Cardiol. 2024 Jun 1;9(6):555. doi: 10.1001/jamacardio.2024.0684.
  • Sayed A, Abramov D, Fonarow GC, Mamas MA, Kobo O, Butler J, Fudim M Reversals in the Decline of Heart Failure Mortality in the US, 1999 to 2021. JAMA Cardiol. 2024 Jun 1;9(6):585-589. doi: 10.1001/jamacardio.2024.0615.
  • McCarthy CP, Wasfy JH, Januzzi JL Jr Is Myocardial Infarction Overdiagnosed? JAMA. 2024 May 21;331(19):1623-1624. doi: 10.1001/jama.2024.5235.
  • Elsayed E, Farag YMK, Ravi KS, Chertow GM, Mc Causland FR Association of Changes in Vector Length with Changes in Left Ventricular Mass among Patients on Maintenance Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial. Kidney360. 2024 Jun 1;5(6):870-876. doi: 10.34067/KID.0000000000000443. Epub 2024 Apr 24.
  • Kobayashi J, Baron SJ, Takagi K, Thompson CA, Jiao X, Yamabe K Cost-effectiveness analysis of transcatheter aortic valve implantation in aortic stenosis patients at low- and intermediate-surgical risk in Japan. J Med Econ. 2024 Jan-Dec;27(1):697-707. doi: 10.1080/13696998.2024.2346397. Epub 2024 May 6.
  • Anker SD, Friede T, von Bardeleben RS, Butler J, Fatima K, Diek M, Heinrich J, Hasenfuss G, Schillinger W, Ponikowski P Randomized investigation of the MitraClip device in heart failure: Design and rationale of the RESHAPE-HF2 trial design. Eur J Heart Fail. 2024 Apr;26(4):984-993. doi: 10.1002/ejhf.3247. Epub 2024 Apr 23.
  • Gandhi RT, Gibson CM, Jaber WA A cross-sectional study of outcomes for patients undergoing mechanical thrombectomy for pulmonary embolism during 2018-2022: Insights from the PINC AI Healthcare Database. Health Sci Rep. 2024 Apr 21;7(4):e2031. doi: 10.1002/hsr2.2031. eCollection 2024 Apr.
  • Niu J, Rosales O, Oluyomi A, Lew SQ, Winkelmayer WC, Chertow GM, Erickson KF The Use of Telemedicine by US Nephrologists for In-Center Hemodialysis Care During the Pandemic: An Analysis of National Medicare Claims. Kidney Med. 2024 Feb 17;6(4):100798. doi: 10.1016/j.xkme.2024.100798. eCollection 2024 Apr.
  • Gouda P, Islam S, Dover DC, Kaul P, Bainey KR, Welsh RC Outcomes of management strategies in patients with prior coronary artery bypass grafting presenting with an acute coronary syndrome. Atherosclerosis. 2024 Jun;393:117477. doi: 10.1016/j.atherosclerosis.2024.117477. Epub 2024 Feb 16.
  • Nangaku M, Herrington WG, Goto S, Maruyama S, Kashihara N, Ueki K, Wada J, Watada H, Nakashima E, Lee R, Massey D, Mayne KJ, Tomita A, Haynes R, Hauske SJ, Kadowaki T Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA-KIDNEY. Clin Exp Nephrol. 2024 Jun;28(6):588-595. doi: 10.1007/s10157-024-02489-4. Epub 2024 Apr 20.
  • Warisawa T, Cook CM, Ahmad Y, Howard JP, Seligman H, Rajkumar C, Toya T, Doi S, Nakajima A, Nakayama M, Vera-Urquiza R, Yuasa S, Sato T, Kikuta Y, Kawase Y, Nishina H, Al-Lamee R, Sen S, Lerman A, Matsuo H, Akashi YJ, Escaned J, Davies JE Physiological Assessment with iFR prior to FFR Measurement in Left Main Disease. Cardiovasc Interv Ther. 2024 Jul;39(3):241-251. doi: 10.1007/s12928-024-00989-4. Epub 2024 Apr 20.
  • Edmonston D, Mulder H, Lydon E, Chiswell K, Lampron Z, Shay C, Marsolo K, Jones WS, Butler J, Shah RC, Chamberlain AM, Ford DE, Gordon HS, Hwang W, Chang A, Rao A, Bosworth HB, Pagidipati N Kidney and Cardiovascular Effectiveness of Empagliflozin Compared With Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes. Am J Cardiol. 2024 Jun 15;221:52-63. doi: 10.1016/j.amjcard.2024.04.011. Epub 2024 Apr 17.
  • Baron SJ, Gibson CM, Gandhi RT, Mittleider D, Dexter D, Jaber WA Trends in Percutaneous Device Use for the Treatment of Venous Thromboembolism Over Time in the PINC AI Healthcare Database and the National Inpatient Sample. Am J Cardiol. 2024 Jul 1;222:167-174. doi: 10.1016/j.amjcard.2024.04.014. Epub 2024 Apr 18.
  • Greene SJ, Gaggin HK, Zhou M, Bash LD, Lautsch D, Djatche L, Song Y, Signorovitch J, Stevenson AS, Blaustein RO, Butler J Treatment patterns of patients with worsening heart failure with reduced ejection fraction. ESC Heart Fail. 2024 Aug;11(4):1932-1946. doi: 10.1002/ehf2.14805. Epub 2024 Apr 19.
  • Fanaroff AC, Dayoub EJ, Yang L, Schultz K, Ramadan OI, Wang GJ, Damrauer SM, Genovese EA, Secemsky EA, Parikh SA, Nathan AS, Kohi MP, Weinberg MD, Jaff MR, Groeneveld PW, Giri JS Association Between Diagnosis-to-Limb Revascularization Time and Clinical Outcomes in Outpatients With Chronic Limb-Threatening Ischemia: Insights From the CLIPPER Cohort. J Am Heart Assoc. 2024 May 7;13(9):e033898. doi: 10.1161/JAHA.123.033898. Epub 2024 Apr 19.
  • Teramoto K, Tay WT, Tromp J, Ouwerkerk W, Teng TK, Chandramouli C, Liew OW, Chong J, Poppe KK, Lund M, Devlin G, Troughton RW, Doughty RN, Richards AM, Lam CSP Longitudinal NT-proBNP: Associations With Echocardiographic Changes and Outcomes in Heart Failure. J Am Heart Assoc. 2024 May 7;13(9):e032254. doi: 10.1161/JAHA.123.032254. Epub 2024 Apr 19.
  • Pyun AJ, Goodney PP, Eldrup-Jorgensen J, Wadzinski J, Secemsky EA, Cigarroa JE Device regulation and surveillance in vascular care: Challenges and opportunities. Catheter Cardiovasc Interv. 2024 Jul;104(1):84-91. doi: 10.1002/ccd.31053. Epub 2024 Apr 19.
  • Butler J, Nair A, Khan MS Body Mass Index Distribution Among Patients With Heart Failure and Reduced Ejection Fraction: Implication for Future Trials. J Card Fail. 2024 Jul;30(7):958-960. doi: 10.1016/j.cardfail.2024.03.009. Epub 2024 Apr 17.
  • Patel N, Mittal N, Wilkinson MJ, Taub PR Unique features of dyslipidemia in women across a lifetime and a tailored approach to management. Am J Prev Cardiol. 2024 Apr 5;18:100666. doi: 10.1016/j.ajpc.2024.100666. eCollection 2024 Jun.
  • Wallner M, Biber ME, Stolfo D, Sinagra G, Benson L, Dahlstrom U, Gudbjornsdottir S, Cosentino F, Mol PGM, Rosano GMC, Butler J, Metra M, Lund LH, Ferrannini G, Savarese G Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries. Eur Heart J Cardiovasc Pharmacother. 2024 Jul 16;10(4):296-306. doi: 10.1093/ehjcvp/pvae026.
  • Simon MV, Rutkove SB, Ngo L, Fehnel CR, Das AS, Sarge T, Bose S, Selim M, Kumar S Understanding the variability of the electrophysiologic laryngeal adductor reflex. Clin Neurophysiol. 2024 Jun;162:141-150. doi: 10.1016/j.clinph.2024.03.019. Epub 2024 Mar 26.
  • Patel RB, Silvestry FE, Komtebedde J, Solomon SD, Hasenfuss G, Litwin SE, Borlaug BA, Price MJ, Kawash R, Hummel SL, Cutlip DE, Leon MB, van Veldhuisen DJ, Rieth AJ, McKenzie S, Bugger H, Mazurek JA, Kapadia SR, Vanderheyden M, Ky B, Shah SJ Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial. JAMA Cardiol. 2024 Jun 1;9(6):507-522. doi: 10.1001/jamacardio.2024.0520.
  • Li Y, Li J, Wang B, Jing Q, Zeng Y, Hou A, Wang Z, Liu A, Zhang J, Zhang Y, Zhang P, Jiang D, Liu B, Fan J, Zhang J, Li L, Su G, Yang M, Jiang W, Qu P, Zeng H, Li L, Qiu M, Ru L, Chen S, Zhou Y, Qiao S, Stone GW, Angiolillo DJ, Han Y, OPT-BIRISK Investigators Extended Clopidogrel Monotherapy vs DAPT in Patients With Acute Coronary Syndromes at High Ischemic and Bleeding Risk: The OPT-BIRISK Randomized Clinical Trial. JAMA Cardiol. 2024 Jun 1;9(6):523-531. doi: 10.1001/jamacardio.2024.0534.
  • Rajkumar CA, Thomas KE, Foley M, Ganesananthan S, Evans H, Simader F, Syam S, Nour D, Beattie C, Khan C, Reddy RK, Ahmed-Jushuf F, Francis DP, Shun-Shin M, Al-Lamee RK Placebo Control and Blinding in Randomized Trials of Procedural Interventions: A Systematic Review and Meta-Regression. JAMA Surg. 2024 Jul 1;159(7):776-790. doi: 10.1001/jamasurg.2024.0718.
  • Aggarwal R, Bhatt DL, Szarek M, Leiter LA, Cannon CP, Lopes RD, Davies MJ, Banks P, Pitt B, Steg PG Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease: Insights from the SCORED randomized trial. Eur J Heart Fail. 2024 Apr;26(4):1093-1095. doi: 10.1002/ejhf.3240. Epub 2024 Apr 17.
  • Dauerman HL, Lahoud R The miracle of left ventricular recovery after transcatheter aortic valve implantation. EuroIntervention. 2024 Apr 15;20(8):e463-e464. doi: 10.4244/EIJ-E-24-00006.
  • Fung WWS, Luyckx VA, Tuttle KR, writing team and the World Kidney Day Joint Steering Committee The authors reply. Kidney Int. 2024 Jun;105(6):1321-1322. doi: 10.1016/j.kint.2024.03.015. Epub 2024 Apr 6.
  • Fung WWS, Luyckx VA, Tuttle KR, World Kidney Day Joint Steering Committee The authors reply. Kidney Int. 2024 Jun;105(6):1323-1324. doi: 10.1016/j.kint.2024.03.013. Epub 2024 Apr 6.
  • Siracuse JJ, Menard MT, Rosenfield K, Conte MS, Powell R, Hamburg N, Doros G, Strong MB, Farber A Characterization of cardiovascular serious adverse events after bypass or endovascular revascularization for limb-threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2024 Sep;80(3):774-779. doi: 10.1016/j.jvs.2024.04.025. Epub 2024 Apr 16.
  • Spirito A, Krishnan SL, Capodanno D, Angiolillo DJ, Mehran R Antiplatelet De-Escalation Strategies in Patients Undergoing Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2024 Apr;17(4):e013263. doi: 10.1161/CIRCINTERVENTIONS.123.013263. Epub 2024 Apr 16.
  • Agarwal A, Tromp J, Almahmeed W, Angermann C, Chandramouli C, Cho H, Choi DJ, Damasceno A, Filippatos G, Fonarow GC, Harikrishnan S, Lund L, Masoudi F, Mensah GA, Pathan A, Perel P, Pinto F, Ribeiro AL, Rich S, Sakata Y, Sliwa K, Sundstrom J, Wong R, Yancy C, Yiu K, Zhang J, Zhang Y, Lam CSP, Roth GA, Global Heart Failure Roundtable Group Toward a Universal Definition of Etiologies in Heart Failure: Categorizing Causes and Advancing Registry Science. Circ Heart Fail. 2024 Apr;17(4):e011095. doi: 10.1161/CIRCHEARTFAILURE.123.011095. Epub 2024 Apr 16.
  • Calvo-Lopez M, Ortega-Paz L, Jimenez-Trinidad FR, Brugaletta S, Sabate M, Dantas AP Sex-associated differences in cardiac ageing: Clinical aspects and molecular mechanisms. Eur J Clin Invest. 2024 Jul;54(7):e14215. doi: 10.1111/eci.14215. Epub 2024 Apr 16.
  • Jalloh MB, Bot VA, Borjaille CZ, Thabane L, Li G, Butler J, Zannad F, Granger CB, Van Spall HGC Reporting quality of heart failure randomized controlled trials 2000-2020: Temporal trends in adherence to CONSORT criteria. Eur J Heart Fail. 2024 Jun;26(6):1369-1380. doi: 10.1002/ejhf.3229. Epub 2024 Apr 16.
  • Fletcher RA, Herrington WG, Agarwal R, Mayne KJ, Arnott C, Jardine MJ, Mahaffey KW, Perkovic V, Staplin N, Wheeler DC, Chertow GM, Heerspink HJL, Neuen BL Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression Trials. Clin J Am Soc Nephrol. 2024 Apr 16;19(9):1180-2. doi: 10.2215/CJN.0000000000000470.
  • Aggarwal R, Ruff CT, Virdone S, Perreault S, Kakkar AK, Palazzolo MG, Dorais M, Kayani G, Yeh RW Response by Aggarwal et al to Letter Regarding Article, “Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants”. Circulation. 2024 Apr 16;149(16):e1111-e1112. doi: 10.1161/CIRCULATIONAHA.123.068239. Epub 2024 Apr 15.
  • Neuen BL, Tuttle KR, Vaduganathan M Accelerated Risk-Based Implementation of Guideline-Directed Medical Therapy for Type 2 Diabetes and Chronic Kidney Disease. Circulation. 2024 Apr 16;149(16):1238-1240. doi: 10.1161/CIRCULATIONAHA.123.068524. Epub 2024 Apr 15.
  • Harrington J, Sattar N, Felker GM, Januzzi JL, Lam CSP, Pagidipati NJ, Pandey A, Van Spall HGC, McGuire DK Putting More Weight on Obesity Trials in Heart Failure. Curr Heart Fail Rep. 2024 Jun;21(3):194-202. doi: 10.1007/s11897-024-00655-z. Epub 2024 Apr 15.
  • Kataoka Y, Kitahara S, Funabashi S, Makino H, Matsubara M, Matsuo M, Omura-Ohata Y, Koezuka R, Tochiya M, Tamanaha T, Tomita T, Honda-Kohmo K, Noguchi M, Murai K, Sawada K, Iwai T, Matama H, Honda S, Fujino M, Nakao K, Yoneda S, Takagi K, Otsuka F, Asaumi Y, Hosoda K, Nicholls SJ, Yasuda S, Noguchi T Glucagon-like Peptide-1 analogues and delipidation of coronary atheroma in statin-treated type 2 diabetic patients with coronary artery disease: The prespecified sub-analysis of the OPTIMAL randomized clinical trial. Atheroscler Plus. 2024 Apr 4;56:1-6. doi: 10.1016/j.athplu.2024.03.001. eCollection 2024 Jun.
  • Khan MS, Januzzi JL Jr, Liu Y, Xu J, Shaw W, Sattar N, Mahaffey KW, Neal B, Hansen MK, Butler J Natriuretic Peptides and Prognosis in Patients With Type 2 Diabetes Mellitus and High Risk for Cardiovascular Events. J Card Fail. 2024 Dec;30(12):1544-1551. doi: 10.1016/j.cardfail.2024.03.010. Epub 2024 Apr 16.
  • Abraham J, Butler J, Anker SD Thinner is better: Intentional weight loss and cardiovascular risk. Med. 2024 Apr 12;5(4):275-277. doi: 10.1016/j.medj.2024.01.016.
  • Park DY, Jamil Y, Ahmad Y, Coles T, Bosworth HB, Sikand N, Davila C, Babapour G, Damluji AA, Rao SV, Nanna MG, Samsky MD Frailty and In-Hospital Outcomes for Management of Cardiogenic Shock without Acute Myocardial Infarction. J Clin Med. 2024 Apr 3;13(7):2078. doi: 10.3390/jcm13072078.
  • Licordari R, Costa F, Garcia-Ruiz V, Mamas MA, Marquis-Gravel G, de la Torre Hernandez JM, Gomez Doblas JJ, Jimenez-Navarro M, Rodriguez-Capitan J, Urbano-Carrillo C, Ortega-Paz L, Piccolo R, Versace AG, Di Bella G, Ando G, Angiolillo DJ, Valgimigli M, Micari A The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome. J Clin Med. 2024 Mar 25;13(7):1885. doi: 10.3390/jcm13071885.
  • Bhatty A, Wilkinson C, Batra G, Alfredsson J, Erlinge D, Ferreira J, Guethmundsdottir IJ, Hrafnkelsdottir ThornJ, Ingimarsdottir IJ, Irs A, Jarai Z, Janosi A, Popescu BA, Santos M, Vasko P, Vinereanu D, Yap J, Maggioni AP, Wallentin L, Casadei B, Gale CP Cohort profile: the European Unified Registries On Heart Care Evaluation and Randomized Trials (EuroHeart)-acute coronary syndrome and percutaneous coronary intervention. Eur Heart J Qual Care Clin Outcomes. 2024 Aug 8;10(5):386-390. doi: 10.1093/ehjqcco/qcae025.
  • Anderson TS, Herzig SJ, Marcantonio ER, Yeh RW, Souza J, Landon BE Medicare Transitional Care Management Program and Changes in Timely Postdischarge Follow-Up. JAMA Health Forum. 2024 Apr 5;5(4):e240417. doi: 10.1001/jamahealthforum.2024.0417.
  • Nurmohamed NS, van Rosendael AR, Danad I, Ngo-Metzger Q, Taub PR, Ray KK, Figtree G, Bonaca MP, Hsia J, Rodriguez F, Sandhu AT, Nieman K, Earls JP, Hoffmann U, Bax JJ, Min JK, Maron DJ, Bhatt DL Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography. Eur Heart J. 2024 May 27;45(20):1783-1800. doi: 10.1093/eurheartj/ehae190.
  • Huang W, Ong WC, Wong MKF, Ng EYK, Koh T, Chandramouli C, Ng CT, Hummel Y, Huang F, Lam CSP, Tromp J Applying the UTAUT2 framework to patients’ attitudes toward healthcare task shifting with artificial intelligence. BMC Health Serv Res. 2024 Apr 11;24(1):455. doi: 10.1186/s12913-024-10861-z.
  • Foley MJ, Rajkumar CA, Ahmed-Jushuf F, Simader FA, Chotai S, Pathimagaraj RH, Mohsin M, Salih A, Wang D, Dixit P, Davies JR, Keeble TR, Cosgrove C, Spratt JC, O’Kane PD, De Silva R, Hill JM, Nijjer SS, Sen S, Petraco R, Mikhail GW, Khamis R, Kotecha T, Harrell FE, Kellman P, Francis DP, Howard JP, Cole GD, Shun-Shin MJ, Al-Lamee RK Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial. Lancet. 2024 Apr 20;403(10436):1543-1553. doi: 10.1016/S0140-6736(24)00256-3. Epub 2024 Apr 8.
  • Goldfarb MJ, Saylor MA, Bozkurt B, Code J, Di Palo KE, Durante A, Flanary K, Masterson Creber R, Ogunniyi MO, Rodriguez F, Gulati M, American Heart Association Council on Clinical Cardiology; Council on, Cardiovascular and Stroke Nursing; Council on Hypertension; Council on Lifestyle, and Cardiometabolic Health; Council on Peripheral Vascular Disease; and Council, on Quality of Care and Outcomes Research Patient-Centered Adult Cardiovascular Care: A Scientific Statement From the American Heart Association. Circulation. 2024 May 14;149(20):e1176-e1188. doi: 10.1161/CIR.0000000000001233. Epub 2024 Apr 11.
  • Iribarren C, Lu M, Elosua R, Gulati M, Wong ND, Blumenthal RS, Nissen S, Rana JS Polygenic risk and incident coronary heart disease in a large multiethnic cohort. Am J Prev Cardiol. 2024 Mar 28;18:100661. doi: 10.1016/j.ajpc.2024.100661. eCollection 2024 Jun.
  • Egbuna O, Audard V, Manos G, Tian S, Hagos F, Chertow GM Safety and Tolerability of the APOL1 Inhibitor, Inaxaplin, following Single- and Multiple-Ascending Doses in Healthy Adults. Glomerular Dis. 2024 Mar 14;4(1):64-73. doi: 10.1159/000538255. eCollection 2024 Jan-Dec.
  • Thomas CD, Franchi F, Rossi JS, Keeley EC, Anderson RD, Beitelshees AL, Duarte JD, Ortega-Paz L, Gong Y, Kerensky RA, Kulick N, McDonough CW, Nguyen AB, Wang Y, Winget M, Yang WE, Johnson JA, Winterstein AG, Stouffer GA, Angiolillo DJ, Lee CR, Cavallari LH Effectiveness of Clopidogrel vs Alternative P2Y(12) Inhibitors Based on the ABCD-GENE Score. J Am Coll Cardiol. 2024 Apr 16;83(15):1370-1381. doi: 10.1016/j.jacc.2024.02.015.
  • Korjian S, Gibson CM Flowing Beyond Conventions: Rethinking Coronary Slow Flow in the Diagnosis of Microvascular Dysfunction. JACC Cardiovasc Interv. 2024 Apr 8;17(7):930-932. doi: 10.1016/j.jcin.2024.02.006.
  • Shoji S, Kaltenbach LA, Granger BB, Fonarow GC, Al-Khalidi HR, Albert NM, Butler J, Allen LA, Felker GM, Harrison RW, Fudim M, Nelson AJ, Granger CB, Hernandez AF, Devore AD Remote Follow-up in a Heart Failure Pragmatic Trial: Insights From the CONNECT-HF. J Card Fail. 2024 Nov;30(11):1403-1410. doi: 10.1016/j.cardfail.2024.03.006. Epub 2024 Apr 8.
  • Butler J, Shah SJ, Petrie MC, Borlaug BA, Abildstrom SZ, Davies MJ, Hovingh GK, Kitzman DW, Moller DV, Verma S, Einfeldt MN, Lindegaard ML, Rasmussen S, Abhayaratna W, Ahmed FZ, Ben-Gal T, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Melenovsky V, Merkely B, Nunez J, Perna E, Schou M, Senni M, Sharma K, van der Meer P, Von Lewinski D, Wolf D, Kosiborod MN, STEP-HFpEF Trial Committees and Investigators Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials. Lancet. 2024 Apr 27;403(10437):1635-1648. doi: 10.1016/S0140-6736(24)00469-0. Epub 2024 Apr 7.
  • Vazquez MA, Oliver G, Amarasingham R, Sundaram V, Chan K, Ahn C, Zhang S, Bickel P, Parikh SM, Wells B, Miller RT, Hedayati S, Hastings J, Jaiyeola A, Nguyen TM, Moran B, Santini N, Barker B, Velasco F, Myers L, Meehan TP, Fox C, Toto RD, ICD-Pieces Study Group Pragmatic Trial of Hospitalization Rate in Chronic Kidney Disease. N Engl J Med. 2024 Apr 4;390(13):1196-1206. doi: 10.1056/NEJMoa2311708.
  • Vranckx P, Valgimigli M Comparison of 1-month vs. 12-month dual antiplatelet therapy after implantation of drug-eluting stents in patients with acute coronary syndrome: the ULTIMATE-DAPT trial. Eur Heart J Acute Cardiovasc Care. 2024 May 7;13(4):368-369. doi: 10.1093/ehjacc/zuae048.
  • Greene SJ, Ayodele I, Pierce JB, Khan MS, Lewsey SC, Yancy CW, Alhanti B, Van Spall HGC, Allen LA, Fonarow GC Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure. JACC Heart Fail. 2024 Aug;12(8):1365-1377. doi: 10.1016/j.jchf.2024.03.001. Epub 2024 Mar 25.
  • Januzzi JL Jr, Butler J, Del Prato S, Ezekowitz JA, Ibrahim NE, Lam CSP, Lewis GD, Marwick TH, Perfetti R, Rosenstock J, Solomon SD, Tang WHW, Zannad F Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy. J Am Coll Cardiol. 2024 Jul 9;84(2):137-148. doi: 10.1016/j.jacc.2024.03.380. Epub 2024 Apr 8.
  • Damluji AA, Nanna MG, Rymer J, Kochar A, Lowenstern A, Baron SJ, Narins CR, Alkhouli M Chronological vs Biological Age in Interventional Cardiology: A Comprehensive Approach to Care for Older Adults: JACC Family Series. JACC Cardiovasc Interv. 2024 Apr 22;17(8):961-978. doi: 10.1016/j.jcin.2024.01.284. Epub 2024 Apr 8.
  • Salahshurian E, Pozehl BJ, Lundgren SW, Bills S, Pandey A, Carbone S, Alonso WW ‘Working me to life’: longitudinal perceptions from adults with heart failure with preserved ejection fraction enrolled in an exercise training clinical trial. Eur J Cardiovasc Nurs. 2024 Oct 21;23(7):763-770. doi: 10.1093/eurjcn/zvae049.
  • Ortega-Paz L, Bor W, Franchi F, van den Broek WWA, Rollini F, Giordano S, Galli M, Been L, Ghanem G, Shalhoub A, Garabedian H, Al Saleh T, Uzunoglu E, Zhou X, Rivas A, Pineda AM, Suryadevara S, Soffer D, Mahowald MK, Choi CY, Zenni MM, Phoenix F, Ajjan RA, Ten Berg JM, Angiolillo DJ P2Y(12) Inhibition in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention: The SWAP-AC-2 Study. JACC Cardiovasc Interv. 2024 Jun 10;17(11):1356-1370. doi: 10.1016/j.jcin.2024.03.027. Epub 2024 Apr 7.
  • Wadhera RK, Secemsky EA, Xu J, Yeh RW, Song Y, Goldhaber SZ Community Socioeconomic Status, Acute Cardiovascular Hospitalizations, and Mortality in Medicare, 2003 to 2019. Circ Cardiovasc Qual Outcomes. 2024 Apr;17(4):e010090. doi: 10.1161/CIRCOUTCOMES.123.010090. Epub 2024 Apr 10.
  • Kotanidis CP, Mills GB, Bendz B, Berg ES, Hildick-Smith D, Hirlekar G, Milasinovic D, Morici N, Myat A, Tegn N, Sanchis J, Savonitto S, De Servi S, Fox KAA, Pocock S, Kunadian V Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis. Eur Heart J. 2024 Jun 14;45(23):2052-2062. doi: 10.1093/eurheartj/ehae151.
  • Arias-Mendoza A [Pharmacoinvasive strategy in Latin America. Why don’t we see it as our option?]. Arch Peru Cardiol Cir Cardiovasc. 2024 Mar 19;5(1):61-62. doi: 10.47487/apcyccv.v4i4.355. eCollection 2024 Jan-Mar.
  • Netuka I, Tucanova Z, Ivak P, Gregor S, Kolesar DM, Marek T, Melenovsky V, Binova J, Dorazilova Z, Hegarova M, Podolec M, Riha H, Connors JM, Mehra MR A Prospective Randomized Trial of Direct Oral Anticoagulant Therapy With a Fully Magnetically Levitated LVAD: The DOT-HM3 Study. Circulation. 2024 Aug 6;150(6):509-511. doi: 10.1161/CIRCULATIONAHA.124.069726. Epub 2024 Apr 9.
  • Kaur G, Masket D, Reddy T, Revankar S, Satish P, Paquin A, Mulvagh S, O’Donoghue ML, Zieroth S, Farkouh M, Gulati M Socioeconomic Disparities in Women’s Cardiovascular Health in the United States and Canada. Can J Cardiol. 2024 Jun;40(6):1056-1068. doi: 10.1016/j.cjca.2024.04.001. Epub 2024 Apr 7.
  • Castillo Rodriguez B, Secemsky EA, Swaminathan RV, Feldman DN, Schlaich M, Battaglia Y, Filippone EJ, Krittanawong C Opportunities and Limitations of Renal Denervation: Where Do We Stand? Am J Med. 2024 Aug;137(8):712-718. doi: 10.1016/j.amjmed.2024.04.006. Epub 2024 Apr 7.
  • Povsic TJ, Korjian S, Bahit MC, Chi G, Duffy D, Alexander JH, Vinereanu D, Tricoci P, Mears SJ, Deckelbaum LI, Bonaca M, Ridker PM, Goodman SG, Cornel JH, Lewis BS, Parkhomenko A, Lopes RD, Aylward P, Lincoff AM, Heise M, Sacks F, Nicolau JC, Merkely B, Trebacz J, Libby P, Nicholls SJ, Pocock S, Bhatt DL, Kastelein J, Bode C, Mahaffey KW, Steg PG, Tendera M, Bainey KR, Harrington RA, Mehran R, Duerschmied D, Kingwell BA, Gibson CM, AEGIS-II Committees and Investigators Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI. J Am Coll Cardiol. 2024 Jun 4;83(22):2163-2174. doi: 10.1016/j.jacc.2024.03.396. Epub 2024 Apr 6.
  • Udell JA, Petrie MC, Jones WS, Anker SD, Harrington J, Mattheus M, Seide S, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chen Y, Chopra VK, Figtree G, Ge J, Goodman SG, Gotcheva N, Goto S, Gasior T, Jamal W, Januzzi JL, Jeong MH, Lopatin Y, Lopes RD, Merkely B, Martinez-Traba M, Parikh PB, Parkhomenko A, Ponikowski P, Rossello X, Schou M, Simic D, Steg PG, Szachniewicz J, van der Meer P, Vinereanu D, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Hernandez AF, Butler J Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction. J Am Coll Cardiol. 2024 Jun 11;83(23):2233-2246. doi: 10.1016/j.jacc.2024.03.405. Epub 2024 Apr 6.
  • Alshahrani NS, Hartley A, Howard J, Hajhosseiny R, Khawaja S, Seligman H, Akbari T, Alharbi BA, Bassett P, Al-Lamee R, Francis D, Kaura A, Kelshiker MA, Peters NS, Khamis R Randomized Trial of Remote Assessment of Patients After an Acute Coronary Syndrome. J Am Coll Cardiol. 2024 Jun 11;83(23):2250-2259. doi: 10.1016/j.jacc.2024.03.398. Epub 2024 Apr 6.
  • Haywood HB, Graham AJ, Chermak D, Achanta A, Butler J, Fonarow GC, Greene SJ Estimating the Proportion of Heart Failure Admissions Potentially Eligible for Hospital at Home. J Card Fail. 2024 Aug;30(8):1060-1062. doi: 10.1016/j.cardfail.2024.03.004. Epub 2024 Apr 6.
  • Kunadian V Role of Physiology in the Management of Nonculprit Lesions in Acute Coronary Syndrome. N Engl J Med. 2024 Apr 25;390(16):1527-1529. doi: 10.1056/NEJMe2403527. Epub 2024 Apr 8.
  • Siegler JE, Sposato LA, Yaghi S Toward More Personalized Management of Device-Detected Atrial Fibrillation. JAMA Neurol. 2024 Jun 1;81(6):573-574. doi: 10.1001/jamaneurol.2024.0673.
  • Nissen SE, Wolski K, Watts GF, Koren MJ, Fok H, Nicholls SJ, Rider DA, Cho L, Romano S, Melgaard C, Rambaran C Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a): A Randomized Clinical Trial. JAMA. 2024 May 14;331(18):1534-1543. doi: 10.1001/jama.2024.4504.
  • Frohlich AK, Porthun J, Talha KM, Lena A, Hadzibegovic S, Wilkenshoff U, Sonntag F, Nikolski A, Ramer LV, Zeller T, Keller U, Bullinger L, Anker SD, Haverkamp W, von Haehling S, Doehner W, Rauch U, Skurk C, Cleland JGF, Butler J, Coats AJS, Landmesser U, Karakas M, Anker MS Association of an impaired GH-IGF-I axis with cardiac wasting in patients with advanced cancer. Clin Res Cardiol. 2024 Apr 8. doi: 10.1007/s00392-024-02400-x.
  • Ferreira JP, Packer M, Sattar N, Butler J, Gonzalez Maldonado S, Panova-Noeva M, Sumin M, Masson S, Pocock SJ, Anker SD, Zannad F, Januzzi JL Insulin-like growth factor binding protein-7 concentrations in chronic heart failure: Results from the EMPEROR programme. Eur J Heart Fail. 2024 Apr;26(4):806-816. doi: 10.1002/ejhf.3227. Epub 2024 Apr 8.
  • Steg PG Routine Beta-Blockers in Secondary Prevention – On Injured Reserve. N Engl J Med. 2024 Apr 18;390(15):1434-1436. doi: 10.1056/NEJMe2402731. Epub 2024 Apr 7.
  • Gibson CM, Duffy D, Korjian S, Bahit MC, Chi G, Alexander JH, Lincoff AM, Heise M, Tricoci P, Deckelbaum LI, Mears SJ, Nicolau JC, Lopes RD, Merkely B, Lewis BS, Cornel JH, Trebacz J, Parkhomenko A, Libby P, Sacks FM, Povsic TJ, Bonaca M, Goodman SG, Bhatt DL, Tendera M, Steg PG, Ridker PM, Aylward P, Kastelein JJP, Bode C, Mahaffey KW, Nicholls SJ, Pocock SJ, Mehran R, Harrington RA, AEGIS-II Committees and Investigators Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction. N Engl J Med. 2024 May 2;390(17):1560-1571. doi: 10.1056/NEJMoa2400969. Epub 2024 Apr 6.
  • Rao SV Mechanical Circulatory Support in Cardiogenic Shock – Persistence and Progress. N Engl J Med. 2024 Apr 18;390(15):1436-1438. doi: 10.1056/NEJMe2402310. Epub 2024 Apr 7.
  • Butler J, Jones WS, Udell JA, Anker SD, Petrie MC, Harrington J, Mattheus M, Zwiener I, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chen Y, Chopra VK, Figtree G, Ge J, Goodman SG, Gotcheva N, Goto S, Gasior T, Jamal W, Januzzi JL, Jeong MH, Lopatin Y, Lopes RD, Merkely B, Parikh PB, Parkhomenko A, Ponikowski P, Rossello X, Schou M, Simic D, Steg PG, Szachniewicz J, van der Meer P, Vinereanu D, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Hernandez AF Empagliflozin after Acute Myocardial Infarction. N Engl J Med. 2024 Apr 25;390(16):1455-1466. doi: 10.1056/NEJMoa2314051. Epub 2024 Apr 6.
  • Kosiborod MN, Petrie MC, Borlaug BA, Butler J, Davies MJ, Hovingh GK, Kitzman DW, Moller DV, Treppendahl MB, Verma S, Jensen TJ, Liisberg K, Lindegaard ML, Abhayaratna W, Ahmed FZ, Ben-Gal T, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Melenovsky V, Merkely B, Nunez J, Perna E, Schou M, Senni M, Sharma K, van der Meer P, Von Lewinski D, Wolf D, Shah SJ, STEP-HFpEF DM Trial Committees and Investigators Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes. N Engl J Med. 2024 Apr 18;390(15):1394-1407. doi: 10.1056/NEJMoa2313917. Epub 2024 Apr 6.
  • Lamy A, Chertow GM, Jessen M, Collar A, Brown CD, Mack CA, Marzouk M, Scavo V, Washburn TB, Savage D, Smith J, Bennetts J, Assi R, Shults C, Arghami A, Butler J, Devereaux PJ, Zager R, Wang C, Snapinn S, Browne A, Rodriguez J, Ruiz S, Singh B, of START Investigators Effects of RBT-1 on preconditioning response biomarkers in patients undergoing coronary artery bypass graft or heart valve surgery: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial. EClinicalMedicine. 2024 Jan 8;68:102364. doi: 10.1016/j.eclinm.2023.102364. eCollection 2024 Feb.
  • Gulati M Heart month: Redesigning the message. Am J Prev Cardiol. 2024 Feb 28;17:100643. doi: 10.1016/j.ajpc.2024.100643. eCollection 2024 Mar.
  • Saha A, Li S, de Lemos JA, Pandey A, Bhatt DL, Fonarow GC, Nallamothu BK, Wang TY, Navar AM, Peterson E, Matsouaka RA, Bavry AA, Das SR, Grodin JL, Khera R, Drazner MH, Kumbhani DJ, NCDR Registry Characteristics of High-Performing Hospitals in Cardiogenic Shock Following Acute Myocardial Infarction. Am J Cardiol. 2024 Jun 15;221:19-28. doi: 10.1016/j.amjcard.2024.04.002. Epub 2024 Apr 5.
  • Lioutas VA, Katsanos AH, Shoamanesh A, Vahidy F, Heistand EC, Foster LD, Yeatts SD, Selim M, iDEF investigators Cognitive Outcome after Acute Spontaneous Intracerebral Hemorrhage: Analysis of the iDEF Randomized Trial. Cerebrovasc Dis. 2024 Apr 5:1-9. doi: 10.1159/000538415.
  • Patel SM, Kang YM, Im K, Neuen BL, Anker SD, Bhatt DL, Butler J, Cherney DZI, Claggett BL, Fletcher RA, Herrington WG, Inzucchi SE, Jardine MJ, Mahaffey KW, McGuire DK, McMurray JJV, Neal B, Packer M, Perkovic V, Solomon SD, Staplin N, Vaduganathan M, Wanner C, Wheeler DC, Zannad F, Zhao Y, Heerspink HJL, Sabatine MS, Wiviott SD Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis. Circulation. 2024 Jun 4;149(23):1789-1801. doi: 10.1161/CIRCULATIONAHA.124.069568. Epub 2024 Apr 7.
  • Gaudet D, Pall D, Watts GF, Nicholls SJ, Rosenson RS, Modesto K, San Martin J, Hellawell J, Ballantyne CM Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: The SHASTA-2 Randomized Clinical Trial. JAMA Cardiol. 2024 Jul 1;9(7):620-630. doi: 10.1001/jamacardio.2024.0959.
  • Nicholls SJ Serial PET imaging to evaluate medical therapies: Is it ready for prime time? Atherosclerosis. 2024 Aug;395:117517. doi: 10.1016/j.atherosclerosis.2024.117517. Epub 2024 Mar 14.
  • Welsh RC, Gouda P, Dover D, Bainey KR, McAlister FA, Kaul P Applicability and impact of the COMPASS trial in a Canadian population of patients with atherosclerotic disease. Atherosclerosis. 2024 Jun;393:117486. doi: 10.1016/j.atherosclerosis.2024.117486. Epub 2024 Mar 16.
  • Cheema HA, Bhanushali K, Sohail A, Fatima A, Hermis AH, Titus A, Ahmad A, Majmundar V, Rehman WU, Sulaiman S, Lakhter V, Baron SJ, Dani SS Immediate Versus Staged Complete Revascularization in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Cardiol. 2024 Jun 1;220:77-83. doi: 10.1016/j.amjcard.2024.03.037. Epub 2024 Apr 4.
  • Cheng TW, Doros G, Jones DW, Vazirani A, Malikova MA Evaluation of Computerized Tomography Utilization in Comparison to Digital Subtraction Angiography in Patients with Peripheral Arterial Disease. Ann Vasc Surg. 2024 Oct;107:214-228. doi: 10.1016/j.avsg.2024.03.001. Epub 2024 Apr 4.
  • Cho L, Plutzky J, Brennan D, Louie MJ, Lei L, Robinson P, Powell HA, Nicholls SJ, Lincoff AM, Nissen SE Impact of Bempedoic Acid on Cardiovascular Outcomes by Sex. Circulation. 2024 May 28;149(22):1775-1777. doi: 10.1161/CIRCULATIONAHA.123.067691. Epub 2024 Apr 6.
  • Hernandez AF, Udell JA, Jones WS, Anker SD, Petrie MC, Harrington J, Mattheus M, Seide S, Zwiener I, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chen Y, Chopra VK, A Figtree G, Ge J, G Goodman S, Gotcheva N, Goto S, Gasior T, Jamal W, Januzzi JL, Jeong MH, Lopatin Y, Lopes RD, Merkely B, Parikh PB, Parkhomenko A, Ponikowski P, Rossello X, Schou M, Simic D, Steg PG, Szachniewicz J, van der Meer P, Vinereanu D, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Butler J Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial. Circulation. 2024 May 21;149(21):1627-1638. doi: 10.1161/CIRCULATIONAHA.124.069217. Epub 2024 Apr 6.
  • Zhang Z, Heerspink HJL, Chertow GM, Correa-Rotter R, Gasparrini A, Jongs N, Langkilde AM, McMurray JJV, Mistry MN, Rossing P, Toto RD, Vart P, Nitsch D, Wheeler DC, Caplin B Ambient heat exposure and kidney function in patients with chronic kidney disease: a post-hoc analysis of the DAPA-CKD trial. Lancet Planet Health. 2024 Apr;8(4):e225-e233. doi: 10.1016/S2542-5196(24)00026-3.
  • Nuti O, Merchan C, Papadopoulos J, Horowitz J, Rao SV, Ahuja T Evaluating the Use of Unfractionated Heparin with Intra-Aortic Balloon Counterpulsation. Heart Lung Circ. 2024 Jul;33(7):975-982. doi: 10.1016/j.hlc.2024.01.032. Epub 2024 Apr 4.
  • Chew NWS, Pan XH, Chong B, Chandramouli C, Muthiah M, Lam CSP Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population. Diabetes Res Clin Pract. 2024 May;211:111652. doi: 10.1016/j.diabres.2024.111652. Epub 2024 Apr 2.
  • Makhlin I, Demissei BG, D’Agostino R, Hundley WG, Baleanu-Gogonea C, Wilcox NS, Chen A, Smith AM, O’Connell NS, Januzzi JL, Lesser GJ, Scherrer-Crosbie M, Ibanez B, Tang WHW, Ky B Statins Do Not Significantly Affect Oxidative Nitrosative Stress Biomarkers in the PREVENT Randomized Clinical Trial. Clin Cancer Res. 2024 Jun 3;30(11):2370-2376. doi: 10.1158/1078-0432.CCR-23-3952.
  • Butt JH, Jhund PS, Docherty KF, Claggett BL, Vaduganathan M, Bachus E, Hernandez AF, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Kosiborod MN, Desai AS, Kober L, Ponikowski P, Sabatine MS, Solomon SD, McMurray JJV Dapagliflozin and Timing of Prior Heart Failure Hospitalization: A Patient-Level Meta-Analysis of DAPA-HF and DELIVER. JACC Heart Fail. 2024 Sep;12(9):1586-1599. doi: 10.1016/j.jchf.2024.01.018. Epub 2024 Apr 3.
  • Achanta A, Belak L, Ritchie CS, Januzzi JL, Wasfy JH Age-Related Usage of GLP-1 Agonists in Obese Patients With Heart Failure and Preserved Ejection Fraction. J Am Coll Cardiol. 2024 Apr 9;83(14):1348-1350. doi: 10.1016/j.jacc.2024.01.033.
  • Costanzo MR, Januzzi JL Early SGLT2 Inhibitors in Acute Heart Failure: Safe Diuretic-Sparing Strategy. J Am Coll Cardiol. 2024 Apr 9;83(14):1307-1309. doi: 10.1016/j.jacc.2024.02.012.
  • Krittanawong C, Rao SV, Razzouk L Spontaneous Coronary Artery Dissection in a Healthy Man With Non-ST Elevation Myocardial Infarction. JAMA Cardiol. 2024 May 1;9(5):486. doi: 10.1001/jamacardio.2024.0381.
  • Breathett K, Lewsey S, Brownell NK, Enright K, Evangelista LS, Ibrahim NE, Iturrizaga J, Matlock DD, Ogunniyi MO, Sterling MR, Van Spall HGC, American Heart Association Heart Failure and Transplantation Committee of the, Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing;, Council on Lifestyle and Cardiometabolic Health; and Council on Quality of Care, and Outcomes Research Implementation Science to Achieve Equity in Heart Failure Care: A Scientific Statement From the American Heart Association. Circulation. 2024 May 7;149(19):e1143-e1163. doi: 10.1161/CIR.0000000000001231. Epub 2024 Apr 3.
  • Koschinsky ML, Bajaj A, Boffa MB, Dixon DL, Ferdinand KC, Gidding SS, Gill EA, Jacobson TA, Michos ED, Safarova MS, Soffer DE, Taub PR, Wilkinson MJ, Wilson DP, Ballantyne CM A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol. 2024 May-Jun;18(3):e308-e319. doi: 10.1016/j.jacl.2024.03.001. Epub 2024 Apr 1.
  • Honigberg MC, Economy KE, Pabon MA, Wang X, Castro C, Brown JM, Divakaran S, Weber BN, Barrett L, Perillo A, Sun AY, Antoine T, Farrohi F, Docktor B, Lau ES, DeFaria Yeh D, Natarajan P, Sarma AA, Weisbrod RM, Hamburg NM, Ho JE, Roh JD, Wood MJ, Scott NS, Di Carli MF Coronary Microvascular Function Following Severe Preeclampsia. Hypertension. 2024 Jun;81(6):1272-1284. doi: 10.1161/HYPERTENSIONAHA.124.22905. Epub 2024 Apr 2.
  • Wilschut JM, Vogel RF, Elscot JJ, Delewi R, Lemmert ME, van der Waarden NWPL, Nuis RJ, Paradies V, Alexopoulos D, Zijlstra F, Montalescot G, Angiolillo DJ, Krucoff MW, Smits PC, Vlachojannis GJ, Van Mieghem NM, Diletti R Prehospital crushed versus integral prasugrel loading dose in STEMI patients with a large myocardial area. EuroIntervention. 2024 Apr 1;20(7):e436-e444. doi: 10.4244/EIJ-D-23-00618.
  • Pandey A, Patel KV, Segar MW, Ayers C, Linge J, Leinhard OD, Anker SD, Butler J, Verma S, Joshi PH, Neeland IJ Effect of liraglutide on thigh muscle fat and muscle composition in adults with overweight or obesity: Results from a randomized clinical trial. J Cachexia Sarcopenia Muscle. 2024 Jun;15(3):1072-1083. doi: 10.1002/jcsm.13445. Epub 2024 Apr 1.
  • Rodes-Cabau J, Lindenfeld J, Abraham WT, Zile MR, Kar S, Bayes-Genis A, Eigler N, Holcomb R, Nunez J, Lee E, Perl ML, Moravsky G, Pfeiffer M, Boehmer J, Gorcsan J, Bax JJ, Anker S, Stone GW Interatrial shunt therapy in advanced heart failure: Outcomes from the open-label cohort of the RELIEVE-HF trial. Eur J Heart Fail. 2024 Apr;26(4):1078-1089. doi: 10.1002/ejhf.3215. Epub 2024 Apr 1.
  • Sattar N, Butler J, Lee MMY, Harrington J, Sharma A, Zannad F, Filippatos G, Verma S, Januzzi JL, Ferreira JP, Pocock SJ, Pfarr E, Ofstad AP, Brueckmann M, Packer M, Anker SD Body mass index and cardiorenal outcomes in the EMPEROR-Preserved trial: Principal findings and meta-analysis with the DELIVER trial. Eur J Heart Fail. 2024 Apr;26(4):900-909. doi: 10.1002/ejhf.3221. Epub 2024 Apr 1.
  • Talha KM, Green J, Filippatos G, Pocock S, Zannad F, Brueckmann M, Schueler E, Ofstad AP, Ferreira JP, Anker SD, Butler J, Rosenstock J, Packer M Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR-Pooled analysis. Diabetes Obes Metab. 2024 Jul;26(7):2578-2587. doi: 10.1111/dom.15572. Epub 2024 Apr 1.
  • Kanbay M, Copur S, Topcu AU, Guldan M, Ozbek L, Gaipov A, Ferro C, Cozzolino M, Cherney DZI, Tuttle KR An update review of post-transplant diabetes mellitus: Concept, risk factors, clinical implications and management. Diabetes Obes Metab. 2024 Jul;26(7):2531-2545. doi: 10.1111/dom.15575. Epub 2024 Apr 1.
  • Sultana S, McCarthy CP, Randhawa M, Cao J, Parakh A, Baliyan V Role of Computed Tomography in Cardiac Electrophysiology. Radiol Clin North Am. 2024 May;62(3):489-508. doi: 10.1016/j.rcl.2023.12.016. Epub 2024 Feb 13.
  • Harrington J, Felker GM, Januzzi JL, Lam CSP, Lingvay I, Pagidipati NJ, Sattar N, Van Spall HGC, Verma S, McGuire DK Worth Their Weight? An Update on New and Emerging Pharmacologic Agents for Obesity and Their Potential Role for Persons with Cardiac Conditions. Curr Cardiol Rep. 2024 Mar;26(3):61-71. doi: 10.1007/s11886-023-02016-z. Epub 2024 Mar 29.
  • Rivera FB, Cha SW, Varona MC, Fernandez Co EM, Magalong JV, Aparece JP, De Oliveira-Gomes D, Kaur G, Gulati M Atherosclerotic coronary plaque regression from lipid-lowering therapies: A meta-analysis and meta-regression. Am J Prev Cardiol. 2024 Mar 11;18:100645. doi: 10.1016/j.ajpc.2024.100645. eCollection 2024 Jun.
  • D’Amario D, Laborante R, Bianchini E, Ciliberti G, Paglianiti DA, Galli M, Restivo A, Stolfo D, Vergallo R, Rosano GMC, Crea F, Lam CSP, Lund LH, Metra M, Patti G, Savarese G Impact of coronary microvascular dysfunction in heart failure with preserved ejection fraction: a meta-analysis. ESC Heart Fail. 2024 Aug;11(4):2063-2075. doi: 10.1002/ehf2.14626. Epub 2024 Mar 28.
  • Abrahams T, Nicholls SJ, Nelson AJ Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024: Focus on Blood Pressure and Lipids. Med Clin North Am. 2024 May;108(3):441-453. doi: 10.1016/j.mcna.2023.12.005. Epub 2024 Jan 16.
  • Wong NKP, Solly EL, Le R, Nankivell VA, Mulangala J, Psaltis PJ, Nicholls SJ, Ng MKC, Bursill CA, Tan JTM TRIM2 Selectively Regulates Inflammation-Driven Pathological Angiogenesis without Affecting Physiological Hypoxia-Mediated Angiogenesis. Int J Mol Sci. 2024 Mar 15;25(6):3343. doi: 10.3390/ijms25063343.
  • Wright RS, Leiter LA, Lesogor A, Ray KK Reply: Evaluation of the Inclisiran Safety in High-Risk Populations. J Am Coll Cardiol. 2024 Apr 2;83(13):e129. doi: 10.1016/j.jacc.2024.01.032. Epub 2024 Mar 25.
  • Rodriguez F, Cho L, Foody J, Lincoff AM, Lei L, Nicholls SJ, Nissen SE, Powell HA, Plutzky J Characteristics and Outcomes for Hispanic/Latinx Participants With Statin Intolerance Receiving Bempedoic Acid. J Am Coll Cardiol. 2024 May 28;83(21):2130-2132. doi: 10.1016/j.jacc.2024.03.390. Epub 2024 Mar 25.
  • Winkelmayer WC, Lensing AWA, Thadhani RI, Mahaffey KW, Walsh M, Pap AF, Willmann S, Thelen K, Hodge S, Solms A, Ingham SJM, Eikelboom J, RE-THINC investigators A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis. Kidney Int. 2024 Jul;106(1):145-153. doi: 10.1016/j.kint.2024.02.024. Epub 2024 Mar 26.
  • Nissen SE, Linnebjerg H, Nicholls SJ Lepodisiran for Elevated Lipoprotein(a)-Reply. JAMA. 2024 Apr 23;331(16):1417-1418. doi: 10.1001/jama.2024.0848.
  • McDowell K, Kondo T, Talebi A, Teh K, Bachus E, de Boer RA, Campbell RT, Claggett B, Desai AS, Docherty KF, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Simpson J, Vaduganathan M, Jhund PS, Solomon SD, McMurray JJV Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction. JAMA Cardiol. 2024 May 1;9(5):457-465. doi: 10.1001/jamacardio.2024.0284.
  • Sumner JA, Kim ESH, Wood MJ, Chi G, Nolen J, Grodzinsky A, Gornik HL, Kadian-Dodov D, Wells BJ, Hess CN, Lewey J, Tam L, Henkin S, Orford J, Wells G, Kumbhani DJ, Lindley KJ, Gibson CM, Leon KK, Naderi S Posttraumatic Stress Disorder After Spontaneous Coronary Artery Dissection: A Report of the International Spontaneous Coronary Artery Dissection Registry. J Am Heart Assoc. 2024 Apr 2;13(7):e032819. doi: 10.1161/JAHA.123.032819. Epub 2024 Mar 27.
  • Vranckx P, Morrow D, Van Diepen S, Verbrugge F Acute cardiac and intensive care chronicles: navigating the intersection of cardiovascular health, recreational drug use, and beyond! Eur Heart J Acute Cardiovasc Care. 2024 May 7;13(4):323. doi: 10.1093/ehjacc/zuae030.
  • Dalal PJ, Giro P, Rasmussen-Torvik LJ, Yancy CW, Shah SJ, Reiner AP, Haring B, Martin LW, Wells GL, Manson JE, Kooperberg C, Eaton CB, Patel RB Heart Failure Risk Among African-American Women With an ICAM1 Missense Variant. JACC Heart Fail. 2024 Sep;12(9):1614-1624. doi: 10.1016/j.jchf.2024.02.002. Epub 2024 Mar 25.
  • Szarek M, Bhatt DL, Miller M, Brinton EA, Jacobson TA, Tardif JC, Ballantyne CM, Mason RP, Ketchum SB, Lira Pineda A, Doyle RT Jr, Steg PG, REDUCE-IT Investigators Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl. J Am Coll Cardiol. 2024 Apr 23;83(16):1529-1539. doi: 10.1016/j.jacc.2024.02.016. Epub 2024 Mar 25.
  • Gupta T, Zimmer J, Lahoud RN, Murphy HR, Harris AH, Kolte D, Hirashima F, Dauerman HL National Trends and Outcomes of Acute Myocardial Infarction After Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2024 May 27;17(10):1267-1276. doi: 10.1016/j.jcin.2024.02.026. Epub 2024 Mar 25.
  • Van Edom CJ, Swol J, Castelein T, Gramegna M, Huber K, Leonardi S, Mueller T, Pappalardo F, Price S, Schaubroeck H, Schrage B, Tavazzi G, Vercaemst L, Vranckx P, Vandenbriele C European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: a survey of the Association for Acute CardioVascular Care of the ESC and the European branch of the Extracorporeal Life Support Organization. Eur Heart J Acute Cardiovasc Care. 2024 Jun 30;13(6):458-469. doi: 10.1093/ehjacc/zuae040.
  • Shariq K, Siddiqi TJ, Van Spall H, Greene SJ, Fudim M, DeVore AD, Pandey A, Butler J, Khan MS Role of telemedicine in the management of obesity: State-of-the-art review. Obes Rev. 2024 Jun;25(6):e13734. doi: 10.1111/obr.13734. Epub 2024 Mar 26.
  • Klonoff DC, Aaron RE, Tian T, DuNova AY, Pandey A, Rhee C, Fleming GA, Sacks DB, Pop-Busui R, Kerr D Advanced Glycation Endproducts: A Marker of Long-term Exposure to Glycemia. J Diabetes Sci Technol. 2024 Mar 25:19322968241240436. doi: 10.1177/19322968241240436.
  • Sylvester KW, Grandoni J, Rhoten M, Coakley L, Lyons-Matiello E, Frankel K, Fortin B, Jolley K, Park HS, Freedman RY, Mehra MR, Givertz MM, Connors JM Assessment of Temporary Warfarin Reversal in Patients With Left Ventricular Assist Devices: the KVAD Study. J Card Fail. 2024 Sep;30(9):1111-1119. doi: 10.1016/j.cardfail.2024.02.022. Epub 2024 Mar 21.
  • Ray KK, Bloedon L, Li N, Nissen SE, co-authors Evaluating the effect of bempedoic acid on kidney function: call for cautious implementation – Authors’ reply. Lancet Diabetes Endocrinol. 2024 Apr;12(4):228-229. doi: 10.1016/S2213-8587(24)00063-9.
  • Schuchman M, Brady TM, Glenn DA, Tuttle KR, Cara-Fuentes G, Levy RV, Gonzalez-Vicente A, Alakwaa FM, Srivastava T, Sethna CB Association of mental health-related patient reported outcomes with blood pressure in adults and children with primary proteinuric glomerulopathies. J Nephrol. 2024 Apr;37(3):647-660. doi: 10.1007/s40620-024-01919-6. Epub 2024 Mar 21.
  • Brown SA, Beavers C, Bauer B, Cheng RK, Berman G, Marshall CH, Guha A, Jain P, Steward A, DeCara JM, Olaye IM, Hansen K, Logan J, Bergom C, Glide-Hurst C, Loh I, Gambril JA, MacLeod J, Maddula R, McGranaghan PJ, Batra A, Campbell C, Hamid A, Gunturkun F, Davis R, Jefferies J, Fradley M, Albert K, Blaes A, Choudhuri I, Ghosh AK, Ryan TD, Ezeoke O, Leedy DJ, Williams W, Roman S, Lehmann L, Sarkar A, Sadler D, Polter E, Ruddy KJ, Bansal N, Yang E, Patel B, Cho D, Bailey A, Addison D, Rao V, Levenson JE, Itchhaporia D, Watson K, Gulati M, Williams K, Lloyd-Jones D, Michos E, Gralow J, Martinez H Advancing the care of individuals with cancer through innovation & technology: Proceedings from the cardiology oncology innovation summit 2020 and 2021. Am Heart J Plus. 2023 Dec 25;38:100354. doi: 10.1016/j.ahjo.2023.100354. eCollection 2024 Feb.
  • Ranasinghe S, Cui Y, Muhyieddeen A, Obrutu O, Wei J, Gulati M, Bittner V, Reis S, Handberg E, Pepine CJ, Merz CNB Elevated high-density lipoprotein cholesterol and adverse outcomes in women with symptoms of ischemic heart disease. Am Heart J Plus. 2024 Feb 29;40:100376. doi: 10.1016/j.ahjo.2024.100376. eCollection 2024 Apr.
  • Wang TF, Connors JM The Pursuit of “Best” Anticoagulant for Cancer-Associated Thrombosis: Are We There Yet? JACC CardioOncol. 2024 Jan 9;6(1):114-116. doi: 10.1016/j.jaccao.2023.12.001. eCollection 2024 Feb.
  • Dafaalla M, Abramov D, Van Spall HGC, Ghosh AK, Gale CP, Zaman S, Rashid M, Mamas MA Heart Failure Readmission in Patients With ST-Segment Elevation Myocardial Infarction and Active Cancer. JACC CardioOncol. 2024 Jan 9;6(1):117-129. doi: 10.1016/j.jaccao.2023.10.011. eCollection 2024 Feb.
  • Asnani A, Wadhera RK, Yeh RW Assessing STEMI Outcomes in Patients With Cancer: A Call for Integrated Cardiovascular and Cancer Phenotyping. JACC CardioOncol. 2024 Jan 9;6(1):130-132. doi: 10.1016/j.jaccao.2023.12.002. eCollection 2024 Feb.
  • Talasaz AH, Sadeghipour P, Ortega-Paz L, Kakavand H, Aghakouchakzadeh M, Beavers C, Fanikos J, Eikelboom JW, Siegal DM, Monreal M, Jimenez D, Vaduganathan M, Castellucci LA, Cuker A, Barnes GD, Connors JM, Secemsky EA, Van Tassell BW, De Caterina R, Kurlander JE, Aminian A, Piazza G, Goldhaber SZ, Moores L, Middeldorp S, Kirtane AJ, Elkind MSV, Angiolillo DJ, Konstantinides S, Lip GYH, Stone GW, Cushman M, Krumholz HM, Mehran R, Bhatt DL, Bikdeli B Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease. Nat Rev Cardiol. 2024 Aug;21(8):574-592. doi: 10.1038/s41569-024-01003-3. Epub 2024 Mar 20.
  • Sposato LA, Andrade JG, Field TS Detection of atrial fibrillation in patients after stroke – Authors’ reply. Lancet Neurol. 2024 Apr;23(4):336-337. doi: 10.1016/S1474-4422(24)00088-7.
  • White HD A Placebo-Controlled Trial of PCI for Stable Angina. Reply. N Engl J Med. 2024 Mar 21;390(12):10.1056/NEJMc2400751#sa5. doi: 10.1056/NEJMc2400751.
  • Al-Lamee RK, Rajkumar CA A Placebo-Controlled Trial of PCI for Stable Angina. Reply. N Engl J Med. 2024 Mar 21;390(12):1151-1152. doi: 10.1056/NEJMc2400751.
  • Ezquerra-Osorio A, Arias-Mendoza A, Robles-Ledesma M, Cruz-Martinez JE, Najera-Rojas NA, de Los Rios-Arce LF, Gopar-Nieto R, Gonzalez-Pacheco H, Sierra-Lara-Martinez D, Briseno-de la Cruz JL, Gomez-Mont-Wiechers J, Araiza-Garaygordobil D Safety of helicopter transport in patients with acute coronary syndrome. Arch Cardiol Mex. 2024;94(1):65-70. doi: 10.24875/ACM.23000044.
  • Valgimigli M, Gragnano F, Branca M, Franzone A, da Costa BR, Baber U, Kimura T, Jang Y, Hahn JY, Zhao Q, Windecker S, Gibson CM, Watanabe H, Kim BK, Song YB, Zhu Y, Vranckx P, Mehta S, Ando K, Hong SJ, Gwon HC, Serruys PW, Dangas GD, McFadden EP, Angiolillo DJ, Heg D, Calabro P, Juni P, Mehran R, Single Versus Dual Antiplatelet Therapy (Sidney-3) Collaboration Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-Analysis. JAMA Cardiol. 2024 May 1;9(5):437-448. doi: 10.1001/jamacardio.2024.0133.
  • Razavi AC, Kohli P, McGuire DK, Martin SS, Polonsky TS, McEvoy JW, Whelton SP, Blumenthal RS PREVENT Equations: A New Era in Cardiovascular Disease Risk Assessment. Circ Cardiovasc Qual Outcomes. 2024 Apr;17(4):e010763. doi: 10.1161/CIRCOUTCOMES.123.010763. Epub 2024 Mar 20.
  • Rivera FB, Lumbang GNO, Gaid DRM, Cruz LLA, Magalong JV, Bantayan NRB, Lara-Breitinger KM, Gulati M, Bakris G Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression. Diabetes Obes Metab. 2024 Jun;26(6):2209-2228. doi: 10.1111/dom.15529. Epub 2024 Mar 20.
  • Tromp J, Sarra C, Nidhal B, Mejdi BM, Zouari F, Hummel Y, Mzoughi K, Kraiem S, Fehri W, Gamra H, Lam CSP, Mebazaa A, Addad F Nurse-led home-based detection of cardiac dysfunction by ultrasound: results of the CUMIN pilot study. Eur Heart J Digit Health. 2023 Dec 12;5(2):163-169. doi: 10.1093/ehjdh/ztad079. eCollection 2024 Mar.
  • Schulman S, Arnold DM, Bradbury CA, Broxmeyer L, Connors JM, Falanga A, Iba T, Kaatz S, Levy JH, Middeldorp S, Minichiello T, Nazy I, Ramacciotti E, Resnick HE, Samama CM, Sholzberg M, Thachil J, Zarychanski R, Spyropoulos AC, International Society on Thrombosis and Haemostasis 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19. J Thromb Haemost. 2024 Jun;22(6):1779-1797. doi: 10.1016/j.jtha.2024.02.011. Epub 2024 Mar 18.
  • Ortega-Paz L, Franchi F, Angiolillo DJ The Lipid-Platelet Interplay: Unraveling the Effects of PCSK9 Inhibition on Platelet Reactivity. Thromb Haemost. 2024 Jun;124(6):528-532. doi: 10.1055/s-0044-1782161. Epub 2024 Mar 19.
  • Bugiardini R, Gulati M Closing the sex gap in cardiovascular mortality by achieving both horizontal and vertical equity. Atherosclerosis. 2024 May;392:117500. doi: 10.1016/j.atherosclerosis.2024.117500. Epub 2024 Mar 6.
  • Ali ZA, Garcia JJ, Karimi Galougahi K, Horst J, Gallo A, Shin D, Ben-Yehuda O, Chen S, Redfors B, Kappetein AP, Sabik JF 3rd, Serruys PW, Stone GW Impact of Incomplete Revascularization After PCI in Left Main Disease: The EXCEL Trial. Circ Cardiovasc Interv. 2024 Mar;17(3):e013192. doi: 10.1161/CIRCINTERVENTIONS.123.013192. Epub 2024 Mar 19.
  • Ablooglu AJ, Chen WS, Xie Z, Desai A, Paul S, Lack JB, Scott LA, Eisch AR, Dudek AZ, Parikh SM, Druey KM Intrinsic endothelial hyperresponsiveness to inflammatory mediators drives acute episodes in models of Clarkson disease. J Clin Invest. 2024 Mar 19;134(10):e169137. doi: 10.1172/JCI169137.
  • Szarek M, Reijnders E, Steg PG, Jukema JW, Schwertfeger M, Bhatt DL, Bittner VA, Diaz R, Fazio S, Garon G, Goodman SG, Harrington RA, White HD, Zeiher AM, Cobbaert C, Schwartz GG Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES. Eur J Prev Cardiol. 2024 Aug 9;31(10):e75-e78. doi: 10.1093/eurjpc/zwae110.
  • Bornstein SR, de Zeeuw D, Heerspink HJL, Schulze F, Cronin L, Wenz A, Tuttle KR, Hadjadj S, Rossing P Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial. Diabetes Obes Metab. 2024 Jun;26(6):2128-2138. doi: 10.1111/dom.15518. Epub 2024 Mar 18.
  • Honigberg MC, Economy KE, Pabon MA, Wang X, Castro C, Brown JM, Divakaran S, Weber BN, Barrett L, Perillo A, Sun AY, Antoine T, Farrohi F, Docktor B, Lau ES, Yeh DD, Natarajan P, Sarma AA, Weisbrod RM, Hamburg NM, Ho JE, Roh JD, Wood MJ, Scott NS, Carli MFD Coronary Microvascular Function Following Severe Preeclampsia. medRxiv [Preprint]. 2024 Mar 5:2024.03.04.24303728. doi: 10.1101/2024.03.04.24303728.
  • Marchina S, Yeatts SD, Foster LD, Janis S, Shoamanesh A, Khatri P, Bernstein K, Perlmutter A, Stever C, Heistand EC, Broderick JP, Greenberg SM, Leira EC, Rosand J, Lioutas VA, Salman RAS, Tirschwell D, Marti-Fabregas J, Selim M Rationale and Design of the Statins Use in Intracerebral Hemorrhage Patients (SATURN) Trial. Cerebrovasc Dis. 2024 Mar 16:10.1159/000538195. doi: 10.1159/000538195.
  • Peikert A, Vaduganathan M, Claggett BL, Kulac IJ, Foa A, Desai AS, Jhund PS, Carberry J, Lam CSP, Kosiborod MN, Inzucchi SE, Martinez FA, de Boer RA, Hernandez AF, Shah SJ, Kober L, Ponikowski P, Sabatine MS, Petersson M, Langkilde AM, McMurray JJV, Solomon SD Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant-level pooled analysis of DAPA-HF and DELIVER. Eur J Heart Fail. 2024 Apr;26(4):912-924. doi: 10.1002/ejhf.3184. Epub 2024 Mar 15.
  • Norris CM, Mullen KA, Foulds HJA, Jaffer S, Nerenberg K, Gulati M, Parast N, Tegg N, Gonsalves CA, Grewal J, Hart D, Levinsson ALE, Mulvagh SL The Canadian Women’s Heart Health Alliance ATLAS on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women – Chapter 7: Sex, Gender, and the Social Determinants of Health. CJC Open. 2023 Aug 4;6(2Part B):205-219. doi: 10.1016/j.cjco.2023.07.013. eCollection 2024 Feb.
  • Mulvagh SL, Colella TJF, Gulati M, Crosier R, Allana S, Randhawa VK, Bruneau J, Pacheco C, Jaffer S, Cotie L, Mensour E, Clavel MA, Hill B, Kirkham AA, Foulds H, Liblik K, Van Damme A, Grace SL, Bouchard K, Tulloch H, Robert H, Pike A, Benham JL, Tegg N, Parast N, Adreak N, Boivin-Proulx LA, Parry M, Gomes Z, Sarfi H, Iwegim C, Van Spall HGC, Nerenberg KA, Wright SP, Limbachia JA, Mullen KA, Norris CM The Canadian Women’s Heart Health Alliance ATLAS on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women – Chapter 9: Summary of Current Status, Challenges, Opportunities, and Recommendations. CJC Open. 2023 Dec 7;6(2Part B):258-278. doi: 10.1016/j.cjco.2023.12.001. eCollection 2024 Feb.
  • Jaffer S, Noble M, Pozgay A, Randhawa V, Gulati M, Mensour E, Parast N, Tegg N, Theberge E, Harchaoui EK, Mulvagh SL The Development of a Chest-Pain Protocol for Women Presenting to the Emergency Department. CJC Open. 2023 Dec 9;6(2Part B):517-529. doi: 10.1016/j.cjco.2023.12.003. eCollection 2024 Feb.
  • Clavel MA, Van Spall HGC, Mantella LE, Foulds H, Randhawa V, Parry M, Liblik K, Kirkham AA, Cotie L, Jaffer S, Bruneau J, Colella TJF, Ahmed S, Dhukai A, Gomes Z, Adreak N, Keeping-Burke L, Limbachia J, Liu S, Jacques KE, Mullen KA, Mulvagh SL, Norris CM The Canadian Women’s Heart Health Alliance ATLAS on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women – Chapter 8: Knowledge Gaps and Status of Existing Research Programs in Canada. CJC Open. 2023 Nov 17;6(2Part B):220-257. doi: 10.1016/j.cjco.2023.11.013. eCollection 2024 Feb.
  • Giacona JM, Afridi A, Bezan Petric U, Johnson T, Pastor J, Ren J, Sandon L, Malloy C, Pandey A, Shah A, Berry JD, Moe OW, Vongpatanasin W Association between dietary phosphate intake and skeletal muscle energetics in adults without cardiovascular disease. J Appl Physiol (1985). 2024 Apr 1;136(4):1007-1014. doi: 10.1152/japplphysiol.00818.2023. Epub 2024 Mar 14.
  • Paraskevas KI, Dardik A, Schermerhorn ML, Liapis CD, Mansilha A, Lal BK, Gray WA, Brown MM, Myrcha P, Lavie CJ, Zeebregts CJ, Secemsky EA, Saba L, Blecha M, Gurevich V, Silvestrini M, Blinc A, Svetlikov A, Fernandes E Fernandes J, Schneider PA, Gloviczki P, White CJ, AbuRahma AF Why selective screening for asymptomatic carotid stenosis is currently appropriate: a special report. Expert Rev Cardiovasc Ther. 2024 Apr-May;22(4-5):159-165. doi: 10.1080/14779072.2024.2330660. Epub 2024 Mar 18.
  • Korjian S, Baron SJ Seeing Beyond the Surface: Is Intravascular Imaging Cost-Effective? Circ Cardiovasc Qual Outcomes. 2024 Mar;17(3):e010745. doi: 10.1161/CIRCOUTCOMES.123.010745. Epub 2024 Mar 13.
  • Yokose C, McCormick N, Abhishek A, Dalbeth N, Pascart T, Liote F, Gaffo A, FitzGerald J, Terkeltaub R, Sise ME, Januzzi JL, Wexler DJ, Choi HK The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout. Nat Rev Rheumatol. 2024 Apr;20(4):216-231. doi: 10.1038/s41584-024-01092-x. Epub 2024 Mar 12.
  • Imazio M, Klein AL, Brucato A, Abbate A, Arad M, Cremer PC, Insalaco A, LeWinter MM, Lewis BS, Lin D, Luis SA, Nicholls SJ, Sutej P, Wasserstrum Y, Clair J, Agarwal I, Wang S, Paolini JF, RHAPSODY Investigators Sustained Pericarditis Recurrence Risk Reduction With Long-Term Rilonacept. J Am Heart Assoc. 2024 Mar 19;13(6):e032516. doi: 10.1161/JAHA.123.032516. Epub 2024 Mar 12.
  • Chen RT, Nelson AJ, Tan S, Clark RA, Zoungas S, Nicholls SJ The effectiveness of visualising plaque on cardiac computed tomography in modifying risk factors for cardiovascular disease: A systematic review. J Cardiovasc Comput Tomogr. 2024 May-Jun;18(3):223-232. doi: 10.1016/j.jcct.2024.02.007. Epub 2024 Mar 11.
  • Maddox TM, Januzzi JL Jr, Allen LA, Breathett K, Brouse S, Butler J, Davis LL, Fonarow GC, Ibrahim NE, Lindenfeld J, Masoudi FA, Motiwala SR, Oliveros E, Walsh MN, Wasserman A, Yancy CW, Youmans QR 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2024 Apr 16;83(15):1444-1488. doi: 10.1016/j.jacc.2023.12.024. Epub 2024 Mar 8.
  • Yeh RW, Shlofmitz R, Moses J, Bachinsky W, Dohad S, Rudick S, Stoler R, Jefferson BK, Nicholson W, Altman J, Bateman C, Krishnaswamy A, Grantham JA, Zidar FJ, Marso SP, Tremmel JA, Grines C, Ahmed MI, Latib A, Tehrani B, Abbott JD, Batchelor W, Underwood P, Allocco DJ, Kirtane AJ, AGENT IDE Investigators Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical Trial. JAMA. 2024 Mar 26;331(12):1015-1024. doi: 10.1001/jama.2024.1361.
  • Chyou JY, Qin H, Butler J, Voors AA, Lam CSP Sex-related similarities and differences in responses to heart failure therapies. Nat Rev Cardiol. 2024 Jul;21(7):498-516. doi: 10.1038/s41569-024-00996-1. Epub 2024 Mar 8.
  • Krucoff M, Spirito A, Baber U, Sartori S, Angiolillo DJ, Briguori C, Cohen DJ, Collier T, Dangas G, Dudek D, Escaned J, Gibson CM, Han YL, Huber K, Kastrati A, Kaul U, Kornowski R, Kunadian V, Vogel B, Mehta SR, Moliterno D, Sardella G, Shlofmitz RA, Sharma S, Steg PG, Pocock S, Mehran R Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial. Am Heart J. 2024 Jun;272:11-22. doi: 10.1016/j.ahj.2024.03.002. Epub 2024 Mar 6.
  • Wilkinson MJ, Bajaj A, Brousseau ME, Taub PR Harnessing RNA Interference for Cholesterol Lowering: The Bench-to-Bedside Story of Inclisiran. J Am Heart Assoc. 2024 Mar 19;13(6):e032031. doi: 10.1161/JAHA.123.032031. Epub 2024 Mar 8.
  • Tan S, Kader Z, Day D, Chen D, Nicholls SJ, Ramkumar S Cardiotoxicity in Oncology Guidelines: Discrepancies Do Matter. Heart Lung Circ. 2024 May;33(5):553-557. doi: 10.1016/j.hlc.2024.02.007. Epub 2024 Mar 6.
  • Ezekowitz J, Alemayehu W, Edelmann F, Ponikowski P, Lam CSP, O’Connor CM, Butler J, Corda S, McMullan CJ, Westerhout CM, Voors AA, Mentz RJ, Armstrong PW, VICTORIA Study Group Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trial. Eur J Heart Fail. 2024 Mar;26(3):628-637. doi: 10.1002/ejhf.3179. Epub 2024 Mar 7.
  • Jolly SS, Lee SF, Mian R, Kedev S, Lavi S, Moreno R, Montalescot G, Hillani A, Henry TD, Asani V, Storey RF, Silvain J, Spratt JCS, d’Entremont MA, Stankovic G, Zafirovska B, Natarajan MK, Sabate M, Shreenivas S, Pinilla-Echeverri N, Sheth T, Altisent OA, Ribas N, Skuriat E, Tyrwhitt J, Mehta SR SYNERGY-Everolimus-Eluting Stent With a Bioabsorbable Polymer in ST-Elevation Myocardial Infarction: CLEAR SYNERGY OASIS-9 Registry. Am J Cardiol. 2024 Jun 1;220:111-117. doi: 10.1016/j.amjcard.2024.02.021. Epub 2024 Mar 4.
  • Ray KK, Gunn LH, Conde LG, Raal FJ, Wright RS, Gosselin NH, Leiter LA, Koenig W, Schwartz GG, Landmesser U, ORION investigators Estimating potential cardiovascular health benefits of improved population level control of LDL cholesterol through a twice-yearly siRNA-based approach: A simulation study of a health-system level intervention. Atherosclerosis. 2024 Apr;391:117472. doi: 10.1016/j.atherosclerosis.2024.117472. Epub 2024 Feb 15.
  • Celutkiene J, Cerlinskaite-Bajore K, Cotter G, Edwards C, Adamo M, Arrigo M, Barros M, Biegus J, Chioncel O, Cohen-Solal A, Damasceno A, Diaz R, Filippatos G, Gayat E, Kimmoun A, Leopold V, Metra M, Novosadova M, Pagnesi M, Pang PS, Ponikowski P, Saidu H, Sliwa K, Takagi K, Ter Maaten JM, Tomasoni D, Lam CSP, Voors AA, Mebazaa A, Davison B Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF Trial. Circ Heart Fail. 2024 Apr;17(4):e011221. doi: 10.1161/CIRCHEARTFAILURE.123.011221. Epub 2024 Mar 6.
  • Nelson AJ, Nicholls SJ Managing hypercholesterolaemia. Aust Prescr. 2024 Feb;47(1):7-14. doi: 10.18773/austprescr.2024.006.
  • Pagnesi M, Vilamajo OAG, Meirino A, Dumont CA, Mebazaa A, Davison B, Adamo M, Arrigo M, Barros M, Biegus J, Celutkiene J, Cerlinskaite-Bajore K, Chioncel O, Cohen-Solal A, Damasceno A, Diaz R, Edwards C, Filippatos G, Gayat E, Kimmoun A, Lam CSP, Novosadova M, Pang PS, Ponikowski P, Saidu H, Sliwa K, Takagi K, Ter Maaten JM, Tomasoni D, Voors AA, Cotter G, Metra M Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial. Eur J Heart Fail. 2024 Mar;26(3):638-651. doi: 10.1002/ejhf.3174. Epub 2024 Mar 5.
  • Iyer NR, Chan SP, Liew OW, Chong JPC, Bryant JA, Le TT, Chandramouli C, Cozzone PJ, Eisenhaber F, Foo R, Richards AM, Lam CSP, Ugander M, Chin CW, ATTRaCT investigators Global longitudinal strain and plasma biomarkers for prognosis in heart failure complicated by diabetes: a prospective observational study. BMC Cardiovasc Disord. 2024 Mar 5;24(1):141. doi: 10.1186/s12872-024-03810-5.
  • Beleigoli A, Foote J, Gebremichael LG, Bulamu NB, Astley C, Keech W, Tavella R, Gulyani A, Nesbitt K, Pinero de Plaza MA, Ramos JS, Ludlow M, Nicholls SJ, Chew DP, Beltrame J, Clark RA Clinical Effectiveness and Utilisation of Cardiac Rehabilitation After Hospital Discharge: Data Linkage Analysis of 84,064 Eligible Discharged Patients (2016-2021). Heart Lung Circ. 2024 Jul;33(7):1036-1045. doi: 10.1016/j.hlc.2024.01.018. Epub 2024 Mar 5.
  • Kaski JC, Al-Lamee R, Boden WE The year in cardiovascular medicine 2023: the top 10 papers in ischaemic heart disease. Eur Heart J. 2024 Apr 7;45(14):1201-1204. doi: 10.1093/eurheartj/ehae113.
  • Reynolds MR, Stanford K, Melendez DM, Schwartzkopf-Genswein KS, McAllister TA, Blakley BR, McKinnon JJ, Ribeiro GO Effect of continuous or intermittent feeding of ergot contaminated grain in a mash or pelleted form on the performance and health of feedlot beef steers. J Anim Sci. 2024 Jan 3;102:skae060. doi: 10.1093/jas/skae060.
  • Yan AF, Williams MY, Shi Z, Oyekan R, Yoon C, Bowen R, Chertow GM Bias and Accuracy of Glomerular Filtration Rate Estimating Equations in the US: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2024 Mar 4;7(3):e241127. doi: 10.1001/jamanetworkopen.2024.1127.
  • Badea RS, Mihaila-Baldea S, Ribigan A, Negrila A, Grecu N, Marinescu AN, Antochi F, Tiu C, Vinereanu D, Popescu BO PFO-spectrum disorder: two different cerebrovascular diseases in patients with PFO as detected by AI brain imaging software. Front Neurol. 2024 Feb 19;15:1357348. doi: 10.3389/fneur.2024.1357348. eCollection 2024.
  • Butler J, Mentz RJ, Hernandez AF Iron replacement therapy in heart failure: Contextualizing the results of the HEART-FID trial. Eur J Heart Fail. 2024 Mar;26(3):537-539. doi: 10.1002/ejhf.3193. Epub 2024 Mar 4.
  • Ferreira JP, Zannad F, Packer M, Filippatos G, Pocock SJ, Vasques-Novoa F, Bohm M, Butler J, Anker S Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR-Preserved analysis. Eur J Heart Fail. 2024 Apr;26(4):952-959. doi: 10.1002/ejhf.3180. Epub 2024 Mar 4.
  • Ferreira JP, Packer M, Sattar N, Butler J, Pocock SJ, Anker SD, Maldonado SG, Panova-Noeva M, Sumin M, Masson S, Zannad F, Januzzi JL Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programme. Eur J Heart Fail. 2024 Apr;26(4):788-802. doi: 10.1002/ejhf.3166. Epub 2024 Mar 4.
  • Chunawala ZS, Keshvani N, Segar MW, Patel KV, Usman MS, Subramanian V, Raygor V, Chandra A, Khan MS, Pandey A Association of diabetes-specific heart failure risk score with presence of subclinical cardiomyopathy among individuals with diabetes: A prospective study. Eur J Heart Fail. 2024 Mar;26(3):699-701. doi: 10.1002/ejhf.3176. Epub 2024 Mar 4.
  • Masri A, Van Spall HGC In adults with ATTR cardiac amyloidosis, patisiran reduced decline in functional capacity at 12 mo. Ann Intern Med. 2024 Mar;177(3):JC30. doi: 10.7326/J24-0004. Epub 2024 Mar 5.
  • Sandner S, Gaudino M, Redfors B, Angiolillo DJ, Ben-Yehuda O, Bhatt DL, Fremes SE, Lamy A, Marano R, Mehran R, Pocock S, Rao SV, Spertus JA, Weinsaft JW, Wells G, Ruel M One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trial. EuroIntervention. 2024 Mar 4;20(5):e322-e328. doi: 10.4244/EIJ-D-23-00699.
  • Dirjayanto VJ, Pompei G, Rubino F, Biscaglia S, Campo G, Mihailidou AS, den Ruijter H, Kunadian V Non-invasive vascular measures as prognostic predictors for older patients with non-ST elevation acute coronary syndrome. Coron Artery Dis. 2024 Aug 1;35(5):368-381. doi: 10.1097/MCA.0000000000001352. Epub 2024 Mar 4.
  • Cossio Aranda JE, Jain V, Figueiras-Graillet LM, Arias-Mendoza A, Cuellar JL, Berni Betancourt A, Liprandi AS, Pinto F, Eisele JL, Pineiro DJ Toward a Better Understanding of Cardiovascular Risk in the Transgender and Gender-Diverse Community: A Global Call to Action. Glob Heart. 2024 Feb 29;19(1):27. doi: 10.5334/gh.1300. eCollection 2024.
  • Singh S, Garg A, Tantry US, Bliden K, Gurbel PA, Gulati M Cardiovascular Outcomes With Empagliflozin and Dapagliflozin in Patients Without Diabetes. Am J Cardiol. 2024 May 1;218:24-31. doi: 10.1016/j.amjcard.2024.02.039. Epub 2024 Mar 1.
  • Al-Lamee RK Angina pectoris 2023: With and without obstructive coronary artery disease: Epidemiology, diagnosis, prognosis, and treatment. Vascul Pharmacol. 2024 Jun;155:107285. doi: 10.1016/j.vph.2024.107285. Epub 2024 Mar 1.
  • Mehdipoor G, Redfors B, Chen S, Gkargkoulas F, Zhang Z, Patel MR, Granger CB, Ohman EM, Maehara A, Eitel I, Ben-Yehuda O, de Waha-Thiele S, Thiele H, Stone GW Hypertension, microvascular obstruction and infarct size in patients with STEMI undergoing PCI: Pooled analysis from 7 cardiac magnetic resonance imaging studies. Am Heart J. 2024 May;271:148-155. doi: 10.1016/j.ahj.2024.02.023. Epub 2024 Mar 1.
  • Wiernik E, Renuy A, Kab S, Steg PG, Goldberg M, Zins M, Caligiuri G, Bouchard P, Carra MC Prevalence of self-reported severe periodontitis: Data from the population-based CONSTANCES cohort. J Clin Periodontol. 2024 Jul;51(7):884-894. doi: 10.1111/jcpe.13969. Epub 2024 Mar 2.
  • Bertero E, Carmisciano L, Jonasson C, Butler J, Maack C, Ameri P Association of inflammatory markers with incident heart failure or cancer in the HUNT3 and Health ABC population studies. Eur J Prev Cardiol. 2024 Aug 22;31(11):1400-1407. doi: 10.1093/eurjpc/zwae089.
  • Rashedi S, Greason CM, Sadeghipour P, Talasaz AH, O’Donoghue ML, Jimenez D, Monreal M, Anderson CD, Elkind MSV, Kreuziger LMB, Lang IM, Goldhaber SZ, Konstantinides SV, Piazza G, Krumholz HM, Braunwald E, Bikdeli B Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications. Semin Thromb Hemost. 2024 Jul;50(5):773-789. doi: 10.1055/s-0044-1781451. Epub 2024 Mar 1.
  • Iba T, Levy JH, Maier CL, Connors JM, Levi M Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned? J Thromb Haemost. 2024 Jun;22(6):1541-1549. doi: 10.1016/j.jtha.2024.02.013. Epub 2024 Feb 29.
  • Park B, Bakbak E, Teoh H, Krishnaraj A, Dennis F, Quan A, Rotstein OD, Butler J, Hess DA, Verma S GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage. Am J Physiol Heart Circ Physiol. 2024 May 1;326(5):H1159-H1176. doi: 10.1152/ajpheart.00574.2023. Epub 2024 Mar 1.
  • Nakayama M, Goto S, Goto S Development of the Integrated Computer Simulation Model of the Intracellular, Transmembrane, and Extracellular Domain of Platelet Integrin alpha (IIb) beta (3) (Platelet Membrane Glycoprotein: GPIIb-IIIa). TH Open. 2024 Feb 29;8(1):e96-e105. doi: 10.1055/a-2247-9438. eCollection 2024 Jan.
  • Tuttle KR CKD screening for better kidney health: Why? Who? How? When? Nephrol Dial Transplant. 2024 Sep 27;39(10):1537-1539. doi: 10.1093/ndt/gfae055.
  • Huang L, Mahmood F, Laham R, Sharma RK, Belani K Percutaneous Approach to Mechanical Aortic Valve Prosthesis Paravalvular Leak Closure: Lessons Learned. J Cardiothorac Vasc Anesth. 2024 May;38(5):1203-1210. doi: 10.1053/j.jvca.2024.01.031. Epub 2024 Feb 1.
  • Alexandrou M, Simsek B, Rempakos A, Kostantinis S, Karacsonyi J, Rangan BV, Mastrodemos OC, Allana SS, Rao SV, Linzer M, Egred M, Milkas A, Sandoval Y, Burke MN, Brilakis ES Burnout in cardiology: a narrative review. J Invasive Cardiol. 2024 May;36(5). doi: 10.25270/jic/23.00292.
  • Mann DL, Nicolas J, Claggett B, Miao ZM, Granger CB, Kerkar P, Kober L, Lewis EF, McMurray JJV, Maggioni AP, Nunez J, Ntsekhe M, Rouleau JL, Sim D, Solomon SD, Steg PG, van der Meer P, Braunwald E, Pfeffer MA, Mehran R Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI. J Am Coll Cardiol. 2024 Mar 5;83(9):904-914. doi: 10.1016/j.jacc.2024.01.002.
  • Berman AN, Biery DW, Besser SA, Singh A, Shiyovich A, Weber BN, Huck DM, Divakaran S, Hainer J, Kaur G, Blaha MJ, Cannon CP, Plutzky J, Januzzi JL, Booth JN 3rd, Lopez JAG, Kent ST, Nasir K, Di Carli MF, Bhatt DL, Blankstein R Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease. J Am Coll Cardiol. 2024 Mar 5;83(9):873-886. doi: 10.1016/j.jacc.2023.12.031.
  • Segar MW, Nair A, Pandey A An exercise enigma: Unravelling the complexity of exercise intolerance in heart failure with preserved ejection fraction. Eur J Heart Fail. 2024 Mar;26(3):578-580. doi: 10.1002/ejhf.3170. Epub 2024 Feb 27.
  • Sattar N, Presslie C, Rutter MK, McGuire DK Cardiovascular and Kidney Risks in Individuals With Type 2 Diabetes: Contemporary Understanding With Greater Emphasis on Excess Adiposity. Diabetes Care. 2024 Apr 1;47(4):531-543. doi: 10.2337/dci23-0041.
  • Watson NW, Weinberg I, Dicks AB, Carroll BJ, Secemsky EA Clinical Outcomes and Predictors of Advanced Therapy for the Management of Right Heart Thrombus. Circ Cardiovasc Interv. 2024 Apr;17(4):e013637. doi: 10.1161/CIRCINTERVENTIONS.123.013637. Epub 2024 Feb 27.
  • Price AL, Amin AP, Rogers S, Messenger JC, Moussa ID, Miller JM, Jennings J, Masoudi FA, Abbott JD, Young R, Wojdyla DM, Rao SV Implementation of a Multidimensional Strategy to Reduce Post-PCI Bleeding Risk. Circ Cardiovasc Interv. 2024 Mar;17(3):e013003. doi: 10.1161/CIRCINTERVENTIONS.123.013003. Epub 2024 Feb 27.
  • McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Piepoli MF, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, ESC Scientific Document Group [2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. G Ital Cardiol (Rome). 2024 Mar;25(3):202-213. doi: 10.1714/4209.42008.
  • Ducrocq G, Cachanado M, Simon T, Puymirat E, Lemesle G, Lattuca B, Ariza-Sole A, Silvain J, Ferrari E, Gonzalez-Juanatey JR, Martinez-Selles M, Lermusier T, Coste P, Vanzetto G, Cottin Y, Dillinger JG, Calvo G, Steg PG, REALITY Investigators Restrictive vs Liberal Blood Transfusions for Patients With Acute Myocardial Infarction and Anemia by Heart Failure Status: An RCT Subgroup Analysis. Can J Cardiol. 2024 Sep;40(9):1705-1714. doi: 10.1016/j.cjca.2024.02.013. Epub 2024 Feb 24.
  • Arias-Mendoza A, Gopar-Nieto R, Juarez-Tolen J, Ordonez-Olvera JC, Gonzalez-Pacheco H, Briseno-De la Cruz JL, Sierra-Lara Martinez D, Mendoza-Garcia S, Altamirano-Castillo A, Montanez-Orozco A, Arzate-Ramirez A, Baeza-Herrera LA, Ortega-Hernandez JA, Miranda-Cerda G, Cruz-Martinez JE, Baranda-Tovar FM, Zabal-Cerdeira C, Araiza-Garaygordobil D Long-Term Outcomes of Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction: A Study from Mexico City. Am J Cardiol. 2024 May 1;218:7-15. doi: 10.1016/j.amjcard.2024.02.016. Epub 2024 Feb 23.
  • Abrahams T, Nicholls SJ Perspectives on the success of plasma lipidomics in cardiovascular drug discovery and future challenges. Expert Opin Drug Discov. 2024 Mar;19(3):281-290. doi: 10.1080/17460441.2023.2292039. Epub 2023 Dec 12.
  • Januzzi JL Jr, Liu Y, Sattar N, Yavin Y, Pollock CA, Butler J, Jardine M, Heerspink HJL, Masson S, Breyer M, Hansen MK Vascular endothelial growth factors and risk of cardio-renal events: Results from the CREDENCE trial. Am Heart J. 2024 May;271:38-47. doi: 10.1016/j.ahj.2024.02.016. Epub 2024 Feb 22.
  • McEwan P, Davis JA, Gabb PD, Wheeler DC, Rossing P, Chertow GM, Correa-Rotter R, Tamura K, Barone S, Garcia Sanchez JJ Dapagliflozin in chronic kidney disease: cost-effectiveness beyond the DAPA-CKD trial. Clin Kidney J. 2024 Feb 9;17(2):sfae025. doi: 10.1093/ckj/sfae025. eCollection 2024 Feb.
  • Amin S, Baron SJ, Galper BZ Aortic valve replacement today: Outcomes, costs, and opportunities for improvement. Cardiovasc Revasc Med. 2024 Jul;64:78-86. doi: 10.1016/j.carrev.2024.02.004. Epub 2024 Feb 10.
  • Mohebi R, Jones PG, Spertus JA, Lingvay I, Lanfear DE, Gosch KL, Birmingham M, Kosiborod MN, Butler J, Januzzi JL Jr Early Longitudinal Change in Heart Failure Health Status Following Initiation of Canagliflozin. JACC Heart Fail. 2024 Apr;12(4):711-718. doi: 10.1016/j.jchf.2024.01.005. Epub 2024 Feb 21.
  • Perello J, Alberti J, Torres JV, Ferrer MD, Perez MM, Bassissi F, Gold A, Raggi P, Chertow GM, Salcedo C Hexasodium fytate exposure-response correlations in a randomized, placebo-controlled study of patients on dialysis with cardiovascular calcification. Front Pharmacol. 2024 Feb 7;15:1325186. doi: 10.3389/fphar.2024.1325186. eCollection 2024.
  • Ji H, Gulati M, Huang TY, Kwan AC, Ouyang D, Ebinger JE, Casaletto K, Moreau KL, Skali H, Cheng S Sex Differences in Association of Physical Activity With All-Cause and Cardiovascular Mortality. J Am Coll Cardiol. 2024 Feb 27;83(8):783-793. doi: 10.1016/j.jacc.2023.12.019.
  • Goodman SG, Roy D, Pollack CV Jr, Leblanc K, Kwaku KF, Barnes GD, Bonaca MP, True Hills M, Campello E, Fanikos J, Connors JM, Weitz JI Current Gaps in the Provision of Safe and Effective Anticoagulation in Atrial Fibrillation and the Potential for Factor XI-Directed Therapeutics. Crit Pathw Cardiol. 2024 Jun 1;23(2):47-57. doi: 10.1097/HPC.0000000000000351. Epub 2024 Feb 21.
  • Talha KM, Januzzi JL Jr, Meng T, Greene SJ, Vaduganathan M, Janicijevic TK, John A, Bayes-Genis A, Butler J Use of natriuretic peptides and echocardiography for diagnosing heart failure. Eur J Heart Fail. 2024 Mar;26(3):551-560. doi: 10.1002/ejhf.3165. Epub 2024 Feb 20.
  • Lin YC, Swendeman S, Moreira IS, Ghosh A, Kuo A, Rosario-Ferreira N, Guo S, Culbertson A, Levesque MV, Cartier A, Seno T, Schmaier A, Galvani S, Inoue A, Parikh SM, FitzGerald GA, Zurakowski D, Liao M, Flaumenhaft R, Gumus ZH, Hla T Designer high-density lipoprotein particles enhance endothelial barrier function and suppress inflammation. Sci Signal. 2024 Feb 20;17(824):eadg9256. doi: 10.1126/scisignal.adg9256. Epub 2024 Feb 20.
  • Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, Hsiao LL, Khalife M, Kumaraswami LA, Loud F, Raghavan V, Roumeliotis S, Sierra M, Ulasi I, Wang B, Lui SF, Liakopoulos V, Balducci A, World Kidney Day Joint Steering Committee Mind the gap in kidney care: translating what we know into what we do. Kidney Int. 2024 Mar;105(3):406-417. doi: 10.1016/j.kint.2023.12.003.
  • Wang X, Lam CSP, Vaduganathan M, Kondo T, Yang M, Han Y, Pham VN, Chiang CE, Kitakaze M, Miao ZM, Jhund PS, Desai AS, Inzucchi SE, de Boer RA, Martinez FA, Kosiborod MN, Hernandez AF, Claggett B, Langkilde AM, McMurray JJV, Solomon SD Effects of Dapagliflozin in Patients in Asia: A Post Hoc Subgroup Analysis From the DELIVER Trial. JACC Asia. 2023 Dec 5;4(2):108-118. doi: 10.1016/j.jacasi.2023.10.005. eCollection 2024 Feb.
  • Los J, Mensink FB, Mohammadnia N, Opstal TSJ, Damman P, Volleberg RHJA, Peeters DAM, van Royen N, Garcia-Garcia HM, Cornel JH, El Messaoudi S, van Geuns RM Invasive coronary imaging of inflammation to further characterize high-risk lesions: what options do we have? Front Cardiovasc Med. 2024 Feb 1;11:1352025. doi: 10.3389/fcvm.2024.1352025. eCollection 2024.
  • Minamisawa M, Inciardi RM, Claggett B, Cikes M, Liu L, Prasad N, Biering-Sorensen T, Lam CSP, Shah SJ, Zile MR, O’Meara E, Redfield MM, McMurray JJV, Solomon SD, Shah AM Clinical implications of subclinical left ventricular dysfunction in heart failure with preserved ejection fraction: The PARAGON-HF study. Eur J Heart Fail. 2024 Apr;26(4):871-881. doi: 10.1002/ejhf.3167. Epub 2024 Feb 18.
  • Secemsky EA, Yeh RW, Schneider PA, Gray W, Parikh S The End of a Controversy: The Rise, Fall, and Redemption of Paclitaxel-Coated Devices. Am J Cardiol. 2024 Apr 1;216:43-45. doi: 10.1016/j.amjcard.2024.01.027. Epub 2024 Feb 17.
  • Conte MS, Azene E, Doros G, Gasper WJ, Hamza T, Kashyap VS, Guzman R, Mena-Hurtado C, Menard MT, Rosenfield K, Rowe VL, Strong M, Farber A Secondary interventions following open vs endovascular revascularization for chronic limb threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2024 Jun;79(6):1428-1437.e4. doi: 10.1016/j.jvs.2024.02.005. Epub 2024 Feb 17.
  • Heerspink HJ, Provenzano M, Vart P, Jongs N, Correa-Rotter R, Rossing P, Mark PB, Pecoits-Filho R, McMurray JJ, Langkilde AM, Wheeler DC, Toto RB, Chertow GM Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria. Am Heart J. 2024 Apr;270:125-135. doi: 10.1016/j.ahj.2024.02.006. Epub 2024 Feb 15.
  • Gosev I, Pham DT, Um JY, Anyanwu AC, Itoh A, Kotkar K, Takeda K, Naka Y, Peltz M, Silvestry SC, Couper G, Leacche M, Rao V, Sun B, Tedford RJ, Mokadam N, McNutt R, Crandall D, Mehra MR, Salerno CT Ventricular assist device using a thoracotomy-based implant technique: Multi-Center Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical Techniques Other Than Full Median Sternotomy (HM3 SWIFT). J Thorac Cardiovasc Surg. 2024 Nov;168(5):1474-1484.e12. doi: 10.1016/j.jtcvs.2024.02.013. Epub 2024 Feb 15.
  • Engle J, Saberi P, Bain P, Ikram A, Selim M, Soman S Oxygen extraction fraction (OEF) values and applications in neurological diseases. Neurol Sci. 2024 Jul;45(7):3007-3020. doi: 10.1007/s10072-024-07362-6. Epub 2024 Feb 17.
  • Weitz JI, Tanko LB, Floege J, Fox KAA, Bhatt DL, Thadhani R, Hung J, Pap AF, Kubitza D, Winkelmayer WC, CONVERT Investigators Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial. Nat Med. 2024 Feb;30(2):435-442. doi: 10.1038/s41591-023-02794-7. Epub 2024 Feb 16.
  • Mentz RJ, Stebbins A, Butler J, Chiang CE, Ezekowitz JA, Hernandez AF, Hilkert R, Lam CSP, McDonald K, O’Connor CM, Pieske B, Ponikowski P, Roessig L, Sweitzer NK, Voors AA, Anstrom KJ, Armstrong PW, VICTORIA Study Group Recurrent Hospitalizations and Response to Vericiguat in Heart Failure and Reduced Ejection Fraction. JACC Heart Fail. 2024 May;12(5):839-846. doi: 10.1016/j.jchf.2023.12.005. Epub 2024 Feb 14.
  • Foley MJ, Rajkumar CA, Ahmed-Jushuf F, Nowbar AN, Simader F, Bello O, Al-Lamee R Why Does a Cardiologist Believe in a Therapy? The Role of Intuitiveness and Understanding the Mechanism. Circ Cardiovasc Qual Outcomes. 2024 Mar;17(3):e010664. doi: 10.1161/CIRCOUTCOMES.123.010664. Epub 2024 Feb 16.
  • Muthalaly RG, Abrahams TB, Nerlekar N, Nelson AJ, Tan S, Chan J, Phan T, Ma H, Nicholls SJ Asymptomatic coronary artery disease in ischaemic stroke survivors: A systematic review and meta-analysis. Eur Stroke J. 2024 Sep;9(3):540-554. doi: 10.1177/23969873241231702. Epub 2024 Feb 15.
  • Mihan A, Van Spall HGC Interventions to enhance digital health equity in cardiovascular care. Nat Med. 2024 Mar;30(3):628-630. doi: 10.1038/s41591-024-02815-z.
  • Angiolillo DJ, Cao D, Baber U, Mehran R Reply: Decoding Ticagrelor Dyspnea: Central Apnea Screening Before Drug Discontinuation. JACC Cardiovasc Interv. 2024 Feb 12;17(3):452-453. doi: 10.1016/j.jcin.2023.12.035.
  • Krishnaraj A, Bakbak E, Teoh H, Pan Y, Firoz IN, Pandey AK, Terenzi DC, Verma R, Bari B, Bakbak AI, Kunjummar SP, Yanagawa B, Connelly KA, Mazer CD, Rotstein OD, Quan A, Bhatt DL, McGuire DK, Hess DA, Verma S Vascular Regenerative Cell Deficiencies in South Asian Adults. J Am Coll Cardiol. 2024 Feb 20;83(7):755-769. doi: 10.1016/j.jacc.2023.12.012.
  • Jotwani V, Yang SY, Thiessen-Philbrook H, Parikh CR, Katz R, Tranah GJ, Ix JH, Cummings S, Waikar SS, Shlipak MG, Sarnak MJ, Parikh SM, Arking DE Mitochondrial genetic variation and risk of chronic kidney disease and acute kidney injury in UK Biobank participants. Hum Genet. 2024 Feb;143(2):151-157. doi: 10.1007/s00439-023-02615-4. Epub 2024 Feb 13.
  • Mohr K, Keeling B, Kaier K, Neusius T, Rosovsky RP, Moriarty JM, Rosenfield K, Abele C, Farmakis IT, Keller K, Barco S, Channick RN, Giri JS, Lookstein RA, Todoran TM, Christodoulou KC, Hobohm L, Lanno M, Reed J, Binder H, Konstantinides SV, Valerio L, Secemsky EA Modelling costs of interventional pulmonary embolism treatment: implications of US trends for a European healthcare system. Eur Heart J Acute Cardiovasc Care. 2024 Jun 30;13(6):501-505. doi: 10.1093/ehjacc/zuae019.
  • Subramanian V, Keshvani N, Segar MW, Kondamudi NJ, Chandra A, Maddineni B, Matulevicius SA, Michos ED, Lima JAC, Berry JD, Pandey A Association of global longitudinal strain by feature tracking cardiac magnetic resonance imaging with adverse outcomes among community-dwelling adults without cardiovascular disease: The Dallas Heart Study. Eur J Heart Fail. 2024 Feb;26(2):208-215. doi: 10.1002/ejhf.3158. Epub 2024 Feb 12.
  • Koczo A, Brickshawana A, Zhu J, Thoma F, Countouris M, Berlacher K, Gulati M, Michos ED, Reis S, Mulukutla S, Saeed A Sex-Based Utilization of Guideline Recommended Statin Therapy and Cardiovascular Disease Outcomes: A Primary Prevention Healthcare Network Registry. medRxiv [Preprint]. 2024 Jan 23:2024.01.22.24301511. doi: 10.1101/2024.01.22.24301511.
  • Jenkins K, Pompei G, Ganzorig N, Brown S, Beltrame J, Kunadian V Vasospastic angina: a review on diagnostic approach and management. Ther Adv Cardiovasc Dis. 2024 Jan-Dec;18:17539447241230400. doi: 10.1177/17539447241230400.
  • Eggers KM, Batra G, Lindahl B, Ghukasyan Lakic T, Lindback J, Budaj A, Cornel JH, Giannitsis E, Katus HA, Storey RF, Becker RC, Siegbahn A, Wallentin L Temporal biomarker concentration patterns during the early course of acute coronary syndrome. Clin Chem Lab Med. 2024 Feb 13;62(6):1167-1176. doi: 10.1515/cclm-2023-1253. Print 2024 May 27.
  • Nicholls SJ, Tofe S, le Roux CW, D’Alessio DA, Wiese RJ, Pavo I, Brown K, Weerakkody GJ, Zeytinoglu M, Romera IC Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program. Cardiovasc Diabetol. 2024 Feb 10;23(1):63. doi: 10.1186/s12933-024-02147-9.
  • Duell PB, Banach M, Catapano AL, Laufs U, Mancini GBJ, Ray KK, Broestl C, Zhang Y, Lei L, Goldberg AC Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials. J Clin Lipidol. 2024 Mar-Apr;18(2):e153-e165. doi: 10.1016/j.jacl.2023.12.005. Epub 2024 Jan 11.
  • Kumbhani DJ, Manandhar P, Bavry AA, Chhatriwalla AK, Giri J, Mack M, Carroll J, Pandey A, Kosinski A, Peterson ED, Kaneko T, de Lemos JA, Vemulapalli S National Variation in Hospital MTEER Outcomes and Correlation With TAVR Outcomes: STS/ACC TVT Registry Analysis. JACC Cardiovasc Interv. 2024 Feb 26;17(4):505-515. doi: 10.1016/j.jcin.2023.11.012. Epub 2024 Feb 7.
  • Singleton AC, Redfern J, Diaz A, Koczwara B, Nicholls SJ, Negishi K, La Gerche A, Playford D, Conyers R, Cehic DA, Garvey G, Williams TD, Hunt L, Doyle K, Figtree GA, Ngo DTM, Sverdlov AL, Australian Cardiovascular Alliance Cardio-Oncology Working Group Integrating Cardio-Oncology Across the Research Pipeline, Policy, and Practice in Australia-An Australian Cardiovascular Alliance Perspective. Heart Lung Circ. 2024 May;33(5):564-575. doi: 10.1016/j.hlc.2024.01.011. Epub 2024 Feb 9.
  • Patel L, Segar MW, Keshvani N, Subramanian V, Pandey A, Chandra A Association of Beta-Blocker Use With Exercise Capacity in Participants With Heart Failure With Preserved Ejection Fraction: A Post Hoc Analysis of the RELAX Trial. Am J Cardiol. 2024 Apr 1;216:48-53. doi: 10.1016/j.amjcard.2024.01.023. Epub 2024 Feb 7.
  • Bahit MC, Gibson CM Thrombin as target for prevention of recurrent events after acute coronary syndromes. Thromb Res. 2024 Mar;235:116-121. doi: 10.1016/j.thromres.2024.02.003. Epub 2024 Feb 5.
  • Alexandrou M, Simsek B, Rempakos A, Kostantinis S, Karacsonyi J, Rangan BV, Mastrodemos OC, Kirtane AJ, Bortnick AE, Jneid H, Azzalini L, Milkas A, Alaswad K, Linzer M, Egred M, Rao SV, Allana SS, Sandoval Y, Brilakis ES Sex differences in the well-being of interventional cardiologists. J Invasive Cardiol. 2024 Feb;36(2). doi: 10.25270/jic/23.00151.
  • Kaushik M, Beyer SE, Nashel J, Kholdani C, Dowlatshahi AS, Secemsky EA, Carroll BJ Advanced Raynaud’s disease: A vascular medicine-initiated team-based approach and nationwide cohort analysis. Vasc Med. 2024 Apr;29(2):120-122. doi: 10.1177/1358863X231220609. Epub 2024 Feb 9.
  • Kobo O, Michos ED, Roguin A, Bagur R, Gulati M, Mamas MA Recommended and observed statin use among US adults with and without cancer. Eur J Prev Cardiol. 2024 Aug 9;31(10):1251-1257. doi: 10.1093/eurjpc/zwae057.
  • Vora J, Cherney D, Kosiborod MN, Spaak J, Kanumilli N, Khunti K, Lam CSP, Bachmann M, Fenici P, CaReMe Global Alliance Inter-relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management. Diabetes Obes Metab. 2024 May;26(5):1567-1581. doi: 10.1111/dom.15485. Epub 2024 Feb 8.
  • Tao J, Liu S, Montez-Rath M, Charu V, Chertow GM Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Active Kidney Involvement in the United States: 2016-2020. Glomerular Dis. 2024 Jan 10;4(1):33-42. doi: 10.1159/000536168. eCollection 2024 Jan-Dec.
  • Selvam PV, Grandhi GR, Leucker TM, Arbab-Zadeh A, Gulati M, Blumenthal RS, Whelton SP Recent advances in cardiovascular risk assessment: The added value of non-invasive anatomic imaging. J Cardiovasc Comput Tomogr. 2024 Mar-Apr;18(2):113-119. doi: 10.1016/j.jcct.2024.01.012. Epub 2024 Feb 6.
  • Fudim M, Butler J, Kittipibul V Implantable Hemodynamic-GUIDE Monitors: A CHAMPION Among Devices for Heart Failure. J Am Coll Cardiol. 2024 Feb 13;83(6):695-698. doi: 10.1016/j.jacc.2023.12.008.
  • Lindenfeld J, Costanzo MR, Zile MR, Ducharme A, Troughton R, Maisel A, Mehra MR, Paul S, Sears SF, Smart F, Johnson N, Henderson J, Adamson PB, Desai AS, Abraham WT, GUIDE-HF, CHAMPION, and LAPTOP-HF Investigators Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol. 2024 Feb 13;83(6):682-694. doi: 10.1016/j.jacc.2023.11.030.
  • Eikelboom JW, Mundl H, Alexander JH, Caso V, Connolly SJ, Coppolecchia R, Gebel M, Hart RG, Holberg G, Keller L, Patel MR, Piccini JP, Rao SV, Shoamanesh A, Tamm M, Viethen T, Yassen A, Bonaca MP Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials. J Am Coll Cardiol. 2024 Feb 13;83(6):669-678. doi: 10.1016/j.jacc.2023.12.004.
  • Holtrop J, Bhatt DL, Ray KK, Mach F, Smulders YM, Carballo D, Steg PG, Visseren FLJ, Dorresteijn JAN Impact of the 2021 European Society for Cardiology prevention guideline’s stepwise approach for cardiovascular risk factor treatment in patients with established atherosclerotic cardiovascular disease. Eur J Prev Cardiol. 2024 Apr 18;31(6):754-762. doi: 10.1093/eurjpc/zwae038.
  • Gaist D, Selim M Lipid-Lowering Therapy and Hemorrhagic Stroke: A Never-Ending Debate of Clinical Implications. Have We Found the Answer? J Am Heart Assoc. 2024 Feb 20;13(4):e034099. doi: 10.1161/JAHA.124.034099. Epub 2024 Feb 7.
  • Spahillari A, Jackson L, Varrias D, Michelhaugh SA, Januzzi JL, Shahideh B, Daghfal D, Valkov N, Murtagh G, Das S MicroRNAs are associated with cardiac biomarkers, cardiac structure and function and incident outcomes in heart failure. ESC Heart Fail. 2024 Jun;11(3):1400-1410. doi: 10.1002/ehf2.14649. Epub 2024 Feb 6.
  • Hamid A, Fonarow GC, Butler J, Hall ME How do breast cancer clinical trials approach cardiovascular safety: targeted or generalized? Cardiooncology. 2024 Feb 7;10(1):6. doi: 10.1186/s40959-024-00201-9.
  • Sarma AA, Lau ES, Sharma G, King LP, Economy KE, Wood R, Wood MJ, Feinberg L, Isselbacher EM, Hameed AB, DeFaria Yeh D, Scott NS Maternal Cardiovascular Health Post-Dobbs. NEJM Evid. 2024 Feb;3(2):EVIDra2300273. doi: 10.1056/EVIDra2300273. Epub 2024 Jan 23.
  • James S, Erlinge D, Storey RF, McGuire DK, de Belder M, Eriksson N, Andersen K, Austin D, Arefalk G, Carrick D, Hofmann R, Hoole SP, Jones DA, Lee K, Tygesen H, Johansson PA, Langkilde AM, Ridderstrale W, Parvaresh Rizi E, Deanfield J, Oldgren J Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure. NEJM Evid. 2024 Feb;3(2):EVIDoa2300286. doi: 10.1056/EVIDoa2300286. Epub 2023 Nov 11.
  • Zhao X, Chang TI, Winkelmayer WC, Long J, Liu S, Marsenic O Intradialytic Hypotension and Mortality in Adolescents and Young Adults With Kidney Failure Receiving Maintenance Hemodialysis. Kidney Med. 2023 Dec 9;6(2):100773. doi: 10.1016/j.xkme.2023.100773. eCollection 2024 Feb.
  • Galli M, Angiolillo DJ Role of the P2Y12 receptor on thrombus formation and evolution in therapeutic strategies. Expert Opin Ther Targets. 2024 Jan-Feb;28(1-2):5-8. doi: 10.1080/14728222.2024.2315017. Epub 2024 Feb 6.
  • van Essen BJ, Tharshana GN, Ouwerkerk W, Yeo PSD, Sim D, Jaufeerally F, Ong HY, Ling LH, Soon DKN, Lee SGS, Leong G, Loh SY, San Tan R, Ramachandra CJ, Hausenloy DJ, Liew OW, Chong J, Voors AA, Lam CSP, Richards AM, Tromp J Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: A phenomics approach. Eur J Heart Fail. 2024 Apr;26(4):841-850. doi: 10.1002/ejhf.3156. Epub 2024 Feb 4.
  • Connors JM, Ariens RAS Uncertainties about the roles of anticoagulation and microclots in post-acute sequelae of SARS-CoV-2 infection-response to the letter by Kell et al. J Thromb Haemost. 2024 Feb;22(2):569-571. doi: 10.1016/j.jtha.2023.11.005.
  • Ozaki Y, Hong SJ, Heg D, Frigoli E, Vranckx P, Morice MC, Chevalier B, Onuma Y, Windecker S, Di Biasi M, Whitbourn R, Dudek D, Raffel OC, Shimizu K, Calabro P, Frobert O, Cura F, Berg JT, Smits PC, Valgimigli M Geographical Variations in the Effectiveness and Safety of Abbreviated or Standard Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients at High Bleeding Risk. Can J Cardiol. 2024 Sep;40(9):1671-1674. doi: 10.1016/j.cjca.2024.01.032. Epub 2024 Feb 2.
  • Maher TR, Raza AS, Tapias C, Garcia F, Reynolds MR, Chaudry GM, Saenz LC, Valderrabano M, d’Avila A Ventricular septal defect as a complication of bipolar radiofrequency ablation for ventricular tachycardia. Heart Rhythm. 2024 Jun;21(6):950-955. doi: 10.1016/j.hrthm.2024.01.052. Epub 2024 Feb 1.
  • Prandoni P, Haas S, Fluharty M, Schellong S, Goto S, MacCallum P, Tse E, Pieper K, Kayani G, Kakkar A, GARFIELD-VTE investigators Incidence and risk factors of post-thrombotic syndrome in patients with isolated calf vein thrombosis. Findings from the GARFIELD-VTE registry. Thromb Res. 2024 Mar;235:75-78. doi: 10.1016/j.thromres.2024.01.023. Epub 2024 Feb 1.
  • Kanbay M, Copur S, Bakir CN, Covic A, Ortiz A, Tuttle KR Glomerular hyperfiltration as a therapeutic target for CKD. Nephrol Dial Transplant. 2024 Jul 31;39(8):1228-1238. doi: 10.1093/ndt/gfae027.
  • Campos-Franco DR, Gonzalez-Pacheco H, Arias-Mendoza A [Correlation of left ventricular contractile function with the presence of collateral coronary circulation in non-reperfused acute myocardial infarction]. Arch Cardiol Mex. 2024 Feb 2;94(3):286-291. doi: 10.24875/ACM.23000084.
  • Sanchez-Amaya DJ, Gutierrez-Castaneda MD, Araiza-Garaygordobil D, Arias-Mendoza A Multiple pulmonary aneurysms and infective endocarditis as initial presentation of persistent ductus arteriosus. Arch Cardiol Mex. 2024 Feb 2;94(2):240-242. doi: 10.24875/ACM.23000058.
  • Averbuch T, Lee SF, Zagorski B, Mebazaa A, Fonarow GC, Thabane L, Van Spall HGC Effect of a transitional care model following hospitalization for heart failure: 3-year outcomes of the Patient-Centered Care Transitions in Heart Failure (PACT-HF) randomized controlled trial. Eur J Heart Fail. 2024 Mar;26(3):652-660. doi: 10.1002/ejhf.3134. Epub 2024 Feb 1.
  • Januzzi JL, Del Prato S, Rosenstock J, Butler J, Ezekowitz J, Ibrahim NE, Lam CSP, Marwick T, Wilson Tang WH, Liu Y, Mohebi R, Urbinati A, Zannad F, Perfetti R Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial. Cardiovasc Diabetol. 2024 Feb 1;23(1):49. doi: 10.1186/s12933-024-02135-z.
  • Eisenstein EL, Hill KD, Wood N, Kirchner JL, Anstrom KJ, Granger CB, Rao SV, Baldwin HS, Jacobs JP, Jacobs ML, Kannankeril PJ, Graham EM, O’Brien SM, Li JS Evaluating registry-based trial economics: Results from the STRESS clinical trial. Contemp Clin Trials Commun. 2024 Jan 10;38:101257. doi: 10.1016/j.conctc.2024.101257. eCollection 2024 Apr.
  • Ren QW, Katherine Teng TH, Tse YK, Wei Tsang CT, Yu SY, Wu MZ, Li XL, Hung D, Tse HF, Lam CSP, Yiu KH Statins and risks of dementia among patients with heart failure: a population-based retrospective cohort study in Hong Kong. Lancet Reg Health West Pac. 2024 Jan 17;44:101006. doi: 10.1016/j.lanwpc.2023.101006. eCollection 2024 Mar.
  • Segar MW, Pandey A Understanding the language of the heart: The promise of natural language processing to diagnose heart failure with preserved ejection fraction. Eur J Heart Fail. 2024 Feb;26(2):311-313. doi: 10.1002/ejhf.3154. Epub 2024 Jan 31.
  • Parikh PB, Mack M, Stone GW, Anker SD, Gilchrist IC, Kalogeropoulos AP, Packer M, Skopicki HA, Butler J Transcatheter aortic valve replacement in heart failure. Eur J Heart Fail. 2024 Feb;26(2):460-470. doi: 10.1002/ejhf.3151. Epub 2024 Jan 31.
  • Nicholls SJ Integrating lipoprotein(a) into preventive cardiology: probably important to get the measurement right. Eur J Prev Cardiol. 2024 May 11;31(7):901-902. doi: 10.1093/eurjpc/zwae037.
  • Abrahams T, Nelson AJ, Nicholls SJ How Will Our Practice Change After the CLEAR Outcomes Trial? Curr Atheroscler Rep. 2024 Mar;26(3):83-89. doi: 10.1007/s11883-024-01188-5. Epub 2024 Jan 31.
  • van Diepen S, Zheng Y, Senaratne JM, Tyrrell BD, Das D, Thiele H, Henry TD, Bainey KR, Welsh RC Reperfusion in Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock and Prolonged Interhospital Transport Times. Circ Cardiovasc Interv. 2024 Feb;17(2):e013415. doi: 10.1161/CIRCINTERVENTIONS.123.013415. Epub 2024 Jan 31.
  • Aaron RE, Tian T, Fleming GA, Sacks DB, Januzzi JL Jr, Facc MD, Pop-Busui R, Hashim IA, Wu AHB, Pandey A, Klonoff DC Emerging Biomarkers in the Laboratory and in Practice: A Novel Approach to Diagnosing Heart Failure in Diabetes. J Diabetes Sci Technol. 2024 May;18(3):733-740. doi: 10.1177/19322968241227898. Epub 2024 Jan 31.
  • Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan GA, Dweck MR, Galbraith M, Gilard M, Hinterbuchner L, Jankowska EA, Juni P, Kimura T, Kunadian V, Leosdottir M, Lorusso R, Pedretti RFE, Rigopoulos AG, Rubini Gimenez M, Thiele H, Vranckx P, Wassmann S, Wenger NK, Ibanez B, ESC Scientific Document Group [2023 ESC Guidelines for the management of acute coronary syndromes]. G Ital Cardiol (Rome). 2024 Feb;25(2 Suppl 2):e1-e112. doi: 10.1714/4191.41785.
  • Kostick-Quenet KM, Lang B, Dorfman N, Estep J, Mehra MR, Bhimaraj A, Civitello A, Jorde U, Trachtenberg B, Uriel N, Kaplan H, Gilmore-Szott E, Volk R, Kassi M, Blumenthal-Barby JS Patients’ and physicians’ beliefs and attitudes towards integrating personalized risk estimates into patient education about left ventricular assist device therapy. Patient Educ Couns. 2024 May;122:108157. doi: 10.1016/j.pec.2024.108157. Epub 2024 Jan 24.
  • Rowin EJ, Wadid M, Maron MS, White M, Hook BG, Harnish P, Silver JS, Reynolds MR, Maron BJ Assessing the impact of atrial fibrillation on symptoms and quality of life in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2024 Apr;35(4):654-663. doi: 10.1111/jce.16192. Epub 2024 Jan 30.
  • Lehrke M, Vogt A, Schettler V, Girndt M, Fraass U, Tabbert-Zitzler A, Bridges I, Dhalwani NN, Ray KK Evolocumab-Based LDL-C Management in High and Very High Cardiovascular Risk Patients in German Clinical Practice: The HEYMANS Study. Adv Ther. 2024 Mar;41(3):1184-1200. doi: 10.1007/s12325-023-02757-x. Epub 2024 Jan 30.
  • Watson NW, Carroll BJ, Krawisz A, Schmaier A, Secemsky EA Trends in Discharge Rates for Acute Pulmonary Embolism in U.S. Emergency Departments. Ann Intern Med. 2024 Feb;177(2):134-143. doi: 10.7326/M23-2442. Epub 2024 Jan 30.
  • Corcoran DM, Kovacevic MP, Dell’Orfano H, Sylvester KW, Connors JM Impact of as Needed Heparin Boluses on Supratherapeutic Activated Partial Thromboplastin Time in Patients Managed With Extracorporeal Membrane Oxygenation. Crit Pathw Cardiol. 2024 Sep 1;23(3):159-165. doi: 10.1097/HPC.0000000000000347. Epub 2024 Jan 29.
  • Levin L, Sheldon M, McDonough RS, Aronson N, Rovers M, Gibson CM, Tunis SR, Kuntz RE Early technology review: towards an expedited pathway. Int J Technol Assess Health Care. 2024 Jan 29;40(1):e13. doi: 10.1017/S0266462324000047.
  • Nguyen T, Zuin M, Ngo K, Gibson CM Myocardial Infarction During SARS-CoV-2 Infection: Another Piece in the Long-COVID Puzzle. Am J Cardiol. 2024 Mar 15;215:92-93. doi: 10.1016/j.amjcard.2024.01.013. Epub 2024 Jan 24.
  • Sridhar VS, Bhatt DL, Odutayo A, Szarek M, Davies MJ, Banks P, Pitt B, Steg PG, Cherney DZI Sotagliflozin and Kidney Outcomes, Kidney Function, and Albuminuria in Type 2 Diabetes and CKD: A Secondary Analysis of the SCORED Trial. Clin J Am Soc Nephrol. 2024 May 1;19(5):557-564. doi: 10.2215/CJN.0000000000000414. Epub 2024 Jan 26.
  • Myhre PL, Lam CSP Angiotensin Receptor Neprilysin Inhibition Across Ejection Fraction and Acuity Spectra in Heart Failure. JACC Heart Fail. 2024 Mar;12(3):583-587. doi: 10.1016/j.jchf.2023.11.021. Epub 2024 Jan 24.
  • Mentias A, Desai MY, Aminian A, Patel KV, Keshvani N, Verma S, Cho L, Jacob M, Alvarez P, Lincoff AM, Van Spall HGC, Lam CSP, Butler J, Nissen SE, Pandey A Trends and Outcomes Associated With Bariatric Surgery and Pharmacotherapies With Weight Loss Effects Among Patients With Heart Failure and Obesity. Circ Heart Fail. 2024 Feb;17(2):e010453. doi: 10.1161/CIRCHEARTFAILURE.122.010453. Epub 2024 Jan 26.
  • Vranckx P, Morrow DA, van Diepen S, Verbrugge FH Acute cardiovascular and intensive care chronicles: ‘inception revealed-navigating the veno-arterial extracorporeal membrane oxygenation terrain and beyond’. Eur Heart J Acute Cardiovasc Care. 2024 Feb 16;13(2):189-190. doi: 10.1093/ehjacc/zuae008.
  • Galli M, Occhipinti G, Angiolillo DJ Aspirin hypersensitivity and intolerance. Eur Heart J Cardiovasc Pharmacother. 2024 May 4;10(3):173-174. doi: 10.1093/ehjcvp/pvae008.
  • Vardeny O, Desai AS, Jhund PS, Fang JC, Claggett B, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez FA, Shah SJ, Mc Causland FR, Petrie MC, Vaduganathan M, McMurray JJV, Solomon SD Dapagliflozin and Mode of Death in Heart Failure With Improved Ejection Fraction: A Post Hoc Analysis of the DELIVER Trial. JAMA Cardiol. 2024 Mar 1;9(3):283-289. doi: 10.1001/jamacardio.2023.5318.
  • Sterling KM, Goldhaber SZ, Sharp ASP, Kucher N, Jones N, Maholic R, Meneveau N, Zlotnick D, Sayfo S, Konstantinides SV, Piazza G Prospective Multicenter International Registry of Ultrasound-Facilitated Catheter-Directed Thrombolysis in Intermediate-High and High-Risk Pulmonary Embolism (KNOCOUT PE). Circ Cardiovasc Interv. 2024 Mar;17(3):e013448. doi: 10.1161/CIRCINTERVENTIONS.123.013448. Epub 2024 Jan 24.
  • Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Barone Gibbs B, Beaton AZ, Boehme AK, Commodore-Mensah Y, Currie ME, Elkind MSV, Evenson KR, Generoso G, Heard DG, Hiremath S, Johansen MC, Kalani R, Kazi DS, Ko D, Liu J, Magnani JW, Michos ED, Mussolino ME, Navaneethan SD, Parikh NI, Perman SM, Poudel R, Rezk-Hanna M, Roth GA, Shah NS, St-Onge MP, Thacker EL, Tsao CW, Urbut SM, Van Spall HGC, Voeks JH, Wang NY, Wong ND, Wong SS, Yaffe K, Palaniappan LP, American Heart Association Council on Epidemiology and Prevention Statistics, Committee and Stroke Statistics Subcommittee 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2024 Feb 20;149(8):e347-e913. doi: 10.1161/CIR.0000000000001209. Epub 2024 Jan 24.
  • Al Said S, Kaier K, Sumaya W, Alsaid D, Duerschmied D, Storey RF, Gibson CM, Westermann D, Alabed S Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis. Cochrane Database Syst Rev. 2024 Jan 24;1(1):CD014678. doi: 10.1002/14651858.CD014678.pub2.
  • Myhre PL, Hung CL, Frost MJ, Jiang Z, Ouwerkerk W, Teramoto K, Svedlund S, Saraste A, Hage C, Tan RS, Beussink-Nelson L, Fermer ML, Gan LM, Hummel YM, Lund LH, Shah SJ, Lam CSP, Tromp J External validation of a deep learning algorithm for automated echocardiographic strain measurements. Eur Heart J Digit Health. 2023 Nov 20;5(1):60-68. doi: 10.1093/ehjdh/ztad072. eCollection 2024 Jan.
  • Ali N, Aktaa S, Younsi T, Beska B, Batra G, Blackman DJ, James S, Ludman P, Mamas MA, Abdel-Wahab M, Borregaard B, Iung B, Joner M, Kunadian V, Modine T, Neylon A, Petronio AS, Pibarot P, Popescu BA, Sabate M, Stortecky S, Teles RC, Treede H, Gale CP European Society of Cardiology quality indicators for the care and outcomes of adults undergoing transcatheter aortic valve implantation. Eur Heart J Qual Care Clin Outcomes. 2024 Dec 19;10(8):723-736. doi: 10.1093/ehjqcco/qcae006.
  • Ortega-Paz L, Bonaca M, Angiolillo DJ Optimizing LDL-cholesterol management in ACS patients: Breaking inertia and implementing intensified therapies. Int J Cardiol. 2024 Apr 1;400:131803. doi: 10.1016/j.ijcard.2024.131803. Epub 2024 Jan 21.
  • Bansal S, Boucher R, Shen J, Wei G, Chertow GM, Whelton PK, Cushman WC, Cheung AK, Beddhu S, , on behalf of SPRINT Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial: A Post Hoc Analysis. Clin J Am Soc Nephrol. 2024 May 1;19(5):620-627. doi: 10.2215/CJN.0000000000000406. Epub 2024 Jan 23.
  • Sumarsono A, Xie L, Keshvani N, Zhang C, Patel L, Alonso WW, Thibodeau JT, Fonarow GC, Van Spall HGC, Messiah SE, Pandey A Sex Disparities in Longitudinal Use and Intensification of Guideline-Directed Medical Therapy Among Patients With Newly Diagnosed Heart Failure With Reduced Ejection Fraction. Circulation. 2024 Feb 13;149(7):510-520. doi: 10.1161/CIRCULATIONAHA.123.067489. Epub 2024 Jan 23.
  • Sherratt SCR, Mason RP, Libby P, Steg PG, Bhatt DL Do patients benefit from omega-3 fatty acids? Cardiovasc Res. 2024 Feb 17;119(18):2884-2901. doi: 10.1093/cvr/cvad188.
  • Petrie MC, Rouleau JL, Claggett B, Jering K, van der Meer P, Kober L, Miao ZM, Lewis E, Granger C, De Pasqulae CG, Mann D, Steg PG, Maggioni A, Amir O, Lefkowitz M, Braunwald E, Solomon SD, McMurray JJV, Pfeffer MA Pulmonary Congestion and Left Ventricular Dysfunction After Myocardial Infarction: Insights From the PARADISE-MI Trial. Circulation. 2024 Jan 23;149(4):335-338. doi: 10.1161/CIRCULATIONAHA.123.066163. Epub 2024 Jan 22.
  • Sayah N, Bhatt DL, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Jiao L, Pineda AL, Doyle RT Jr, Tardif JC, Ballantyne CM, Steg PG Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial. Eur Heart J. 2024 Apr 1;45(13):1173-1176. doi: 10.1093/eurheartj/ehad889.
  • Harrington J, Mentz RJ, Rockhold FW, Garg J, Butler J, De Pasquale CG, Ezekowitz JA, Lewis GD, O’Meara E, Ponikowski P, Troughton RW, Wong YW, Adamczyk R, Storie T, Blackman N, Hernandez AF Hierarchical End Points in Prior Heart Failure Trials and the HEART-FID Trial. Circ Heart Fail. 2024 Feb;17(2):e010676. doi: 10.1161/CIRCHEARTFAILURE.123.010676. Epub 2024 Jan 22.
  • Rastogi T, Ferreira JP, Butler J, Kraus BJ, Mattheus M, Brueckmann M, Filippatos G, Wanner C, Pocock SJ, Packer M, Anker SD, Zannad F Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Preserved. Eur J Heart Fail. 2024 Apr;26(4):885-896. doi: 10.1002/ejhf.3136. Epub 2024 Jan 21.
  • Gulati M, Michos ED, Boden WE, Guyton JR JCL roundtable: Evolution of preventive cardiology and clinical lipidology. J Clin Lipidol. 2024 Jan-Feb;18(1):e10-e20. doi: 10.1016/j.jacl.2023.12.004. Epub 2023 Dec 15.
  • Shahid I, Khan MS, Fonarow GC, Butler J, Greene SJ Bridging gaps and optimizing implementation of guideline-directed medical therapy for heart failure. Prog Cardiovasc Dis. 2024 Jan-Feb;82:61-69. doi: 10.1016/j.pcad.2024.01.008. Epub 2024 Jan 18.
  • Krychtiuk KA, Andersson TL, Bodesheim U, Butler J, Curtis LH, Elkind M, Hernandez AF, Hornik C, Lyman GH, Khatri P, Mbagwu M, Murakami M, Nichols G, Roessig L, Young AQ, Schilsky RL, Pagidipati N Drug development for major chronic health conditions-aligning with growing public health needs: Proceedings from a multistakeholder think tank. Am Heart J. 2024 Apr;270:23-43. doi: 10.1016/j.ahj.2024.01.004. Epub 2024 Jan 17.
  • Akhtar KH, Khan MS, Baron SJ, Zieroth S, Estep J, Burkhoff D, Butler J, Fudim M The spectrum of post-myocardial infarction care: From acute ischemia to heart failure. Prog Cardiovasc Dis. 2024 Jan-Feb;82:15-25. doi: 10.1016/j.pcad.2024.01.017. Epub 2024 Jan 17.
  • Foley KM, Kennedy KF, Lima FV, Secemsky EA, Banerjee S, Goodney PP, Shishehbor MH, Soukas PA, Hyder ON, Abbott JD, Aronow HD Treatment Variability Among Patients Hospitalized for Chronic Limb-Threatening Ischemia: An Analysis of the 2016 to 2018 US National Inpatient Sample. J Am Heart Assoc. 2024 Feb 6;13(3):e030899. doi: 10.1161/JAHA.123.030899. Epub 2024 Jan 19.
  • Wasfy JH, Price M, Normand ST, Januzzi JL Jr, McCarthy CP, Hsu J Classification Algorithm to Distinguish Between Type 1 and Type 2 Myocardial Infarction in Administrative Claims Data. Circ Cardiovasc Qual Outcomes. 2024 Feb;17(2):e009986. doi: 10.1161/CIRCOUTCOMES.123.009986. Epub 2024 Jan 19.
  • Singh S, Garg A, Tantry US, Bliden K, Gurbel PA, Gulati M Safety and efficacy of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or obese non-diabetic patients. Curr Probl Cardiol. 2024 Mar;49(3):102403. doi: 10.1016/j.cpcardiol.2024.102403. Epub 2024 Jan 17.
  • Greene SJ, Khan MS, Butler J Why do clinicians not prescribe quadruple medical therapy for heart failure with reduced ejection fraction? Eur J Heart Fail. 2024 Feb;26(2):338-341. doi: 10.1002/ejhf.3133. Epub 2024 Jan 18.
  • Usman MS, Januzzi JL, Anker SD, Salman A, Parikh PB, Adamo M, Filippatos G, Khan MS, Lala A, Verma S, Metra M, Butler J The effect of sodium-glucose cotransporter 2 inhibitors on left cardiac remodelling in heart failure with reduced ejection fraction: Systematic review and meta-analysis. Eur J Heart Fail. 2024 Feb;26(2):373-382. doi: 10.1002/ejhf.3129. Epub 2024 Jan 18.
  • Bejjani A, Khairani CD, Assi A, Piazza G, Sadeghipour P, Talasaz AH, Fanikos J, Connors JM, Siegal DM, Barnes GD, Martin KA, Angiolillo DJ, Kleindorfer D, Monreal M, Jimenez D, Middeldorp S, Elkind MSV, Ruff CT, Goldhaber SZ, Krumholz HM, Mehran R, Cushman M, Eikelboom JW, Lip GYH, Weitz JI, Lopes RD, Bikdeli B When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024 Jan 23;83(3):444-465. doi: 10.1016/j.jacc.2023.10.038.
  • Bergler-Klein J, Gotcheva N, Kalejs O, Kalarus Z, Kovacic D, Persic V, Shlyakhto E, Uuetoa T, Huisman MV, Lip GYH, Vinereanu D, GLORIA-AF Investigators Antithrombotic Usage, Including Three-Year Outcomes With Dabigatran and Vitamin K Antagonists for Atrial Fibrillation, in Eastern Europe: A Descriptive Analysis From Phase 3 of the GLORIA-AF Registry. Am J Ther. 2024 Jan-Feb 01;31(1):e1-e12. doi: 10.1097/MJT.0000000000001655. Epub 2023 Jan 10.
  • Nicholls SJ, Nelson AJ, Lincoff AM, Brennan D, Ray KK, Cho L, Menon V, Li N, Bloedon L, Nissen SE Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical Trial. JAMA Cardiol. 2024 Mar 1;9(3):245-253. doi: 10.1001/jamacardio.2023.5155.
  • Costabel JP, Quintana M, Perea J, Lamelas P, Candiello A, Sanhueza P, Arias-Mendoza A, Saavedra I, Rivera-Toquica A, de Castro ML, Alvarez-Gaviria M, Belardi J, Cequier A, Sosa-Liprandi A, Villarreal R [Position statement for improvement in reperfusion of ST-elevation myocardial infarction in Latin America]. Arch Cardiol Mex. 2024 Jan 16;94(2):208-218. doi: 10.24875/ACM.23000045.
  • Weyhenmeyer JA, Peterson ED, Beam C, Wayte P, Marvel FA, Bakken S, Sandhu A, Nallamothu B, Martin S, Beaton A, Au R, Brown NA American Heart Association Focusing Research Rigor on Digital Health. J Am Heart Assoc. 2024 Jan 16;13(2):e032870. doi: 10.1161/JAHA.123.032870. Epub 2024 Jan 16.
  • Cusick MM, Tisdale RL, Chertow GM, Owens DK, Goldhaber-Fiebert JD Population-Wide Screening for Chronic Kidney Disease. Ann Intern Med. 2024 Jan;177(1):eL230370. doi: 10.7326/L23-0370.
  • Polyak A, Wei J, Gulati M, Merz NB Clinical aspects of ischemia with no obstructive coronary artery disease (INOCA). Am Heart J Plus. 2024 Jan;37:100352. doi: 10.1016/j.ahjo.2023.100352. Epub 2023 Dec 6.
  • Misfeld M, Sandner S, Caliskan E, Boning A, Aramendi J, Salzberg SP, Choi YH, Perrault LP, Tekin I, Cuerpo GP, Lopez-Menendez J, Weltert LP, Adsuar-Gomez A, Thielmann M, Serraino GF, Doros G, Borger MA, Emmert MY, European DuraGraft Registry investigators Outcomes after surgical revascularization in diabetic patients. Interdiscip Cardiovasc Thorac Surg. 2024 Feb 2;38(2):ivae014. doi: 10.1093/icvts/ivae014.
  • Felker GM, Solomon SD, Metra M, Mcmurray JJV, Diaz R, Claggett B, Lanfear DE, Vandekerckhove H, Biering-Sorensen T, Lopes RD, Arias-Mendoza A, Momomura SI, Corbalan R, Ramires FJA, Zannad F, Heitner SB, Divanji PH, Kupfer S, Malik FI, Teerlink JR Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study. J Card Fail. 2024 Jun;30(6):755-763. doi: 10.1016/j.cardfail.2023.11.021. Epub 2024 Jan 11.
  • Vijay A, Yancy CW Health equity in heart failure. Prog Cardiovasc Dis. 2024 Jan-Feb;82:55-60. doi: 10.1016/j.pcad.2024.01.005. Epub 2024 Jan 10.
  • Levy JH, Sniecinski RM, Maier CL, Despotis GJ, Ghadimi K, Helms J, Ranucci M, Steiner ME, Tanaka KA, Connors JM Finding a common definition of heparin resistance in adult cardiac surgery: communication from the ISTH SSC subcommittee on perioperative and critical care thrombosis and hemostasis. J Thromb Haemost. 2024 Apr;22(4):1249-1257. doi: 10.1016/j.jtha.2024.01.001. Epub 2024 Jan 11.
  • Foley MJ, Rajkumar CA, Ahmed-Jushuf F, Simader F, Pathimagaraj RH, Nijjer S, Sen S, Petraco R, Clesham G, Johnson T, Harrell FE Jr, Kellman P, Francis D, Shun-Shin M, Howard J, Cole GD, Al-Lamee R A double-blind, randomised, placebo-controlled trial of the coronary sinus Reducer in refractory angina: design and rationale of the ORBITA-COSMIC trial. EuroIntervention. 2024 Feb 5;20(3):e216-e223. doi: 10.4244/EIJ-D-23-00567.
  • Cutlip DE Acute Inflammatory Markers and Early Stent Thrombosis: Association or Causation? J Am Heart Assoc. 2024 Jan 16;13(2):e033592. doi: 10.1161/JAHA.123.033592. Epub 2024 Jan 12.
  • Kornowski R, Konigstein M, Jonas M, Assali A, Vaknin-Assa H, Segev A, Danenberg H, Halabi M, Roguin A, Kerner A, Lev E, Karamasis GV, Johnson TW, Anderson R, Blaxill J, Jadhav S, Hoole S, Witberg G, Issever MO, Ben-Yehuda O, Baumbach A Percutaneous Coronary Interventions Using a Ridaforolimus-Eluting Stent in Patients at High Bleeding Risk. J Am Heart Assoc. 2024 Jan 16;13(2):e029051. doi: 10.1161/JAHA.122.029051. Epub 2024 Jan 12.
  • Neumiller JJ, Alicic RZ, Tuttle KR Optimization of guideline-directed medical therapies in patients with diabetes and chronic kidney disease. Clin Kidney J. 2023 Nov 16;17(1):sfad285. doi: 10.1093/ckj/sfad285. eCollection 2024 Jan.
  • Abohashem S, Nasir K, Munir M, Sayed A, Aldosoky W, Abbasi T, Michos ED, Gulati M, Rana JS Lack of leisure time physical activity and variations in cardiovascular mortality across US communities: a comprehensive county-level analysis (2011-2019). Br J Sports Med. 2024 Feb 9;58(4):204-212. doi: 10.1136/bjsports-2023-107220.
  • Secemsky EA, Aronow HD, Kwolek CJ, Meissner M, Muck PE, Parikh SA, Winokur RS, George JC, Salazar G, Murphy EH, Costantino MM, Zhou W, Li J, Lookstein R, Desai KR Intravascular Ultrasound Use in Peripheral Arterial and Deep Venous Interventions: Multidisciplinary Expert Opinion From SCAI/AVF/AVLS/SIR/SVM/SVS. J Vasc Interv Radiol. 2024 Mar;35(3):335-348. doi: 10.1016/j.jvir.2023.11.006. Epub 2024 Jan 9.
  • Saha S, Keshvani N, Segar MW, Patel KV, Fudim M, Rohatgi A, Ayers C, VanWagner LB, Rao VN, Drazner MH, Garg S, Singal AG, Rich NE, Browning JD, Neeland IJ, Pandey A Association of Hepatic Triglyceride Content With Cardiac Structure and Function Among Community-Dwelling Adults. JACC Heart Fail. 2024 May;12(5):958-960. doi: 10.1016/j.jchf.2023.10.016. Epub 2024 Jan 10.
  • Diamond JE, Kaltenbach LA, Granger BB, Fonarow GC, Al-Khalidi HR, Albert NM, Butler J, Allen LA, Lanfear DE, Thibodeau JT, Granger CB, Hernandez AF, Ariely D, DeVore AD Access to Mobile Health Interventions Among Patients Hospitalized With Heart Failure: Insights Into the Digital Divide From the CONNECT-HF mHealth Substudy. Circ Heart Fail. 2024 Feb;17(2):e011140. doi: 10.1161/CIRCHEARTFAILURE.123.011140. Epub 2024 Jan 11.
  • Herrera CJ, Saldarriaga C, Feliz E, Bacal F, Pina P, Arias-Mendoza A Heart Failure in Latin American Women: A Call for Action. J Card Fail. 2024 Mar;30(3):505-508. doi: 10.1016/j.cardfail.2023.12.013. Epub 2024 Jan 8.
  • Patel L, Dhruve R, Keshvani N, Pandey A Role of exercise therapy and cardiac rehabilitation in heart failure. Prog Cardiovasc Dis. 2024 Jan-Feb;82:26-33. doi: 10.1016/j.pcad.2024.01.002. Epub 2024 Jan 9.
  • Tuttle KR, Abner CW, Walker PD, Wang K, Rava A, Heo J, Bunke M Clinical Characteristics and Histopathology in Adults With Focal Segmental Glomerulosclerosis. Kidney Med. 2023 Nov 27;6(2):100748. doi: 10.1016/j.xkme.2023.100748. eCollection 2024 Feb.
  • Cohen AT, Creeper KJ, Alikhan R, Er C, Connors JM, Huisman MV, Munoz A, Vescovo G, Bauersachs R, Ageno W, Agnelli G, Becattini C Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer. Thromb Haemost. 2024 Jul;124(7):676-683. doi: 10.1055/s-0043-1778642. Epub 2024 Jan 9.
  • Nadarajah R, Ludman P, Laroche C, Appelman Y, Brugaletta S, Budaj A, Bueno H, Huber K, Kunadian V, Leonardi S, Lettino M, Milasinovic D, Ajjan R, Marx N, Gale CP Diabetes mellitus and presentation, care and outcomes of patients with NSTEMI: the Association for Acute Cardiovascular Care-European Association of Percutaneous Cardiovascular Interventions EURObservational Research Programme NSTEMI Registry of the European Society of Cardiology. Eur Heart J Qual Care Clin Outcomes. 2024 Dec 19;10(8):709-722. doi: 10.1093/ehjqcco/qcae002.
  • Khan MS, Sperry BW, Butler J Kidney involvement in transthyretin cardiac amyloidosis – Role of urinary albumin to creatinine ratio and need for further evidence generation. Eur J Heart Fail. 2024 Jan;26(1):74-76. doi: 10.1002/ejhf.3127. Epub 2024 Jan 8.
  • Garcia LP, Liu S, Lenihan CR, Montez-Rath ME, Chang TI, Winkelmayer WC, Khairallah P Dialysis Modality, Transplant Characteristics, and Incident Atrial Fibrillation After Kidney Transplant: An Observational Study Using USRDS Data. Kidney Med. 2023 Oct 12;6(1):100741. doi: 10.1016/j.xkme.2023.100741. eCollection 2024 Jan.
  • Rhee JJ, Han J, Montez-Rath ME, Chertow GM Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease. Diabetes Obes Metab. 2024 Apr;26(4):1273-1281. doi: 10.1111/dom.15427. Epub 2024 Jan 8.
  • Sardella G, Spirito A, Sartori S, Angiolillo DJ, Vranckx P, Hernandez JMT, Krucoff MW, Bangalore S, Bhatt DL, Campo G, Cao D, Chehab BM, Choi JW, Feng Y, Ge J, Godfrey K, Hermiller J, Kunadian V, Makkar RR, Maksoud A, Neumann FJ, Picon H, Saito S, Thiele H, Toelg R, Varenne O, Vogel B, Zhou Y, Valgimigli M, Windecker S, Mehran R 1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global Program. Am J Cardiol. 2024 Mar 1;214:94-104. doi: 10.1016/j.amjcard.2023.12.049. Epub 2024 Jan 6.
  • Greene SJ, Butler J, Kosiborod MN Chapter 3: Clinical Trials of Sodium-Glucose Co-Transporter-2 Inhibitors for Treatment of Heart Failure. Am J Med. 2024 Feb;137(2S):S25-S34. doi: 10.1016/j.amjmed.2023.04.019.
  • Sudano I, Krahenbuhl S, Mach F, Anstett A, Dhalwani N, Bridges I, Sibartie M, Ray KK Evolocumab use in clinical practice in Switzerland: final data of the observational HEYMANS cohort study. Ther Adv Cardiovasc Dis. 2024 Jan-Dec;18:17539447231213288. doi: 10.1177/17539447231213288.
  • Bikdeli B, Sadeghipour P, Lou J, Bejjani A, Khairani CD, Rashedi S, Lookstein R, Lansky A, Vedantham S, Sobieszczyk P, Mena-Hurtado C, Aghayev A, Henke P, Mehdipoor G, Tufano A, Chatterjee S, Middeldorp S, Wasan S, Bashir R, Lang IM, Shishehbor MH, Gerhard-Herman M, Giri J, Menard MT, Parikh SA, Mazzolai L, Moores L, Monreal M, Jimenez D, Goldhaber SZ, Krumholz HM, Piazza G Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review. Semin Thromb Hemost. 2024 Sep;50(6):851-865. doi: 10.1055/s-0043-1777991. Epub 2024 Jan 4.
  • Kobayashi T, Pugliese S, Sethi SS, Parikh SA, Goldberg J, Alkhafan F, Vitarello C, Rosenfield K, Lookstein R, Keeling B, Klein A, Gibson CM, Glassmoyer L, Khandhar S, Secemsky E, Giri J Contemporary Management and Outcomes of Patients With High-Risk Pulmonary Embolism. J Am Coll Cardiol. 2024 Jan 2;83(1):35-43. doi: 10.1016/j.jacc.2023.10.026.
  • Ikram A, Sharma R, Selim M, Kim-Sun G, Shahraki T, Thomas AJ, Filippidis A, Wen Y, Spincemaille P, Wang Y, Soman S mcTFI QSM MRI ABC/2 intracranial hemorrhage to noncontrast head CT volume measurement equivalence. J Neurol Sci. 2024 Jan 15;456:122859. doi: 10.1016/j.jns.2023.122859. Epub 2023 Dec 30.
  • Landi A, Aboyans V, Angiolillo DJ, Atar D, Capodanno D, Fox KAA, Halvorsen S, James S, Juni P, Leonardi S, Mehran R, Montalescot G, Navarese EP, Niebauer J, Oliva A, Piccolo R, Price S, Storey RF, Voller H, Vranckx P, Windecker S, Valgimigli M Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelines. Eur Heart J Acute Cardiovasc Care. 2024 Feb 9;13(1):173-180. doi: 10.1093/ehjacc/zuad158.
  • Schuermans A, Truong B, Ardissino M, Bhukar R, Slob EAW, Nakao T, Dron JS, Small AM, Cho SMJ, Yu Z, Hornsby W, Antoine T, Lannery K, Postupaka D, Gray KJ, Yan Q, Butterworth AS, Burgess S, Wood MJ, Scott NS, Harrington CM, Sarma AA, Lau ES, Roh JD, Januzzi JL Jr, Natarajan P, Honigberg MC Genetic Associations of Circulating Cardiovascular Proteins With Gestational Hypertension and Preeclampsia. JAMA Cardiol. 2024 Mar 1;9(3):209-220. doi: 10.1001/jamacardio.2023.4994.
  • Marx N, Kolkailah AA, Rosenstock J, Johansen OE, Cooper ME, Alexander JH, Toto RD, Wanner C, Espeland MA, Mattheus M, Schnaidt S, Perkovic V, Gollop ND, McGuire DK Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin: A Secondary Analysis of Randomized Clinical Trials. JAMA Cardiol. 2024 Feb 1;9(2):134-143. doi: 10.1001/jamacardio.2023.4602.
  • Kaur G, Mason RP, Steg PG, Bhatt DL Omega-3 fatty acids for cardiovascular event lowering. Eur J Prev Cardiol. 2024 Jun 3;31(8):1005-1014. doi: 10.1093/eurjpc/zwae003.
  • McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, Cleland JGF, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, Authors/Task Force Members:, ESC Scientific Document Group 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2024 Jan;26(1):5-17. doi: 10.1002/ejhf.3024. Epub 2024 Jan 3.
  • Vranckx P, Morrow D, van Diepen S, Verbrugge F As we reflect on the year 2023……. Eur Heart J Acute Cardiovasc Care. 2024 Feb 9;13(1):1. doi: 10.1093/ehjacc/zuad137.
  • Correa-Rotter R, Maple-Brown LJ, Sahay R, Tuttle KR, Ulasi II New and emerging therapies for diabetic kidney disease. Nat Rev Nephrol. 2024 Mar;20(3):156-160. doi: 10.1038/s41581-023-00782-1. Epub 2024 Jan 2.
  • Steg PG, Feldman LJ, Omerovic E Observational studies play little role in guiding evidence-based medicine: pros and cons. EuroIntervention. 2024 Jan 1;20(1):29-31. doi: 10.4244/EIJ-E-23-00023.
  • Goldberg AC, Soffer D, Ballantyne C, Gulati M, Shapiro M NLA/ASPC response to the USPSTF recommendation statement on screening lipid panel in children and adolescents. Am J Prev Cardiol. 2023 Dec 7;17:100628. doi: 10.1016/j.ajpc.2023.100628. eCollection 2024 Mar.
  • Coats AJS, Butler J, Tsutsui H, Doehner W, Filippatos G, Ferreira JP, Bohm M, Chopra VK, Verma S, Nordaby M, Iwata T, Nitta D, Ponikowski P, Zannad F, Packer M, Anker SD Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR-Preserved. J Cachexia Sarcopenia Muscle. 2024 Feb;15(1):412-424. doi: 10.1002/jcsm.13393. Epub 2023 Dec 29.
  • Greene SJ, Fonarow GC, Butler J SGLT2 Inhibitors for Heart Failure with Preserved Ejection Fraction: What Hospitalists Need to Know. Am J Cardiovasc Drugs. 2024 Jan;24(1):1-4. doi: 10.1007/s40256-023-00624-2. Epub 2023 Dec 29.
  • Lamy A, Eikelboom J, Tong W, Yuan F, Bangdiwala SI, Bosch J, Connolly S, Lonn E, Dagenais GR, Branch KRH, Wang WJ, Bhatt DL, Probstfield J, Ertl G, Stork S, Steg PG, Aboyans V, Durand-Zaleski I, Ryden L, Yusuf S, COMPASS Investigators The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective. Am J Cardiovasc Drugs. 2024 Jan;24(1):117-127. doi: 10.1007/s40256-023-00620-6. Epub 2023 Dec 28.
  • Secemsky EA, Kirksey L, Quiroga E, King CM, Martinson M, Hasegawa JT, West NEJ, Wadhera RK Impact of Intensity of Vascular Care Preceding Major Amputation Among Patients With Chronic Limb-Threatening Ischemia. Circ Cardiovasc Interv. 2024 Jan;17(1):e012798. doi: 10.1161/CIRCINTERVENTIONS.122.012798. Epub 2023 Dec 28.
  • Abu-Much A, Grines CL, Batchelor WB, Maini AS, Zhang Y, Redfors B, Bellumkonda L, Bharadwaj AS, Moses JW, Truesdell AG, Li Y, Baron SJ, Lansky AJ, Basir MB, Cohen DJ, O’Neill WW Influence of left ventricular ejection fraction in patients undergoing contemporary pLVAD-supported high-risk PCI. Am Heart J. 2024 Mar;269:139-148. doi: 10.1016/j.ahj.2023.12.015. Epub 2023 Dec 26.
  • Cotter G, Deniau B, Davison B, Edwards C, Adamo M, Arrigo M, Barros M, Biegus J, Celutkiene J, Cerlinskaite-Bajore K, Chioncel O, Cohen-Solal A, Damasceno A, Diaz R, Filippatos G, Gayat E, Kimmoun A, Lam CSP, Metra M, Novosadova M, Pang PS, Pagnesi M, Ponikowski P, Saidu H, Sliwa K, Takagi K, Ter Maaten JM, Tomasoni D, Voors A, Mebazaa A Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial. JAMA Cardiol. 2024 Feb 1;9(2):114-124. doi: 10.1001/jamacardio.2023.4553.
  • Sposato LA, Albin CSW, Elkind MSV, Kamel H, Saver JL Patent Foramen Ovale Management for Secondary Stroke Prevention: State-of-the-Art Appraisal of Current Evidence. Stroke. 2024 Jan;55(1):236-247. doi: 10.1161/STROKEAHA.123.040546. Epub 2023 Nov 21.
  • Smith EE, Yaghi S, Sposato LA, Fisher M Atrial Fibrillation Detection and Load: Knowledge Gaps Related to Stroke Prevention. Stroke. 2024 Jan;55(1):205-213. doi: 10.1161/STROKEAHA.123.043665. Epub 2023 Nov 21.
  • Verma S, Pandey A, Pandey AK, Butler J, Lee JS, Teoh H, Mazer CD, Kosiborod MN, Cosentino F, Anker SD, Connelly KA, Bhatt DL Aldosterone and aldosterone synthase inhibitors in cardiorenal disease. Am J Physiol Heart Circ Physiol. 2024 Mar 1;326(3):H670-H688. doi: 10.1152/ajpheart.00419.2023. Epub 2023 Dec 22.
  • Patel SM, Morrow DA, Bellavia A, Berg DD, Bhatt DL, Jarolim P, Leiter LA, McGuire DK, Raz I, Steg PG, Wilding JPH, Sabatine MS, Wiviott SD, Braunwald E, Scirica BM, Bohula EA Natriuretic peptides, body mass index and heart failure risk: Pooled analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61. Eur J Heart Fail. 2024 Feb;26(2):260-269. doi: 10.1002/ejhf.3118. Epub 2024 Jan 4.
  • Savarese G, Lindberg F, Filippatos G, Butler J, Anker SD Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists. Diabetologia. 2024 Feb;67(2):246-262. doi: 10.1007/s00125-023-06031-1. Epub 2023 Dec 21.
  • Fuery MA, Leifer ES, Samsky MD, Sen S, O’Connor CM, Fiuzat M, Ezekowitz J, Pina I, Whellan D, Mark D, Felker GM, Desai NR, Januzzi JL, Ahmad T Prognostic Impact of Repeated NT-proBNP Measurements in Patients With Heart Failure With Reduced Ejection Fraction. JACC Heart Fail. 2024 Mar;12(3):479-487. doi: 10.1016/j.jchf.2023.11.007. Epub 2023 Dec 20.
  • Jacobs JA, Zheutlin AR, Derington CG, King JB, Pandey A, Bress AP Glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter 2 inhibitor use among adults with diabetes mellitus by cardiovascular-kidney disease risk: National Health and Nutrition Examination Surveys, 2015-2020. Am J Prev Cardiol. 2023 Nov 27;17:100624. doi: 10.1016/j.ajpc.2023.100624. eCollection 2024 Mar.
  • Monzo L, Girerd N, Ferreira JP, Lamiral Z, Anker SD, Cleland JGF, Kondo T, McMurray JJV, Lam CSP, Mehra MR, Veldhuisen DJV, Greenberg B, Zannad F High Risk of Stroke in Patients With Worsening Heart Failure, Reduced Ejection Fraction, Coronary Heart Disease and Sinus Rhythm: Risk Prediction Score Analysis From the COMMANDER-HF Trial. J Card Fail. 2024 Apr;30(4):618-623. doi: 10.1016/j.cardfail.2023.11.020. Epub 2023 Dec 18.
  • Gerstein HC, Mian R, Ramasundarahettige C, Branch KRH, Del Prato S, Lam CSP, Lopes RD, Pratley R, Rosenstock J, Sattar N Cardiovascular and renal outcomes with varying degrees of kidney disease in high-risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE-O trial. Diabetes Obes Metab. 2024 Apr;26(4):1216-1223. doi: 10.1111/dom.15417. Epub 2023 Dec 20.
  • Araki M, Park SJ, Dauerman HL, Uemura S, Kim JS, Di Mario C, Johnson TW, Guagliumi G, Kastrati A, Joner M, Holm NR, Alfonso F, Wijns W, Adriaenssens T, Nef H, Rioufol G, Amabile N, Souteyrand G, Meneveau N, Gerbaud E, Opolski MP, Gonzalo N, Tearney GJ, Bouma B, Aguirre AD, Mintz GS, Stone GW, Bourantas CV, Raber L, Gili S, Mizuno K, Kimura S, Shinke T, Hong MK, Jang Y, Cho JM, Yan BP, Porto I, Niccoli G, Montone RA, Thondapu V, Papafaklis MI, Michalis LK, Reynolds H, Saw J, Libby P, Weisz G, Iannaccone M, Gori T, Toutouzas K, Yonetsu T, Minami Y, Takano M, Raffel OC, Kurihara O, Soeda T, Sugiyama T, Kim HO, Lee T, Higuma T, Nakajima A, Yamamoto E, Bryniarski KL, Di Vito L, Vergallo R, Fracassi F, Russo M, Seegers LM, McNulty I, Park S, Feldman M, Escaned J, Prati F, Arbustini E, Pinto FJ, Waksman R, Garcia-Garcia HM, Maehara A, Ali Z, Finn AV, Virmani R, Kini AS, Daemen J, Kume T, Hibi K, Tanaka A, Akasaka T, Kubo T, Yasuda S, Croce K, Granada JF, Lerman A, Prasad A, Regar E, Saito Y, Sankardas MA, Subban V, Weissman NJ, Chen Y, Yu B, Nicholls SJ, Barlis P, West NEJ, Arbab-Zadeh A, Ye JC, Dijkstra J, Lee H, Narula J, Crea F, Nakamura S, Kakuta T, Fujimoto J, Fuster V, Jang IK Author Correction: Optical coherence tomography in coronary atherosclerosis assessment and intervention. Nat Rev Cardiol. 2024 May;21(5):348. doi: 10.1038/s41569-023-00982-z.
  • Bajwa TK, Laham RJ, Khabbaz K, Dauerman HL, Waksman R, Weiss E, Allaqaband S, Badr S, Caskey M, Byrne T, Applegate RJ, Kon ND, Li S, Kleiman NS, Reardon MJ, Chetcuti SJ, Deeb GM Five-Year Follow-Up from the CoreValve Expanded Use Transcatheter Aortic Valve-in-Surgical Aortic Valve Study. Am J Cardiol. 2024 Mar 1;214:1-7. doi: 10.1016/j.amjcard.2023.11.071. Epub 2023 Dec 17.
  • Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, Heerspink HJL, Hugo C, Nangaku M, Rotter RC, Silva A, Shah SV, Sun Z, Urbach D, de Zeeuw D, Rossing P, ASi in CKD group Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial. Lancet. 2024 Jan 27;403(10424):379-390. doi: 10.1016/S0140-6736(23)02408-X. Epub 2023 Dec 15.
  • Luyckx VA, Elmaghrabi A, Sahay M, Scholes-Robertson N, Sola L, Speare T, Tannor EK, Tuttle KR, Okpechi IG Equity and Quality of Global Chronic Kidney Disease Care: What Are We Waiting for? Am J Nephrol. 2024;55(3):298-315. doi: 10.1159/000535864. Epub 2023 Dec 18.
  • Goto S, Mikami O, Nagasawa Y, Watanabe A Bovine neutrophils stimulated with Streptococcus uberis induce neutrophil extracellular traps, and cause cytotoxicity and transcriptional upregulation of inflammatory cytokine genes in bovine mammary epithelial cells. J Vet Med Sci. 2024 Feb 8;86(2):141-149. doi: 10.1292/jvms.23-0302. Epub 2023 Dec 18.
  • Butt JH, Jering K, DE Boer RA, Claggett BL, Desai AS, Hernandez AF, Inzucchi SE, Jhund PS, Kober L, Kosiborod MN, Lam CSP, Martinez FA, Ponikowski P, Sabatine MS, Shah SJ, Vaduganathan M, Langkilde AM, Bengtsson O, Petersson M, Sjostrand M, Wilderang U, Solomon SD, McMurray JJV Heart Failure, Investigator-Reported Sleep Apnea and Dapagliflozin: A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVER. J Card Fail. 2024 Mar;30(3):436-448. doi: 10.1016/j.cardfail.2023.08.027. Epub 2023 Dec 15.
  • Monagle SR, Spear E, Abrahams T, Thakur U, Pol D, Tan S, Bellamy K, Hickman J, Jackson B, Chan J, Nicholls SJ, Nelson AJ Cardiologists’ knowledge and perceptions of the seasonal influenza immunisation. Int J Cardiol. 2024 Mar 15;399:131654. doi: 10.1016/j.ijcard.2023.131654. Epub 2023 Dec 15.
  • Bainey KR, Marquis-Gravel G, Belley-Cote E, Turgeon RD, Ackman ML, Babadagli HE, Bewick D, Boivin-Proulx LA, Cantor WJ, Fremes SE, Graham MM, Lordkipanidze M, Madan M, Mansour S, Mehta SR, Potter BJ, Shavadia J, So DF, Tanguay JF, Welsh RC, Yan AT, Bagai A, Bagur R, Bucci C, Elbarouni B, Geller C, Lavoie A, Lawler P, Liu S, Mancini J, Wong GC Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology 2023 Focused Update of the Guidelines for the Use of Antiplatelet Therapy. Can J Cardiol. 2024 Feb;40(2):160-181. doi: 10.1016/j.cjca.2023.10.013. Epub 2023 Oct 29.
  • Weinfurter JT, Bennett SN, Reynolds MR A SMART method for isolating monoclonal antibodies from individual rhesus macaque memory B cells. J Immunol Methods. 2024 Feb;525:113602. doi: 10.1016/j.jim.2023.113602. Epub 2023 Dec 14.
  • Li L, Lai J, Zhang J, Van Spall HGC, Thabane L, Lip GYH, Li G Remnant cholesterol and risk of premature mortality: an analysis from a nationwide prospective cohort study. Eur Heart J Qual Care Clin Outcomes. 2024 Sep 13;10(6):543-551. doi: 10.1093/ehjqcco/qcad071.
  • Mohebi R, Liu Y, Hansen MK, Yavin Y, Sattar N, Pollock CA, Butler J, Jardine M, Masson S, Heerspink HJL, Januzzi JL Jr Associations of Angiopoietin 2 and Vascular Endothelial Growth Factor-A Concentrations with Clinical End Points. Clin J Am Soc Nephrol. 2024 Apr 1;19(4):429-437. doi: 10.2215/CJN.0000000000000389. Epub 2023 Dec 14.
  • Dimond MG, Ibrahim NE, Fiuzat M, McMurray JJV, Lindenfeld J, Ahmad T, Bozkurt B, Bristow MR, Butler J, Carson PE, Felker GM, Jessup M, Murillo J, Kondo T, Solomon SD, Abraham WT, O’Connor CM, Psotka MA Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping. JACC Heart Fail. 2024 Mar;12(3):451-460. doi: 10.1016/j.jchf.2023.11.005. Epub 2023 Dec 13.
  • Segar MW, Khan MS, Patel KV, Butler J, Ravichandran AK, Walsh MN, Willett D, Fonarow GC, Drazner MH, Mentz RJ, Hall J, Farr MA, Hedayati SS, Yancy C, Allen LA, Tang WHW, Pandey A A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure. JACC Heart Fail. 2024 Mar;12(3):508-520. doi: 10.1016/j.jchf.2023.09.029. Epub 2023 Dec 13.
  • Yu MK, Vart P, Jongs N, Correa-Rotter R, Rossing P, McMurray JJV, Hou FF, Douthat W, Khullar D, Langkilde AM, Wheeler DC, Heerspink HJL, Chertow GM Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex. J Gen Intern Med. 2024 May;39(6):921-930. doi: 10.1007/s11606-023-08397-9. Epub 2023 Dec 14.
  • Ortega-Paz L, Mehran R, Angiolillo DJ North American perspective on the 2023 European Society of Cardiology guidelines for the management of acute coronary syndromes. Eur Heart J Acute Cardiovasc Care. 2024 Feb 9;13(1):165-172. doi: 10.1093/ehjacc/zuad153.
  • Pergola PE, Davidson M, Jensen C, Mohseni Zonoozi AA, Raj DS, Andreas Schytz P, Tuttle KR, Perkovic V Effect of Ziltivekimab on Determinants of Hemoglobin in Patients with CKD Stage 3-5: An Analysis of a Randomized Trial (RESCUE). J Am Soc Nephrol. 2024 Jan 1;35(1):74-84. doi: 10.1681/ASN.0000000000000245. Epub 2023 Dec 13.
  • Ludmir J, Suero-Abreu GA, Gonzalez de la Nuez A, Robles M, Wood MJ, Del Carmen MG, Wasfy JH Building a post-myocardial infarction discharge intervention program for Hispanic patients. Healthc (Amst). 2024 Mar;12(1):100730. doi: 10.1016/j.hjdsi.2023.100730. Epub 2023 Dec 12.
  • Gonzalez A, Lopez B, Ravassa S, San Jose G, Latasa I, Butler J, Diez J Myocardial Interstitial Fibrosis in Hypertensive Heart Disease: From Mechanisms to Clinical Management. Hypertension. 2024 Feb;81(2):218-228. doi: 10.1161/HYPERTENSIONAHA.123.21708. Epub 2023 Dec 12.
  • Mayne KJ, Staplin N, Keane DF, Wanner C, Brenner S, Cejka V, Stegbauer J, Judge PK, Preiss D, Emberson J, Trinca D, Dayanandan R, Lee R, Nolan J, Omata A, Green JB, Cherney DZI, Hooi LS, Pontremoli R, Tuttle KR, Lees JS, Mark PB, Davies SJ, Hauske SJ, Steubl D, Bruckmann M, Landray MJ, Baigent C, Haynes R, Herrington WG, EMPA-KIDNEY Collaborative Group Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD. J Am Soc Nephrol. 2024 Feb 1;35(2):202-215. doi: 10.1681/ASN.0000000000000271. Epub 2023 Dec 12.
  • Lau KHV, Prokaeva T, Zheng L, Doros G, Kaku MC, Spencer B, Berk J, Sanchorawala V Neurofilament light chain kinetics as a biomarker for polyneuropathy in V122I hereditary transthyretin amyloidosis. Amyloid. 2024 Jun;31(2):150-152. doi: 10.1080/13506129.2023.2289340. Epub 2023 Dec 11.
  • Mehra MR, Castagna F, Butler J The transformative potential of left ventricular assist devices in advanced heart failure: no more a therapeutic orphan. Eur Heart J. 2024 Feb 21;45(8):626-628. doi: 10.1093/eurheartj/ehad555.
  • Rao VS, Ivey-Miranda JB, Cox ZL, Moreno-Villagomez J, Maulion C, Bellumkonda L, Chang J, Field MP, Wiederin DR, Butler J, Collins SP, Turner JM, Wilson FP, Inzucchi SE, Wilcox CS, Ellison DH, Testani JM Empagliflozin in Heart Failure: Regional Nephron Sodium Handling Effects. J Am Soc Nephrol. 2024 Feb 1;35(2):189-201. doi: 10.1681/ASN.0000000000000269. Epub 2023 Dec 11.
  • Charu V, Liang JW, Chertow GM, Li J, Montez-Rath ME, Geldsetzer P, de Boer IH, Tian L, Tamura MK Heterogeneous Treatment Effects of Intensive Glycemic Control on Kidney Microvascular Outcomes and Mortality in ACCORD. J Am Soc Nephrol. 2024 Feb 1;35(2):216-228. doi: 10.1681/ASN.0000000000000272. Epub 2023 Dec 11.
  • Reynolds MR, Passman R, Swindle J, Mohammadi I, Wright B, Boyle K, Turakhia MP, Mittal S Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries. Am Heart J. 2024 Mar;269:25-34. doi: 10.1016/j.ahj.2023.12.002. Epub 2023 Dec 10.
  • Lala A, Hamo CE, Bozkurt B, Fiuzat M, Blumer V, Bukhoff D, Butler J, Costanzo MR, Felker GM, Filippatos G, Konstam MA, McMurray JJV, Mentz RJ, Metra M, Psotka MA, Solomon SD, Teerlink J, Abraham WT, O’Connor CM, HF-ARC (Heart Failure Collaboratory and Academic Research Consortium) Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies: HF-ARC Expert Panel Paper. JACC Heart Fail. 2024 Jan;12(1):1-15. doi: 10.1016/j.jchf.2023.09.030. Epub 2023 Dec 6.
  • Virk ZM, Leaf RK, Kuter DJ, Goodarzi K, Connell NT, Connors JM, Al-Samkari H Avatrombopag for adults with early versus chronic immune thrombocytopenia. Am J Hematol. 2024 Feb;99(2):155-162. doi: 10.1002/ajh.27080. Epub 2023 Dec 8.
  • Zhang RS, Alam U, Sharp ASP, Giri JS, Greco AA, Secemsky EA, Postelnicu R, Sethi SS, Alviar CL, Bangalore S Validating the Composite Pulmonary Embolism Shock Score for Predicting Normotensive Shock in Intermediate-Risk Pulmonary Embolism. Circ Cardiovasc Interv. 2024 Feb;17(2):e013399. doi: 10.1161/CIRCINTERVENTIONS.123.013399. Epub 2023 Dec 8.
  • Kato ET, Ono K, Lewis BS SGLT2 inhibitors in acute myocardial infarction: what can we learn from the DAPA-MI trial? More news from American Heart Association Scientific Meeting. Eur Heart J Cardiovasc Pharmacother. 2024 Feb 23;10(2):95-97. doi: 10.1093/ehjcvp/pvad099.
  • Grewal J, Tripathi N, Bortner B, Gregoski MJ, Cook D, Britt A, Hajj J, Rofael M, Sheidu M, Montovano MJ, Mehta M, Hajduczok AG, Rajapreyar IN, Brailovsky Y, Genuardi MV, Kanwar MK, Atluri P, Lander M, Shah P, Hsu S, Kilic A, Houston BA, Mehra MR, Sheikh FH, Tedford RJ A multicenter evaluation of the HeartMate 3 risk score. J Heart Lung Transplant. 2024 Apr;43(4):626-632. doi: 10.1016/j.healun.2023.11.018. Epub 2023 Dec 6.
  • Ray KK, Nicholls SJ, Li N, Louie MJ, Brennan D, Lincoff AM, Nissen SE, CLEAR OUTCOMES Committees and Investigators Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial. Lancet Diabetes Endocrinol. 2024 Jan;12(1):19-28. doi: 10.1016/S2213-8587(23)00316-9. Epub 2023 Dec 4.
  • Coisne A, Scotti A, Granada JF, Grayburn PA, Mack MJ, Cohen DJ, Kar S, Lim DS, Lindenfeld J, Bax J, Kotinkaduwa LN, Redfors B, Weissman NJ, Asch FM, Stone GW Regurgitant volume to LA volume ratio in patients with secondary MR: the COAPT trial. Eur Heart J Cardiovasc Imaging. 2024 Apr 30;25(5):616-625. doi: 10.1093/ehjci/jead328.
  • Pompei G, van de Hoef TP, den Ruijter HM, Kunadian V Reading 2023 ESC ACS guidelines between the lines: Gaps in evidence in women. Eur J Clin Invest. 2024 Feb;54(2):e14148. doi: 10.1111/eci.14148. Epub 2023 Dec 6.
  • Pareek M, Kristensen AMD, Vaduganathan M, Byrne C, Biering-Sorensen T, Hojbjerg Lassen MC, Johansen ND, Skaarup KG, Rosberg V, Pallisgaard JL, Mortensen MB, Maeng M, Polcwiartek CB, Frangeskos J, McCarthy CP, Bonde AN, Lee CJ, Fosbol EL, Kober L, Olsen NT, Gislason GH, Torp-Pedersen C, Bhatt DL, Kragholm KH Serial troponin-I and long-term outcomes in subjects with suspected acute coronary syndrome. Eur J Prev Cardiol. 2024 Mar 27;31(5):615-626. doi: 10.1093/eurjpc/zwad373.
  • Farber A, Siracuse JJ, Giles K, Jones DW, Laskowski IA, Powell RJ, Rosenfield K, Strong MB, White CJ, Doros G, Menard MT Investigator attitudes on equipoise and practice patterns in the BEST-CLI trial. J Vasc Surg. 2024 Apr;79(4):865-874. doi: 10.1016/j.jvs.2023.11.045. Epub 2023 Dec 5.
  • Ghosh AK, Venkatraman S, Nanna MG, Safford MM, Colantonio LD, Brown TM, Pinheiro LC, Peterson ED, Navar AM, Sterling MR, Soroka O, Nahid M, Banerjee S, Goyal P Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification. JAMA Cardiol. 2024 Jan 1;9(1):55-62. doi: 10.1001/jamacardio.2023.4520.
  • Khan SS, Yancy CW Race, Racism, and Risk-Implications of Social Determinants of Health in Cardiovascular Disease Prediction. JAMA Cardiol. 2024 Jan 1;9(1):63. doi: 10.1001/jamacardio.2023.4529.
  • Galli M, Niccoli G, De Maria G, Brugaletta S, Montone RA, Vergallo R, Benenati S, Magnani G, D’Amario D, Porto I, Burzotta F, Abbate A, Angiolillo DJ, Crea F Author Correction: Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction. Nat Rev Cardiol. 2024 May;21(5):347. doi: 10.1038/s41569-023-00974-z.
  • Olson K, Houston DK, Ross J, Wing RR, Simpson FR, Pandey A, Walkup MP, Yang M, Espeland MA Associations that Cardiorespiratory Fitness and Body Mass Index Loss Have with Deficit Accumulation Frailty. Med Sci Sports Exerc. 2024 Apr 1;56(4):717-724. doi: 10.1249/MSS.0000000000003353. Epub 2023 Nov 27.
  • Tan S, Spear E, Sane N, Chan J, Nelson AJ, Alamgeer M, Nerlekar N, Segelov E, Nicholls SJ Atherosclerotic Cardiovascular Events in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Retrospective Cohort Study. Heart Lung Circ. 2024 May;33(5):721-729. doi: 10.1016/j.hlc.2023.10.008. Epub 2023 Dec 1.
  • Ali MR, Lam CSP, Stromberg A, Hand SPP, Booth S, Zaccardi F, Squire I, McCann GP, Khunti K, Lawson CA Symptoms and signs in patients with heart failure: association with 3-month hospitalisation and mortality. Heart. 2024 Mar 22;110(8):578-585. doi: 10.1136/heartjnl-2023-323295.
  • Ferreira JP, Butler J, Anker SD, Januzzi JL, Panova-Noeva M, Reese-Petersen AL, Sattar N, Schueler E, Pocock SJ, Filippatos G, Packer M, Sumin M, Zannad F, EMPEROR Committees and Investigators Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials. Eur J Heart Fail. 2024 Feb;26(2):274-284. doi: 10.1002/ejhf.3101. Epub 2023 Dec 28.
  • Owen R, Buchan R, Frenneaux M, Jarman JWE, Baruah R, Lota AS, Halliday BP, Roberts AM, Izgi C, Van Spall HGC, Michos ED, McMurray JJV, Januzzi JL, Pennell DJ, Cook SA, Ware JS, Barton PJ, Gregson J, Prasad SK, Tayal U Sex Differences in the Clinical Presentation and Natural History of Dilated Cardiomyopathy. JACC Heart Fail. 2024 Feb;12(2):352-363. doi: 10.1016/j.jchf.2023.10.009. Epub 2023 Nov 29.
  • Lewis BS First-in-human trial of PCSK9 gene editing therapy for lowering cholesterol: a new frontier in cardiovascular pharmacotherapy? News from AHA. Eur Heart J Cardiovasc Pharmacother. 2024 Feb 23;10(2):87-88. doi: 10.1093/ehjcvp/pvad095.
  • Sposato LA, Lip GYH, Haeusler KG Atrial fibrillation first detected after stroke: is timing and detection intensity relevant for stroke risk? Eur Heart J. 2024 Feb 1;45(5):396-398. doi: 10.1093/eurheartj/ehad744.
  • D’Amario D, Galli M, Restivo A, Canonico F, Vergallo R, Migliaro S, Trani C, Burzotta F, Aurigemma C, Laborante R, Romagnoli E, Francese F, Ceccarelli I, Borovac JA, Angiolillo DJ, Tavazzi B, Leone AM, Crea F, Patti G, Porto I Ticagrelor enhances the cardioprotective effects of ischemic preconditioning in stable patients undergoing percutaneous coronary intervention: the TAPER-S randomized study. Eur Heart J Cardiovasc Pharmacother. 2024 May 4;10(3):190-200. doi: 10.1093/ehjcvp/pvad092.
  • Galli M, Niccoli G, De Maria G, Brugaletta S, Montone RA, Vergallo R, Benenati S, Magnani G, D’Amario D, Porto I, Burzotta F, Abbate A, Angiolillo DJ, Crea F Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction. Nat Rev Cardiol. 2024 May;21(5):283-298. doi: 10.1038/s41569-023-00953-4. Epub 2023 Nov 24.
  • Karady J, Mayrhofer T, Januzzi JL, Udelson JE, Fleg JL, Merkely B, Lu MT, Peacock WF, Nagurney JT, Koenig W, Ferencik M, Hoffmann U Agreement among high-sensitivity cardiac troponin assays and non-invasive testing, clinical outcomes, and quality-of-care outcomes based on the 2020 European Society of Cardiology Guidelines. Eur Heart J Acute Cardiovasc Care. 2024 Feb 9;13(1):15-23. doi: 10.1093/ehjacc/zuad146.
  • Gupta K, Sauer AJ, VAN Spall HGC Heart Failure Risk Under Covers: Sleeping With the Enemy. J Card Fail. 2024 Mar;30(3):449-451. doi: 10.1016/j.cardfail.2023.10.484. Epub 2023 Nov 23.
  • Litwin SE, Komtebedde J, Seidler T, Borlaug BA, Winkler S, Solomon SD, Eicher JC, Mazimba S, Khawash R, Sverdlov AL, Hummel SL, Bugger H, Boenner F, Hoendermis E, Cikes M, Demers C, Silva G, van Empel V, Starling RC, Penicka M, Cutlip DE, Leon MB, Kitzman DW, van Veldhuisen DJ, Shah SJ, REDUCE LAP-HF Investigators and Research Staff Obesity in heart failure with preserved ejection fraction: Insights from the REDUCE LAP-HF II trial. Eur J Heart Fail. 2024 Jan;26(1):177-189. doi: 10.1002/ejhf.3092. Epub 2023 Dec 7.
  • Perreault L, Bergman BC Out of stock: A brief clinical reference for rough equivalency of glucagon-like peptide-1 (GLP-1) +/- glucose-dependent insulinotropic polypeptide (GIP) receptor agonists for A1c and weight reduction in people with type 2 diabetes. J Diabetes. 2024 Jun;16(6):e13505. doi: 10.1111/1753-0407.13505. Epub 2023 Nov 20.
  • Butler J, Khan MS, Gasior T, Erickson TR, Vlajnic V, Kramer F, Blaustein RO, Goldsbury D, Roessig L, Lam CSP, Anstrom KJ, Armstrong PW, VITALITY Study Group Accelerometer vs. other activity measures in heart failure with preserved ejection fraction: the VITALITY-HFpEF trial. ESC Heart Fail. 2024 Feb;11(1):293-298. doi: 10.1002/ehf2.14572. Epub 2023 Nov 20.
  • Sunner SS, Welsh RC, Bainey KR Prevalence of Peripheral Arterial Disease in Patients With Coronary Artery Disease After Cardiac Catheterization: A Prospective Observational Study. Am J Cardiol. 2024 Jan 15;211:251-254. doi: 10.1016/j.amjcard.2023.11.028. Epub 2023 Nov 18.
  • Lyons ARM, Stevens CAT, Dharmayat KI, Vallejo-Vaz DAJ, Ray KK Overview of a collaborative global effort to address the burden of familial hypercholesterolaemia. Indian Heart J. 2024 Mar;76 Suppl 1(Suppl 1):S113-S116. doi: 10.1016/j.ihj.2023.11.005. Epub 2023 Nov 18.
  • Denfeld QE, Butler J The In- and Out-(Patient) Context of Omecamtiv Mecarbil Initiation: Assuaging Concerns and Opening Opportunities. J Card Fail. 2024 Jan;30(1):36-38. doi: 10.1016/j.cardfail.2023.11.013. Epub 2023 Nov 14.
  • Elsayed E, Farag YMK, Ravi KS, Chertow GM, Mc Causland FR Association of Bioimpedance Parameters with Increases in Blood Pressure during Hemodialysis. Clin J Am Soc Nephrol. 2024 Mar 1;19(3):329-335. doi: 10.2215/CJN.0000000000000356. Epub 2023 Nov 16.
  • Ferreira JP, Packer M, Butler J, Filippatos G, Pocock SJ, Januzzi JL, Sattar N, Maldonado SG, Panova-Noeva M, Sumin M, Masson S, Anker SD, Zannad F Growth differentiation factor-15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR program. Eur J Heart Fail. 2024 Jan;26(1):155-164. doi: 10.1002/ejhf.3078. Epub 2023 Nov 22.
  • Galli M, Laborante R, Occhipinti G, Zito A, Spadafora L, Biondi-Zoccai G, Nerla R, Castriota F, D’Amario D, Capodanno D, Jeong YH, Kimura T, Mehran R, Angiolillo DJ Impact of ethnicity on antiplatelet treatment regimens for bleeding reduction in acute coronary syndromes: a systematic review and pre-specified subgroup meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2024 Feb 23;10(2):158-169. doi: 10.1093/ehjcvp/pvad085.
  • Kosiborod MN, Verma S, Borlaug BA, Butler J, Davies MJ, Jon Jensen T, Rasmussen S, Erlang Marstrand P, Petrie MC, Shah SJ, Ito H, Schou M, Melenovsky V, Abhayaratna W, Kitzman DW, STEP-HFpEF Trial Committees and Investigators Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial. Circulation. 2024 Jan 16;149(3):204-216. doi: 10.1161/CIRCULATIONAHA.123.067505. Epub 2023 Nov 12.
  • Mc Causland FR, Claggett BL, Vaduganathan M, Desai A, Jhund P, Vardeny O, Fang JC, de Boer RA, Docherty KF, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Saraiva JFK, McGrath MM, Shah SJ, Verma S, Langkilde AM, Petersson M, McMurray JJV, Solomon SD Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial. JAMA Cardiol. 2024 Feb 1;9(2):144-152. doi: 10.1001/jamacardio.2023.4664.
  • Bays HE, Bloedon LT, Lin G, Powell HA, Louie MJ, Nicholls SJ, Lincoff AM, Nissen SE Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance. J Clin Lipidol. 2024 Jan-Feb;18(1):e59-e69. doi: 10.1016/j.jacl.2023.10.011. Epub 2023 Oct 31.
  • Patel KV, Segar MW, Klonoff DC, Khan MS, Usman MS, Lam CSP, Verma S, DeFilippis AP, Nasir K, Bakker SJL, Westenbrink BD, Dullaart RPF, Butler J, Vaduganathan M, Pandey A Optimal Screening for Predicting and Preventing the Risk of Heart Failure Among Adults With Diabetes Without Atherosclerotic Cardiovascular Disease: A Pooled Cohort Analysis. Circulation. 2024 Jan 23;149(4):293-304. doi: 10.1161/CIRCULATIONAHA.123.067530. Epub 2023 Nov 11.
  • Mahaffey KW, Gibson CM, Lopes RD Innovation in Event Adjudication-Human vs Machine. JAMA Cardiol. 2024 Feb 1;9(2):101-102. doi: 10.1001/jamacardio.2023.4900.
  • Joseph T, Foley M, Al-Lamee R Physiology and Intravascular Imaging Coregistration-Best of all Worlds? Cardiol Clin. 2024 Feb;42(1):77-87. doi: 10.1016/j.ccl.2023.07.006.
  • Gibson LE, Davis EF, Ponzini F, Wood MJ Longitudinal Strain Patterns in Stress (Takotsubo) Cardiomyopathy: Evidence of Global Myocardial Injury and Incomplete Recovery. Am J Cardiol. 2024 Jan 15;211:193-198. doi: 10.1016/j.amjcard.2023.10.091. Epub 2023 Nov 8.
  • Paraskevas KI, Mikhailidis DP, Ringleb PA, Brown MM, Dardik A, Poredos P, Gray WA, Nicolaides AN, Lal BK, Mansilha A, Antignani PL, de Borst GJ, Cambria RP, Loftus IM, Lavie CJ, Blinc A, Lyden SP, Matsumura JS, Jezovnik MK, Bacharach JM, Meschia JF, Clair DG, Zeebregts CJ, Lanza G, Capoccia L, Spinelli F, Liapis CD, Jawien A, Parikh SA, Svetlikov A, Menyhei G, Davies AH, Musialek P, Roubin G, Stilo F, Sultan S, Proczka RM, Faggioli G, Geroulakos G, Fernandes E Fernandes J, Ricco JB, Saba L, Secemsky EA, Pini R, Myrcha P, Rundek T, Martinelli O, Kakkos SK, Sachar R, Goudot G, Schlachetzki F, Lavenson GS Jr, Ricci S, Topakian R, Millon A, Di Lazzaro V, Silvestrini M, Chaturvedi S, Eckstein HH, Gloviczki P, White CJ An international, multispecialty, expert-based Delphi Consensus document on controversial issues in the management of patients with asymptomatic and symptomatic carotid stenosis. J Vasc Surg. 2024 Feb;79(2):420-435.e1. doi: 10.1016/j.jvs.2023.09.031. Epub 2023 Nov 7.
  • Sayed A, Awad K, ElRefaei M, Salah HM, Abushouk AI, Kapadia S, Butler J, Anker SD, Fudim M, Savarese G Is Reducing Heart Failure Hospitalization Associated With Reducing Mortality in Heart Failure Trials? JACC Heart Fail. 2024 Apr;12(4):776-778. doi: 10.1016/j.jchf.2023.09.024. Epub 2023 Nov 8.
  • Zile MR, Kahwash R, Sarkar S, Koehler J, Zielinski T, Mehra MR, Fonarow GC, Gulati S, Butler J A Novel Heart Failure Diagnostic Risk Score Using a Minimally Invasive Subcutaneous Insertable Cardiac Monitor. JACC Heart Fail. 2024 Jan;12(1):182-196. doi: 10.1016/j.jchf.2023.09.014. Epub 2023 Nov 8.
  • Mentias A, Keshvani N, Sumarsono A, Desai R, Khan MS, Menon V, Hsich E, Bress AP, Jacobs J, Vasan RS, Fonarow GC, Pandey A Patterns, Prognostic Implications, and Rural-Urban Disparities in Optimal GDMT Following HFrEF Diagnosis Among Medicare Beneficiaries. JACC Heart Fail. 2024 Jun;12(6):1044-1055. doi: 10.1016/j.jchf.2023.08.027. Epub 2023 Nov 8.
  • Wu MZ, Teng TK, Tsang CT, Chan YH, Lee CH, Ren QW, Huang JY, Cheang IF, Tse YK, Li XL, Xu X, Tse HF, Lam CSP, Yiu KH Risk of hyperkalaemia in patients with type 2 diabetes mellitus prescribed with SGLT2 versus DPP-4 inhibitors. Eur Heart J Cardiovasc Pharmacother. 2024 Jan 5;10(1):45-52. doi: 10.1093/ehjcvp/pvad081.
  • Paraskevas KI, Brown MM, Lal BK, Myrcha P, Lyden SP, Schneider PA, Poredos P, Mikhailidis DP, Secemsky EA, Musialek P, Mansilha A, Parikh SA, Silvestrini M, Lavie CJ, Dardik A, Blecha M, Liapis CD, Zeebregts CJ, Nederkoorn PJ, Poredos P, Gurevich V, Jawien A, Lanza G, Gray WA, Gupta A, Svetlikov AV, Fernandes E Fernandes J, Nicolaides AN, White CJ, Meschia JF, Cronenwett JL, Schermerhorn ML, AbuRahma AF Recent advances and controversial issues in the optimal management of asymptomatic carotid stenosis. J Vasc Surg. 2024 Mar;79(3):695-703. doi: 10.1016/j.jvs.2023.11.004. Epub 2023 Nov 7.
  • Natarajan P, Yancy CW Mendelian Randomization and Cardiovascular Disease-Enabling Expert Readership. JAMA Cardiol. 2024 Jan 1;9(1):89-90. doi: 10.1001/jamacardio.2023.4126.
  • Desson Z, Sharman JE, Searles A, Schutte AE, Delles C, Olsen MH, Ordunez P, Hure A, Morton R, Figtree G, Webster J, Jennings G, Redfern J, Nicholls SJ, McNamara M, Deeming S, Doyle K, Ramanathan S Improving the accuracy of blood pressure measuring devices in Australia: a modelled return on investment study. J Hum Hypertens. 2024 Feb;38(2):177-186. doi: 10.1038/s41371-023-00866-2. Epub 2023 Nov 8.
  • Schou M, Claggett B, Miao ZM, Fernandez A, Filippatos G, Granger C, Jering K, Maggioni AP, McCausland F, Villota JN, Rouleau JL, Mody FV, van der Meer P, Vinereanu D, McGrath M, Zhou Y, Mann DL, Solomon SD, Steg PG, Braunwald E, McMurray JJV, Pfeffer MA, Kober L Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial. Eur J Heart Fail. 2024 Jan;26(1):130-139. doi: 10.1002/ejhf.3079. Epub 2023 Nov 29.
  • Lewis BS, Hasegawa K Factor XIa inhibitors: collecting the clinical evidence. Eur Heart J Cardiovasc Pharmacother. 2024 Jan 5;10(1):5-6. doi: 10.1093/ehjcvp/pvad076.
  • Ridker PM, Lei L, Louie MJ, Haddad T, Nicholls SJ, Lincoff AM, Libby P, Nissen SE, CLEAR Outcomes Investigators Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance. Circulation. 2024 Jan 2;149(1):28-35. doi: 10.1161/CIRCULATIONAHA.123.066213. Epub 2023 Nov 6.
  • Nadarajah R, Ludman P, Laroche C, Appelman Y, Brugaletta S, Budaj A, Bueno H, Huber K, Kunadian V, Leonardi S, Lettino M, Milasinovic D, Gale CP Sex-specific presentation, care, and clinical events in individuals admitted with NSTEMI: the ACVC-EAPCI EORP NSTEMI registry of the European Society of Cardiology. Eur Heart J Acute Cardiovasc Care. 2024 Feb 9;13(1):36-45. doi: 10.1093/ehjacc/zuad134.
  • Alkasab M, Bainey KR Clopidogrel Monotherapy in Older Stable Ischemic Heart Disease Patients Receiving Percutaneous Coronary Intervention: A Paradigm Shift? Can J Cardiol. 2024 Jan;40(1):53-55. doi: 10.1016/j.cjca.2023.10.026. Epub 2023 Nov 3.
  • Kim JH, Sadri V, Chen H, Bhat S, Kohli K, Makkar R, Babaliaros VC, Sharma RP, Yoganathan AP Effect of Ascending Aortic Curvature on Flow in the Sinus and Neo-sinus Following TAVR: A Patient-Specific Study. Ann Biomed Eng. 2024 Feb;52(2):425-439. doi: 10.1007/s10439-023-03392-x. Epub 2023 Nov 3.
  • Goldhaber SZ, Bassand JP, Camm AJ, Virdone S, Pieper K, Cools F, Corbalan R, Gersh BJ, Goto S, Haas S, Misselwitz F, Parkhomenko A, Steffel J, Stepinska J, Turpie AGG, Verheugt FWA, Kayani G, Kakkar AK, GARFIELD-AF Investigators Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF Registry. Am J Med. 2024 Feb;137(2):128-136.e13. doi: 10.1016/j.amjmed.2023.10.027. Epub 2023 Oct 31.
  • Avdic T, Carlsen HK, Isaksson R, Gudbjornsdottir S, Mandalenakis Z, Franzen S, Sattar N, Beckman JA, McGuire DK, Eliasson B Risk Factors for and Risk of Peripheral Artery Disease in Swedish Individuals With Type 2 Diabetes: A Nationwide Register-Based Study. Diabetes Care. 2024 Jan 1;47(1):109-116. doi: 10.2337/dc23-1198.
  • Kumar A, Connelly K, Vora K, Bainey KR, Howarth A, Leipsic J, Betteridge-LeBlanc S, Prato FS, Leong-Poi H, Main A, Atoui R, Saw J, Larose E, Graham MM, Ruel M, Dharmakumar R The Canadian Cardiovascular Society Classification of Acute Atherothrombotic Myocardial Infarction Based on Stages of Tissue Injury Severity: An Expert Consensus Statement. Can J Cardiol. 2024 Jan;40(1):1-14. doi: 10.1016/j.cjca.2023.09.020. Epub 2023 Oct 28.
  • Tuttle KR, Rossing P, Hauske SJ, Cronin L, Hussain J, de Zeeuw D, Heerspink HJL Methods Article for a Study Protocol: Study Design and Baseline Characteristics for Aldosterone Synthase Inhibition in Chronic Kidney Disease. Am J Nephrol. 2024;55(2):262-272. doi: 10.1159/000534808. Epub 2023 Oct 30.
  • Harrington J, Felker GM, Lingvay I, Pagidipati NJ, Pandey A, McGuire DK Managing Obesity in Heart Failure: A Chance to Tip the Scales? JACC Heart Fail. 2024 Jan;12(1):28-34. doi: 10.1016/j.jchf.2023.09.005. Epub 2023 Oct 25.
  • Tan ESJ, Chan SP, Liew OW, Chong JPC, Gerard Leong KT, Daniel Yeo PS, Ong HY, Jaufeerally F, Sim D, Ling LH, Lam CSP, Richards AM Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure. JACC Heart Fail. 2024 Mar;12(3):461-474. doi: 10.1016/j.jchf.2023.09.011. Epub 2023 Oct 25.
  • Agarwal MA, AlMahmeed W, Butler J Cardiac Biomarkers in Dyspnea Hospitalizations – Still Breathing Not Predictively. Cardiology. 2024;149(1):51-54. doi: 10.1159/000534369. Epub 2023 Oct 26.
  • Galea R, Meneveau N, De Marco F, Aminian A, Heg D, Chalkou K, Grani C, Anselme F, Franzone A, Vranckx P, Fischer U, Bedogni F, Raber L, Valgimigli M One-Year Outcomes After Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: A Prespecified Analysis of the SWISS-APERO Randomized Clinical Trial. Circulation. 2024 Feb 6;149(6):484-486. doi: 10.1161/CIRCULATIONAHA.123.067599. Epub 2023 Oct 24.
  • Boulet J, Wanderley MRB Jr, Mehra MR Contemporary Left Ventricular Assist Device Therapy as a Bridge or Alternative to Transplantation. Transplantation. 2024 Jun 1;108(6):1333-1341. doi: 10.1097/TP.0000000000004834. Epub 2023 Oct 24.
  • Victoria-Castro AM, Corona-Villalobos CP, Xu AY, Onul I, Huynh C, Chen SW, Ugwuowo U, Sarkisova N, Dighe AL, Blank KN, Blanc VM, Rose MP, Himmelfarb J, de Boer IH, Tuttle KR, Roberts GV, Kidney Precision Medicine Project Participant Experience with Protocol Research Kidney Biopsies in the Kidney Precision Medicine Project. Clin J Am Soc Nephrol. 2024 Feb 1;19(2):202-212. doi: 10.2215/CJN.0000000000000334. Epub 2023 Oct 23.
  • Baron SJ, Ryan MP, Chikermane SG, Thompson C, Clancy S, Gunnarsson CL Long-term risk of reintervention after transcatheter aortic valve replacement. Am Heart J. 2024 Jan;267:44-51. doi: 10.1016/j.ahj.2023.10.002. Epub 2023 Oct 21.
  • Bainey KR, Wood DA, Bossard M, Campo G, Cantor WJ, Lavi S, Madan M, Mehran R, Pinilla-Echeverri N, Rao S, Sarma J, Sheth T, Stankovic G, Steg PG, Storey RF, Tanguay JF, Velianou JL, Welsh RC, Mani T, Cairns JA, Mehta SR, COMPLETE trial investigators Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease (COMPLETE-AGE). Am Heart J. 2024 Jan;267:70-80. doi: 10.1016/j.ahj.2023.10.004. Epub 2023 Oct 21.
  • Giordano S, Franchi F, Rollini F, Al Saleh T, Uzunoglu E, Costa F, Angiolillo DJ, Ortega-Paz L Effect of lipid-lowering therapy on platelet reactivity in patients treated with and without antiplatelet therapy. Minerva Cardiol Angiol. 2024 Oct;72(5):489-505. doi: 10.23736/S2724-5683.23.06411-6. Epub 2023 Oct 23.
  • Singh M, Teodorescu DL, Rowlett M, Wang SX, Balcells M, Park C, Bernardo B, McGarel S, Reeves C, Mehra MR, Zhao X, Yuk H, Roche ET A Tunable Soft Silicone Bioadhesive for Secure Anchoring of Diverse Medical Devices to Wet Biological Tissue. Adv Mater. 2024 Jan;36(3):e2307288. doi: 10.1002/adma.202307288. Epub 2023 Dec 3.
  • Asch FM, Sharma RP, Cubeddu RJ, Genereux P, Dobbles M, Verhoef K, Kwon M, Rodriguez E, Thomas JD, Gillam LD Response to Letter to the Editor: Can We Use an Algorithm as an “Ariadne’s Thread” to Escape the Maze of Mitral Regurgitation Phenotype? J Am Soc Echocardiogr. 2024 Mar;37(3):373-374. doi: 10.1016/j.echo.2023.10.005. Epub 2023 Oct 14.
  • Sposato LA, Field TS, Schnabel RB, Wachter R, Andrade JG, Hill MD Towards a new classification of atrial fibrillation detected after a stroke or a transient ischaemic attack. Lancet Neurol. 2024 Jan;23(1):110-122. doi: 10.1016/S1474-4422(23)00326-5. Epub 2023 Oct 12.
  • Goto S, Goto S Dual Antiplatelet Therapy or Dual Pathway Inhibition. Thromb Haemost. 2024 Mar;124(3):274-276. doi: 10.1055/a-2191-7627. Epub 2023 Oct 13.
  • Torii S, Chiang CE, Hong SJ, Goto S, Huang WC, Chan MY, Kajiya T, Goto S Asian perspective on the recently published practice guideline for acute coronary syndrome by ESC. Eur Heart J Acute Cardiovasc Care. 2024 Feb 9;13(1):162-164. doi: 10.1093/ehjacc/zuad126.
  • Rubino F, Pompei G, Brugaletta S, Collet C, Kunadian V The role of physiology in the contemporary management of coronary artery disease. Heart. 2024 Feb 23;110(6):391-398. doi: 10.1136/heartjnl-2023-322641.
  • Delgado C, Powe NR, Chertow GM, Grimes B, Johansen KL Muscle Mass and Serum Creatinine Concentration by Race and Ethnicity among Hemodialysis Patients. J Am Soc Nephrol. 2024 Jan 1;35(1):66-73. doi: 10.1681/ASN.0000000000000240. Epub 2023 Oct 12.
  • Tomasoni D, Davison B, Adamo M, Pagnesi M, Mebazaa A, Edwards C, Arrigo M, Barros M, Biegus J, Celutkiene J, Cerlinskaite-Bajore K, Chioncel O, Cohen-Solal A, Damasceno A, Diaz R, Filippatos G, Gayat E, Kimmoun A, Lam CSP, Novosadova M, Pang PS, Ponikowski P, Saidu H, Sliwa K, Takagi K, ter Maaten JM, Voors A, Cotter G, Metra M Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial. J Card Fail. 2024 Apr;30(4):525-537. doi: 10.1016/j.cardfail.2023.09.002. Epub 2023 Oct 9.
  • Guerra PG, Simpson CS, Van Spall HGC, Asgar AW, Billia P, Cadrin-Tourigny J, Chakrabarti S, Cheung CC, Dore A, Fordyce CB, Gouda P, Hassan A, Krahn A, Luc JGY, Mak S, McMurtry S, Norris C, Philippon F, Sapp J, Sheldon R, Silversides C, Steinberg C, Wood DA, Co-chairs:, Writing Panel: Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive. Can J Cardiol. 2024 Apr;40(4):500-523. doi: 10.1016/j.cjca.2023.09.033. Epub 2023 Oct 10.
  • Omar AMS, Murphy S, Felker GM, Pina I, Butler J, Liu Y, Mohebi R, Bhatia K, Ward JH, Williamson KM, Solomon SD, Januzzi JL, Contreras J Isovolumic Contraction Velocity in Heart Failure With Reduced Ejection Fraction and Effect of Sacubitril/Valsartan: the PROVE-HF Study. J Card Fail. 2024 May;30(5):653-665. doi: 10.1016/j.cardfail.2023.10.001. Epub 2023 Oct 8.
  • Dirjayanto VJ, Alkhalil M, Dodson J, Mills G, Pompei G, Rubino F, Kunadian V Cognitive impairment and outcomes in older adults with non-ST-elevation acute coronary syndrome. Heart. 2024 Feb 23;110(6):416-424. doi: 10.1136/heartjnl-2023-323224.
  • Goldhaber SZ Obesity and Pulmonary Embolism: Can We Dismantle the “Obesity Paradox”. Thromb Haemost. 2024 Jan;124(1):58-60. doi: 10.1055/a-2187-0966. Epub 2023 Oct 6.
  • Vidal-Cales P, Ortega-Paz L, Brugaletta S, Garcia J, Rodes-Cabau J, Angiolillo DJ, Regueiro A, Freixa X, Abdul-Jawad O, Cepas-Guillen PL, Andrea R, de Diego O, Tizon-Marcos H, Tomas-Querol C, Gomez-Hospital JA, Carrillo X, Cardenas M, Rojas S, Munoz-Camacho JF, Garcia-Picart J, Lidon RM, Sabate M Long-term survival after cardiac arrest in patients undergoing emergent coronary angiography. Cardiovasc Revasc Med. 2024 Mar;60:18-26. doi: 10.1016/j.carrev.2023.09.008. Epub 2023 Sep 28.
  • Peikert A, Bart BA, Vaduganathan M, Claggett BL, Kulac IJ, Kosiborod MN, Desai AS, Jhund PS, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Hernandez AF, Shah SJ, Petersson M, Langkilde AM, McMurray JJV, Solomon SD, Vardeny O Contemporary Use and Implications of Beta-Blockers in Patients With HFmrEF or HFpEF: The DELIVER Trial. JACC Heart Fail. 2024 Apr;12(4):631-644. doi: 10.1016/j.jchf.2023.09.007. Epub 2023 Sep 27.
  • Nicholls SJ, Bhatt DL, Buse JB, Prato SD, Kahn SE, Lincoff AM, McGuire DK, Nauck MA, Nissen SE, Sattar N, Zinman B, Zoungas S, Basile J, Bartee A, Miller D, Nishiyama H, Pavo I, Weerakkody G, Wiese RJ, D’Alessio D, SURPASS-CVOT investigators Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics. Am Heart J. 2024 Jan;267:1-11. doi: 10.1016/j.ahj.2023.09.007. Epub 2023 Sep 25.
  • Bhatt AS, Fonarow GC, Greene SJ, Holmes DN, Alhanti B, Devore AD, Butler J, Heidenreich PA, Huang JC, Kittleson MM, Linganathan K, Joyntmaddox KE, McDermott JJ, Owens AT, Peterson PN, Solomon SD, Vardeny O, Yancy CW, Vaduganathan M Medical Therapy Before, During and After Hospitalization in Medicare Beneficiaries With Heart Failure and Diabetes: Get With The Guidelines – Heart Failure Registry. J Card Fail. 2024 Feb;30(2):319-328. doi: 10.1016/j.cardfail.2023.09.005. Epub 2023 Sep 25.
  • Guo ZN, Qu Y, Abuduxukuer R, Zhang P, Wang L, Liu Y, Teng RH, Gao JH, Jin F, Wang HF, Cao Y, Xue YQ, Zhao JF, Selim MH, Nguyen TN, Yang Y Safety and efficacy of remote ischemic conditioning for spontaneous intracerebral hemorrhage (SERIC-ICH): A multicenter, randomized, parallel-controlled clinical trial study design and protocol. Eur Stroke J. 2024 Mar;9(1):259-264. doi: 10.1177/23969873231201712. Epub 2023 Sep 26.
  • Olszowka M, Hagstrom E, Hadziosmanovic N, Ljunggren M, Denchev S, Manolis A, Wallentin L, White HD, Stewart RAH, Held C, STABILITY Investigators Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndrome. Int J Cardiol. 2024 Jan 1;394:131395. doi: 10.1016/j.ijcard.2023.131395. Epub 2023 Sep 23.
  • Iba T, Connors JM, Levy JH What Role Does Microthrombosis Play in Long COVID? Semin Thromb Hemost. 2024 Jun;50(4):527-536. doi: 10.1055/s-0043-1774795. Epub 2023 Sep 25.
  • Secemsky EA, Giri J, Brodmann M, Goueffic Y, Fu W, Greenberg-Worisek AJ, Jaff MR, Kirksey L, Kohi MP Implementing methods in the ELEGANCE registry to increase diversity in clinical research. J Vasc Surg. 2024 Jan;79(1):136-145.e3. doi: 10.1016/j.jvs.2023.08.131. Epub 2023 Sep 22.
  • Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan GA, Dweck MR, Galbraith M, Gilard M, Hinterbuchner L, Jankowska EA, Juni P, Kimura T, Kunadian V, Leosdottir M, Lorusso R, Pedretti RFE, Rigopoulos AG, Rubini Gimenez M, Thiele H, Vranckx P, Wassmann S, Wenger NK, Ibanez B, ESC Scientific Document Group 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J Acute Cardiovasc Care. 2024 Feb 9;13(1):55-161. doi: 10.1093/ehjacc/zuad107.
  • Afolabi H, Zhang BM, O’Shaughnessy M, Chertow GM, Lafayette R, Charu V The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease. Am J Kidney Dis. 2024 Jan;83(1):79-89. doi: 10.1053/j.ajkd.2023.06.005. Epub 2023 Sep 20.
  • Ibrahim NE, Januzzi JL Jr NT-proBNP Concentrations in the Community: Elevation, Deficiency, and Everything in Between. JACC Heart Fail. 2024 Jan;12(1):64-66. doi: 10.1016/j.jchf.2023.08.014. Epub 2023 Sep 20.
  • Dhakal K, Rosenthal ES, Kulpanowski AM, Dodelson JA, Wang Z, Cudemus-Deseda G, Villien M, Edlow BL, Presciutti AM, Januzzi JL, Ning M, Taylor Kimberly W, Amorim E, Brandon Westover M, Copen WA, Schaefer PW, Giacino JT, Greer DM, Wu O Increased task-relevant fMRI responsiveness in comatose cardiac arrest patients is associated with improved neurologic outcomes. J Cereb Blood Flow Metab. 2024 Jan;44(1):50-65. doi: 10.1177/0271678X231197392. Epub 2023 Sep 20.
  • Jonas M, Genereux P, Maehara A, Ben-Yehuda O, Stone GW, Chernin G Control of diabetes mellitus and the risk of neointimal hyperplasia after percutaneous coronary intervention: Post-hoc analysis from the BLADE-PCI trial. Atherosclerosis. 2024 Jul;394:117264. doi: 10.1016/j.atherosclerosis.2023.117264. Epub 2023 Sep 3.
  • Zhuang Y, Ortega-Ribera M, Thevkar Nagesh P, Joshi R, Huang H, Wang Y, Zivny A, Mehta J, Parikh SM, Szabo G Bile acid-induced IRF3 phosphorylation mediates cell death, inflammatory responses, and fibrosis in cholestasis-induced liver and kidney injury via regulation of ZBP1. Hepatology. 2024 Apr 1;79(4):752-767. doi: 10.1097/HEP.0000000000000611. Epub 2023 Sep 19.
  • Briggs B, Garcia-Garcia G, Ibarra-Hernandez M, Alcantar-Vallin L, Walker G, Yu E, ElBadry A, Fisher B, Williamson D, Chertow GM Performance characteristics of a prototype dialysate turbidity monitoring system to detect peritonitis in patients receiving peritoneal dialysis. Perit Dial Int. 2024 Nov;44(6):419-425. doi: 10.1177/08968608231195532. Epub 2023 Sep 18.
  • Dhingra NK, Verma S, Butler J, Anker SD, Ferreira JP, Filippatos G, Januzzi JL, Lam CSP, Sattar N, Zaremba-Pechmann L, Bohm M, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M, EMPEROR-Reduced Trial Committees and Investigators Efficacy and Safety of Empagliflozin According to Background Diuretic Use in HFrEF: Post-Hoc Analysis of EMPEROR-Reduced. JACC Heart Fail. 2024 Jan;12(1):35-46. doi: 10.1016/j.jchf.2023.06.036. Epub 2023 Sep 13.
  • Jiang GY, Lee C, Kearing SA, Wadhera RK, Gavin MC, Wasfy JH, Zeitler EP IV Diuresis in Alternative Treatment Settings for the Management of Heart Failure: Implications for Mortality, Hospitalizations and Cost. J Card Fail. 2024 Jan;30(1):4-11. doi: 10.1016/j.cardfail.2023.07.017. Epub 2023 Sep 14.
  • Stedman MR, Kurella Tamura M, Chertow GM Using Relative Survival to Estimate the Burden of Kidney Failure. Am J Kidney Dis. 2024 Jan;83(1):28-36.e1. doi: 10.1053/j.ajkd.2023.05.015. Epub 2023 Sep 9.
  • Tsukagoshi J, Shimoda T, Yokoyama Y, Secemsky EA, Shirasu T, Nakama T, Jujo K, Wiley J, Takagi H, Aikawa T, Kuno T The mid-term effect of intravascular ultrasound on endovascular interventions for lower extremity peripheral arterial disease: A systematic review and meta-analysis. J Vasc Surg. 2024 Apr;79(4):963-972.e11. doi: 10.1016/j.jvs.2023.08.128. Epub 2023 Sep 9.
  • Bond R, Gibson CM, Talasaz AH, Van Tassell BW Analysis of Gender and Race in Pharmacy Faculty and Administrators. Am J Pharm Educ. 2024 Jan;88(1):100585. doi: 10.1016/j.ajpe.2023.100585. Epub 2023 Sep 9.
  • Asch FM, Sharma RP, Cubeddu RJ, Genereux P, Dobbles M, Verhoef K, Kwon M, Rodriguez E, Thomas JD, Gillam LD Gaps in Contemporary Echocardiographic Reporting Quality for Mechanisms of Mitral Regurgitation: A Call to Action. J Am Soc Echocardiogr. 2024 Jan;37(1):108-110. doi: 10.1016/j.echo.2023.08.021. Epub 2023 Sep 4.
  • Ortega-Paz L, Mehran R, Angiolillo DJ Nonadherence to dual antiplatelet therapy: old problems without new solutions. Rev Esp Cardiol (Engl Ed). 2024 Feb;77(2):125-128. doi: 10.1016/j.rec.2023.08.003. Epub 2023 Sep 1.
  • Wang CS, Glenn DA, Helmuth M, Smith AR, Bomback AS, Canetta PA, Coppock GM, Khalid M, Tuttle KR, Bou-Matar R, Greenbaum LA, Robinson BM, Holzman LB, Smoyer WE, Rheault MN, Gipson D, Mariani LH, Cure Glomerulonephropathy (CureGN) Study Consortium Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study. Am J Kidney Dis. 2024 Jan;83(1):37-46. doi: 10.1053/j.ajkd.2023.07.008. Epub 2023 Aug 31.
  • Zafeiropoulos S, Farmakis IT, Milioglou I, Doundoulakis I, Gorodeski EZ, Konstantinides SV, Cooper L, Zanos S, Stavrakis S, Giamouzis G, Butler J, Giannakoulas G Pharmacological Treatments in Heart Failure With Mildly Reduced and Preserved Ejection Fraction: Systematic Review and Network Meta-Analysis. JACC Heart Fail. 2024 Apr;12(4):616-627. doi: 10.1016/j.jchf.2023.07.014. Epub 2023 Aug 30.
  • Gautier A, Picard F, Ducrocq G, Elbez Y, Fox KM, Ferrari R, Ford I, Tardif JC, Tendera M, Steg PG, CLARIFY investigators New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry. Eur Heart J. 2024 Feb 1;45(5):366-375. doi: 10.1093/eurheartj/ehad556.
  • Szarek M, Reijnders E, Jukema JW, Bhatt DL, Bittner VA, Diaz R, Fazio S, Garon G, Goodman SG, Harrington RA, Ruhaak LR, Schwertfeger M, Tsimikas S, White HD, Steg PG, Cobbaert C, Schwartz GG, ODYSSEY OUTCOMES Investigators Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests. Circulation. 2024 Jan 16;149(3):192-203. doi: 10.1161/CIRCULATIONAHA.123.066398. Epub 2023 Aug 26.
  • Foley M, Rajkumar CA, Ahmed-Jushuf F, Nour D, Fung CH, Seligman H, Pathimagaraj RH, Petraco R, Sen S, Nijjer S, Howard JP, Ahmad Y, Allahwala U, Bhindi R, Chamie D, Doi S, Kuwata S, Kaihara T, Koga M, Ishibashi Y, Higuma T, Tanabe Y, Nakayama M, Kawase Y, Watanabe A, Funayama N, Horinaka R, Hijikata N, Takahashi T, Matsuo H, Hansen PS, Manica A, Weaver J, Alzuhairi K, Yong TH, Warisawa T, Francis DP, Shun-Shin MJ, Al-Lamee RK The ability of contemporary cardiologists to judge the ischemic impact of a coronary lesion visually. Cardiovasc Revasc Med. 2024 Feb;59:60-66. doi: 10.1016/j.carrev.2023.08.003. Epub 2023 Aug 12.
  • Sofi F, Dinu M, Reboldi G, Lotti S, Genovese L, Tritto I, Gensini G, Gibson CM, Ambrosio G Worldwide impact of COVID-19 on hospital admissions for non-ST-elevation acute coronary syndromes (NSTACS): a systematic review with meta-analysis of 553 038 cases. Eur Heart J Qual Care Clin Outcomes. 2024 May 22;10(3):265-283. doi: 10.1093/ehjqcco/qcad048.
  • Pollock C, Sanchez JJG, Carrero JJ, Kumar S, Pecoits-Filho R, Lam CSP, Chen H, Kanda E, Lainscak M, Wheeler DC Glucose-lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classification. Diabet Med. 2024 Feb;41(2):e15200. doi: 10.1111/dme.15200. Epub 2023 Aug 26.
  • Khan MS, Fatima K, Butler J Creation of next generation of diverse cardiovascular physician-scientists from developing countries: insights from Research Council of Pakistan. Eur Heart J. 2024 Jan 27;45(4):243-246. doi: 10.1093/eurheartj/ehad493.
  • Segar MW, Keshvani N, Singh S, Patel L, Parsa S, Betts T, Reeves GR, Mentz RJ, Forman DE, Razavi M, Saeed M, Kitzman DW, Pandey A Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HF. JACC Heart Fail. 2024 Apr;12(4):757-767. doi: 10.1016/j.jchf.2023.06.009. Epub 2023 Aug 9.
  • Shetty NS, Parcha V, Patel N, Pampana A, Kalra R, Pandey A, Li P, Morris AA, Prabhu SD, Arora G, Arora P Incident Heart Failure Risk Reclassification With Race-Independent Estimated Glomerular Filtration Rate: A National Heart, Lung, and Blood Institute Pooled Cohorts Analysis. J Card Fail. 2024 Jan;30(1):14-22. doi: 10.1016/j.cardfail.2023.07.009. Epub 2023 Aug 4.
  • Vart P, Butt JH, Jongs N, Schechter M, Chertow GM, Wheeler DC, Pecoits-Filho R, Langkilde AM, Correa-Rotter R, Rossing P, McMurray JJV, Heerspink HJL Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of Frailty. J Gerontol A Biol Sci Med Sci. 2024 Feb 1;79(2):glad181. doi: 10.1093/gerona/glad181.
  • Ebenbichler C, Drexel H, Hanusch U, Toplak H, Dhalwani NN, Bridges I, Hoelzl R, Hemetsberger M, Ray KK Evolocumab effectiveness in the real-world setting: Austrian data from the pan-European observational HEYMANS study. Wien Klin Wochenschr. 2024 Feb;136(3-4):77-86. doi: 10.1007/s00508-023-02245-w. Epub 2023 Jul 31.
  • Verardi FM, Bujak K, Tolomeo P, Gomez-Lara J, Jimenez-Diaz V, Jimenez M, Jimenez-Quevedo P, Diletti R, Bordes P, Campo G, Silvestro A, Maristany J, Flores X, de Miguel-Castro A, Iniguez A, Ielasi A, Tespili M, Lenzen M, Gonzalo N, Tebaldi M, Biscaglia S, Vidal-Cales P, Ortega-Paz L, Romaguera R, Gomez-Hospital JA, Serruys PW, Sabate M, Brugaletta S Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trial. Rev Esp Cardiol (Engl Ed). 2024 Mar;77(3):215-225. doi: 10.1016/j.rec.2023.07.001. Epub 2023 Jul 26.
  • Trimarchi S, Mandigers TJ, Bissacco D, Nienaber C, Isselbacher EM, Evangelista A, Suzuki T, Bossone E, Pape LA, Januzzi JL, Harris KM, O’Gara PT, Gilon D, Hutchison S, Patel HJ, Woznicki EM, Montgomery D, Kline-Rogers E, Eagle KA Twenty-five years of observations from the International Registry of Acute Aortic Dissection (IRAD) and its impact on the cardiovascular scientific community. J Thorac Cardiovasc Surg. 2024 Oct;168(4):977-989.e24. doi: 10.1016/j.jtcvs.2023.06.021. Epub 2023 Jul 13.
  • Sverdlov AL, Koczwara B, Cehic DA, Clark RA, Hunt L, Nicholls SJ, Thomas L, Thornton-Benko E, Kritharides L, Clinical Oncology Society of Australia (COSA)-Cardiac Society of Australia and, New Zealand (CSANZ) Cardio-Oncology Working Group When Cancer and Cardiovascular Disease Intersect: The Challenge and the Opportunity of Cardio-Oncology. Heart Lung Circ. 2024 May;33(5):558-563. doi: 10.1016/j.hlc.2023.04.301. Epub 2023 Jun 14.
  • Moledina SM, Matetic A, Weight N, Rashid M, Sun L, Fischman DL, Van Spall HGC, Mamas MA Trends in ST-elevation myocardial infarction hospitalization among young adults: a binational analysis. Eur Heart J Qual Care Clin Outcomes. 2024 May 22;10(3):216-227. doi: 10.1093/ehjqcco/qcad035.
  • Weight N, Moledina S, Sun L, Kragholm K, Freeman P, Diaz-Arocutipa C, Dafaalla M, Gulati M, Mamas MA Ethnic Disparities in ST-Segment Elevation Myocardial Infarction Outcomes and Processes of Care in Patients With and Without Standard Modifiable Cardiovascular Risk Factors: A Nationwide Cohort Study. Angiology. 2024 Sep;75(8):742-753. doi: 10.1177/00033197231182555. Epub 2023 Jun 12.
  • Sposato LA, Martins S, Scheitz JF, Aspberg S, Gurol ME, Abdalla M, Arauz A, Cano-Nigenda V, Fiorilli P, Israel C, Kusano K, Mansour O, Messe SR, Pille A, Secchi T, Polanczyk CA, Biolo A, Ramadan I, Sallam A, Schabitz W, Toyoda K, Valencia S, Wang S, Xiong Y, Zaki A, Saposnik G, Fisher M, Bahit MC World Stroke Organization Brain & hEart globAl iniTiative Program. Cerebrovasc Dis. 2024;53(1):115-124. doi: 10.1159/000530471. Epub 2023 Jun 5.
  • Ortega-Paz L, Franchi F, Rollini F, Galli M, Been L, Ghanem G, Shalhoub A, Ossi T, Rivas A, Zhou X, Pineda AM, Suryadevara S, Soffer D, Zenni MM, Jennings LK, Angiolillo DJ Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study. Thromb Haemost. 2024 Mar;124(3):263-273. doi: 10.1055/a-2098-6639. Epub 2023 May 24.
  • Lam CSP, Lund LH, Shah SJ, Voors AA, Erlinge D, Saraste A, Pirazzi C, Grove EL, Barasa A, Schou M, Aziz A, Svedlund S, Wijngaarden JV, Lindstedt EL, Gustavsson A, Nelander K, Garkaviy P, Gan LM, Gabrielsen A Myeloperoxidase Inhibition in Heart Failure With Preserved or Mildly Reduced Ejection Fraction: SATELLITE Trial Results. J Card Fail. 2024 Jan;30(1):104-110. doi: 10.1016/j.cardfail.2023.04.003. Epub 2023 Apr 16.
  • Wert L, Stewart GC, Mehra MR, Milwidsky A, Jorde UP, Goldstein DJ, Selzman CH, Stehlik J, Alshamdin FD, Khaliel FH, Gustafsson F, Boschi S, Loforte A, Ajello S, Scandroglio AM, Tucanova Z, Netuka I, Schloglhofer T, Zimpfer D, Zijderhand CF, Caliskan K, Dogan G, Schmitto JD, Maier S, Schibilsky D, Jawad K, Saeed D, Faerber G, Morshuis M, Hanuna M, Muller CS, Mulzer J, Kempfert J, Falk V, Potapov EV A multicenter evaluation of external outflow graft obstruction with a fully magnetically levitated left ventricular assist device. J Thorac Cardiovasc Surg. 2024 Apr;167(4):1322-1330.e6. doi: 10.1016/j.jtcvs.2022.09.051. Epub 2022 Oct 3.
  • Koenig W, Conde LG, Landmesser U, Leiter LA, Ray KK, Schwartz GG, Wright RS, Han J, Raal FJ Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials. Cardiovasc Drugs Ther. 2024 Jun;38(3):493-503. doi: 10.1007/s10557-022-07413-0. Epub 2022 Dec 23.
  • Christiansen SD, Liu J, Bullrich MB, Sharma M, Boulton M, Pandey SK, Sposato LA, Drangova M Deep learning prediction of stroke thrombus red blood cell content from multiparametric MRI. Interv Neuroradiol. 2024 Aug;30(4):541-549. doi: 10.1177/15910199221140962. Epub 2022 Nov 28.
  • Triska J, Maitra N, Deshotels MR, Haddadin F, Angiolillo DJ, Vilahur G, Jneid H, Atar D, Birnbaum Y A Comprehensive Review of the Pleiotropic Effects of Ticagrelor. Cardiovasc Drugs Ther. 2024 Aug;38(4):775-797. doi: 10.1007/s10557-022-07373-5. Epub 2022 Aug 24.
  • Khawaja M, Thakker J, Kherallah R, Kitakaze M, Jneid H, Angiolillo DJ, Birnbaum Y Antacid Therapy in Coronary Artery Disease and Heart Failure: Proton Pump Inhibitors vs. H(2) Receptor Blockers. Cardiovasc Drugs Ther. 2024 Feb;38(1):181-189. doi: 10.1007/s10557-022-07358-4. Epub 2022 Jun 18.
  • van de Borne P, Peeters A, Janssens L, Leone A, Lemmens R, Verhaegen A, De Meulemeester M, Balthazar Y, Heijmans S, Calozet Y, Paquot N, Carlier S, Hemelsoet D, Bray S, Ray KK Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study. Acta Cardiol. 2024 Feb;79(1):20-29. doi: 10.1080/00015385.2022.2030568. Epub 2022 Apr 20.

NEWS

ABOUT US

PUBLICATIONS

CAREERS

CONTACT US

SERVICES

CENTERS OF EXCELLENCE

CLINICAL RESEARCH

Copyright - Baim Institute ®